cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
KIRP	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.67	6.45	5.38E-10	Crohn's disease	
KIRP	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.42	5.6	5.46E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs10002541	chr4:56395011	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.71	3.94E-6	Personality dimensions	
KIRP	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.28	5.09	6.94E-7	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs10005989	chr4:56405206	SRD5A3	chr4:56212409-56237866:+	-0.31	-5.03	8.97E-7	Personality dimensions	
KIRP	cis	1	rs10005989	chr4:56405206	TMEM165	chr4:56262090-56292342:+	0.25	3.99	8.48E-5	Personality dimensions	
KIRP	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.44	-6.48	4.38E-10	Longevity	
KIRP	cis	1	rs1001021	chr22:26403599	HPS4	chr22:26847447-26879820:-	-0.39	-3.98	9.02E-5	Schizophrenia, bipolar disorder and depression (combined)	
KIRP	cis	1	rs1001021	chr22:26403599	SRRD	chr22:26879846-26887903:+	-0.48	-4.01	7.9E-5	Schizophrenia, bipolar disorder and depression (combined)	
KIRP	cis	1	rs10016506	chr4:56396674	SRD5A3	chr4:56212409-56237866:+	-0.29	-4.62	6.03E-6	Personality dimensions	
KIRP	cis	1	rs1002675	chr3:38445226	EXOG	chr3:38537763-38567796:+	-0.18	-4.34	2.06E-5	Electrocardiographic conduction measures	
KIRP	cis	1	rs1002676	chr3:38444932	EXOG	chr3:38537763-38567796:+	0.16	3.82	0.000165	Electrocardiographic conduction measures	
KIRP	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.28	4.79	2.73E-6	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs10034433	chr4:56421176	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.92	1.52E-6	Personality dimensions	
KIRP	cis	1	rs10034433	chr4:56421176	TMEM165	chr4:56262090-56292342:+	0.25	3.97	9.11E-5	Personality dimensions	
KIRP	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.46	-8.24	7.81E-15	Eye color traits	
KIRP	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.46	4.57	7.65E-6	Crohn's disease	
KIRP	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.8	10.94	3.12E-23	Type 2 diabetes	
KIRP	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.62	6.29	1.32E-9	Crohn's disease	
KIRP	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.63	6.44	5.6E-10	Crohn's disease	
KIRP	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.62	6.29	1.32E-9	Crohn's disease	
KIRP	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.63	6.44	5.6E-10	Crohn's disease	
KIRP	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.56	5.56	6.7E-8	Crohn's disease	
KIRP	cis	1	rs1006396	chr22:30017000	MTMR3	chr22:30279158-30426855:+	-0.24	-3.83	0.000162	Lipid traits	
KIRP	cis	1	rs1006396	chr22:30017000	NF2	chr22:29999545-30094583:+	-0.31	-3.99	8.45E-5	Lipid traits	
KIRP	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.63	6.44	5.6E-10	Crohn's disease	
KIRP	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.56	5.77	2.23E-8	Crohn's disease	
KIRP	cis	1	rs10080429	chr6:109738106	AKD1	chr6:109814059-110012415:-	-0.22	-3.81	0.000174	Height	
KIRP	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.31	5.94	9.16E-9	Height	
KIRP	cis	1	rs1009051	chr3:49521549	NCKIPSD	chr3:48711280-48723334:-	0.29	4.27	2.71E-5	Menarche (age at onset)	
KIRP	cis	1	rs1009051	chr3:49521549	P4HTM	chr3:49027341-49044579:+	0.24	4.46	1.2E-5	Menarche (age at onset)	
KIRP	cis	1	rs1009242	chr9:131916832	PPP2R4	chr9:131873244-131911223:+	0.25	3.96	9.6E-5	Blood metabolite ratios	
KIRP	cis	1	rs1010447	chr1:11269796	PEX14	chr1:10535003-10690813:+	0.2	4.37	1.76E-5	Body mass index	
KIRP	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.41	-5.96	7.87E-9	Rheumatoid arthritis	
KIRP	cis	1	rs10136948	chr14:75511075	RPS6KL1	chr14:75372347-75389958:-	0.22	3.81	0.000171	Height	
KIRP	cis	1	rs1013766	chr21:39856415	SH3BGR	chr21:40817797-40887426:+	-0.38	-3.91	0.000117	Multiple sclerosis	
KIRP	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.2	4.23	3.25E-5	Height	
KIRP	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.29	-6.6	2.27E-10	Common traits (Other)	
KIRP	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.27	-6.15	2.83E-9	Common traits (Other)	
KIRP	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.19	3.95	0.0001	Height	
KIRP	cis	1	rs10146482	chr14:75574087	RPS6KL1	chr14:75372347-75389958:-	0.24	4.13	4.93E-5	Height	
KIRP	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.19	-3.94	0.000106	Height	
KIRP	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.27	-6.15	2.91E-9	Common traits (Other)	
KIRP	cis	1	rs10152119	chr15:84570381	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs10152139	chr15:84570262	LOC388152	chr15:84867600-84898920:-	-0.24	-4.06	6.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs10153800	chr2:242179134	FARP2	chr2:242295711-242434255:+	0.29	3.83	0.000159	Chronic lymphocytic leukemia	
KIRP	cis	1	rs10155014	chr3:49432321	NCKIPSD	chr3:48711280-48723334:-	0.31	4.46	1.19E-5	Menarche (age at onset)	
KIRP	cis	1	rs10155014	chr3:49432321	P4HTM	chr3:49027341-49044579:+	0.24	4.47	1.15E-5	Menarche (age at onset)	
KIRP	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-1	-20.23	1.13E-55	Homocysteine levels	
KIRP	cis	1	rs10161328	chr12:133481884	EP400NL	chr12:132568828-132600084:+;chr12	-0.45	-4.4	1.55E-5	Cognitive function	
KIRP	cis	1	rs10164319	chr19:18569833	LRRC25	chr19:18501955-18508421:-	-0.12	-4.1	5.5E-5	Breast cancer	
KIRP	cis	1	rs10164319	chr19:18569833	SSBP4	chr19:18530221-18545371:+	-0.16	-4.4	1.57E-5	Breast cancer	
KIRP	cis	1	rs10164323	chr19:18569492	LRRC25	chr19:18501955-18508421:-	-0.13	-4.36	1.85E-5	Breast cancer	
KIRP	cis	1	rs10164323	chr19:18569492	SSBP4	chr19:18530221-18545371:+	-0.16	-4.42	1.42E-5	Breast cancer	
KIRP	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs10169736	chr2:641082	SNTG2	chr2:946555-1371382:+	-0.43	-4.26	2.79E-5	Body mass index	
KIRP	cis	1	rs10172769	chr2:646345	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs1017302	chr12:9367402	LOC642846	chr12:9436253-9466684:+	0.31	4.42	1.43E-5	Non-alcoholic fatty liver disease histology (AST)	
KIRP	cis	1	rs10173081	chr2:102957348	IL1RL1	chr2:102927962-102968497:+	0.44	5.45	1.16E-7	Asthma	
KIRP	cis	1	rs10173167	chr2:646767	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.38	5.05	8.08E-7	Metabolite levels	
KIRP	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.3	3.91	0.000119	Urinary metabolites	
KIRP	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.32	4.19	3.85E-5	Metabolite levels	
KIRP	cis	1	rs10179458	chr2:102934974	IL1RL1	chr2:102927962-102968497:+	0.38	4.88	1.82E-6	Asthma	
KIRP	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.49	7.36	2.33E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.38	5.11	6.25E-7	Metabolite levels	
KIRP	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.37	4.96	1.25E-6	Metabolite levels	
KIRP	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.32	3.98	9.07E-5	Metabolite levels	
KIRP	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.37	4.87	1.91E-6	Metabolite levels	
KIRP	cis	1	rs10189154	chr2:102937544	IL1RL1	chr2:102927962-102968497:+	0.38	4.88	1.82E-6	Asthma	
KIRP	cis	1	rs10189526	chr2:102937883	IL1RL1	chr2:102927962-102968497:+	0.38	4.88	1.82E-6	Asthma	
KIRP	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.37	4.89	1.77E-6	Metabolite levels	
KIRP	cis	1	rs10189761	chr2:646364	SNTG2	chr2:946555-1371382:+	0.48	4.52	9.34E-6	Body mass index	
KIRP	cis	1	rs10190052	chr2:646674	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.3	3.94	0.000103	Metabolite levels	
KIRP	cis	1	rs10190313	chr2:647577	SNTG2	chr2:946555-1371382:+	-0.37	-3.9	0.000122	Body mass index	
KIRP	cis	1	rs10192350	chr2:652607	SNTG2	chr2:946555-1371382:+	0.4	4.14	4.63E-5	Body mass index	
KIRP	cis	1	rs10193244	chr2:647580	SNTG2	chr2:946555-1371382:+	-0.37	-3.9	0.000122	Body mass index	
KIRP	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.5	-8.07	2.4E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs10193610	chr2:240940618	NDUFA10	chr2:240900158-240964798:-	0.22	3.89	0.000126	Odorant perception (isobutyraldehyde)	
KIRP	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.37	4.97	1.21E-6	Metabolite levels	
KIRP	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.3	3.95	0.000101	Metabolite levels	
KIRP	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.35	4.67	4.8E-6	Inflammatory skin disease	
KIRP	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.4	5.34	1.98E-7	Inflammatory skin disease	
KIRP	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.94	13.86	3.12E-33	Diastolic blood pressure	
KIRP	cis	1	rs10216533	chr8:143763690	LY6K	chr8:143781529-143785582:+	0.34	4.79	2.75E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs10216533	chr8:143763690	LYNX1	chr8:143845758-143859640:-	-0.26	-4.16	4.38E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.6	7.3	3.26E-12	Coronary heart disease	
KIRP	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.53	7.1	1.11E-11	Paget's disease	
KIRP	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.44	-5.39	1.54E-7	Paget's disease	
KIRP	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.9	11.75	6.23E-26	Diastolic blood pressure	
KIRP	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.31	5.37	1.69E-7	Longevity;Endometriosis	
KIRP	cis	1	rs10278546	chr7:100516003	ACHE	chr7:100487616-100494539:-	-0.32	-4.47	1.14E-5	Resting heart rate	
KIRP	cis	1	rs1028337	chr20:9364249	PAK7	chr20:9518037-9819687:-	0.37	3.87	0.000137	Neutrophil count	
KIRP	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.34	4.42	1.45E-5	Atopic dermatitis	
KIRP	cis	1	rs1029406	chr11:2309580	C11orf21	chr11:2317507-2323143:-	-0.32	-4.02	7.68E-5	Obesity-related traits	
KIRP	cis	1	rs1029407	chr11:2309582	C11orf21	chr11:2317507-2323143:-	-0.32	-4.02	7.68E-5	Obesity-related traits	
KIRP	cis	1	rs1029408	chr11:2309855	C11orf21	chr11:2317507-2323143:-	-0.31	-3.96	9.45E-5	Obesity-related traits	
KIRP	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.45	-5.9	1.09E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.39	-6.55	2.9E-10	Melanoma;Esophageal squamous cell carcinoma	
KIRP	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.46	-6.05	4.95E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1039665	chr2:228717392	WDR69	chr2:228736327-228789026:+	0.3	4.41	1.52E-5	Blood pressure	
KIRP	cis	1	rs10403249	chr19:18604942	LRRC25	chr19:18501955-18508421:-	-0.13	-4.26	2.88E-5	Breast cancer	
KIRP	cis	1	rs10403249	chr19:18604942	SSBP4	chr19:18530221-18545371:+	-0.16	-4.39	1.67E-5	Breast cancer	
KIRP	cis	1	rs1040393	chr1:166861596	MAEL	chr1:166958519-166991447:+	0.46	5.12	5.95E-7	Schizophrenia	
KIRP	cis	1	rs10404486	chr19:53284135	ZNF600	chr19:53268750-53290034:-	0.42	6.74	1.0E-10	Phospholipid levels (plasma)	
KIRP	cis	1	rs10405636	chr19:18538742	LRRC25	chr19:18501955-18508421:-	-0.12	-4.08	6.07E-5	Breast cancer	
KIRP	cis	1	rs10405636	chr19:18538742	SSBP4	chr19:18530221-18545371:+	-0.16	-4.32	2.23E-5	Breast cancer	
KIRP	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000161	IFN-related cytopenia	
KIRP	cis	1	rs10409483	chr19:18590223	LRRC25	chr19:18501955-18508421:-	-0.13	-4.32	2.18E-5	Breast cancer	
KIRP	cis	1	rs10409483	chr19:18590223	SSBP4	chr19:18530221-18545371:+	-0.17	-4.53	9.06E-6	Breast cancer	
KIRP	cis	1	rs10409505	chr19:18590251	LRRC25	chr19:18501955-18508421:-	-0.13	-4.32	2.18E-5	Breast cancer	
KIRP	cis	1	rs10409505	chr19:18590251	SSBP4	chr19:18530221-18545371:+	-0.17	-4.53	9.06E-6	Breast cancer	
KIRP	cis	1	rs10411009	chr19:18606266	LRRC25	chr19:18501955-18508421:-	-0.13	-4.21	3.44E-5	Breast cancer	
KIRP	cis	1	rs10411009	chr19:18606266	SSBP4	chr19:18530221-18545371:+	-0.16	-4.39	1.64E-5	Breast cancer	
KIRP	cis	1	rs10416218	chr19:33599127	RHPN2	chr19:33469499-33555824:-	-0.23	-3.9	0.000122	Bone properties (heel)	
KIRP	cis	1	rs10416265	chr19:33605300	RHPN2	chr19:33469499-33555824:-	-0.24	-4.1	5.6E-5	Bone properties (heel)	
KIRP	cis	1	rs10416600	chr19:18386063	JUND	chr19:18390563-18392432:-	-0.22	-4.08	5.91E-5	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs10416600	chr19:18386063	KIAA1683	chr19:18367906-18385319:-	-0.31	-5.48	9.96E-8	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs10423531	chr19:33600140	RHPN2	chr19:33469499-33555824:-	-0.23	-3.9	0.000122	Bone properties (heel)	
KIRP	cis	1	rs10425982	chr19:18586519	LRRC25	chr19:18501955-18508421:-	-0.13	-4.29	2.48E-5	Breast cancer	
KIRP	cis	1	rs10425982	chr19:18586519	SSBP4	chr19:18530221-18545371:+	-0.17	-4.59	6.94E-6	Breast cancer	
KIRP	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.55	-10.21	7.26E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs10427083	chr19:18550276	LRRC25	chr19:18501955-18508421:-	-0.12	-4.11	5.31E-5	Breast cancer	
KIRP	cis	1	rs10427083	chr19:18550276	SSBP4	chr19:18530221-18545371:+	-0.16	-4.42	1.44E-5	Breast cancer	
KIRP	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.37	4.81	2.49E-6	Multiple sclerosis	
KIRP	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.3	-5.82	1.68E-8	Multiple sclerosis	
KIRP	cis	1	rs10431765	chr15:66044551	DPP8	chr15:65737999-65810035:-	-0.12	-4.55	8.15E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs10438781	chr17:45323819	LOC100272146	chr17:45500843-45504056:+	-0.16	-3.91	0.000117	Body mass index	
KIRP	cis	1	rs10442	chr19:18545341	LRRC25	chr19:18501955-18508421:-	-0.12	-4.09	5.83E-5	Breast cancer	
KIRP	cis	1	rs10442	chr19:18545341	SSBP4	chr19:18530221-18545371:+	-0.16	-4.43	1.4E-5	Breast cancer	
KIRP	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.44	-7.37	2.12E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs10445344	chr17:53367788	HLF	chr17:53342321-53402426:+	0.43	5.55	6.78E-8	QRS duration	
KIRP	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-1.01	-20.43	2.27E-56	Homocysteine levels	
KIRP	cis	1	rs10454142	chr2:48646399	KLRAQ1	chr2:48667908-48742524:+	0.29	4.04	7.0E-5	Sex hormone-binding globulin levels	
KIRP	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.5	-7.33	2.71E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs1045531	chr8:143763547	LY6K	chr8:143781529-143785582:+	0.35	4.9	1.69E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs1045531	chr8:143763547	LYNX1	chr8:143845758-143859640:-	-0.26	-4.12	5.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.57	-7.84	1.11E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.59	-8.25	7.63E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.5	-7.33	2.71E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs1045547	chr8:143763757	LY6K	chr8:143781529-143785582:+	0.34	4.79	2.83E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs1045547	chr8:143763757	LYNX1	chr8:143845758-143859640:-	-0.26	-4.18	3.9E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.33	4.7	4.11E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs1045574	chr8:143763958	LYNX1	chr8:143845758-143859640:-	-0.24	-3.83	0.000161	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs10455768	chr6:159364322	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455769	chr6:159374007	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455770	chr6:159374304	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455772	chr6:159396403	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455830	chr6:159361236	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455832	chr6:159364354	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455835	chr6:159392353	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10455836	chr6:159394754	RSPH3	chr6:159398268-159421198:-	0.37	4.61	6.32E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs1045605	chr8:143764101	LY6K	chr8:143781529-143785582:+	0.35	4.91	1.58E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs1045605	chr8:143764101	LYNX1	chr8:143845758-143859640:-	-0.26	-4.14	4.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.19	5.25	3.11E-7	Folate pathway vitamin levels	
KIRP	cis	1	rs1046073	chr20:25281333	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1046073	chr20:25281333	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.75	10.26	5.06E-21	Type 2 diabetes	
KIRP	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.56	5.56	6.7E-8	Crohn's disease	
KIRP	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.58	5.48	9.88E-8	Crohn's disease	
KIRP	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs1046875	chr17:80685426	FN3K	chr17:80693452-80709073:+	0.22	4.51	9.66E-6	Glycated hemoglobin levels	
KIRP	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.44	5.74	2.52E-8	Glycated hemoglobin levels	
KIRP	cis	1	rs1046896	chr17:80685533	FN3K	chr17:80693452-80709073:+	0.23	4.72	3.8E-6	Glycated hemoglobin levels	
KIRP	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.45	5.86	1.36E-8	Glycated hemoglobin levels	
KIRP	cis	1	rs1046917	chr17:80685655	FN3K	chr17:80693452-80709073:+	0.22	4.51	9.66E-6	Glycated hemoglobin levels	
KIRP	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.44	5.74	2.52E-8	Glycated hemoglobin levels	
KIRP	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.27	-5.93	9.23E-9	Longevity	
KIRP	cis	1	rs1047171	chr20:25428786	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1047171	chr20:25428786	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs10478026	chr5:110196467	TMEM232	chr5:109624934-110062381:-	0.29	3.99	8.42E-5	Asthma and hay fever	
KIRP	cis	1	rs10494260	chr1:149943784	MTMR11	chr1:149900544-149908791:-	0.31	3.84	0.000157	Height	
KIRP	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.38	5.04	8.57E-7	Metabolite levels	
KIRP	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.37	4.77	3.07E-6	Metabolite levels	
KIRP	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.58	8.05	2.87E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.82	6.5	3.97E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs10504857	chr8:89582625	MMP16	chr8:89049462-89339717:-	-0.3	-4.24	3.13E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs10506839	chr12:81445603	LIN7A	chr12:81191171-81331694:-	0.27	3.99	8.4E-5	Neuroticism	
KIRP	cis	1	rs10509677	chr10:96576110	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs10509678	chr10:96576190	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.22	-5	1.07E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10509767	chr10:74045917	DNAJB12	chr10:74092588-74114907:-	-0.25	-4.1	5.41E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10517073	chr4:25417371	ANAPC4	chr4:25378848-25420119:+	-0.21	-5.05	8.17E-7	Rheumatoid arthritis	
KIRP	cis	1	rs10518060	chr4:70330250	UGT2B11	chr4:70066053-70080449:-	0.28	4.04	7.01E-5	Bacteremia	
KIRP	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.38	5.17	4.65E-7	Blood metabolite levels;Blood metabolite ratios	
KIRP	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.96	-14.31	8.42E-35	Diastolic blood pressure	
KIRP	cis	1	rs1053639	chr10:74035041	DNAJB12	chr10:74092588-74114907:-	0.26	4.22	3.3E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.32	-4.9	1.68E-6	Narcolepsy	
KIRP	cis	1	rs1057911	chr10:96748737	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs1060330	chr3:52288945	GNL3	chr3:52719936-52728508:+	-0.21	-3.98	8.95E-5	Electroencephalogram traits	
KIRP	cis	1	rs1072752	chr10:96678696	C10orf129	chr10:96953957-96988685:+	0.79	7.36	2.25E-12	Blood metabolite levels	
KIRP	cis	1	rs10733886	chr10:74039074	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.45E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.26	4.09	5.81E-5	Pancreatic cancer	
KIRP	cis	1	rs10734765	chr12:9369385	LOC642846	chr12:9436253-9466684:+	0.31	4.42	1.43E-5	Non-alcoholic fatty liver disease histology (AST)	
KIRP	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.83	15.37	1.47E-38	Homocysteine levels	
KIRP	cis	1	rs10736724	chr11:62913258	SLC22A24	chr11:62847414-62911693:-	0.51	7.54	7.51E-13	Conotruncal heart defects	
KIRP	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.41	-6.76	8.51E-11	Hematology traits	
KIRP	cis	1	rs10740397	chr10:74039762	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.45E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10740398	chr10:74046191	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.41E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.37	4.64	5.59E-6	Multiple sclerosis	
KIRP	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.31	-5.94	8.78E-9	Multiple sclerosis	
KIRP	cis	1	rs10747783	chr12:58176614	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.15	4.45E-5	Multiple sclerosis	
KIRP	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs10749860	chr1:46328210	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.37	6.23	1.81E-9	Height	
KIRP	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.39	-6.27	1.48E-9	Hematology traits	
KIRP	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.42	-6.49	4.26E-10	Rheumatoid arthritis	
KIRP	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.41	-6.1	3.84E-9	Rheumatoid arthritis	
KIRP	cis	1	rs10762504	chr10:74039335	DNAJB12	chr10:74092588-74114907:-	0.25	4.04	7.0E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10762505	chr10:74046212	DNAJB12	chr10:74092588-74114907:-	-0.27	-4.35	1.94E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.26	4.93	1.46E-6	Breast size	
KIRP	cis	1	rs1077889	chr20:25267893	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.09	3.99E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1077889	chr20:25267893	FAM182B	chr20:25744102-25848786:-	0.3	4.21	3.53E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs10781661	chr12:133431979	EP400NL	chr12:132568828-132600084:+;chr12	-0.41	-4.9	1.64E-6	Cognitive function	
KIRP	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.36	4.51	9.92E-6	Multiple sclerosis	
KIRP	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.31	-5.96	8.2E-9	Multiple sclerosis	
KIRP	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.36	4.51	9.92E-6	Multiple sclerosis	
KIRP	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.31	-5.96	8.2E-9	Multiple sclerosis	
KIRP	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs10789475	chr1:46304177	MUTYH	chr1:45794915-45806142:-	0.18	4.25	2.98E-5	Body mass index	
KIRP	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.99	6.9E-9	Body mass index	
KIRP	cis	1	rs10789481	chr1:46383583	MUTYH	chr1:45794915-45806142:-	0.17	3.99	8.63E-5	Body mass index	
KIRP	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.38	-5.86	1.39E-8	Height	
KIRP	cis	1	rs10792441	chr11:64360629	SLC22A12	chr11:64358282-64369820:+	-0.24	-4.33	2.12E-5	Urate levels in obese individuals	
KIRP	cis	1	rs10794639	chr16:377367	C16orf13	chr16:684429-686347:-	0.14	3.9	0.000124	Bone mineral density (spine);Bone mineral density	
KIRP	cis	1	rs10798304	chr1:171258642	FMO4	chr1:171283486-171311222:+	-0.25	-3.9	0.000121	Sudden cardiac arrest	
KIRP	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.39	-6.53	3.27E-10	Melanoma;Esophageal squamous cell carcinoma	
KIRP	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.32	5.79	2.01E-8	Height	
KIRP	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.31	4.66	5.04E-6	Height	
KIRP	cis	1	rs10806701	chr6:159385223	RSPH3	chr6:159398268-159421198:-	0.42	4.84	2.22E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.2	-4.35	1.96E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10813951	chr9:33128021	B4GALT1	chr9:33110639-33167356:-	0.38	4.5	1.03E-5	IgG glycosylation	
KIRP	cis	1	rs10813957	chr9:33153527	B4GALT1	chr9:33110639-33167356:-	-0.36	-4.25	2.96E-5	IgG glycosylation	
KIRP	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.41	-6.08	4.17E-9	Rheumatoid arthritis	
KIRP	cis	1	rs10819469	chr9:131882067	PPP2R4	chr9:131873244-131911223:+	0.27	4.27	2.73E-5	Blood metabolite ratios	
KIRP	cis	1	rs10823911	chr10:74040034	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.45E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs10827728	chr10:19930367	NSUN6	chr10:18802051-18940550:-	-0.27	-3.86	0.000141	Ankylosing spondylitis	
KIRP	cis	1	rs10833824	chr11:22847485	SVIP	chr11:22843600-22851382:-	-0.27	-4.53	8.84E-6	Dialysis-related mortality	
KIRP	cis	1	rs10838634	chr11:46929954	HARBI1	chr11:46624857-46638777:-	-0.36	-4.2	3.69E-5	Schizophrenia	
KIRP	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.53	-6.98	2.37E-11	Subjective well-being	
KIRP	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.02	1.83E-11	Subjective well-being	
KIRP	cis	1	rs10838747	chr11:47716324	PSMC3	chr11:47440320-47448024:-	0.2	3.99	8.68E-5	Subjective well-being	
KIRP	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.5	-6.69	1.33E-10	Subjective well-being	
KIRP	cis	1	rs10838748	chr11:47716381	PSMC3	chr11:47440320-47448024:-	0.2	3.99	8.56E-5	Subjective well-being	
KIRP	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.51	-6.88	4.37E-11	Subjective well-being	
KIRP	cis	1	rs10838757	chr11:47763016	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000126	Subjective well-being	
KIRP	cis	1	rs10845106	chr12:10472338	KLRD1	chr12:10457050-10469849:+	-0.25	-4.23	3.17E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRP	cis	1	rs10846156	chr12:15321921	RERG	chr12:15260718-15374304:-	0.39	5.21	3.81E-7	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs10846157	chr12:15325031	RERG	chr12:15260718-15374304:-	0.34	4.85	2.11E-6	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.32	1.13E-9	Body mass index	
KIRP	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.24	3.97	9.35E-5	Systemic lupus erythematosus	
KIRP	cis	1	rs10862222	chr12:81436607	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs10865548	chr2:631606	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs10865549	chr2:631759	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs10865550	chr2:641718	SNTG2	chr2:946555-1371382:+	-0.42	-4.15	4.4E-5	Body mass index	
KIRP	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.97	-14.41	3.84E-35	Diastolic blood pressure	
KIRP	cis	1	rs10865956	chr3:49581559	NCKIPSD	chr3:48711280-48723334:-	0.3	4.15	4.47E-5	Menarche (age at onset)	
KIRP	cis	1	rs10865956	chr3:49581559	P4HTM	chr3:49027341-49044579:+	0.25	4.49	1.06E-5	Menarche (age at onset)	
KIRP	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.3	5.8	1.93E-8	Height	
KIRP	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.35	4.26	2.88E-5	Multiple sclerosis	
KIRP	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.33	-6.15	2.9E-9	Multiple sclerosis	
KIRP	cis	1	rs10877012	chr12:58162085	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.04	7.09E-5	Multiple sclerosis	
KIRP	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.37	4.76	3.25E-6	Multiple sclerosis	
KIRP	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.3	-5.89	1.18E-8	Multiple sclerosis	
KIRP	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.37	4.78	2.97E-6	Multiple sclerosis	
KIRP	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.31	-5.96	7.92E-9	Multiple sclerosis	
KIRP	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.35	4.2	3.66E-5	Multiple sclerosis	
KIRP	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.31	-5.77	2.22E-8	Multiple sclerosis	
KIRP	cis	1	rs10877015	chr12:58167788	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-3.94	0.000106	Multiple sclerosis	
KIRP	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.36	-4.27	2.7E-5	Multiple sclerosis	
KIRP	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.32	5.94	8.91E-9	Multiple sclerosis	
KIRP	cis	1	rs10877019	chr12:58172929	XRCC6BP1	chr12:58335445-58351051:+	0.27	4.02	7.55E-5	Multiple sclerosis	
KIRP	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.2	-4.5	1.02E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.2	-4.5	1.0E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.17	-3.9	0.000124	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.98E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.22	-4.73	3.6E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.17	-3.87	0.000137	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.2	-4.11	5.36E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs10888576	chr1:150200792	MRPS21	chr1:150266269-150280818:+	-0.16	-4.25	2.96E-5	Morning vs. evening chronotype	
KIRP	cis	1	rs10889664	chr1:67635475	IL23R	chr1:67604590-67725648:+	-0.29	-4.07	6.15E-5	Psoriasis	
KIRP	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.44E-9	Body mass index	
KIRP	cis	1	rs10890352	chr1:46283628	MUTYH	chr1:45794915-45806142:-	0.16	3.87	0.000139	Body mass index	
KIRP	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs10890354	chr1:46305347	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.12	3.43E-9	Body mass index	
KIRP	cis	1	rs10890361	chr1:46346234	MUTYH	chr1:45794915-45806142:-	0.18	4.04	7.11E-5	Body mass index	
KIRP	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.39	6.04	5.27E-9	Body mass index	
KIRP	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.42	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs10894804	chr11:134247842	GLB1L2	chr11:134201768-134248235:+	-0.3	-4.18	3.96E-5	Verbal declarative memory	
KIRP	cis	1	rs10897518	chr11:64360705	SLC22A12	chr11:64358282-64369820:+	0.24	4.25	3.01E-5	Urate levels in obese individuals	
KIRP	cis	1	rs10906982	chr15:84568158	LOC388152	chr15:84867600-84898920:-	-0.25	-4.16	4.33E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs10906983	chr15:84569183	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs10908907	chr9:92249584	SECISBP2	chr9:91933412-91974561:+	0.22	3.84	0.000155	Alcoholism (heaviness of drinking)	
KIRP	cis	1	rs10912749	chr1:171277506	FMO4	chr1:171283486-171311222:+	0.26	4	8.13E-5	Sudden cardiac arrest	
KIRP	cis	1	rs10916154	chr1:227707361	JMJD4	chr1:227918891-227923112:-	0.21	4.14	4.66E-5	Height	
KIRP	cis	1	rs10916157	chr1:227714477	JMJD4	chr1:227918891-227923112:-	0.21	4.12	5.14E-5	Height	
KIRP	cis	1	rs10916160	chr1:227728219	JMJD4	chr1:227918891-227923112:-	-0.22	-4.19	3.75E-5	Height	
KIRP	cis	1	rs10916162	chr1:227737793	JMJD4	chr1:227918891-227923112:-	0.24	4.5	1.04E-5	Height	
KIRP	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.32	-4.43	1.38E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.33	4.5	1.01E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.46	7.27	4.13E-12	Urinary metabolites	
KIRP	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.23	1.86E-9	Height	
KIRP	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.29	-4.41	1.51E-5	Height	
KIRP	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.49	-7.08	1.32E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.57	-7.89	8.09E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.5	-7.31	3.15E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.5	-7.33	2.71E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs10945581	chr6:159376252	RSPH3	chr6:159398268-159421198:-	0.42	4.86	2.01E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs10954655	chr7:139369376	C7orf55	chr7:139025897-139030539:+	0.17	4.7	4.1E-6	Neuroticism	
KIRP	cis	1	rs10954872	chr8:29978612	MBOAT4	chr8:29989188-30002200:-	-0.35	-3.8	0.000177	Migraine	
KIRP	cis	1	rs10957961	chr8:81031822	TPD52	chr8:80831096-81083836:-	-0.23	-4.5	1.02E-5	Metabolite levels (Pyroglutamine)	
KIRP	cis	1	rs10963455	chr9:18105578	SH3GL2	chr9:17578953-17797120:+	0.52	4.03	7.4E-5	Heart failure	
KIRP	cis	1	rs10966	chr20:25282944	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.19	2.24E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs10966	chr20:25282944	FAM182B	chr20:25744102-25848786:-	0.29	4.07	6.32E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs10988125	chr9:131572903	C9orf114	chr9:131584346-131592085:-	0.28	4.29	2.49E-5	Blood metabolite levels	
KIRP	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.23	5.07	7.39E-7	Blood metabolite levels	
KIRP	cis	1	rs10988223	chr9:131903021	PPP2R4	chr9:131873244-131911223:+	0.28	4.28	2.59E-5	Blood metabolite ratios	
KIRP	cis	1	rs10988232	chr9:131915348	PPP2R4	chr9:131873244-131911223:+	0.24	3.89	0.000126	Blood metabolite ratios	
KIRP	cis	1	rs11026804	chr11:22841582	SVIP	chr11:22843600-22851382:-	0.25	4.22	3.29E-5	Dialysis-related mortality	
KIRP	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.51	-6.84	5.61E-11	Subjective well-being	
KIRP	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs11039390	chr11:47796295	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.17	7.51E-12	Subjective well-being	
KIRP	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.16	8.08E-12	Subjective well-being	
KIRP	cis	1	rs11043222	chr12:122301275	WDR66	chr12:122356480-122441830:+	0.43	3.85	0.000149	Urinary metabolites	
KIRP	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.48	5.32	2.25E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs11071846	chr15:65792839	DPP8	chr15:65737999-65810035:-	0.13	4.81	2.59E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs1107328	chr9:131917534	PPP2R4	chr9:131873244-131911223:+	-0.33	-4.9	1.67E-6	Blood metabolite ratios	
KIRP	cis	1	rs11075551	chr16:52631964	AKTIP	chr16:53525193-53537170:-	0.23	3.91	0.000116	Breast cancer	
KIRP	cis	1	rs11076106	chr16:55614447	LPCAT2	chr16:55542913-55620581:+	-0.2	-3.86	0.00014	Thyroid hormone levels	
KIRP	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.25	-4.3	2.39E-5	Fibrinogen levels	
KIRP	cis	1	rs11079159	chr17:53373550	HLF	chr17:53342321-53402426:+	0.5	6.16	2.73E-9	QRS duration	
KIRP	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.55E-5	Body mass index	
KIRP	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.29	3.99	8.49E-5	Body mass index	
KIRP	cis	1	rs11079707	chr17:65835617	LOC440461	chr17:66194801-66196436:+	-0.31	-3.87	0.00014	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs1108431	chr16:31054607	HSD3B7	chr16:30996519-31000473:+	0.26	4.97	1.19E-6	Response to metformin (IC50)	
KIRP	cis	1	rs11085466	chr19:21751811	ZNF429	chr19:21688437-21739068:+	0.3	4.14	4.66E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs11086102	chr19:18398628	KIAA1683	chr19:18367906-18385319:-	-0.31	-5.59	5.53E-8	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs11087520	chr20:25436827	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.36	8.83E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs11087520	chr20:25436827	FAM182B	chr20:25744102-25848786:-	0.31	4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs11087521	chr20:25440648	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.61	5.19E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs11087521	chr20:25440648	FAM182B	chr20:25744102-25848786:-	0.3	4	8.37E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1109114	chr5:148615946	AFAP1L1	chr5:148651401-148721365:+	0.44	5.58	5.82E-8	Body mass index	
KIRP	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.25	-5.42	1.37E-7	Longevity	
KIRP	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.46	5.04	8.65E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs11100	chr20:25281184	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs11100	chr20:25281184	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs11114703	chr12:81434989	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs11114704	chr12:81436269	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs11114710	chr12:81440183	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs11114711	chr12:81440265	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs11114720	chr12:81443764	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs11114722	chr12:81447755	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114723	chr12:81449343	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114724	chr12:81449717	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114735	chr12:81457413	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114736	chr12:81457508	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114737	chr12:81457732	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114739	chr12:81459675	LIN7A	chr12:81191171-81331694:-	0.27	4.15	4.54E-5	Neuroticism	
KIRP	cis	1	rs11114740	chr12:81459887	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs11114743	chr12:81464705	LIN7A	chr12:81191171-81331694:-	0.27	3.91	0.000118	Neuroticism	
KIRP	cis	1	rs11121706	chr1:11302065	SRM	chr1:11114649-11120091:-	0.17	3.84	0.000151	Body mass index	
KIRP	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.69	-13.23	5.04E-31	Renal function-related traits (BUN)	
KIRP	cis	1	rs111237243	chr14:59991030	JKAMP	chr14:59951161-59972080:+	0.67	4.44	1.33E-5	Schizophrenia	
KIRP	cis	1	rs111237645	chr10:96462701	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.35	-5.93	9.25E-9	Body mass index	
KIRP	cis	1	rs11127483	chr2:623691	SNTG2	chr2:946555-1371382:+	-0.41	-3.83	0.000161	Body mass index	
KIRP	cis	1	rs11127485	chr2:632028	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs11127486	chr2:632101	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs11127487	chr2:639900	SNTG2	chr2:946555-1371382:+	-0.43	-4.26	2.79E-5	Body mass index	
KIRP	cis	1	rs11127488	chr2:646061	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs11127489	chr2:646081	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs11127491	chr2:646145	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.25	-5.57	6.39E-8	Longevity	
KIRP	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.26	-5.62	4.78E-8	Longevity	
KIRP	cis	1	rs11130189	chr3:49347357	NCKIPSD	chr3:48711280-48723334:-	0.32	4.51	9.55E-6	Menarche (age at onset)	
KIRP	cis	1	rs11130189	chr3:49347357	P4HTM	chr3:49027341-49044579:+	0.22	3.96	9.58E-5	Menarche (age at onset)	
KIRP	cis	1	rs11130190	chr3:49402137	NCKIPSD	chr3:48711280-48723334:-	0.32	4.38	1.69E-5	Menarche (age at onset)	
KIRP	cis	1	rs11130190	chr3:49402137	P4HTM	chr3:49027341-49044579:+	0.25	4.32	2.21E-5	Menarche (age at onset)	
KIRP	cis	1	rs11130213	chr3:49712297	RBM6	chr3:49977592-50137484:+	0.16	4.49	1.06E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs11130213	chr3:49712297	UBA7	chr3:49842639-49851391:-	0.35	6.17	2.57E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs11130214	chr3:49735746	UBA7	chr3:49842639-49851391:-	0.3	5.57	6.13E-8	Resting heart rate	
KIRP	cis	1	rs11130216	chr3:49736172	UBA7	chr3:49842639-49851391:-	-0.3	-5.46	1.09E-7	Resting heart rate	
KIRP	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.38	-5.74	2.55E-8	Height	
KIRP	cis	1	rs11130520	chr3:56441119	SPATA12	chr3:57094469-57109460:+	-0.25	-4.44	1.31E-5	Night sleep phenotypes	
KIRP	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.89	-10.12	1.44E-20	Triptolide cytotoxicity	
KIRP	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.42	-7.5	9.48E-13	Kawasaki disease	
KIRP	cis	1	rs11133399	chr4:56413831	SRD5A3	chr4:56212409-56237866:+	-0.29	-4.43	1.35E-5	Personality dimensions	
KIRP	cis	1	rs111355947	chr14:59911985	JKAMP	chr14:59951161-59972080:+	0.66	4.64	5.57E-6	Schizophrenia	
KIRP	cis	1	rs11147098	chr12:133406374	EP400NL	chr12:132568828-132600084:+;chr12	-0.42	-4.54	8.71E-6	Cognitive function	
KIRP	cis	1	rs111476301	chr14:59920191	JKAMP	chr14:59951161-59972080:+	0.66	4.64	5.57E-6	Schizophrenia	
KIRP	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.32	-7.05	1.53E-11	Lewy body disease	
KIRP	cis	1	rs111485167	chr10:96394254	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs111489600	chr14:59993021	JKAMP	chr14:59951161-59972080:+	0.67	4.44	1.33E-5	Schizophrenia	
KIRP	cis	1	rs111501284	chr10:96392063	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.37	4.93	1.44E-6	Atopic dermatitis	
KIRP	cis	1	rs11157696	chr14:50105746	PPIL5	chr14:50065415-50081389:+	-0.22	-3.81	0.000174	Carotid intima media thickness	
KIRP	cis	1	rs11157696	chr14:50105746	RPL36AL	chr14:50085407-50087349:-	-0.31	-6.09	3.96E-9	Carotid intima media thickness	
KIRP	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.27	6.11	3.61E-9	Common traits (Other)	
KIRP	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.2	4.2	3.69E-5	Height	
KIRP	cis	1	rs11159117	chr14:75584867	RPS6KL1	chr14:75372347-75389958:-	0.22	3.91	0.000119	Height	
KIRP	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs11161510	chr1:76210289	ACADM	chr1:76190043-76229353:+	-0.22	-5.07	7.44E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs11161511	chr1:76210477	ACADM	chr1:76190043-76229353:+	-0.2	-4.62	5.91E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs11161515	chr1:76212559	ACADM	chr1:76190043-76229353:+	0.21	4.82	2.47E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs11161521	chr1:76216330	ACADM	chr1:76190043-76229353:+	0.21	4.79	2.72E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs11163924	chr1:76132070	ACADM	chr1:76190043-76229353:+	-0.23	-5.51	8.54E-8	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.74	7.23	5.26E-12	Crohn's disease	
KIRP	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.45	4.36	1.89E-5	Crohn's disease	
KIRP	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.7	5.86	1.36E-8	Crohn's disease	
KIRP	cis	1	rs1117010	chr4:48410949	CNGA1	chr4:47937996-48018610:-	0.23	3.83	0.00016	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.35	4.23	3.16E-5	Multiple sclerosis	
KIRP	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.32	-6.02	5.66E-9	Multiple sclerosis	
KIRP	cis	1	rs11172333	chr12:58170335	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.1	5.58E-5	Multiple sclerosis	
KIRP	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.35	4.24	3.05E-5	Multiple sclerosis	
KIRP	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.33	-6.07	4.46E-9	Multiple sclerosis	
KIRP	cis	1	rs11172335	chr12:58175201	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.1	5.42E-5	Multiple sclerosis	
KIRP	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.34	4.07	6.19E-5	Multiple sclerosis	
KIRP	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.33	-6.11	3.48E-9	Multiple sclerosis	
KIRP	cis	1	rs11172342	chr12:58187758	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-3.99	8.5E-5	Multiple sclerosis	
KIRP	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.34	4.07	6.19E-5	Multiple sclerosis	
KIRP	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.33	-6.11	3.48E-9	Multiple sclerosis	
KIRP	cis	1	rs11172343	chr12:58188157	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-3.99	8.5E-5	Multiple sclerosis	
KIRP	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.36	4.51	9.92E-6	Multiple sclerosis	
KIRP	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.31	-5.96	8.2E-9	Multiple sclerosis	
KIRP	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.36	4.34	1.99E-5	Multiple sclerosis	
KIRP	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.33	-6.04	5.2E-9	Multiple sclerosis	
KIRP	cis	1	rs11172349	chr12:58212528	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-3.84	0.000153	Multiple sclerosis	
KIRP	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.36	4.34	1.99E-5	Multiple sclerosis	
KIRP	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.33	-6.04	5.2E-9	Multiple sclerosis	
KIRP	cis	1	rs11172351	chr12:58213485	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-3.84	0.000153	Multiple sclerosis	
KIRP	cis	1	rs111767681	chr10:96720169	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs111882043	chr14:59899356	JKAMP	chr14:59951161-59972080:+	0.62	4.48	1.13E-5	Schizophrenia	
KIRP	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.76	6.12	3.34E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.22	-4.72	3.79E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.17	-3.98	9.02E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190596	chr10:102293238	SEC31B	chr10:102246403-102289636:-	-0.2	-4.25	3.01E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.2	-4.39	1.67E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.18	-4.14	4.72E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.18	4.1	5.59E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.3	-5.15	5.13E-7	Schizophrenia	
KIRP	cis	1	rs11201297	chr10:81793749	LOC219347	chr10:81805991-81838949:-	0.89	8.19	1.09E-14	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs11201298	chr10:81793751	LOC219347	chr10:81805991-81838949:-	0.9	8.28	6.18E-15	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	0.95	8.48	1.56E-15	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-1.06	-9.54	1.01E-18	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.78	-7.26	4.39E-12	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs11210359	chr1:74339167	LRRIQ3	chr1:74491704-74663871:-	0.32	4.66	4.94E-6	Bipolar disorder and schizophrenia	
KIRP	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-1	-20.38	3.41E-56	Homocysteine levels	
KIRP	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs11211199	chr1:46287869	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.54E-9	Body mass index	
KIRP	cis	1	rs11211208	chr1:46334256	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000141	Body mass index	
KIRP	cis	1	rs112112261	chr10:96650048	C10orf129	chr10:96953957-96988685:+	1.04	9.08	2.6E-17	Blood metabolite levels	
KIRP	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.3	1.27E-9	Body mass index	
KIRP	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs11216316	chr11:117081500	PCSK7	chr11:117075789-117102811:-	0.39	4.29	2.46E-5	Protein quantitative trait loci	
KIRP	cis	1	rs1122326	chr17:40274873	DHX58	chr17:40253422-40264751:-	-0.25	-4.11	5.19E-5	Fibrinogen levels	
KIRP	cis	1	rs112261101	chr14:59917544	JKAMP	chr14:59951161-59972080:+	0.66	4.64	5.57E-6	Schizophrenia	
KIRP	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.36	5.58	5.84E-8	Height	
KIRP	cis	1	rs112476368	chr14:59991452	JKAMP	chr14:59951161-59972080:+	0.67	4.44	1.33E-5	Schizophrenia	
KIRP	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.27	3.97	9.21E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11248013	chr4:311425	ZNF718	chr4:53272-156488:+	0.29	4.23	3.24E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.95	13.68	1.31E-32	Diastolic blood pressure	
KIRP	cis	1	rs112555934	chr14:59977232	JKAMP	chr14:59951161-59972080:+	0.67	4.44	1.33E-5	Schizophrenia	
KIRP	cis	1	rs112573749	chr10:96547736	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs11259928	chr15:84568095	LOC388152	chr15:84867600-84898920:-	-0.24	-4.07	6.22E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259929	chr15:84577202	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259930	chr15:84577350	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259932	chr15:84580057	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259933	chr15:84580156	LOC388152	chr15:84867600-84898920:-	-0.24	-4.03	7.32E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259934	chr15:84580171	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259935	chr15:84580427	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259936	chr15:84580582	LOC388152	chr15:84867600-84898920:-	0.24	4.07	6.32E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11259937	chr15:84587833	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs112661971	chr14:59901054	JKAMP	chr14:59951161-59972080:+	0.62	4.48	1.13E-5	Schizophrenia	
KIRP	cis	1	rs112732395	chr10:96533173	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs112779036	chr10:96498813	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs113066613	chr7:1094128	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.77	3.03E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs113089853	chr10:96545632	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs113103955	chr10:96414633	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs1131095	chr3:49714225	DOCK3	chr3:50712672-51421628:+	-0.29	-4.33	2.14E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs1131095	chr3:49714225	RBM6	chr3:49977592-50137484:+	0.16	4.49	1.06E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs1131095	chr3:49714225	UBA7	chr3:49842639-49851391:-	0.35	6.17	2.57E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs113172694	chr14:59998219	JKAMP	chr14:59951161-59972080:+	0.66	4.31	2.26E-5	Schizophrenia	
KIRP	cis	1	rs113244272	chr10:96400221	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs113251361	chr10:96626220	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.43	-7.17	7.53E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs1133483	chr4:100023923	ADH4	chr4:100044835-100065449:-	-0.25	-3.97	9.11E-5	HDL cholesterol	
KIRP	cis	1	rs113348400	chr10:96704918	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs113374757	chr19:47256542	PRKD2	chr19:47177574-47220384:-	0.28	3.91	0.000117	Type 1 diabetes	
KIRP	cis	1	rs113535483	chr10:96436439	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs113546720	chr10:96561988	C10orf129	chr10:96953957-96988685:+	1.03	8.94	6.71E-17	Blood metabolite levels	
KIRP	cis	1	rs113558975	chr14:59998385	JKAMP	chr14:59951161-59972080:+	0.66	4.31	2.26E-5	Schizophrenia	
KIRP	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.6	6.68E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.94	11.2	4.4E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs113638727	chr15:40706101	IVD	chr15:40697686-40713512:+	-0.33	-4.01	7.84E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs113739251	chr10:96502658	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs113770724	chr6:159370137	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.35	6.43	6.05E-10	Height	
KIRP	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.28	4.34	2.0E-5	Height	
KIRP	cis	1	rs113858334	chr7:1073476	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.58	7.15E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs113869004	chr14:59918731	JKAMP	chr14:59951161-59972080:+	0.71	4.97	1.23E-6	Schizophrenia	
KIRP	cis	1	rs113878281	chr14:59917494	JKAMP	chr14:59951161-59972080:+	0.66	4.64	5.57E-6	Schizophrenia	
KIRP	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.25	4.06	6.39E-5	Pancreatic cancer	
KIRP	cis	1	rs114121665	chr10:96533587	C10orf129	chr10:96953957-96988685:+	0.73	7.44	1.41E-12	Blood metabolite levels	
KIRP	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.18	4.85	2.07E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.35	4.56	7.79E-6	Atopic dermatitis	
KIRP	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs114604770	chr8:89587010	MMP16	chr8:89049462-89339717:-	0.31	4.45	1.24E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs114628972	chr10:96744732	C10orf129	chr10:96953957-96988685:+	1.08	9.57	7.73E-19	Blood metabolite levels	
KIRP	cis	1	rs11465753	chr1:67631423	IL23R	chr1:67604590-67725648:+	-0.31	-4.4	1.59E-5	Psoriasis	
KIRP	cis	1	rs11465754	chr1:67631431	IL23R	chr1:67604590-67725648:+	-0.26	-3.86	0.00014	Psoriasis	
KIRP	cis	1	rs1147610	chr10:105941167	C10orf79	chr10:105889647-105992120:-	0.21	4.98	1.15E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs11485508	chr1:152253167	HRNR	chr1:152184558-152196669:-	0.44	5.49	9.51E-8	Atopic dermatitis	
KIRP	cis	1	rs114931426	chr10:96552327	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.48	-7.83	1.16E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs11513782	chr12:81464588	LIN7A	chr12:81191171-81331694:-	0.27	3.91	0.000118	Neuroticism	
KIRP	cis	1	rs11519750	chr12:81464627	LIN7A	chr12:81191171-81331694:-	0.27	3.91	0.000118	Neuroticism	
KIRP	cis	1	rs1152591	chr14:64680848	MTHFD1	chr14:64854759-64926727:+	-0.2	-3.88	0.000134	Atrial fibrillation	
KIRP	cis	1	rs11532322	chr12:123731423	CDK2AP1	chr12:123745542-123756687:-	0.25	4.01	7.92E-5	Schizophrenia	
KIRP	cis	1	rs11532322	chr12:123731423	PITPNM2	chr12:123468027-123635285:-	0.32	4.68	4.53E-6	Schizophrenia	
KIRP	cis	1	rs11542436	chr17:61778689	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.51E-5	Body mass index	
KIRP	cis	1	rs1154513	chr12:122391963	WDR66	chr12:122356480-122441830:+	-0.47	-4.17	4.19E-5	Urinary metabolites	
KIRP	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.51	-8.15	1.43E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.95	11.27	2.58E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs11557072	chr15:40713374	IVD	chr15:40697686-40713512:+	-0.33	-3.99	8.6E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs11568732	chr10:96521574	C10orf129	chr10:96953957-96988685:+	0.71	6.96	2.6E-11	Blood metabolite levels	
KIRP	cis	1	rs11569494	chr19:6692512	GPR108	chr19:6729927-6737633:-	-0.43	-3.98	8.82E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569495	chr19:6692443	GPR108	chr19:6729927-6737633:-	-0.43	-3.98	8.82E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569496	chr19:6692321	GPR108	chr19:6729927-6737633:-	-0.43	-3.98	8.82E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569507	chr19:6690805	GPR108	chr19:6729927-6737633:-	-0.38	-3.86	0.000143	Complement C3 and C4 levels	
KIRP	cis	1	rs11569511	chr19:6690571	GPR108	chr19:6729927-6737633:-	-0.43	-4.14	4.63E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569513	chr19:6690460	GPR108	chr19:6729927-6737633:-	-0.41	-4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569514	chr19:6690276	GPR108	chr19:6729927-6737633:-	-0.41	-4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569515	chr19:6690244	GPR108	chr19:6729927-6737633:-	-0.41	-4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569519	chr19:6689854	GPR108	chr19:6729927-6737633:-	-0.41	-4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569520	chr19:6689507	GPR108	chr19:6729927-6737633:-	-0.41	-4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs11569521	chr19:6689487	GPR108	chr19:6729927-6737633:-	-0.41	-4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs115743514	chr22:51011933	CPT1B	chr22:51007291-51017096:-	-0.31	-4.74	3.57E-6	Narcolepsy	
KIRP	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.44	6.84	5.39E-11	Body mass index	
KIRP	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.38	5.41	1.4E-7	Body mass index	
KIRP	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.56	4.74	3.49E-6	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs11602903	chr11:64358241	SLC22A12	chr11:64358282-64369820:+	-0.23	-4.07	6.24E-5	Urate levels in obese individuals	
KIRP	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.54	-7.19	6.43E-12	Subjective well-being	
KIRP	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.3	5.69	3.43E-8	Breast size	
KIRP	cis	1	rs116139393	chr7:6771660	PMS2	chr7:6010556-6048737:-	0.29	4.08	6.0E-5	Alzheimer's disease (APOE e4 interaction)	
KIRP	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.19	-3.84	0.000152	Height	
KIRP	cis	1	rs11623413	chr14:75588824	RPS6KL1	chr14:75372347-75389958:-	-0.23	-3.94	0.000106	Height	
KIRP	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.27	6.3	1.22E-9	Common traits (Other)	
KIRP	cis	1	rs116300850	chr5:76852234	WDR41	chr5:76728069-76788332:-	0.44	5.81	1.77E-8	Alzheimer disease and age of onset	
KIRP	cis	1	rs11632310	chr15:65882326	DPP8	chr15:65737999-65810035:-	-0.14	-5.1	6.37E-7	Mean corpuscular hemoglobin	
KIRP	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.38	-5.81	1.83E-8	Schizophrenia	
KIRP	cis	1	rs11633204	chr15:54761405	CCPG1	chr15:55647438-55790782:-	0.36	3.8	0.000177	Post-traumatic stress disorder	
KIRP	cis	1	rs11633301	chr15:84585038	LOC388152	chr15:84867600-84898920:-	0.25	4.27	2.74E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.24	-4.05	6.75E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs11636148	chr15:65796880	DPP8	chr15:65737999-65810035:-	0.14	5.02	9.31E-7	Mean corpuscular hemoglobin	
KIRP	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.38	-5.88	1.22E-8	Schizophrenia	
KIRP	cis	1	rs11637431	chr15:65882251	DPP8	chr15:65737999-65810035:-	-0.13	-4.77	2.99E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs11637866	chr15:84587958	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.37	-5.63	4.69E-8	Schizophrenia	
KIRP	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.4	-5.89	1.16E-8	Schizophrenia	
KIRP	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.41	-6.02	5.85E-9	Schizophrenia	
KIRP	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.56	7.09	1.19E-11	Urinary metabolites	
KIRP	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.5	-8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.5	8.42	2.38E-15	Eye color traits	
KIRP	cis	1	rs11654335	chr17:61797579	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.28	3.95	0.000101	Body mass index	
KIRP	cis	1	rs11657081	chr17:61792339	TCAM1P	chr17:61934376-61941738:+	-0.31	-3.94	0.000103	Body mass index	
KIRP	cis	1	rs11657120	chr17:61857218	FTSJ3	chr17:61896795-61905031:-	0.31	4.44	1.33E-5	Body mass index	
KIRP	cis	1	rs11657306	chr17:61704822	TCAM1P	chr17:61934376-61941738:+	-0.33	-4.27	2.75E-5	Body mass index	
KIRP	cis	1	rs11658175	chr17:61923838	FTSJ3	chr17:61896795-61905031:-	0.31	4.49	1.09E-5	Body mass index	
KIRP	cis	1	rs11658329	chr17:61763031	TCAM1P	chr17:61934376-61941738:+	0.33	4.39	1.66E-5	Body mass index	
KIRP	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.31	4.36	1.88E-5	Body mass index	
KIRP	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.37	4.88	1.84E-6	Metabolite levels	
KIRP	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.75E-5	Diabetic kidney disease	
KIRP	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.22	-5.42	1.34E-7	Body mass index	
KIRP	cis	1	rs116795182	chr5:76852236	WDR41	chr5:76728069-76788332:-	0.44	5.81	1.77E-8	Alzheimer disease and age of onset	
KIRP	cis	1	rs11681777	chr2:192121467	MYO1B	chr2:192110107-192290115:+	0.31	5.04	8.59E-7	Obesity-related traits	
KIRP	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.33	5.56	6.63E-8	Body mass index	
KIRP	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.38	5.11	6.25E-7	Metabolite levels	
KIRP	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.32	5.32	2.24E-7	Body mass index	
KIRP	cis	1	rs11691372	chr2:192114678	MYO1B	chr2:192110107-192290115:+	0.32	5.33	2.08E-7	Obesity-related traits	
KIRP	cis	1	rs117031571	chr15:84572654	LOC388152	chr15:84867600-84898920:-	-0.24	-3.97	9.35E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.44	-4.12	4.98E-5	Cholesterol, total;LDL cholesterol	
KIRP	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.32	5.79	1.94E-8	Height	
KIRP	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.29	4.31	2.29E-5	Height	
KIRP	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs11709525	chr3:49690496	RBM6	chr3:49977592-50137484:+	0.15	4.36	1.88E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs11709525	chr3:49690496	UBA7	chr3:49842639-49851391:-	0.35	6.21	2.06E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs117104023	chr10:96515342	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs11710434	chr3:49346130	NCKIPSD	chr3:48711280-48723334:-	0.33	4.67	4.87E-6	Menarche (age at onset)	
KIRP	cis	1	rs11710434	chr3:49346130	P4HTM	chr3:49027341-49044579:+	0.22	3.91	0.000119	Menarche (age at onset)	
KIRP	cis	1	rs11710675	chr3:49751900	UBA7	chr3:49842639-49851391:-	-0.3	-5.55	6.94E-8	Resting heart rate	
KIRP	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.38	4	8.23E-5	Immune reponse to smallpox (secreted IL-2)	
KIRP	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.25	-5.53	7.48E-8	Longevity	
KIRP	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.39	6.55	2.94E-10	Cognitive performance	
KIRP	cis	1	rs11717256	chr3:49868520	RBM6	chr3:49977592-50137484:+	-0.13	-3.85	0.000147	Resting heart rate	
KIRP	cis	1	rs11717256	chr3:49868520	UBA7	chr3:49842639-49851391:-	-0.29	-5.35	1.9E-7	Resting heart rate	
KIRP	cis	1	rs11718165	chr3:49696797	RBM6	chr3:49977592-50137484:+	0.15	4.22	3.31E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs11718165	chr3:49696797	UBA7	chr3:49842639-49851391:-	0.36	6.32	1.1E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs11718752	chr3:53130745	RFT1	chr3:53122503-53164470:-	0.38	4.14	4.64E-5	Immune reponse to smallpox (secreted IL-2)	
KIRP	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.39	6.48	4.49E-10	Cognitive performance	
KIRP	cis	1	rs11719762	chr3:49409002	NCKIPSD	chr3:48711280-48723334:-	0.31	4.46	1.19E-5	Menarche (age at onset)	
KIRP	cis	1	rs11719762	chr3:49409002	P4HTM	chr3:49027341-49044579:+	0.24	4.47	1.15E-5	Menarche (age at onset)	
KIRP	cis	1	rs11720542	chr3:49357427	NCKIPSD	chr3:48711280-48723334:-	0.33	4.66	4.99E-6	Menarche (age at onset)	
KIRP	cis	1	rs11720542	chr3:49357427	P4HTM	chr3:49027341-49044579:+	0.22	3.95	9.95E-5	Menarche (age at onset)	
KIRP	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.37	6.05	4.84E-9	Cognitive performance	
KIRP	cis	1	rs117215113	chr10:96406092	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.29	4.3	2.4E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.29	4.3	2.4E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.29	4.3	2.4E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.3	4.55	8.11E-6	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.28	5.48	9.76E-8	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.27	3.96	9.69E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.27	3.96	9.69E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11725321	chr4:120611912	PDE5A	chr4:120415552-120549981:-	-0.41	-3.98	8.99E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs11726609	chr4:56400869	SRD5A3	chr4:56212409-56237866:+	0.25	3.8	0.000177	Personality dimensions	
KIRP	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.28	4.87	1.94E-6	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.29	4.22	3.3E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs117317596	chr10:96573396	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.35	5.09	6.73E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.29	5.49	9.22E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs11733864	chr4:56321530	SRD5A3	chr4:56212409-56237866:+	0.31	4.99	1.11E-6	Personality dimensions	
KIRP	cis	1	rs11733864	chr4:56321530	TMEM165	chr4:56262090-56292342:+	-0.25	-3.96	9.78E-5	Personality dimensions	
KIRP	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.28	4.87	1.94E-6	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs117381226	chr10:96553520	C10orf129	chr10:96953957-96988685:+	0.71	6.96	2.6E-11	Blood metabolite levels	
KIRP	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.8	10.89	4.44E-23	Type 2 diabetes	
KIRP	cis	1	rs117395468	chr10:96529544	C10orf129	chr10:96953957-96988685:+	0.72	7.59	5.46E-13	Blood metabolite levels	
KIRP	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.73	6.33	1.04E-9	Crohn's disease	
KIRP	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.72	6.48	4.45E-10	Crohn's disease	
KIRP	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.75	-6	6.51E-9	Crohn's disease	
KIRP	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.74	6.12	3.33E-9	Crohn's disease	
KIRP	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.82	6.49	4.25E-10	Crohn's disease	
KIRP	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.7	6.53	3.38E-10	Crohn's disease	
KIRP	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.72	6.48	4.45E-10	Crohn's disease	
KIRP	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.43	-4.26	2.89E-5	Crohn's disease	
KIRP	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.62	6.29	1.32E-9	Crohn's disease	
KIRP	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.6	6.13	3.2E-9	Crohn's disease	
KIRP	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.82	6.49	4.25E-10	Crohn's disease	
KIRP	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.59	6.03	5.5E-9	Crohn's disease	
KIRP	cis	1	rs117530406	chr10:96397876	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.6	5.58	6.07E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.55	-7.67	3.38E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.55	-7.96	5.17E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs11761941	chr7:1097183	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs117626067	chr10:96653255	C10orf129	chr10:96953957-96988685:+	1.04	9.08	2.6E-17	Blood metabolite levels	
KIRP	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.98	1.13E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11763793	chr7:1094342	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.77	3.03E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11763835	chr7:1094513	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.77	3.03E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11765693	chr7:75985373	UPK3B	chr7:76139745-76157197:+	-0.3	-4.11	5.35E-5	Multiple sclerosis	
KIRP	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11767527	chr7:1097394	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11768761	chr7:1069807	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.63	5.69E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs117756203	chr10:96601144	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.84	-8.25	7.32E-15	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.55	-8.67	4.46E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs117957238	chr10:96652882	C10orf129	chr10:96953957-96988685:+	0.8	7.53	8.13E-13	Blood metabolite levels	
KIRP	cis	1	rs118059236	chr7:1073202	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.58	7.15E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.32	1.1E-9	Body mass index	
KIRP	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	1	8.96	6.1E-17	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs118150848	chr10:96653493	C10orf129	chr10:96953957-96988685:+	1.04	9.08	2.6E-17	Blood metabolite levels	
KIRP	cis	1	rs118161033	chr10:96389223	C10orf129	chr10:96953957-96988685:+	0.77	7.25	4.65E-12	Blood metabolite levels	
KIRP	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.18	-4.17	4.21E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs1185260	chr12:122389248	WDR66	chr12:122356480-122441830:+	-0.45	-4.03	7.33E-5	Urinary metabolites	
KIRP	cis	1	rs11853024	chr15:91514797	UNC45A	chr15:91473410-91497322:+	0.29	5.58	5.98E-8	Type 2 diabetes	
KIRP	cis	1	rs11853052	chr15:84576159	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.46	-6.55	3.02E-10	Tumor biomarkers	
KIRP	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.44	-7.28	3.74E-12	Tumor biomarkers	
KIRP	cis	1	rs11856184	chr15:43919162	LCMT2	chr15:43619976-43622891:-	-0.32	-3.85	0.000149	Tumor biomarkers	
KIRP	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.93	10.99	2.14E-23	Heschl's gyrus morphology	
KIRP	cis	1	rs11858714	chr15:40717447	IVD	chr15:40697686-40713512:+	-0.34	-4.11	5.27E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs11860998	chr16:52628418	AKTIP	chr16:53525193-53537170:-	-0.23	-3.95	0.000101	Breast cancer	
KIRP	cis	1	rs11861036	chr16:52628564	AKTIP	chr16:53525193-53537170:-	-0.23	-3.91	0.000118	Breast cancer	
KIRP	cis	1	rs11862744	chr16:31057800	HSD3B7	chr16:30996519-31000473:+	0.29	5.69	3.39E-8	Response to metformin (IC50)	
KIRP	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.2	4.18	4.04E-5	Response to metformin (IC50)	
KIRP	cis	1	rs11869069	chr17:40287101	DHX58	chr17:40253422-40264751:-	-0.25	-4.39	1.65E-5	Fibrinogen levels	
KIRP	cis	1	rs11870797	chr17:61804622	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs11871767	chr17:61698723	FTSJ3	chr17:61896795-61905031:-	0.3	4.13	4.8E-5	Body mass index	
KIRP	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.37	4.08	6.06E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.64	10.64	2.94E-22	Schizophrenia	
KIRP	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.39	-3.89	0.000129	Bronchopulmonary dysplasia	
KIRP	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.5	8.11	1.91E-14	Urinary metabolites	
KIRP	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.38	4.98	1.13E-6	Metabolite levels	
KIRP	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.5	7.86	9.58E-14	Urinary metabolites	
KIRP	cis	1	rs11899576	chr2:86256193	LOC90784	chr2:86247339-86250991:-	-0.5	-5.35	1.86E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs11899576	chr2:86256193	POLR1A	chr2:86253453-86333278:-	0.36	5.35	1.91E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.33	4.17	4.12E-5	Metabolite levels	
KIRP	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.38	5.06	7.71E-7	Metabolite levels	
KIRP	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.38	4.95	1.29E-6	Metabolite levels	
KIRP	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.4	5.22	3.64E-7	Metabolite levels	
KIRP	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.07	4.41E-9	Height	
KIRP	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.8E-6	Height	
KIRP	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.24	4.13	4.94E-5	Resting heart rate	
KIRP	cis	1	rs11920900	chr3:49823024	UBA7	chr3:49842639-49851391:-	-0.31	-5.46	1.1E-7	Resting heart rate	
KIRP	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.95	12.6	7.74E-29	Diastolic blood pressure	
KIRP	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs11928090	chr3:49604904	NCKIPSD	chr3:48711280-48723334:-	0.29	4.2	3.6E-5	Menarche (age at onset)	
KIRP	cis	1	rs11928090	chr3:49604904	P4HTM	chr3:49027341-49044579:+	0.25	4.63	5.61E-6	Menarche (age at onset)	
KIRP	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.32	-5.76	2.28E-8	Height	
KIRP	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.3	-4.61	6.37E-6	Height	
KIRP	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs11931061	chr4:56338793	SRD5A3	chr4:56212409-56237866:+	0.3	4.96	1.25E-6	Personality dimensions	
KIRP	cis	1	rs11931061	chr4:56338793	TMEM165	chr4:56262090-56292342:+	-0.24	-3.98	8.89E-5	Personality dimensions	
KIRP	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.56	5.56	6.7E-8	Crohn's disease	
KIRP	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.57	5.64	4.44E-8	Crohn's disease	
KIRP	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.57	5.64	4.44E-8	Crohn's disease	
KIRP	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.75	-7.37	2.11E-12	Crohn's disease	
KIRP	cis	1	rs11973627	chr7:122056001	AASS	chr7:121713600-121784344:-	0.33	3.82	0.000166	Alzheimer disease and age of onset	
KIRP	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1	15.48	5.95E-39	Educational attainment (years of education)	
KIRP	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.89	1.73E-6	Obesity-related traits	
KIRP	cis	1	rs11976180	chr7:143741580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.47	1.04E-7	Obesity-related traits	
KIRP	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.24	1.68E-9	Body mass index	
KIRP	cis	1	rs12021587	chr1:46472759	MUTYH	chr1:45794915-45806142:-	0.16	3.91	0.000119	Body mass index	
KIRP	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.45	4.74	3.55E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.45	4.74	3.55E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs1203156	chr6:88079694	C6orf162	chr6:88032306-88052043:+	-0.28	-4.33	2.15E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs12037222	chr1:40064961	OXCT2	chr1:40235197-40237020:-	0.38	4.77	3.01E-6	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRP	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.46	4.82	2.4E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.24	1.68E-9	Body mass index	
KIRP	cis	1	rs12049588	chr1:46472422	MUTYH	chr1:45794915-45806142:-	0.16	3.91	0.000119	Body mass index	
KIRP	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.58	5.68	3.59E-8	Crohn's disease	
KIRP	cis	1	rs12091720	chr1:76186949	ACADM	chr1:76190043-76229353:+	0.22	5.06	7.94E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs12092054	chr1:227744249	JMJD4	chr1:227918891-227923112:-	0.23	4.27	2.74E-5	Height	
KIRP	cis	1	rs12093031	chr1:227743875	JMJD4	chr1:227918891-227923112:-	-0.21	-4.16	4.38E-5	Height	
KIRP	cis	1	rs12099085	chr11:63666944	STIP1	chr11:63953587-63972020:+	-0.5	-4.17	4.09E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs12101597	chr15:65935195	DPP8	chr15:65737999-65810035:-	-0.12	-4.57	7.44E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs12120182	chr1:227814332	JMJD4	chr1:227918891-227923112:-	0.21	3.99	8.68E-5	Height	
KIRP	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.45	4.74	3.55E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs12123977	chr1:76209754	ACADM	chr1:76190043-76229353:+	-0.22	-4.64	5.45E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs12123996	chr1:227745090	JMJD4	chr1:227918891-227923112:-	0.23	4.27	2.74E-5	Height	
KIRP	cis	1	rs12126607	chr1:76217097	ACADM	chr1:76190043-76229353:+	0.2	4.75	3.27E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.44	4.56	7.94E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs12127402	chr1:76205643	ACADM	chr1:76190043-76229353:+	0.21	4.97	1.21E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.31	4.32	2.22E-5	Inflammatory skin disease	
KIRP	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.45	4.8	2.66E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.46	5.04	8.65E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.94	8.8E-9	Body mass index	
KIRP	cis	1	rs12139630	chr1:46350935	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000144	Body mass index	
KIRP	cis	1	rs12140848	chr1:227776942	JMJD4	chr1:227918891-227923112:-	0.22	4.11	5.28E-5	Height	
KIRP	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs12144263	chr1:46352446	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.49	-7.08	1.32E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs12158906	chr22:18437382	MICAL3	chr22:18270418-18507325:-	-0.24	-4	8.13E-5	Presence of antiphospholipid antibodies	
KIRP	cis	1	rs12185102	chr15:75352201	MAN2C1	chr15:75648135-75660941:-	0.22	4.01	7.84E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.3	4.43	1.36E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs12190146	chr6:159414155	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.5	-7.14	9.16E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.56	-8.22	9.16E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.53	-7.54	7.32E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.57	-7.93	6.08E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.56	-7.78	1.59E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12196526	chr6:55955754	COL21A1	chr6:55921389-56258892:-	0.31	4.03	7.41E-5	Psychosis (atypical)	
KIRP	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.32	-5.35	1.87E-7	Height	
KIRP	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.33	5.94	8.89E-9	Height	
KIRP	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.53	-7.82	1.28E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.53	-7.94	5.6E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.54	-7.79	1.56E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.55	-7.96	5.17E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.5	-7.29	3.58E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.5	-7.39	1.93E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.49	-7.08	1.32E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.26	-4.18	3.94E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.17	4.72	3.79E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs12202783	chr6:159388629	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12203483	chr6:159386228	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.55	-7.86	9.78E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.55	-7.86	9.78E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.58	-9.06	2.99E-17	Response to antipsychotic treatment	
KIRP	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.5	-7.4	1.8E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.54	-7.78	1.61E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.59	-8.14	1.53E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.53	-7.94	5.6E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.5	-7.53	8.02E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12207795	chr6:159366261	RSPH3	chr6:159398268-159421198:-	0.35	4.12	5.1E-5	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.54	-7.82	1.29E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12208892	chr6:159371192	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12208901	chr6:159371238	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.54	-7.78	1.61E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12210218	chr6:159377219	RSPH3	chr6:159398268-159421198:-	0.41	4.8	2.66E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.56	-8.19	1.09E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12212796	chr6:132565773	ENPP3	chr6:131949582-132068549:+	-0.28	-3.96	9.49E-5	Thrombomodulin levels in ischemic stroke	
KIRP	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.54	-7.82	1.29E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs12213434	chr6:159369128	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.5	-7.45	1.33E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs12214813	chr6:159362013	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12214878	chr6:159362118	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.59	-8.2	1.01E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.46	-6.68	1.44E-10	Response to antipsychotic treatment	
KIRP	cis	1	rs12215936	chr6:159371324	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.56	-8.23	8.81E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.56	-8.27	6.47E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs12216499	chr6:159368524	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs12220311	chr10:79681507	DLG5	chr10:79550551-79686348:-	0.27	4.54	8.44E-6	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs12220328	chr10:79681482	DLG5	chr10:79550551-79686348:-	0.25	4.36	1.85E-5	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-1	-9.99	3.64E-20	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs12220902	chr10:79682918	DLG5	chr10:79550551-79686348:-	0.25	4.26	2.86E-5	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.25	4.09	5.78E-5	Pancreatic cancer	
KIRP	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.25	-3.87	0.000135	Educational attainment;Height;Head circumference (infant)	
KIRP	cis	1	rs12299125	chr12:123862447	PITPNM2	chr12:123468027-123635285:-	-0.3	-4.12	5.12E-5	Educational attainment;Height;Head circumference (infant)	
KIRP	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.25	-4.4	1.58E-5	Colorectal cancer	
KIRP	cis	1	rs12303914	chr12:10471050	KLRD1	chr12:10457050-10469849:+	-0.25	-4.19	3.83E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRP	cis	1	rs12309274	chr12:975948	RAD52	chr12:1021255-1099219:-	-0.24	-3.87	0.000136	Colorectal cancer	
KIRP	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.21	-3.87	0.000139	Colorectal cancer	
KIRP	cis	1	rs12324912	chr15:75361006	MAN2C1	chr15:75648135-75660941:-	0.25	4.62	5.98E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.35	5.17	4.62E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.55E-5	Body mass index	
KIRP	cis	1	rs12329875	chr21:30137796	N6AMT1	chr21:30244513-30257693:-	-0.31	-3.81	0.000174	Cognitive test performance	
KIRP	cis	1	rs12342831	chr9:33124872	B4GALT1	chr9:33110639-33167356:-	-0.36	-4.32	2.22E-5	IgG glycosylation	
KIRP	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs12361031	chr11:47783076	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.53	-6.81	6.59E-11	Subjective well-being	
KIRP	cis	1	rs12372990	chr15:24840137	PWRN1	chr15:24778839-24832924:+	0.27	3.88	0.000134	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.06	4.63E-9	Body mass index	
KIRP	cis	1	rs12405451	chr1:46384326	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000145	Body mass index	
KIRP	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.97	7.61E-9	Body mass index	
KIRP	cis	1	rs12409773	chr1:46358831	MUTYH	chr1:45794915-45806142:-	0.17	4.05	6.74E-5	Body mass index	
KIRP	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.05	4.89E-9	Body mass index	
KIRP	cis	1	rs12410071	chr1:46358886	MUTYH	chr1:45794915-45806142:-	0.17	4.05	6.8E-5	Body mass index	
KIRP	cis	1	rs12410657	chr1:47278471	CYP4A22	chr1:47603107-47614526:+	0.38	3.96	9.75E-5	Blood metabolite levels	
KIRP	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.98	7.11E-9	Body mass index	
KIRP	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.51	-8.13	1.67E-14	Arsenic metabolism	
KIRP	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.13	9.45E-12	Subjective well-being	
KIRP	cis	1	rs12418852	chr11:47868853	PSMC3	chr11:47440320-47448024:-	0.2	3.9	0.000122	Subjective well-being	
KIRP	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.47	6.27	1.43E-9	Subjective well-being	
KIRP	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs12421210	chr11:47779586	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs12422267	chr12:132601596	DDX51	chr12:132621142-132628880:-	0.52	4.26	2.8E-5	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRP	cis	1	rs12422267	chr12:132601596	EP400NL	chr12:132568828-132600084:+;chr12	-0.54	-5.08	6.99E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRP	cis	1	rs1242229	chr11:117062370	PCSK7	chr11:117075789-117102811:-	-0.39	-4.21	3.43E-5	Protein quantitative trait loci	
KIRP	cis	1	rs12425655	chr12:63434463	TMEM5	chr12:64173637-64202887:+	0.27	3.84	0.000154	Hemostatic factors and hematological phenotypes	
KIRP	cis	1	rs12428	chr20:25433821	ENTPD6	chr20:25176339-25207360:+	0.36	6.39	7.43E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs12428	chr20:25433821	FAM182B	chr20:25744102-25848786:-	-0.31	-4.4	1.59E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1243704	chr14:21005062	SUPT16H	chr14:21819631-21852425:-	0.46	3.84	0.000151	Immune response to measles-mumps-rubella vaccine	
KIRP	cis	1	rs12437310	chr14:76642757	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000165	Blood pressure	
KIRP	cis	1	rs12442510	chr15:66099113	DPP8	chr15:65737999-65810035:-	0.13	4.82	2.46E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.45	-6.36	8.96E-10	Tumor biomarkers	
KIRP	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.4	-6.6	2.26E-10	Tumor biomarkers	
KIRP	cis	1	rs12443102	chr15:43932103	LCMT2	chr15:43619976-43622891:-	-0.33	-4	8.08E-5	Tumor biomarkers	
KIRP	cis	1	rs12445650	chr16:31044897	HSD3B7	chr16:30996519-31000473:+	0.29	5.78	2.04E-8	Response to metformin (IC50)	
KIRP	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.2	4.2	3.6E-5	Response to metformin (IC50)	
KIRP	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.45	4.9	1.67E-6	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
KIRP	cis	1	rs12451721	chr17:65939075	LOC440461	chr17:66194801-66196436:+	0.33	3.96	9.56E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs12463617	chr2:629244	SNTG2	chr2:946555-1371382:+	-0.49	-4.88	1.8E-6	Body mass index	
KIRP	cis	1	rs12470837	chr2:132582511	C2orf27A	chr2:132480064-132524977:+	0.33	3.85	0.000148	Cerebrospinal fluid clusterin levels in APOEe4+ carriers;Cerebrospinal fluid clusterin levels	
KIRP	cis	1	rs12470864	chr2:102926362	IL1RL1	chr2:102927962-102968497:+	-0.29	-4.06	6.37E-5	Serum protein levels (sST2)	
KIRP	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.45	-3.83	0.00016	Plasma clusterin levels	
KIRP	cis	1	rs12478744	chr2:23947589	LOC375190	chr2:24299728-24397519:+	0.21	4.48	1.11E-5	Obesity-related traits	
KIRP	cis	1	rs12479210	chr2:102949161	IL1RL1	chr2:102927962-102968497:+	-0.29	-4.06	6.55E-5	Serum protein levels (sST2)	
KIRP	cis	1	rs12483517	chr21:42691920	FAM3B	chr21:42676177-42729654:+	0.41	5.48	9.8E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRP	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs12488768	chr3:53086234	SFMBT1	chr3:52938628-53080070:-	0.42	6.71	1.15E-10	Ulcerative colitis	
KIRP	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.34	6.29	1.29E-9	Height	
KIRP	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.29	4.41	1.49E-5	Height	
KIRP	cis	1	rs12505835	chr4:297525	ZNF718	chr4:53272-156488:+	0.28	3.98	8.91E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs12511282	chr4:70328682	UGT2B11	chr4:70066053-70080449:-	0.28	4.04	7.01E-5	Bacteremia	
KIRP	cis	1	rs12511991	chr4:48422768	CNGA1	chr4:47937996-48018610:-	0.24	3.87	0.000138	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs12524423	chr6:159375364	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12524835	chr6:33730843	WDR46	chr6:33246886-33256991:-	-0.27	-3.82	0.000169	Body mass index	
KIRP	cis	1	rs12527396	chr6:159389017	RSPH3	chr6:159398268-159421198:-	0.44	5	1.04E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.29	1.27E-9	Body mass index	
KIRP	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.99	6.99E-9	Body mass index	
KIRP	cis	1	rs12564541	chr1:46380237	MUTYH	chr1:45794915-45806142:-	0.16	3.87	0.000136	Body mass index	
KIRP	cis	1	rs12567463	chr1:152180128	HRNR	chr1:152184558-152196669:-	-0.37	-3.95	0.000101	Atopic dermatitis	
KIRP	cis	1	rs1257200	chr2:135036696	TMEM163	chr2:135213331-135525334:-	0.27	4.61	6.15E-6	Multiple sclerosis (severity)	
KIRP	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.36	-5.21	3.87E-7	Forced vital capacity	
KIRP	cis	1	rs12583	chr3:49571462	NCKIPSD	chr3:48711280-48723334:-	-0.31	-4.23	3.18E-5	Menarche (age at onset)	
KIRP	cis	1	rs12583	chr3:49571462	P4HTM	chr3:49027341-49044579:+	-0.24	-4.31	2.35E-5	Menarche (age at onset)	
KIRP	cis	1	rs12587386	chr14:88827764	SPATA7	chr14:88852012-88904802:+	-0.26	-3.84	0.000151	Coronary artery calcification	
KIRP	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.21	4.43	1.36E-5	Height	
KIRP	cis	1	rs12588240	chr14:75612083	RPS6KL1	chr14:75372347-75389958:-	0.22	3.98	9.04E-5	Height	
KIRP	cis	1	rs12590407	chr14:24835115	CBLN3	chr14:24895742-24898731:-	-0.29	-4.19	3.82E-5	Height	
KIRP	cis	1	rs12593261	chr15:91520319	UNC45A	chr15:91473410-91497322:+	0.24	4.64	5.51E-6	Type 2 diabetes	
KIRP	cis	1	rs12594061	chr15:66046429	DPP8	chr15:65737999-65810035:-	-0.12	-4.39	1.65E-5	Mean corpuscular hemoglobin	
KIRP	cis	1	rs12600941	chr17:65918807	LOC440461	chr17:66194801-66196436:+	0.33	3.96	9.56E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs12602286	chr17:19236954	RNF112	chr17:19314523-19320587:+	-0.38	-4.61	6.29E-6	Schizophrenia	
KIRP	cis	1	rs12602655	chr17:65909442	LOC440461	chr17:66194801-66196436:+	0.33	3.96	9.56E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.25	-4.29	2.53E-5	Fibrinogen levels	
KIRP	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.24	-4.24	3.03E-5	Fibrinogen levels	
KIRP	cis	1	rs12608504	chr19:18389135	JUND	chr19:18390563-18392432:-	-0.22	-4.14	4.7E-5	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs12608504	chr19:18389135	KIAA1683	chr19:18367906-18385319:-	-0.32	-5.51	8.41E-8	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs12610373	chr19:18398284	JUND	chr19:18390563-18392432:-	-0.22	-4.16	4.32E-5	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs12610373	chr19:18398284	KIAA1683	chr19:18367906-18385319:-	-0.33	-5.74	2.61E-8	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs12617717	chr2:86342303	LOC90784	chr2:86247339-86250991:-	-0.45	-4.3	2.37E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs12618392	chr2:135067102	TMEM163	chr2:135213331-135525334:-	0.23	3.88	0.000132	Multiple sclerosis (severity)	
KIRP	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.43	-4.17	4.1E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs12623832	chr2:192125644	MYO1B	chr2:192110107-192290115:+	0.3	4.93	1.45E-6	Obesity-related traits	
KIRP	cis	1	rs12627787	chr22:51012381	CPT1B	chr22:51007291-51017096:-	-0.32	-4.75	3.33E-6	Narcolepsy	
KIRP	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.94	13.34	2.09E-31	Diastolic blood pressure	
KIRP	cis	1	rs12643926	chr4:56310621	SRD5A3	chr4:56212409-56237866:+	0.31	4.99	1.11E-6	Personality dimensions	
KIRP	cis	1	rs12643926	chr4:56310621	TMEM165	chr4:56262090-56292342:+	-0.25	-3.96	9.78E-5	Personality dimensions	
KIRP	cis	1	rs12646078	chr4:56368204	SRD5A3	chr4:56212409-56237866:+	0.3	4.66	5.05E-6	Personality dimensions	
KIRP	cis	1	rs12648383	chr4:55009315	PDGFRA	chr4:54243820-55164411:+	-0.26	-3.86	0.000141	Lupus nephritis in systemic lupus erythematosus	
KIRP	cis	1	rs12649527	chr4:48376802	CNGA1	chr4:47937996-48018610:-	-0.23	-3.83	0.000159	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.77	7.41	1.73E-12	Crohn's disease	
KIRP	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.78	6.7	1.26E-10	Crohn's disease	
KIRP	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.74	6.5	3.95E-10	Crohn's disease	
KIRP	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.74	6.13	3.13E-9	Crohn's disease	
KIRP	cis	1	rs12659961	chr5:110187004	TMEM232	chr5:109624934-110062381:-	0.3	4.16	4.24E-5	Asthma and hay fever	
KIRP	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.57	-7.89	8.09E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12661334	chr6:51624658	PAQR8	chr6:52226926-52272574:+	-0.29	-3.87	0.000139	Prostate cancer	
KIRP	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.5	-7.4	1.8E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.48	6.88	4.24E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.55	7.87	9.31E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.59	-8.14	1.53E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs12675542	chr8:29986454	MBOAT4	chr8:29989188-30002200:-	-0.47	-5.06	7.82E-7	Migraine	
KIRP	cis	1	rs12681963	chr8:29982518	MBOAT4	chr8:29989188-30002200:-	-0.46	-4.53	8.87E-6	Migraine	
KIRP	cis	1	rs12714414	chr2:651407	SNTG2	chr2:946555-1371382:+	0.39	4.15	4.57E-5	Body mass index	
KIRP	cis	1	rs12714415	chr2:651430	SNTG2	chr2:946555-1371382:+	0.4	4.14	4.63E-5	Body mass index	
KIRP	cis	1	rs12733173	chr1:152173972	FLG2	chr1:152321214-152332482:-	0.27	3.89	0.000126	Inflammatory skin disease	
KIRP	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.3	4.25	2.95E-5	Inflammatory skin disease	
KIRP	cis	1	rs12740374	chr1:109817590	PSRC1	chr1:109822179-109825808:-	0.4	6.69	1.3E-10	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
KIRP	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.43	-6.33	1.01E-9	Body mass index	
KIRP	cis	1	rs12768834	chr10:74043874	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.41E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs12774134	chr10:4963327	AKR1C2	chr10:4964715-5060207:-	0.8	7.14	8.75E-12	Height	
KIRP	cis	1	rs12786214	chr11:64364203	SLC22A12	chr11:64358282-64369820:+	-0.24	-4.31	2.31E-5	Urate levels in obese individuals	
KIRP	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.54	-7.2	6.12E-12	Subjective well-being	
KIRP	cis	1	rs12787330	chr11:47812311	PSMC3	chr11:47440320-47448024:-	0.2	3.92	0.000114	Subjective well-being	
KIRP	cis	1	rs12806663	chr11:62001414	ASRGL1	chr11:62104774-62160885:+	0.24	4.01	7.75E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRP	cis	1	rs12811063	chr12:81440720	LIN7A	chr12:81191171-81331694:-	-0.27	-4.08	5.99E-5	Neuroticism	
KIRP	cis	1	rs12826808	chr12:15323380	RERG	chr12:15260718-15374304:-	0.34	4.79	2.76E-6	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs12827398	chr12:81445457	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.28	4.97	1.22E-6	IgG glycosylation	
KIRP	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.28	-4.89	1.77E-6	IgG glycosylation	
KIRP	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.2	4.21	3.45E-5	Height	
KIRP	cis	1	rs12889309	chr14:75593902	RPS6KL1	chr14:75372347-75389958:-	0.23	4.01	7.97E-5	Height	
KIRP	cis	1	rs12897094	chr14:75579416	RPS6KL1	chr14:75372347-75389958:-	0.22	3.88	0.000131	Height	
KIRP	cis	1	rs12898259	chr15:75369780	MAN2C1	chr15:75648135-75660941:-	0.25	4.69	4.3E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.33	5.01	1.02E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12898311	chr15:91517780	UNC45A	chr15:91473410-91497322:+	0.22	4.22	3.29E-5	Type 2 diabetes	
KIRP	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.38	-5.82	1.73E-8	Schizophrenia	
KIRP	cis	1	rs12900061	chr15:66009248	DPP8	chr15:65737999-65810035:-	-0.14	-4.27	2.73E-5	Educational attainment (years of education)	
KIRP	cis	1	rs12901243	chr15:75374233	MAN2C1	chr15:75648135-75660941:-	0.25	4.74	3.45E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.33	4.95	1.32E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.39	-5.85	1.41E-8	Schizophrenia	
KIRP	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.37	-5.68	3.45E-8	Schizophrenia	
KIRP	cis	1	rs12903201	chr15:75370776	MAN2C1	chr15:75648135-75660941:-	0.25	4.69	4.3E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.33	5.01	1.02E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.39	-5.85	1.41E-8	Schizophrenia	
KIRP	cis	1	rs12904329	chr15:24839870	PWRN1	chr15:24778839-24832924:+	0.27	3.88	0.000134	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.36	-5.37	1.76E-7	Schizophrenia	
KIRP	cis	1	rs12906196	chr15:65884888	DPP8	chr15:65737999-65810035:-	-0.13	-4.77	2.99E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs12906542	chr15:78269472	LOC91450	chr15:78285576-78286567:-	-0.33	-4.2	3.68E-5	Breast cancer	
KIRP	cis	1	rs12907914	chr15:39315358	THBS1	chr15:39873280-39889667:+	0.34	5.57	6.18E-8	Cardiac hypertrophy	
KIRP	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.35	-5.2	3.99E-7	Schizophrenia	
KIRP	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.38	-5.76	2.37E-8	Schizophrenia	
KIRP	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.38	-5.82	1.73E-8	Schizophrenia	
KIRP	cis	1	rs12910644	chr15:75358388	MAN2C1	chr15:75648135-75660941:-	0.24	4.28	2.58E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.32	4.56	7.68E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs12910992	chr15:90372465	ANPEP	chr15:90328127-90358072:-	0.21	4.08	5.9E-5	Type 2 diabetes	
KIRP	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.71	-11.5	4.38E-25	Type 2 diabetes	
KIRP	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.37	-5.79	1.99E-8	Schizophrenia	
KIRP	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.37	-5.68	3.45E-8	Schizophrenia	
KIRP	cis	1	rs12914857	chr15:84581166	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.41	-6.06	4.67E-9	Schizophrenia	
KIRP	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.41	-6.03	5.5E-9	Schizophrenia	
KIRP	cis	1	rs12940106	chr17:53067683	TOM1L1	chr17:52978052-53039328:+	-0.23	-3.99	8.57E-5	Breast cancer	
KIRP	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.49	8.09	2.17E-14	Eye color traits	
KIRP	cis	1	rs1296028	chr8:11698747	CTSB	chr8:11700036-11725646:-	0.25	4.77	2.98E-6	Parkinson's disease	
KIRP	cis	1	rs12973620	chr19:58249643	ZNF548	chr19:57901218-57912785:+	-0.28	-4.02	7.5E-5	Allergic rhinitis	
KIRP	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.37	-4.07	6.31E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs12980403	chr19:18398139	JUND	chr19:18390563-18392432:-	-0.22	-4.16	4.32E-5	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs12980403	chr19:18398139	KIAA1683	chr19:18367906-18385319:-	-0.33	-5.74	2.61E-8	Waist-to-hip ratio adjusted for body mass index	
KIRP	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.37	-3.97	9.14E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs12995666	chr2:629959	SNTG2	chr2:946555-1371382:+	-0.42	-3.97	9.4E-5	Body mass index	
KIRP	cis	1	rs13001325	chr2:102939036	IL1RL1	chr2:102927962-102968497:+	-0.29	-4.06	6.55E-5	Serum protein levels (sST2)	
KIRP	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.4	6.51	3.85E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs13006833	chr2:191205499	HIBCH	chr2:191069361-191184559:-	0.42	8.81	1.7E-16	Urinary metabolites	
KIRP	cis	1	rs13007080	chr2:630024	SNTG2	chr2:946555-1371382:+	-0.43	-4.01	8.01E-5	Body mass index	
KIRP	cis	1	rs13007086	chr2:630034	SNTG2	chr2:946555-1371382:+	-0.43	-4.01	8.01E-5	Body mass index	
KIRP	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.42	5.44	1.23E-7	Inflammatory skin disease	
KIRP	cis	1	rs13012571	chr2:632550	SNTG2	chr2:946555-1371382:+	0.42	4	8.17E-5	Body mass index	
KIRP	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.31	-5.15	5.06E-7	Melanoma;Esophageal squamous cell carcinoma	
KIRP	cis	1	rs13019081	chr2:102950822	IL1RL1	chr2:102927962-102968497:+	0.29	4.06	6.55E-5	Serum protein levels (sST2)	
KIRP	cis	1	rs13021737	chr2:632348	SNTG2	chr2:946555-1371382:+	-0.42	-3.96	9.46E-5	Body mass index	
KIRP	cis	1	rs13026475	chr2:239178455	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.29E-6	Irritable bowel syndrome	
KIRP	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.36	4.84	2.17E-6	Inflammatory skin disease	
KIRP	cis	1	rs13033501	chr2:239181860	LOC151174	chr2:239133754-239140318:-	0.49	4.52	9.14E-6	Irritable bowel syndrome	
KIRP	cis	1	rs13038834	chr20:25441433	ENTPD6	chr20:25176339-25207360:+	-0.32	-5.33	2.1E-7	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs13038834	chr20:25441433	FAM182B	chr20:25744102-25848786:-	0.3	4.07	6.21E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.88	1.22E-8	Height	
KIRP	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.3	-4.56	7.82E-6	Height	
KIRP	cis	1	rs13067306	chr3:94243713	STX19	chr3:93733215-93747454:-	0.52	6.13	3.24E-9	Blood pressure measurement (high sodium intervention)	
KIRP	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.38	4	8.23E-5	Immune reponse to smallpox (secreted IL-2)	
KIRP	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.28	-6.08	4.09E-9	Longevity	
KIRP	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.86	1.36E-8	Height	
KIRP	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.79E-6	Height	
KIRP	cis	1	rs13074025	chr3:38455704	EXOG	chr3:38537763-38567796:+	-0.16	-3.85	0.00015	Electrocardiographic conduction measures	
KIRP	cis	1	rs13074160	chr3:38455650	EXOG	chr3:38537763-38567796:+	-0.16	-3.94	0.000103	Electrocardiographic conduction measures	
KIRP	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.26	-5.62	4.75E-8	Longevity	
KIRP	cis	1	rs13079757	chr3:38491444	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000138	Electrocardiographic conduction measures	
KIRP	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.32	-5.67	3.66E-8	Height	
KIRP	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.75E-6	Height	
KIRP	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.89	1.14E-8	Height	
KIRP	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.82E-6	Height	
KIRP	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.37	6.05	4.84E-9	Cognitive performance	
KIRP	cis	1	rs13085791	chr3:49721798	DOCK3	chr3:50712672-51421628:+	-0.28	-4.25	2.94E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs13085791	chr3:49721798	RBM6	chr3:49977592-50137484:+	0.16	4.55	8.21E-6	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs13085791	chr3:49721798	UBA7	chr3:49842639-49851391:-	0.35	6.21	2.01E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs13086611	chr3:49385417	RBM6	chr3:49977592-50137484:+	0.14	3.96	9.45E-5	Educational attainment	
KIRP	cis	1	rs13086611	chr3:49385417	UBA7	chr3:49842639-49851391:-	0.34	6.14	3.08E-9	Educational attainment	
KIRP	cis	1	rs13087299	chr3:94229344	STX19	chr3:93733215-93747454:-	0.55	6.39	7.58E-10	Blood pressure measurement (high sodium intervention)	
KIRP	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.4	6.54	3.14E-10	Cognitive performance	
KIRP	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.96	-14.41	3.75E-35	Diastolic blood pressure	
KIRP	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs13088309	chr3:49368317	NCKIPSD	chr3:48711280-48723334:-	0.33	4.6	6.5E-6	Menarche (age at onset)	
KIRP	cis	1	rs13088309	chr3:49368317	P4HTM	chr3:49027341-49044579:+	0.22	3.91	0.000115	Menarche (age at onset)	
KIRP	cis	1	rs13088455	chr3:53087482	SFMBT1	chr3:52938628-53080070:-	0.42	6.71	1.15E-10	Ulcerative colitis	
KIRP	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.1	3.84E-9	Height	
KIRP	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.29	-4.43	1.35E-5	Height	
KIRP	cis	1	rs13090388	chr3:49391082	RBM6	chr3:49977592-50137484:+	0.16	4.54	8.51E-6	Educational attainment (years of education)	
KIRP	cis	1	rs13090388	chr3:49391082	UBA7	chr3:49842639-49851391:-	0.34	6.16	2.69E-9	Educational attainment (years of education)	
KIRP	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.86	1.36E-8	Height	
KIRP	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.79E-6	Height	
KIRP	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.24	-5.21	3.74E-7	Longevity	
KIRP	cis	1	rs13096474	chr3:49443081	NCKIPSD	chr3:48711280-48723334:-	-0.31	-4.37	1.8E-5	Menarche (age at onset)	
KIRP	cis	1	rs13096474	chr3:49443081	P4HTM	chr3:49027341-49044579:+	-0.24	-4.4	1.58E-5	Menarche (age at onset)	
KIRP	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.89	1.14E-8	Height	
KIRP	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.82E-6	Height	
KIRP	cis	1	rs13099	chr14:75599155	RPS6KL1	chr14:75372347-75389958:-	-0.22	-3.81	0.00017	Height	
KIRP	cis	1	rs13102385	chr4:56345255	SRD5A3	chr4:56212409-56237866:+	0.3	4.96	1.25E-6	Personality dimensions	
KIRP	cis	1	rs13102385	chr4:56345255	TMEM165	chr4:56262090-56292342:+	-0.24	-3.98	8.89E-5	Personality dimensions	
KIRP	cis	1	rs13105385	chr4:48404094	CNGA1	chr4:47937996-48018610:-	0.23	3.86	0.000141	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.45	-5.92	1.0E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.35	5.09	6.73E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.29	5.49	9.22E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13121235	chr4:56311947	SRD5A3	chr4:56212409-56237866:+	0.31	4.99	1.08E-6	Personality dimensions	
KIRP	cis	1	rs13121235	chr4:56311947	TMEM165	chr4:56262090-56292342:+	-0.24	-3.86	0.000142	Personality dimensions	
KIRP	cis	1	rs13123545	chr4:76535466	CDKL2	chr4:76501705-76555721:-	0.28	3.84	0.000154	Magnesium levels	
KIRP	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.34	4.98	1.14E-6	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.29	5.43	1.3E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.44	-5.89	1.18E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs13130784	chr4:70327454	UGT2B11	chr4:70066053-70080449:-	0.29	4.27	2.72E-5	Bacteremia	
KIRP	cis	1	rs13133311	chr4:88217223	HSD17B11	chr4:88257691-88312455:-	0.24	3.85	0.000148	Platelet count	
KIRP	cis	1	rs13136090	chr4:76534792	CDKL2	chr4:76501705-76555721:-	0.29	4.05	6.69E-5	Magnesium levels	
KIRP	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.38	5.4	1.46E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.28	5.08	7.01E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13141487	chr4:70327795	UGT2B11	chr4:70066053-70080449:-	0.32	4.55	8.33E-6	Bacteremia	
KIRP	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.34	4.98	1.14E-6	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.29	5.43	1.3E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.35	5.16	4.96E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13146880	chr4:48031499	NIPAL1	chr4:48018791-48039078:+	0.29	5.48	9.69E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13161048	chr5:148615269	AFAP1L1	chr5:148651401-148721365:+	-0.41	-5.14	5.24E-7	Body mass index	
KIRP	cis	1	rs1317140	chr3:49878652	RBM6	chr3:49977592-50137484:+	-0.14	-3.98	8.87E-5	Resting heart rate	
KIRP	cis	1	rs1317140	chr3:49878652	UBA7	chr3:49842639-49851391:-	-0.29	-5.26	2.99E-7	Resting heart rate	
KIRP	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.5	-6.42	6.2E-10	Subjective well-being	
KIRP	cis	1	rs13171669	chr5:148601243	AFAP1L1	chr5:148651401-148721365:+	0.42	5.32	2.16E-7	Body mass index	
KIRP	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.55	-7.83	1.2E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-1.12	-7.91	6.84E-14	Schizophrenia	
KIRP	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-1.12	-7.91	6.84E-14	Schizophrenia	
KIRP	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.59	-8.26	7.11E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs1320331	chr2:622161	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000137	Body mass index	
KIRP	cis	1	rs1320332	chr2:621954	SNTG2	chr2:946555-1371382:+	-0.41	-3.88	0.000133	Body mass index	
KIRP	cis	1	rs1320337	chr2:649867	SNTG2	chr2:946555-1371382:+	0.41	4.31	2.32E-5	Body mass index	
KIRP	cis	1	rs1320338	chr2:649347	SNTG2	chr2:946555-1371382:+	0.39	4.04	7.13E-5	Body mass index	
KIRP	cis	1	rs1320448	chr10:105846074	OBFC1	chr10:105637320-105678045:-	0.54	4.15	4.51E-5	Cardiac hypertrophy	
KIRP	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.92	1.54E-6	Obesity-related traits	
KIRP	cis	1	rs1320893	chr7:143752112	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.37	1.72E-7	Obesity-related traits	
KIRP	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.21	3.83E-7	Obesity-related traits	
KIRP	cis	1	rs1320894	chr7:143751802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.64	4.36E-8	Obesity-related traits	
KIRP	cis	1	rs13213582	chr6:151873896	C6orf97	chr6:151815175-151942327:+	0.44	4.11	5.26E-5	Bone mineral density (spine)	
KIRP	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.51	-7.68	3.06E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-1.11	-7.83	1.16E-13	Schizophrenia	
KIRP	cis	1	rs13222291	chr7:6517440	AIMP2	chr7:6048882-6063464:+	0.21	4.16	4.38E-5	Irritable bowel syndrome	
KIRP	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.31	-5.3	2.4E-7	Obesity-related traits	
KIRP	cis	1	rs13226728	chr7:143746578	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.79	2.02E-8	Obesity-related traits	
KIRP	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.31	-5.42	1.35E-7	Obesity-related traits	
KIRP	cis	1	rs13243677	chr7:143746572	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.96	8.13E-9	Obesity-related traits	
KIRP	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.26	3.85	0.00015	Diabetic kidney disease	
KIRP	cis	1	rs1325195	chr1:179071756	TOR3A	chr1:179051112-179065127:+	-0.19	-4	8.14E-5	IgE grass sensitization	
KIRP	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	1.02	21.9	2.17E-61	Bone mineral density	
KIRP	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	1.02	21.96	1.39E-61	Bone mineral density	
KIRP	cis	1	rs13256903	chr8:89596159	MMP16	chr8:89049462-89339717:-	0.3	4.17	4.16E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs13268482	chr8:89596484	MMP16	chr8:89049462-89339717:-	0.31	4.45	1.24E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000162	IFN-related cytopenia	
KIRP	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.27	5.98	7.39E-9	Longevity	
KIRP	cis	1	rs13316695	chr3:49684917	RBM6	chr3:49977592-50137484:+	0.15	4.42	1.46E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs13316695	chr3:49684917	UBA7	chr3:49842639-49851391:-	0.35	6.21	2.02E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.31	5.51	8.62E-8	Height	
KIRP	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.29	4.39	1.61E-5	Height	
KIRP	cis	1	rs13322887	chr3:49555583	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.27	2.78E-5	Menarche (age at onset)	
KIRP	cis	1	rs13322887	chr3:49555583	P4HTM	chr3:49027341-49044579:+	-0.25	-4.48	1.13E-5	Menarche (age at onset)	
KIRP	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.87	10.55	5.96E-22	Diastolic blood pressure	
KIRP	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.58	5.81	1.76E-8	Crohn's disease	
KIRP	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.5	-7.48	1.09E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.54	-7.78	1.61E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs13380863	chr17:61780793	FTSJ3	chr17:61896795-61905031:-	0.29	4.02	7.63E-5	Body mass index	
KIRP	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.31	4.14	4.59E-5	Metabolite levels	
KIRP	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.66	-10.98	2.33E-23	Prostate cancer	
KIRP	cis	1	rs13386517	chr2:650479	SNTG2	chr2:946555-1371382:+	0.39	4.04	7.13E-5	Body mass index	
KIRP	cis	1	rs13386627	chr2:650560	SNTG2	chr2:946555-1371382:+	0.39	4.04	7.13E-5	Body mass index	
KIRP	cis	1	rs13386964	chr2:650828	SNTG2	chr2:946555-1371382:+	-0.38	-4.04	7.1E-5	Body mass index	
KIRP	cis	1	rs13389859	chr2:171948875	GORASP2	chr2:171784982-171823639:+	0.27	3.94	0.000103	Cognitive performance	
KIRP	cis	1	rs13393304	chr2:637830	SNTG2	chr2:946555-1371382:+	-0.41	-3.92	0.000113	Body mass index	
KIRP	cis	1	rs13397165	chr2:653354	SNTG2	chr2:946555-1371382:+	0.37	3.84	0.000153	Body mass index	
KIRP	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.55	5.16	4.91E-7	Rheumatoid arthritis	
KIRP	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.3	3.98	8.97E-5	Metabolite levels	
KIRP	cis	1	rs13401686	chr2:650519	SNTG2	chr2:946555-1371382:+	0.39	4.04	7.13E-5	Body mass index	
KIRP	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.46	-5.29	2.63E-7	Rheumatoid arthritis	
KIRP	cis	1	rs13408569	chr2:102955056	IL1RL1	chr2:102927962-102968497:+	0.41	5.07	7.46E-7	Asthma	
KIRP	cis	1	rs13408661	chr2:102955082	IL1RL1	chr2:102927962-102968497:+	0.41	5.07	7.46E-7	Asthma	
KIRP	cis	1	rs13412194	chr2:653245	SNTG2	chr2:946555-1371382:+	0.38	3.95	9.93E-5	Body mass index	
KIRP	cis	1	rs13412197	chr2:653250	SNTG2	chr2:946555-1371382:+	0.38	3.95	9.93E-5	Body mass index	
KIRP	cis	1	rs13415094	chr2:653093	SNTG2	chr2:946555-1371382:+	0.4	4.15	4.42E-5	Body mass index	
KIRP	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.3	3.92	0.000113	Metabolite levels	
KIRP	cis	1	rs13424612	chr2:240900121	NDUFA10	chr2:240900158-240964798:-	0.23	4.06	6.59E-5	Odorant perception (isobutyraldehyde)	
KIRP	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.38	5.06	7.71E-7	Metabolite levels	
KIRP	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.3	3.95	0.000101	Metabolite levels	
KIRP	cis	1	rs13431828	chr2:102954653	IL1RL1	chr2:102927962-102968497:+	0.41	5.07	7.46E-7	Asthma	
KIRP	cis	1	rs13437605	chr6:118899014	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000167	Renal cell carcinoma	
KIRP	cis	1	rs134869	chr22:42652074	C22orf32	chr22:42475699-42480287:+	0.16	4.05	6.78E-5	Cognitive function	
KIRP	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.19	-3.88	0.000129	Cognitive function	
KIRP	cis	1	rs134869	chr22:42652074	NAGA	chr22:42454339-42466846:-	0.34	4.98	1.16E-6	Cognitive function	
KIRP	cis	1	rs134869	chr22:42652074	WBP2NL	chr22:42120334-42454460:+	0.28	3.96	9.81E-5	Cognitive function	
KIRP	cis	1	rs134873	chr22:42657566	C22orf32	chr22:42475699-42480287:+	0.17	4.17	4.07E-5	Cognitive function	
KIRP	cis	1	rs134873	chr22:42657566	NAGA	chr22:42454339-42466846:-	0.34	4.99	1.11E-6	Cognitive function	
KIRP	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.2	-4.05	6.76E-5	Cognitive function	
KIRP	cis	1	rs134882	chr22:42670965	NAGA	chr22:42454339-42466846:-	0.33	4.82	2.38E-6	Cognitive function	
KIRP	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.2	-4.4	1.54E-5	Cognitive function	
KIRP	cis	1	rs134900	chr22:42683343	NAGA	chr22:42454339-42466846:-	0.28	4.14	4.58E-5	Cognitive function	
KIRP	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.18	-3.91	0.000116	Cognitive function	
KIRP	cis	1	rs1352433	chr4:48393680	CNGA1	chr4:47937996-48018610:-	-0.23	-3.86	0.000141	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs1354181	chr16:55607809	LPCAT2	chr16:55542913-55620581:+	-0.2	-3.89	0.000125	Thyroid hormone levels	
KIRP	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.4	4.2	3.59E-5	Migraine	
KIRP	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.34	6.19	2.34E-9	Height	
KIRP	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.29	4.49	1.07E-5	Height	
KIRP	cis	1	rs1358894	chr10:96681133	C10orf129	chr10:96953957-96988685:+	0.78	7.35	2.45E-12	Blood metabolite levels	
KIRP	cis	1	rs1369313	chr15:66084255	DPP8	chr15:65737999-65810035:-	-0.12	-4.47	1.14E-5	Mean corpuscular hemoglobin	
KIRP	cis	1	rs1371135	chr15:90391270	ANPEP	chr15:90328127-90358072:-	0.21	3.99	8.52E-5	Type 2 diabetes	
KIRP	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.76	-12.21	1.73E-27	Type 2 diabetes	
KIRP	cis	1	rs1375131	chr2:135954797	TMEM163	chr2:135213331-135525334:-	-0.34	-5.5	8.9E-8	Body mass index;Blood metabolite levels;Cholesterol, total	
KIRP	cis	1	rs1383251	chr3:51366840	HEMK1	chr3:50606583-50622419:+	0.26	3.93	0.000107	Melanoma	
KIRP	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.23	-4.07	6.13E-5	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.42	-4.46	1.19E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs1390968	chr14:52517629	NID2	chr14:52471521-52535946:-	0.35	5.71	2.99E-8	Pulmonary function	
KIRP	cis	1	rs1393258	chr16:55608032	LPCAT2	chr16:55542913-55620581:+	-0.21	-4.12	5.13E-5	Thyroid hormone levels	
KIRP	cis	1	rs13943	chr22:22116202	TOP3B	chr22:22311404-22337193:-	-0.19	-4.29	2.52E-5	Multiple sclerosis	
KIRP	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.24	-4.13	4.94E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.21	4.05	6.81E-5	Diabetic kidney disease	
KIRP	cis	1	rs1409005	chr13:79155612	SLAIN1	chr13:78272470-78338377:+	0.41	4.02	7.57E-5	Serum thyroid-stimulating hormone levels	
KIRP	cis	1	rs1409360	chr10:91385304	FLJ37201	chr10:91451057-91457685:-	-0.3	-3.84	0.000152	Metabolic traits	
KIRP	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.23	-4.07	6.13E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.55	-7.86	9.78E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs1420101	chr2:102957716	IL1RL1	chr2:102927962-102968497:+	-0.29	-4.19	3.86E-5	Serum protein levels (sST2)	
KIRP	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.65	8.84	1.41E-16	Type 2 diabetes	
KIRP	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.64	8.82	1.6E-16	Type 2 diabetes	
KIRP	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.47	4.64	5.58E-6	Crohn's disease	
KIRP	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.45	4.4	1.6E-5	Crohn's disease	
KIRP	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.49	4.83	2.33E-6	Crohn's disease	
KIRP	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.46	-4.7	4.1E-6	Crohn's disease	
KIRP	cis	1	rs1435964	chr12:81542215	LIN7A	chr12:81191171-81331694:-	-0.27	-4.28	2.57E-5	Response to antidepressant treatment (citalopram)	
KIRP	cis	1	rs1440133	chr4:46201920	GABRA2	chr4:46251581-46392421:-	-0.26	-4.25	3.0E-5	Epilepsy	
KIRP	cis	1	rs144073979	chr22:18886814	DGCR6	chr22:18893541-18899600:+	-0.42	-3.9	0.000124	3-hydroxypropylmercapturic acid levels in smokers	
KIRP	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.42	-4.57	7.6E-6	Menarche (age at onset)	
KIRP	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.42	-4.57	7.6E-6	Menarche (age at onset)	
KIRP	cis	1	rs1454749	chr2:192105635	MYO1B	chr2:192110107-192290115:+	-0.34	-5.6	5.44E-8	Obesity-related traits	
KIRP	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.26	5.65	4.04E-8	Longevity	
KIRP	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.42	-4.58	7.22E-6	Menarche (age at onset)	
KIRP	cis	1	rs1464569	chr3:49460350	NCKIPSD	chr3:48711280-48723334:-	0.29	4.23	3.17E-5	Menarche (age at onset)	
KIRP	cis	1	rs1464569	chr3:49460350	P4HTM	chr3:49027341-49044579:+	0.24	4.54	8.58E-6	Menarche (age at onset)	
KIRP	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.4	-7.15	8.6E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs1469712	chr19:19528821	HAPLN4	chr19:19366453-19384074:-	0.24	3.86	0.000141	Schizophrenia	
KIRP	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.22	-3.9	0.000121	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs1471552	chr15:84570734	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1471553	chr15:84571038	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.23	-4.07	6.13E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs1480823	chr15:84585746	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1480827	chr15:84577792	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs148734725	chr3:49406708	RBM6	chr3:49977592-50137484:+	0.16	4.68	4.53E-6	Educational attainment (college completion)	
KIRP	cis	1	rs148734725	chr3:49406708	UBA7	chr3:49842639-49851391:-	0.34	6.2	2.12E-9	Educational attainment (college completion)	
KIRP	cis	1	rs1491158	chr3:56436161	SPATA12	chr3:57094469-57109460:+	0.23	3.85	0.000147	Night sleep phenotypes	
KIRP	cis	1	rs1498312	chr1:76177849	ACADM	chr1:76190043-76229353:+	0.23	5.46	1.09E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs1498315	chr1:76159225	ACADM	chr1:76190043-76229353:+	0.23	5.42	1.32E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs1498316	chr1:76159198	ACADM	chr1:76190043-76229353:+	0.23	5.39	1.54E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.36	6.57	2.67E-10	Height	
KIRP	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.31	4.72	3.77E-6	Height	
KIRP	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.27	4.03	7.23E-5	Diabetic kidney disease	
KIRP	cis	1	rs1502006	chr16:55610366	LPCAT2	chr16:55542913-55620581:+	-0.2	-3.89	0.000125	Thyroid hormone levels	
KIRP	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.32	4.43	1.39E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs151222	chr16:20674492	ACSM1	chr16:20634559-20709066:-	-0.48	-4.47	1.16E-5	Schizophrenia	
KIRP	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.41	-8.66	4.68E-16	Ankylosing spondylitis	
KIRP	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.32	4.05	6.63E-5	Ankylosing spondylitis	
KIRP	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.24	-3.94	0.000104	Pancreatic cancer	
KIRP	cis	1	rs1521908	chr6:109613986	SMPD2	chr6:109761931-109765121:+	0.2	3.84	0.000153	Red blood cell traits	
KIRP	cis	1	rs1522106	chr4:56307214	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.62	5.91E-6	Personality dimensions	
KIRP	cis	1	rs1522108	chr4:56380733	SRD5A3	chr4:56212409-56237866:+	0.33	4.99	1.09E-6	Personality dimensions	
KIRP	cis	1	rs1522110	chr4:56380283	SRD5A3	chr4:56212409-56237866:+	0.3	4.82	2.41E-6	Personality dimensions	
KIRP	cis	1	rs1522110	chr4:56380283	TMEM165	chr4:56262090-56292342:+	-0.25	-4.09	5.79E-5	Personality dimensions	
KIRP	cis	1	rs1522111	chr4:56329563	SRD5A3	chr4:56212409-56237866:+	0.29	4.66	4.95E-6	Personality dimensions	
KIRP	cis	1	rs1526080	chr15:84589920	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1526081	chr15:84590066	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs1533266	chr7:143766714	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.03E-5	Obesity-related traits	
KIRP	cis	1	rs1533267	chr7:143766440	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.13	5.53E-7	Obesity-related traits	
KIRP	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs1533268	chr7:143766358	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.13	3.14E-9	Height	
KIRP	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.3	-4.42	1.42E-5	Height	
KIRP	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.35	6.4	6.84E-10	Height	
KIRP	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.81E-5	Height	
KIRP	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.39	5.24	3.22E-7	Metabolite levels	
KIRP	cis	1	rs1535500	chr6:39284050	KCNK17	chr6:39266778-39282237:-	-0.34	-4.9	1.66E-6	Type 2 diabetes	
KIRP	cis	1	rs1535786	chr13:28170189	POLR1D	chr13:28194895-28241547:+	0.25	4.72	3.86E-6	Large B-cell lymphoma	
KIRP	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.43	1.39E-5	Obesity-related traits	
KIRP	cis	1	rs1540894	chr7:143767676	OR2A7	chr7:143955790-143974852:-	0.27	4	8.22E-5	Obesity-related traits	
KIRP	cis	1	rs1540894	chr7:143767676	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5.24	3.33E-7	Obesity-related traits	
KIRP	cis	1	rs1542574	chr3:51395571	HEMK1	chr3:50606583-50622419:+	0.26	4.31	2.31E-5	Melanoma	
KIRP	cis	1	rs1552994	chr1:152171461	FLG2	chr1:152321214-152332482:-	0.27	3.89	0.000126	Inflammatory skin disease	
KIRP	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.3	4.25	2.95E-5	Inflammatory skin disease	
KIRP	cis	1	rs1555398	chr14:67984373	TMEM229B	chr14:67920797-67982202:-	-0.3	-3.99	8.39E-5	Parkinson's disease	
KIRP	cis	1	rs1555399	chr14:67984370	TMEM229B	chr14:67920797-67982202:-	-0.35	-4.64	5.59E-6	Parkinson's disease	
KIRP	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.44	-7.47	1.19E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs1557503	chr22:51013072	CPT1B	chr22:51007291-51017096:-	-0.32	-4.89	1.71E-6	Narcolepsy	
KIRP	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.65	8.82	1.53E-16	Type 2 diabetes	
KIRP	cis	1	rs1561328	chr2:86272758	LOC90784	chr2:86247339-86250991:-	-0.52	-5.45	1.18E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs1561328	chr2:86272758	POLR1A	chr2:86253453-86333278:-	0.36	5.21	3.74E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs15637	chr17:61772050	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs1564473	chr15:84569942	LOC388152	chr15:84867600-84898920:-	-0.24	-4.08	6.05E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1564474	chr15:84570033	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1564475	chr15:84572229	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.93	13.29	3.02E-31	Diastolic blood pressure	
KIRP	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.2	-4.42	1.42E-5	Blood metabolite levels	
KIRP	cis	1	rs1573897	chr1:247215054	ZNF670	chr1:247200087-247242069:-	-0.23	-4	8.27E-5	Response to taxane treatment (docetaxel)	
KIRP	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.56	-8.02	3.48E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.55	-7.86	9.78E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs1581735	chr10:96686366	C10orf129	chr10:96953957-96988685:+	1.01	8.81	1.62E-16	Blood metabolite levels	
KIRP	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.4	-4.33	2.12E-5	Menarche (age at onset)	
KIRP	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.35	4.24	3.05E-5	Multiple sclerosis	
KIRP	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.33	-6.07	4.46E-9	Multiple sclerosis	
KIRP	cis	1	rs1599932	chr12:58177943	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.1	5.42E-5	Multiple sclerosis	
KIRP	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.28	4.56	7.94E-6	Diabetic kidney disease	
KIRP	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.26	-4.66	4.93E-6	Diabetic kidney disease	
KIRP	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.25	4.1	5.6E-5	Diabetic kidney disease	
KIRP	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.25	4.1	5.6E-5	Diabetic kidney disease	
KIRP	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.24	3.98	8.76E-5	Diabetic kidney disease	
KIRP	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.27	4.41	1.52E-5	Diabetic kidney disease	
KIRP	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.41	-6.08	4.17E-9	Rheumatoid arthritis	
KIRP	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.94	-13.67	1.43E-32	Diastolic blood pressure	
KIRP	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.93	13.85	3.51E-33	Diastolic blood pressure	
KIRP	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.93	13.85	3.51E-33	Diastolic blood pressure	
KIRP	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.96	-14.54	1.27E-35	Diastolic blood pressure	
KIRP	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.3	-4.09	5.83E-5	Rheumatoid arthritis	
KIRP	cis	1	rs1655841	chr15:65721043	DPP8	chr15:65737999-65810035:-	-0.13	-4.77	3.08E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs1667583	chr12:122370206	WDR66	chr12:122356480-122441830:+	-0.45	-3.95	0.000101	Urinary metabolites	
KIRP	cis	1	rs166870	chr15:80069762	RASGRF1	chr15:79252291-79383215:-	-0.27	-3.94	0.000103	Disease-free survival in breast cancer	
KIRP	cis	1	rs1678969	chr12:122371474	WDR66	chr12:122356480-122441830:+	-0.45	-3.95	0.000101	Urinary metabolites	
KIRP	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.28	-4.12	5.11E-5	Bone mineral density	
KIRP	cis	1	rs16830945	chr2:135471748	TMEM163	chr2:135213331-135525334:-	0.39	5.58	6.07E-8	Gut microbiome composition (winter)	
KIRP	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.6	6.51	3.81E-10	Rheumatoid arthritis	
KIRP	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.32	-4.49	1.08E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.58	-9.31	5.14E-18	Response to antipsychotic treatment	
KIRP	cis	1	rs16884476	chr8:89584486	MMP16	chr8:89049462-89339717:-	0.3	4.2	3.72E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs16889317	chr6:159414843	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs16889320	chr6:159414899	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs16889325	chr6:159417132	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.59	5.16	4.8E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.57	5.08	7.09E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.57	5.08	7.09E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.55	4.98	1.15E-6	Renal underexcretion gout;Gout	
KIRP	cis	1	rs16913624	chr11:14117566	PDE3B	chr11:14665269-14893602:+	0.33	3.84	0.000157	Inflammatory biomarkers	
KIRP	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.39	-5.43	1.29E-7	Bilirubin levels	
KIRP	cis	1	rs16933829	chr11:17115676	RPS13	chr11:17095940-17099220:-	0.42	4.32	2.24E-5	Response to abacavir-containing treatment in HIV-1 infection (virologic failure);Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
KIRP	cis	1	rs16936317	chr9:18102688	SH3GL2	chr9:17578953-17797120:+	0.49	4.06	6.34E-5	Heart failure	
KIRP	cis	1	rs16947005	chr17:61702989	FTSJ3	chr17:61896795-61905031:-	-0.31	-4.39	1.61E-5	Body mass index	
KIRP	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.3	4.24	3.07E-5	Body mass index	
KIRP	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs16947042	chr17:61766457	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.4	-6.96	2.64E-11	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs16960158	chr17:19163052	RNF112	chr17:19314523-19320587:+	0.41	4.52	9.22E-6	Schizophrenia	
KIRP	cis	1	rs16960499	chr17:19203032	RNF112	chr17:19314523-19320587:+	0.48	5.12	5.95E-7	Schizophrenia	
KIRP	cis	1	rs1697845	chr5:75922504	F2RL2	chr5:75911308-75919240:-	-0.27	-4.9	1.65E-6	Hearing impairment	
KIRP	cis	1	rs16987832	chr22:29978749	NF2	chr22:29999545-30094583:+	-0.32	-4.04	6.97E-5	Lipid traits	
KIRP	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.47	-6.28	1.4E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.49	-6.48	4.55E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.49	-6.48	4.55E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.43	-5.65	4.22E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.45	-5.97	7.5E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.45	-5.97	7.5E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs17007930	chr12:81445762	LIN7A	chr12:81191171-81331694:-	0.26	3.83	0.000158	Neuroticism	
KIRP	cis	1	rs17027011	chr2:86406556	LOC90784	chr2:86247339-86250991:-	-0.46	-4.52	9.16E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.45	4.74	3.55E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.45	4.74	3.47E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.93	13.37	1.7E-31	Diastolic blood pressure	
KIRP	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.92	13.7	1.14E-32	Diastolic blood pressure	
KIRP	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.94	13.34	2.09E-31	Diastolic blood pressure	
KIRP	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.94	13.34	2.09E-31	Diastolic blood pressure	
KIRP	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.93	13.29	3.02E-31	Diastolic blood pressure	
KIRP	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.31	-6.01	6.2E-9	Height	
KIRP	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.54	3.17E-10	Body mass index	
KIRP	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.59	2.3E-10	Body mass index	
KIRP	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.32	1.13E-9	Body mass index	
KIRP	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.34	9.74E-10	Body mass index	
KIRP	cis	1	rs1707336	chr1:46493460	MUTYH	chr1:45794915-45806142:-	0.17	3.95	0.000101	Body mass index	
KIRP	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.59	2.34E-10	Body mass index	
KIRP	cis	1	rs17080292	chr6:118850266	NUS1	chr6:117996617-118031884:+	0.24	4.02	7.73E-5	Renal cell carcinoma	
KIRP	cis	1	rs17085889	chr4:56402115	SRD5A3	chr4:56212409-56237866:+	-0.31	-5.03	8.97E-7	Personality dimensions	
KIRP	cis	1	rs17085889	chr4:56402115	TMEM165	chr4:56262090-56292342:+	0.25	3.99	8.48E-5	Personality dimensions	
KIRP	cis	1	rs17093141	chr14:74326903	LIN52	chr14:74551656-74667117:+	0.25	4.12	5.16E-5	Morning vs. evening chronotype	
KIRP	cis	1	rs17093474	chr14:74342413	LIN52	chr14:74551656-74667117:+	0.23	3.83	0.000157	Morning vs. evening chronotype	
KIRP	cis	1	rs17094021	chr14:74394295	LIN52	chr14:74551656-74667117:+	0.25	4.03	7.42E-5	Morning vs. evening chronotype	
KIRP	cis	1	rs17094891	chr14:93737610	IFI27L1	chr14:94547639-94569059:+	0.21	3.83	0.000163	Body mass index	
KIRP	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.26	5.99	6.81E-9	Common traits (Other)	
KIRP	cis	1	rs17110194	chr10:96441949	C10orf129	chr10:96953957-96988685:+	1.18	9.43	2.2E-18	Blood metabolite levels	
KIRP	cis	1	rs17110236	chr10:96493332	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs17110288	chr10:96732599	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs17110314	chr10:96633434	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs17110317	chr10:96634735	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs17110321	chr10:96639896	C10orf129	chr10:96953957-96988685:+	0.82	7.4	1.83E-12	Blood metabolite levels	
KIRP	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.63	6.44	5.6E-10	Crohn's disease	
KIRP	cis	1	rs17120139	chr11:116774201	PCSK7	chr11:117075789-117102811:-	0.41	4.22	3.32E-5	Protein quantitative trait loci	
KIRP	cis	1	rs17121651	chr14:50097172	RPL36AL	chr14:50085407-50087349:-	0.21	4.08	6.08E-5	Carotid intima media thickness	
KIRP	cis	1	rs17124700	chr14:88905629	SPATA7	chr14:88852012-88904802:+	-0.27	-3.81	0.00017	Coronary artery calcification	
KIRP	cis	1	rs17149161	chr7:75978229	UPK3B	chr7:76139745-76157197:+	-0.3	-4.12	4.97E-5	Multiple sclerosis	
KIRP	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.75E-5	Diabetic kidney disease	
KIRP	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.29	4.28	2.66E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.94	-13.67	1.43E-32	Diastolic blood pressure	
KIRP	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.97	-14.41	3.84E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.31E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.94	-14.33	7.3E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.97	-14.56	1.06E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.93	13.85	3.51E-33	Diastolic blood pressure	
KIRP	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.94	14.06	6.37E-34	Diastolic blood pressure	
KIRP	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.93	13.85	3.51E-33	Diastolic blood pressure	
KIRP	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.97	-14.45	2.59E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.96	14.44	3.0E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.96	-14.54	1.27E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.97	-14.45	2.59E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.96	-14.38	4.75E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.43E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.31E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.95	-13.75	7.47E-33	Diastolic blood pressure	
KIRP	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.94	-13.67	1.43E-32	Diastolic blood pressure	
KIRP	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.98	-14.33	6.96E-35	Diastolic blood pressure	
KIRP	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.31E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.31E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.96	-14.54	1.27E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.94	14.07	6.01E-34	Diastolic blood pressure	
KIRP	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.96	-14.41	3.75E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.97	14.41	3.84E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.95	14.29	9.58E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.96	14.38	4.75E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.96	-14.38	4.75E-35	Diastolic blood pressure	
KIRP	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.91	-13.41	1.21E-31	Diastolic blood pressure	
KIRP	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.96	-14.19	2.28E-34	Diastolic blood pressure	
KIRP	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.93	13.85	3.51E-33	Diastolic blood pressure	
KIRP	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.94	14.06	6.37E-34	Diastolic blood pressure	
KIRP	cis	1	rs1721359	chr2:228751874	WDR69	chr2:228736327-228789026:+	0.31	4.87	1.89E-6	Blood pressure	
KIRP	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.26	-4.38	1.69E-5	Colorectal cancer	
KIRP	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.27	3.91	0.000116	Diabetic kidney disease	
KIRP	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.26	3.82	0.000169	Diabetic kidney disease	
KIRP	cis	1	rs17280791	chr4:76503379	CDKL2	chr4:76501705-76555721:-	0.29	4.05	6.72E-5	Magnesium levels	
KIRP	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.67	-5.63	4.68E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs173334	chr6:88080223	C6orf162	chr6:88032306-88052043:+	-0.29	-4.36	1.88E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.32	4.5	1.0E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs1739655	chr20:36978182	LBP	chr20:36974885-37005653:+	0.63	5	1.06E-6	IgG glycosylation	
KIRP	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.94	18.57	7.34E-50	Carotid intima media thickness	
KIRP	cis	1	rs174551	chr11:61573684	FADS2	chr11:61583728-61634825:+	0.55	8.59	7.72E-16	LDL cholesterol	
KIRP	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.26	4.06	6.43E-5	Sex hormone-binding globulin levels	
KIRP	cis	1	rs17496827	chr2:223353446	SGPP2	chr2:223289322-223423616:+	0.18	4.06	6.41E-5	Anorexia nervosa	
KIRP	cis	1	rs17529963	chr7:137079172	PTN	chr7:136912092-137028546:-	-0.35	-3.93	0.000109	Schizophrenia	
KIRP	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.4	-5.24	3.35E-7	Inflammatory skin disease	
KIRP	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.18	-3.86	0.000142	Height	
KIRP	cis	1	rs175442	chr14:75603564	RPS6KL1	chr14:75372347-75389958:-	-0.22	-3.82	0.000164	Height	
KIRP	cis	1	rs175449	chr14:75590846	RPS6KL1	chr14:75372347-75389958:-	-0.22	-3.87	0.000137	Height	
KIRP	cis	1	rs175492	chr14:75545220	RPS6KL1	chr14:75372347-75389958:-	0.24	4.2	3.68E-5	Height	
KIRP	cis	1	rs175512	chr14:75523382	RPS6KL1	chr14:75372347-75389958:-	-0.23	-3.95	9.92E-5	Height	
KIRP	cis	1	rs1755646	chr9:117875130	TNC	chr9:117782806-117880486:-	0.23	3.95	0.0001	Developmental language disorder (syntactic complexity)	
KIRP	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.42	-5.56	6.73E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.44	5.83	1.57E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.44	-5.89	1.18E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.44	-5.89	1.18E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.42	-5.49	9.52E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.45	-5.95	8.36E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs17584578	chr2:86307624	LOC90784	chr2:86247339-86250991:-	0.47	4.84	2.2E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.39	-5.64	4.29E-8	Forced vital capacity	
KIRP	cis	1	rs17598927	chr6:26184640	HIST1H3E	chr6:26224427-26226589:+	-0.54	-4.42	1.41E-5	Renal underexcretion gout;Gout	
KIRP	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.38	-5.82	1.67E-8	Schizophrenia	
KIRP	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.36	-5.51	8.67E-8	Schizophrenia	
KIRP	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.77	6.16	2.65E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.4	-7.22	5.61E-12	Temperament	
KIRP	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.53	-4.63	5.75E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	1	11.28	2.24E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs17671194	chr15:40667539	IVD	chr15:40697686-40713512:+	-0.34	-3.87	0.000139	Heschl's gyrus morphology	
KIRP	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.81	-10	3.52E-20	Heschl's gyrus morphology	
KIRP	cis	1	rs17671250	chr15:40673124	IVD	chr15:40697686-40713512:+	0.3	3.86	0.000143	Heschl's gyrus morphology	
KIRP	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.35	-3.99	8.6E-5	Menarche (age at onset)	
KIRP	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	3.04E-10	Body mass index	
KIRP	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.4	6.58	2.49E-10	Cognitive performance	
KIRP	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs17694493	chr9:22041998	IFNE	chr9:21480841-21482312:-	0.27	3.86	0.000141	Prostate cancer	
KIRP	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.5	-8.14	1.57E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.47	-7.65	3.66E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.47	-7.57	6.38E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.76	6.15	2.84E-9	Crohn's disease	
KIRP	cis	1	rs17733640	chr3:38446742	EXOG	chr3:38537763-38567796:+	-0.16	-3.84	0.000153	Electrocardiographic conduction measures	
KIRP	cis	1	rs17745344	chr17:53048319	TOM1L1	chr17:52978052-53039328:+	-0.24	-4.19	3.87E-5	Breast cancer	
KIRP	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.18	-4.04	7.07E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs17749748	chr2:71605145	ZNF638	chr2:71503723-71662187:+	-0.23	-4.59	6.76E-6	Height	
KIRP	cis	1	rs1775151	chr1:205745684	PM20D1	chr1:205797154-205819245:-	-0.36	-4.16	4.3E-5	Parkinson's disease	
KIRP	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.24	4.44	1.34E-5	Parkinson's disease	
KIRP	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.41	-4.49	1.08E-5	Menarche (age at onset)	
KIRP	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.45	7.86	9.41E-14	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.41	-7.07	1.39E-11	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs17772064	chr14:88822871	SPATA7	chr14:88852012-88904802:+	-0.27	-4.08	6.08E-5	Coronary artery calcification	
KIRP	cis	1	rs17772288	chr14:88827366	SPATA7	chr14:88852012-88904802:+	-0.27	-4.15	4.39E-5	Coronary artery calcification	
KIRP	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.71	6.59	2.36E-10	Crohn's disease	
KIRP	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.7	6.9	3.76E-11	Crohn's disease	
KIRP	cis	1	rs17809330	chr15:65889250	DPP8	chr15:65737999-65810035:-	0.13	4.81	2.54E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs17818028	chr17:53062755	TOM1L1	chr17:52978052-53039328:+	0.22	4.07	6.3E-5	Breast cancer	
KIRP	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.32	4.45	1.29E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.32	4.42	1.45E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.32	4.44	1.31E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs17831583	chr15:24597222	PWRN1	chr15:24778839-24832924:+	0.29	3.88	0.00013	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.43	-7.17	7.53E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs17839567	chr16:31057945	HSD3B7	chr16:30996519-31000473:+	0.28	5.45	1.15E-7	Response to metformin (IC50)	
KIRP	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.2	4.24	3.05E-5	Response to metformin (IC50)	
KIRP	cis	1	rs17848459	chr22:51012311	CPT1B	chr22:51007291-51017096:-	-0.32	-4.75	3.33E-6	Narcolepsy	
KIRP	cis	1	rs17884832	chr10:96534475	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs17885052	chr10:96610082	C10orf129	chr10:96953957-96988685:+	0.72	7.21	5.84E-12	Blood metabolite levels	
KIRP	cis	1	rs17885348	chr10:96534234	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.41	5.6	5.39E-8	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs180515	chr17:58024275	DHX40P1	chr17:58053385-58096336:-	0.32	4.44	1.3E-5	Multiple sclerosis	
KIRP	cis	1	rs1810049	chr15:84576052	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.36	6.47	4.83E-10	Height	
KIRP	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.32	4.79	2.75E-6	Height	
KIRP	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.36	6.61	2.12E-10	Height	
KIRP	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.32	4.86	1.99E-6	Height	
KIRP	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.48	4.79	2.76E-6	Crohn's disease	
KIRP	cis	1	rs1816537	chr11:112968651	USP28	chr11:113668598-113746256:-	-0.22	-4	8.09E-5	Body mass index	
KIRP	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.39	-5.82	1.66E-8	Schizophrenia	
KIRP	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.26	-4.01	8.05E-5	IgG glycosylation	
KIRP	cis	1	rs1823913	chr2:192118047	MYO1B	chr2:192110107-192290115:+	-0.3	-4.98	1.16E-6	Obesity-related traits	
KIRP	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.64	8.76	2.34E-16	Type 2 diabetes	
KIRP	cis	1	rs183618	chr17:53235974	COX11	chr17:53029259-53046064:-	0.23	4.07	6.16E-5	Menarche (age at onset)	
KIRP	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.28	4.95	1.34E-6	IgG glycosylation	
KIRP	cis	1	rs1840377	chr2:192122718	MYO1B	chr2:192110107-192290115:+	0.32	5.09	6.96E-7	Obesity-related traits	
KIRP	cis	1	rs1841777	chr3:38484819	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000138	Electrocardiographic conduction measures	
KIRP	cis	1	rs1844785	chr3:56435879	SPATA12	chr3:57094469-57109460:+	0.24	4.05	6.78E-5	Night sleep phenotypes	
KIRP	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.41	-6.06	4.67E-9	Schizophrenia	
KIRP	cis	1	rs1852264	chr15:84589940	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1853207	chr10:96665937	C10orf129	chr10:96953957-96988685:+	1.01	8.81	1.62E-16	Blood metabolite levels	
KIRP	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.45	-5.86	1.37E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs1856859	chr6:151860110	C6orf97	chr6:151815175-151942327:+	-0.43	-4.26	2.83E-5	Bone mineral density (spine)	
KIRP	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.55	-7.96	5.17E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.49	-7.08	1.32E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs1858482	chr1:152306921	HRNR	chr1:152184558-152196669:-	0.45	5.51	8.51E-8	Atopic dermatitis	
KIRP	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.64	8.76	2.34E-16	Type 2 diabetes	
KIRP	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.35	6.51	3.73E-10	Height	
KIRP	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.31	4.72	3.77E-6	Height	
KIRP	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.45	4.59	6.77E-6	Crohn's disease	
KIRP	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.42	-6.66	1.61E-10	Height	
KIRP	cis	1	rs1864399	chr10:43610455	CSGALNACT2	chr10:43633934-43680747:+	-0.24	-4.2	3.61E-5	Hirschsprung disease	
KIRP	cis	1	rs1867146	chr15:75354971	MAN2C1	chr15:75648135-75660941:-	0.24	4.3	2.44E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.31	4.53	9.09E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.35	6.44	5.47E-10	Height	
KIRP	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.31	4.73	3.61E-6	Height	
KIRP	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.34	4.07	6.19E-5	Multiple sclerosis	
KIRP	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.33	-6.11	3.48E-9	Multiple sclerosis	
KIRP	cis	1	rs1875124	chr12:58196802	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-3.99	8.5E-5	Multiple sclerosis	
KIRP	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.31	4.29	2.52E-5	Body mass index	
KIRP	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs1880730	chr15:84584184	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.6	6.68E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.37	4.96	1.25E-6	Metabolite levels	
KIRP	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.41	-6.85	5.3E-11	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs1888997	chr20:25298988	ENTPD6	chr20:25176339-25207360:+	0.36	6.08	4.28E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1888997	chr20:25298988	FAM182B	chr20:25744102-25848786:-	-0.28	-3.86	0.000144	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1888998	chr20:25291826	ENTPD6	chr20:25176339-25207360:+	0.33	5.63	4.54E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1888998	chr20:25291826	FAM182B	chr20:25744102-25848786:-	-0.29	-3.89	0.000127	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1888999	chr20:25291848	ENTPD6	chr20:25176339-25207360:+	-0.32	-5.42	1.32E-7	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1888999	chr20:25291848	FAM182B	chr20:25744102-25848786:-	0.29	3.93	0.000109	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs1892846	chr22:22186479	TOP3B	chr22:22311404-22337193:-	-0.18	-4.05	6.77E-5	Multiple sclerosis	
KIRP	cis	1	rs1892848	chr22:22186562	TOP3B	chr22:22311404-22337193:-	-0.18	-4.05	6.77E-5	Multiple sclerosis	
KIRP	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.57	5.82	1.66E-8	Crohn's disease	
KIRP	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.58	5.58	5.84E-8	Crohn's disease	
KIRP	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.56	5.77	2.23E-8	Crohn's disease	
KIRP	cis	1	rs1900120	chr14:76626516	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs1900122	chr14:76629517	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.35	4.04	7.11E-5	Menarche (age at onset)	
KIRP	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.8	10.87	5.12E-23	Type 2 diabetes	
KIRP	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.41	-6.02	5.85E-9	Schizophrenia	
KIRP	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.49	-7.22	5.34E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.77	2.26E-8	Height	
KIRP	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.99E-6	Height	
KIRP	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs1919948	chr7:143762843	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.59	6.97E-6	Obesity-related traits	
KIRP	cis	1	rs1919949	chr7:143767723	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.44	1.22E-7	Obesity-related traits	
KIRP	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.3	2.4E-5	Obesity-related traits	
KIRP	cis	1	rs1919950	chr7:143767898	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5.3	2.48E-7	Obesity-related traits	
KIRP	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.31	2.29E-5	Obesity-related traits	
KIRP	cis	1	rs1919951	chr7:143768891	OR2A7	chr7:143955790-143974852:-	0.27	4.09	5.74E-5	Obesity-related traits	
KIRP	cis	1	rs1919951	chr7:143768891	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-4.93	1.46E-6	Obesity-related traits	
KIRP	cis	1	rs1921348	chr12:81458380	LIN7A	chr12:81191171-81331694:-	0.26	3.97	9.14E-5	Neuroticism	
KIRP	cis	1	rs1921350	chr12:81458279	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs1921352	chr12:81456746	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs1939748	chr11:62911079	SLC22A24	chr11:62847414-62911693:-	0.5	7.63	4.25E-13	Conotruncal heart defects	
KIRP	cis	1	rs1939749	chr11:62910849	SLC22A24	chr11:62847414-62911693:-	0.5	7.63	4.25E-13	Conotruncal heart defects	
KIRP	cis	1	rs1941027	chr11:60312863	MS4A8B	chr11:60467047-60483282:+	0.47	4.63	5.77E-6	Metabolite levels  (X-11787)	
KIRP	cis	1	rs1947826	chr12:122305970	WDR66	chr12:122356480-122441830:+	-0.4	-3.85	0.000149	Urinary metabolites	
KIRP	cis	1	rs1950500	chr14:24830850	CBLN3	chr14:24895742-24898731:-	0.28	3.81	0.00017	Height	
KIRP	cis	1	rs1952012	chr14:50098896	RPL36AL	chr14:50085407-50087349:-	0.22	4.25	3.0E-5	Carotid intima media thickness	
KIRP	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.42	-6.2	2.17E-9	Rheumatoid arthritis	
KIRP	cis	1	rs1955599	chr14:88825132	SPATA7	chr14:88852012-88904802:+	-0.27	-3.93	0.000108	Coronary artery calcification	
KIRP	cis	1	rs1955600	chr14:88825384	SPATA7	chr14:88852012-88904802:+	-0.27	-3.92	0.000115	Coronary artery calcification	
KIRP	cis	1	rs1957977	chr14:50090603	PPIL5	chr14:50065415-50081389:+	0.23	4.11	5.35E-5	Carotid intima media thickness	
KIRP	cis	1	rs1957977	chr14:50090603	RPL36AL	chr14:50085407-50087349:-	0.29	5.72	2.86E-8	Carotid intima media thickness	
KIRP	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.54	-7.75	1.96E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs1966423	chr2:202216661	ALS2CR12	chr2:202153148-202222101:-	-0.24	-3.81	0.000171	Basal cell carcinoma	
KIRP	cis	1	rs1976053	chr17:65833002	LOC440461	chr17:66194801-66196436:+	0.31	4.2	3.7E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs1976054	chr17:65833224	LOC440461	chr17:66194801-66196436:+	0.3	4.06	6.53E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs1977447	chr9:131868196	PPP2R4	chr9:131873244-131911223:+	-0.3	-4.32	2.18E-5	Blood metabolite ratios	
KIRP	cis	1	rs1978968	chr22:18448113	MICAL3	chr22:18270418-18507325:-	0.28	4.26	2.88E-5	Presence of antiphospholipid antibodies	
KIRP	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.98	-7.91	7.14E-14	Schizophrenia	
KIRP	cis	1	rs1982861	chr3:49577665	NCKIPSD	chr3:48711280-48723334:-	0.3	4.15	4.47E-5	Menarche (age at onset)	
KIRP	cis	1	rs1982861	chr3:49577665	P4HTM	chr3:49027341-49044579:+	0.25	4.49	1.06E-5	Menarche (age at onset)	
KIRP	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.28	4.79	2.73E-6	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.49	-7.22	5.34E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.59	6.88E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.53	-7.9	7.63E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.59	5.93	9.36E-9	Crohn's disease	
KIRP	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.36	-5.18	4.32E-7	Forced vital capacity	
KIRP	cis	1	rs2006893	chr22:22128678	TOP3B	chr22:22311404-22337193:-	-0.18	-3.93	0.000106	Multiple sclerosis	
KIRP	cis	1	rs2007981	chr19:18567555	LRRC25	chr19:18501955-18508421:-	-0.13	-4.27	2.74E-5	Breast cancer	
KIRP	cis	1	rs2007981	chr19:18567555	SSBP4	chr19:18530221-18545371:+	-0.15	-4.31	2.32E-5	Breast cancer	
KIRP	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.39	5.05	8.42E-7	Atopic dermatitis	
KIRP	cis	1	rs2011331	chr1:152286002	HRNR	chr1:152184558-152196669:-	-0.39	-4.9	1.69E-6	Atopic dermatitis	
KIRP	cis	1	rs2013288	chr17:61785904	FTSJ3	chr17:61896795-61905031:-	0.31	4.39	1.66E-5	Body mass index	
KIRP	cis	1	rs2014521	chr17:40283413	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.42	-4.95	1.31E-6	Rheumatoid arthritis	
KIRP	cis	1	rs2027003	chr20:25350498	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2027003	chr20:25350498	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2027004	chr20:25350618	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2027004	chr20:25350618	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.75	-11.75	6.33E-26	Type 2 diabetes	
KIRP	cis	1	rs2030838	chr15:84583810	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2030839	chr15:84583959	LOC388152	chr15:84867600-84898920:-	-0.25	-4.14	4.68E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2030840	chr15:84584134	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.26	5.68	3.47E-8	Longevity	
KIRP	cis	1	rs2046120	chr15:84567762	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2052187	chr17:65834737	LOC440461	chr17:66194801-66196436:+	0.3	3.98	9.04E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs2055127	chr1:235598973	B3GALNT2	chr1:235610533-235667781:-	-0.25	-4.72	3.85E-6	Adiposity	
KIRP	cis	1	rs2055619	chr5:176415964	PRR7	chr5:176873796-176883283:+	-0.22	-3.9	0.00012	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs2055712	chr15:84581605	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.37	4.97	1.21E-6	Metabolite levels	
KIRP	cis	1	rs2056566	chr2:228713241	WDR69	chr2:228736327-228789026:+	0.3	4.56	7.83E-6	Blood pressure	
KIRP	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.32	5.74	2.63E-8	Height	
KIRP	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.28	4.24	3.12E-5	Height	
KIRP	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.31	5.51	8.62E-8	Height	
KIRP	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.29	4.39	1.61E-5	Height	
KIRP	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.25	4.08	5.85E-5	Pancreatic cancer	
KIRP	cis	1	rs2061999	chr15:84582740	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2062161	chr12:133428032	EP400NL	chr12:132568828-132600084:+;chr12	-0.46	-4.66	4.98E-6	Cognitive function	
KIRP	cis	1	rs2062162	chr12:133432744	EP400NL	chr12:132568828-132600084:+;chr12	-0.4	-4.74	3.47E-6	Cognitive function	
KIRP	cis	1	rs2066558	chr13:50610595	EBPL	chr13:50234811-50265623:-	-0.29	-4.26	2.88E-5	Height	
KIRP	cis	1	rs2066572	chr13:50648487	EBPL	chr13:50234811-50265623:-	-0.28	-3.94	0.000106	Height	
KIRP	cis	1	rs2066575	chr13:50656582	EBPL	chr13:50234811-50265623:-	-0.28	-3.87	0.000137	Height	
KIRP	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.32	-3.82	0.000166	Multiple sclerosis	
KIRP	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.31	5.62	4.92E-8	Multiple sclerosis	
KIRP	cis	1	rs2069502	chr12:58144665	XRCC6BP1	chr12:58335445-58351051:+	0.3	4.57	7.61E-6	Multiple sclerosis	
KIRP	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.37	-6.02	5.92E-9	Cognitive performance	
KIRP	cis	1	rs2070488	chr3:38442490	EXOG	chr3:38537763-38567796:+	0.16	3.82	0.000165	Electrocardiographic conduction measures	
KIRP	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.34	4.08	5.86E-5	Multiple sclerosis	
KIRP	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.32	-5.96	8.01E-9	Multiple sclerosis	
KIRP	cis	1	rs2072052	chr12:58146719	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-4.52	9.14E-6	Multiple sclerosis	
KIRP	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.26	5.89	1.2E-8	Common traits (Other)	
KIRP	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.3	-4.12	4.97E-5	Multiple sclerosis	
KIRP	cis	1	rs2072883	chr22:43435668	TTLL1	chr22:43435524-43485434:-	-0.24	-4.11	5.2E-5	Schizophrenia	
KIRP	cis	1	rs2074018	chr11:2309634	C11orf21	chr11:2317507-2323143:-	0.32	4.02	7.68E-5	Obesity-related traits	
KIRP	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	0.83	10.65	2.85E-22	IgA nephropathy	
KIRP	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-1	-20.38	3.41E-56	Homocysteine levels	
KIRP	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.28	-4.06	6.52E-5	Basal cell carcinoma	
KIRP	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.47	-6.28	1.4E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs2083731	chr15:75368538	MAN2C1	chr15:75648135-75660941:-	0.25	4.69	4.45E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.32	4.83	2.31E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs2089222	chr12:117002658	NCRNA00173	chr12:116971227-116974317:+	0.29	3.84	0.000157	Acute lymphoblastic leukemia (childhood)	
KIRP	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.23	-3.87	0.000139	IFN-related cytopenia	
KIRP	cis	1	rs2093433	chr10:96638896	C10orf129	chr10:96953957-96988685:+	0.79	7.45	1.32E-12	Blood metabolite levels	
KIRP	cis	1	rs209812	chr6:11953887	ELOVL2	chr6:10980995-11044624:-	-0.32	-3.98	9.02E-5	Disc degeneration (lumbar)	
KIRP	cis	1	rs209813	chr6:11953633	ELOVL2	chr6:10980995-11044624:-	-0.35	-4.27	2.73E-5	Disc degeneration (lumbar)	
KIRP	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.2	-4.28	2.65E-5	Height	
KIRP	cis	1	rs2098297	chr14:75619118	RPS6KL1	chr14:75372347-75389958:-	-0.22	-3.89	0.000126	Height	
KIRP	cis	1	rs2099942	chr22:18438314	MICAL3	chr22:18270418-18507325:-	-0.25	-4.14	4.7E-5	Presence of antiphospholipid antibodies	
KIRP	cis	1	rs2099943	chr22:18438559	MICAL3	chr22:18270418-18507325:-	-0.25	-4.14	4.63E-5	Presence of antiphospholipid antibodies	
KIRP	cis	1	rs2099944	chr22:18438578	MICAL3	chr22:18270418-18507325:-	-0.25	-4.14	4.63E-5	Presence of antiphospholipid antibodies	
KIRP	cis	1	rs2101017	chr12:122306857	WDR66	chr12:122356480-122441830:+	-0.4	-3.85	0.000149	Urinary metabolites	
KIRP	cis	1	rs2103876	chr1:12053100	MFN2	chr1:12040238-12073571:+	-0.22	-3.87	0.000137	Platelet count	
KIRP	cis	1	rs2110001	chr7:150517022	TMEM176A	chr7:150497854-150502208:+	0.21	4.3	2.43E-5	Height	
KIRP	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.79	10.88	4.85E-23	Type 2 diabetes	
KIRP	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.6	5.69	3.27E-8	Crohn's disease	
KIRP	cis	1	rs211718	chr1:76106675	ACADM	chr1:76190043-76229353:+	0.2	4.73	3.64E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs211723	chr1:76103030	ACADM	chr1:76190043-76229353:+	-0.19	-4.7	4.23E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs2120019	chr15:75334184	MAN2C1	chr15:75648135-75660941:-	0.22	3.88	0.000134	Blood trace element (Zn levels)	
KIRP	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.37	5.46	1.12E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.47	-7.39	1.9E-12	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs2127905	chr11:117026374	PCSK7	chr11:117075789-117102811:-	-0.4	-4.34	2.04E-5	Protein quantitative trait loci	
KIRP	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.94	13.58	2.98E-32	Diastolic blood pressure	
KIRP	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.93	13.29	3.02E-31	Diastolic blood pressure	
KIRP	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.46	-9.19	1.22E-17	Kawasaki disease	
KIRP	cis	1	rs2133134	chr1:76179587	ACADM	chr1:76190043-76229353:+	0.23	5.42	1.33E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs2135481	chr2:228706657	WDR69	chr2:228736327-228789026:+	0.3	4.45	1.26E-5	Blood pressure	
KIRP	cis	1	rs2135880	chr15:84589613	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.36	4.87	1.94E-6	Metabolite levels	
KIRP	cis	1	rs2140270	chr3:49439440	NCKIPSD	chr3:48711280-48723334:-	-0.33	-4.54	8.4E-6	Menarche (age at onset)	
KIRP	cis	1	rs2140270	chr3:49439440	P4HTM	chr3:49027341-49044579:+	-0.25	-4.41	1.49E-5	Menarche (age at onset)	
KIRP	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.29	4.2	3.61E-5	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.6	-5.28	2.68E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.6	5.58	5.9E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.34	4.36	1.83E-5	Atopic dermatitis	
KIRP	cis	1	rs2147712	chr14:50091684	PPIL5	chr14:50065415-50081389:+	0.23	4.11	5.35E-5	Carotid intima media thickness	
KIRP	cis	1	rs2147712	chr14:50091684	RPL36AL	chr14:50085407-50087349:-	0.29	5.72	2.86E-8	Carotid intima media thickness	
KIRP	cis	1	rs2149423	chr13:36772381	SOHLH2	chr13:36742347-36871992:-	0.46	6.1	3.79E-9	Glucose homeostasis traits	
KIRP	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.45	-8.06	2.64E-14	Eye color traits	
KIRP	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.4	-6.01	6.21E-9	Height	
KIRP	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.55	-8.61	6.79E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.33	5.2	4.0E-7	Body mass index	
KIRP	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.32	-5.34	1.98E-7	Body mass index	
KIRP	cis	1	rs2172252	chr3:49678307	RBM6	chr3:49977592-50137484:+	0.15	4.3	2.43E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs2172252	chr3:49678307	UBA7	chr3:49842639-49851391:-	0.36	6.26	1.58E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.32	4.43	1.39E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs2177129	chr4:56365414	SRD5A3	chr4:56212409-56237866:+	0.31	4.99	1.11E-6	Personality dimensions	
KIRP	cis	1	rs2177129	chr4:56365414	TMEM165	chr4:56262090-56292342:+	-0.25	-3.96	9.78E-5	Personality dimensions	
KIRP	cis	1	rs2177268	chr3:49439725	NCKIPSD	chr3:48711280-48723334:-	-0.33	-4.54	8.4E-6	Menarche (age at onset)	
KIRP	cis	1	rs2177268	chr3:49439725	P4HTM	chr3:49027341-49044579:+	-0.25	-4.41	1.49E-5	Menarche (age at onset)	
KIRP	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs2179699	chr6:159386594	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs2184000	chr20:25395878	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2184000	chr20:25395878	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2184877	chr1:40996932	DEM1	chr1:40974433-40982212:+	0.33	4.11	5.38E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs2190748	chr15:92685078	LOC100144604	chr15:93111048-93115493:-	0.23	4.23	3.28E-5	Obesity-related traits	
KIRP	cis	1	rs2192008	chr2:191545147	HIBCH	chr2:191069361-191184559:-	-0.22	-4.03	7.3E-5	Bone mineral density (Ward's triangle area)	
KIRP	cis	1	rs2193172	chr12:15332342	RERG	chr12:15260718-15374304:-	0.37	5.27	2.82E-7	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs2224949	chr14:50096560	RPL36AL	chr14:50085407-50087349:-	-0.22	-4.19	3.81E-5	Carotid intima media thickness	
KIRP	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.55	-10.21	7.26E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs2228479	chr16:89985940	FANCA	chr16:89803959-89883065:-	0.77	6.33	1.05E-9	Skin colour saturation	
KIRP	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.35	5.28	2.76E-7	Homocysteine levels	
KIRP	cis	1	rs2233551	chr11:76814471	CLNS1A	chr11:77327197-77348851:-	0.39	3.91	0.000119	Cognitive performance	
KIRP	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.22	-3.84	0.000154	IFN-related cytopenia	
KIRP	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000161	IFN-related cytopenia	
KIRP	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.23	-4	8.32E-5	IFN-related cytopenia	
KIRP	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.23	-3.97	9.12E-5	IFN-related cytopenia	
KIRP	cis	1	rs2236256	chr6:154478440	RBM16	chr6:155054512-155155192:+	-0.18	-4.03	7.27E-5	Chronic lymphocytic leukemia	
KIRP	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.26	6.01	6.19E-9	Common traits (Other)	
KIRP	cis	1	rs2240009	chr17:40283142	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs2240010	chr17:40278081	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs2241389	chr19:6693317	GPR108	chr19:6729927-6737633:-	-0.42	-3.95	9.9E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs2241390	chr19:6693240	GPR108	chr19:6729927-6737633:-	-0.41	-3.86	0.000141	Complement C3 and C4 levels	
KIRP	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.26	5.58	6.05E-8	Longevity	
KIRP	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.43	6.31	1.2E-9	Longevity	
KIRP	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.43	6.31	1.2E-9	Longevity	
KIRP	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.43	6.31	1.2E-9	Longevity	
KIRP	cis	1	rs2242482	chr13:50655879	EBPL	chr13:50234811-50265623:-	-0.29	-4.14	4.72E-5	Height	
KIRP	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.33	4.99	1.1E-6	Diabetic kidney disease	
KIRP	cis	1	rs2247139	chr12:122380274	WDR66	chr12:122356480-122441830:+	-0.47	-4.26	2.84E-5	Urinary metabolites	
KIRP	cis	1	rs2247753	chr22:30022936	NF2	chr22:29999545-30094583:+	-0.32	-4.07	6.23E-5	Lipid traits	
KIRP	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.25	-3.82	0.000164	Homocysteine levels	
KIRP	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.39	-5.96	7.88E-9	Height	
KIRP	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.37	-5.66	3.89E-8	Height	
KIRP	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.38	-5.74	2.55E-8	Height	
KIRP	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.38	-5.74	2.55E-8	Height	
KIRP	cis	1	rs2254230	chr9:131905177	PPP2R4	chr9:131873244-131911223:+	-0.31	-4.54	8.62E-6	Blood metabolite ratios	
KIRP	cis	1	rs2257420	chr20:25275890	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.88	1.23E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257420	chr20:25275890	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.17E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257432	chr20:25271086	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.92	9.87E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257432	chr20:25271086	FAM182B	chr20:25744102-25848786:-	0.3	4.18	3.95E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257496	chr20:25279315	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257496	chr20:25279315	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.27	3.98	9.01E-5	Diabetic kidney disease	
KIRP	cis	1	rs2257808	chr20:25266450	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.03	5.38E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257808	chr20:25266450	FAM182B	chr20:25744102-25848786:-	0.3	4.13	4.95E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257809	chr20:25266476	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.03	5.38E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257809	chr20:25266476	FAM182B	chr20:25744102-25848786:-	0.3	4.13	4.95E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257982	chr20:25269630	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.04	5.21E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257982	chr20:25269630	FAM182B	chr20:25744102-25848786:-	0.3	4.21	3.44E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257985	chr20:25269743	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.04	5.21E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257985	chr20:25269743	FAM182B	chr20:25744102-25848786:-	0.3	4.21	3.44E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257988	chr20:25270003	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.04	5.21E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257988	chr20:25270003	FAM182B	chr20:25744102-25848786:-	0.3	4.21	3.44E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257991	chr20:25270339	ENTPD6	chr20:25176339-25207360:+	0.36	6.21	1.99E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2257991	chr20:25270339	FAM182B	chr20:25744102-25848786:-	-0.31	-4.24	3.09E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258066	chr20:25271326	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.92	9.87E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258066	chr20:25271326	FAM182B	chr20:25744102-25848786:-	0.3	4.18	3.95E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258135	chr20:25272323	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.92	9.87E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258135	chr20:25272323	FAM182B	chr20:25744102-25848786:-	0.3	4.18	3.95E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258201	chr20:25272490	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258201	chr20:25272490	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258563	chr20:25273435	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.78	2.07E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258563	chr20:25273435	FAM182B	chr20:25744102-25848786:-	0.31	4.28	2.67E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258617	chr20:25274318	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258617	chr20:25274318	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258719	chr20:25275843	ENTPD6	chr20:25176339-25207360:+	-0.33	-5.63	4.54E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258719	chr20:25275843	FAM182B	chr20:25744102-25848786:-	0.29	3.89	0.000127	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258769	chr20:25276680	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258769	chr20:25276680	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258879	chr20:25279213	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258879	chr20:25279213	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258884	chr20:25279539	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2258884	chr20:25279539	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259837	chr20:25280205	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259837	chr20:25280205	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259873	chr20:25280781	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259873	chr20:25280781	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259926	chr20:25281733	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259926	chr20:25281733	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259928	chr20:25281834	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259928	chr20:25281834	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259956	chr20:25282433	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2259956	chr20:25282433	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2266967	chr22:22156789	TOP3B	chr22:22311404-22337193:-	-0.18	-4.14	4.63E-5	Multiple sclerosis	
KIRP	cis	1	rs2268753	chr3:38500189	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000138	Electrocardiographic conduction measures	
KIRP	cis	1	rs2268757	chr3:38505853	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000139	Electrocardiographic conduction measures	
KIRP	cis	1	rs2268758	chr3:38514049	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000139	Electrocardiographic conduction measures	
KIRP	cis	1	rs2269381	chr22:51020069	CPT1B	chr22:51007291-51017096:-	-0.38	-4.61	6.26E-6	Narcolepsy	
KIRP	cis	1	rs2269382	chr22:51018911	CPT1B	chr22:51007291-51017096:-	-0.38	-4.61	6.26E-6	Narcolepsy	
KIRP	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.34	5.1	6.5E-7	Height	
KIRP	cis	1	rs2270779	chr3:124692785	HEG1	chr3:124684555-124774802:-	-0.23	-4.37	1.81E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.96	-14.29	9.55E-35	Diastolic blood pressure	
KIRP	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.96	-14.54	1.3E-35	Diastolic blood pressure	
KIRP	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.72	-6.42	6.14E-10	Rheumatoid arthritis	
KIRP	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.18	-4.05	6.71E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.2	-4.46	1.22E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.45	6.78	7.84E-11	Longevity	
KIRP	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.33	1.07E-9	Body mass index	
KIRP	cis	1	rs2276161	chr2:135470735	TMEM163	chr2:135213331-135525334:-	-0.39	-5.5	9.09E-8	Gut microbiome composition (winter)	
KIRP	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.35	-5.53	7.87E-8	Body mass index	
KIRP	cis	1	rs2276834	chr3:52325759	GNL3	chr3:52719936-52728508:+	-0.23	-4.24	3.08E-5	Electroencephalogram traits	
KIRP	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.46	-5.65	4.17E-8	Cholesterol, total	
KIRP	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.25	-4.29	2.54E-5	Colorectal cancer	
KIRP	cis	1	rs2278218	chr10:79680399	DLG5	chr10:79550551-79686348:-	0.27	4.54	8.44E-6	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs2278238	chr19:18576484	LRRC25	chr19:18501955-18508421:-	-0.13	-4.22	3.31E-5	Breast cancer	
KIRP	cis	1	rs2278238	chr19:18576484	SSBP4	chr19:18530221-18545371:+	-0.16	-4.47	1.16E-5	Breast cancer	
KIRP	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.25	-5.42	1.37E-7	Longevity	
KIRP	cis	1	rs2281494	chr20:3235494	C20orf194	chr20:3229948-3388587:-	0.28	3.95	0.0001	IFN-related cytopenia	
KIRP	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.24	-4.07	6.15E-5	IFN-related cytopenia	
KIRP	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs2283792	chr22:22131125	TOP3B	chr22:22311404-22337193:-	-0.18	-4.16	4.29E-5	Multiple sclerosis	
KIRP	cis	1	rs2285657	chr17:40272594	DHX58	chr17:40253422-40264751:-	-0.24	-4.14	4.72E-5	Fibrinogen levels	
KIRP	cis	1	rs2287679	chr19:33600764	RHPN2	chr19:33469499-33555824:-	-0.23	-3.9	0.000122	Bone properties (heel)	
KIRP	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.24	4.71	4.07E-6	Venous thromboembolism (SNP x SNP interaction)	
KIRP	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.41	5.6	5.27E-8	Blood metabolite levels;Blood metabolite ratios	
KIRP	cis	1	rs2290402	chr4:941518	GAK	chr4:843066-926174:-	0.27	3.84	0.000157	Type 2 diabetes	
KIRP	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.26	-5.62	4.75E-8	Longevity	
KIRP	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.54	-7.26	4.43E-12	Subjective well-being	
KIRP	cis	1	rs2290850	chr11:47807774	PSMC3	chr11:47440320-47448024:-	0.2	4.04	7.11E-5	Subjective well-being	
KIRP	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.5	-8.17	1.23E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs2291542	chr3:49751585	UBA7	chr3:49842639-49851391:-	-0.31	-5.78	2.08E-8	Resting heart rate	
KIRP	cis	1	rs2291738	chr12:56815281	MIP	chr12:56843885-56848429:-	-0.28	-3.81	0.000174	Axial length	
KIRP	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.46	7.1	1.14E-11	Cognitive function	
KIRP	cis	1	rs2292255	chr5:176334195	PRR7	chr5:176873796-176883283:+	-0.21	-3.86	0.000144	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs2292256	chr5:176333126	PRR7	chr5:176873796-176883283:+	-0.22	-4.06	6.56E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs2292986	chr19:21776332	ZNF429	chr19:21688437-21739068:+	-0.32	-4.31	2.32E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs2294008	chr8:143761931	LY6K	chr8:143781529-143785582:+	0.34	4.7	4.2E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2294008	chr8:143761931	LYNX1	chr8:143845758-143859640:-	-0.26	-4.15	4.53E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2294010	chr8:143762430	LY6K	chr8:143781529-143785582:+	0.35	4.88	1.84E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2294010	chr8:143762430	LYNX1	chr8:143845758-143859640:-	-0.26	-4.07	6.28E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.22	-4.87	1.91E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.22	-4.87	1.91E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.22	-4.72	3.79E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.18	-4.16	4.36E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.2	-4.24	3.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2297496	chr20:25295787	ENTPD6	chr20:25176339-25207360:+	0.34	5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2297496	chr20:25295787	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2297497	chr20:25297909	ENTPD6	chr20:25176339-25207360:+	0.34	5.92	1.01E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2297497	chr20:25297909	FAM182B	chr20:25744102-25848786:-	-0.28	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.21	4.16	4.22E-5	Height	
KIRP	cis	1	rs2300601	chr14:75639571	RPS6KL1	chr14:75372347-75389958:-	0.23	3.86	0.000141	Height	
KIRP	cis	1	rs2302138	chr14:74363305	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.45	4.41	1.49E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs2303695	chr19:18562624	LRRC25	chr19:18501955-18508421:-	-0.12	-4.13	4.94E-5	Breast cancer	
KIRP	cis	1	rs2303695	chr19:18562624	SSBP4	chr19:18530221-18545371:+	-0.15	-4.25	2.99E-5	Breast cancer	
KIRP	cis	1	rs2303697	chr19:18546678	LRRC25	chr19:18501955-18508421:-	-0.12	-4.15	4.52E-5	Breast cancer	
KIRP	cis	1	rs2303697	chr19:18546678	SSBP4	chr19:18530221-18545371:+	-0.16	-4.41	1.47E-5	Breast cancer	
KIRP	cis	1	rs2303759	chr19:49869051	CCDC155	chr19:49891506-49921246:+	-0.31	-5.08	6.97E-7	Multiple sclerosis	
KIRP	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.46	-6.67	1.48E-10	Multiple sclerosis	
KIRP	cis	1	rs2303759	chr19:49869051	SLC6A16	chr19:49792894-49828474:-	0.25	3.97	9.33E-5	Multiple sclerosis	
KIRP	cis	1	rs2304668	chr2:239168448	LOC151174	chr2:239133754-239140318:-	0.56	4.58	7.23E-6	Irritable bowel syndrome	
KIRP	cis	1	rs2305983	chr11:47858755	NUP160	chr11:47799671-47870057:-	-0.22	-3.91	0.000119	Intraocular pressure	
KIRP	cis	1	rs2306545	chr12:133419296	EP400NL	chr12:132568828-132600084:+;chr12	-0.46	-4.66	4.98E-6	Cognitive function	
KIRP	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.44	4.59	6.93E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.49	5.35	1.86E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs2307021	chr3:49765483	UBA7	chr3:49842639-49851391:-	-0.31	-5.47	1.02E-7	Resting heart rate	
KIRP	cis	1	rs2312462	chr3:49601255	NCKIPSD	chr3:48711280-48723334:-	0.32	4.47	1.18E-5	Menarche (age at onset)	
KIRP	cis	1	rs2312462	chr3:49601255	P4HTM	chr3:49027341-49044579:+	0.26	4.67	4.7E-6	Menarche (age at onset)	
KIRP	cis	1	rs231513	chr17:41965200	NBR2	chr17:41277600-41305687:+	0.34	3.81	0.000174	Cognitive function	
KIRP	cis	1	rs231518	chr17:41961451	NBR2	chr17:41277600-41305687:+	-0.36	-3.94	0.000104	Cognitive function	
KIRP	cis	1	rs2321678	chr2:135067753	TMEM163	chr2:135213331-135525334:-	0.24	4.13	4.89E-5	Multiple sclerosis (severity)	
KIRP	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.58	-8.02	3.45E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs2332352	chr14:24953980	SDR39U1	chr14:24908974-24912064:-	0.36	4.26	2.83E-5	Smooth-surface caries	
KIRP	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.35	-5.24	3.27E-7	Height	
KIRP	cis	1	rs2338555	chr1:152309380	HRNR	chr1:152184558-152196669:-	-0.44	-5.23	3.52E-7	Atopic dermatitis	
KIRP	cis	1	rs2338556	chr1:152309427	HRNR	chr1:152184558-152196669:-	-0.44	-5.23	3.52E-7	Atopic dermatitis	
KIRP	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.45	4.59	6.77E-6	Crohn's disease	
KIRP	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.46	4.52	9.42E-6	Crohn's disease	
KIRP	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs2351706	chr15:90384115	ANPEP	chr15:90328127-90358072:-	0.21	3.95	0.0001	Type 2 diabetes	
KIRP	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.77	-12.08	4.5E-27	Type 2 diabetes	
KIRP	cis	1	rs2351707	chr15:90384045	ANPEP	chr15:90328127-90358072:-	0.21	4	8.28E-5	Type 2 diabetes	
KIRP	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.76	-11.99	9.17E-27	Type 2 diabetes	
KIRP	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.24	3.82	0.000167	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.91	-17.45	6.49E-46	Homocysteine levels	
KIRP	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.83	-15.16	7.99E-38	Homocysteine levels	
KIRP	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.29	-6.81	6.48E-11	Common traits (Other)	
KIRP	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.27	-6.21	2.09E-9	Common traits (Other)	
KIRP	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.27	-5.91	1.03E-8	Longevity	
KIRP	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.28	6.1	3.67E-9	Longevity	
KIRP	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.35	-4.49	1.06E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs2365468	chr17:65841318	LOC440461	chr17:66194801-66196436:+	0.29	3.88	0.000133	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs236918	chr11:117091609	PCSK7	chr11:117075789-117102811:-	0.39	4.29	2.46E-5	Protein quantitative trait loci	
KIRP	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.35	6.18	2.37E-9	Height	
KIRP	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.33	4.92	1.52E-6	Height	
KIRP	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.34	6.29	1.29E-9	Height	
KIRP	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.29	4.41	1.49E-5	Height	
KIRP	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.35	1.92E-5	Obesity-related traits	
KIRP	cis	1	rs2371244	chr7:143757611	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.07	7.49E-7	Obesity-related traits	
KIRP	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.43	1.37E-5	Obesity-related traits	
KIRP	cis	1	rs2371247	chr7:143764179	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5.16	4.85E-7	Obesity-related traits	
KIRP	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs2371248	chr7:143764189	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.97	13.91	2.2E-33	Diastolic blood pressure	
KIRP	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.94	14.16	2.78E-34	Diastolic blood pressure	
KIRP	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.86	1.36E-8	Height	
KIRP	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.79E-6	Height	
KIRP	cis	1	rs2377360	chr1:217200883	USH2A	chr1:215796236-216596738:-	0.28	3.97	9.38E-5	Major depressive disorder	
KIRP	cis	1	rs2386661	chr10:5670275	ASB13	chr10:5680820-5708558:-	0.24	4.14	4.63E-5	Breast cancer	
KIRP	cis	1	rs2387880	chr20:25377787	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2387880	chr20:25377787	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2387881	chr20:25378172	ENTPD6	chr20:25176339-25207360:+	0.35	6.06	4.75E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2387881	chr20:25378172	FAM182B	chr20:25744102-25848786:-	-0.29	-4.03	7.18E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2387884	chr20:25379069	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2387884	chr20:25379069	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2389605	chr2:169830051	METTL5	chr2:170668270-170681420:-	0.18	3.93	0.00011	Cholesterol, total	
KIRP	cis	1	rs2389606	chr2:169829772	METTL5	chr2:170668270-170681420:-	0.18	3.93	0.000109	Cholesterol, total	
KIRP	cis	1	rs2396499	chr2:228724368	WDR69	chr2:228736327-228789026:+	-0.3	-4.62	6.08E-6	Blood pressure	
KIRP	cis	1	rs2400865	chr12:81435638	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs2400866	chr12:81435788	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs2401172	chr15:84576957	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2401173	chr15:84576970	LOC388152	chr15:84867600-84898920:-	-0.24	-4.03	7.41E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2401174	chr15:84576992	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2401175	chr15:84578217	LOC388152	chr15:84867600-84898920:-	0.24	4.03	7.32E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2401176	chr15:84578364	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2401179	chr15:84578948	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs2401180	chr15:84579186	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs241257	chr1:4614822	AJAP1	chr1:4715105-4843850:+	0.38	5.4	1.47E-7	Anxiety disorder	
KIRP	cis	1	rs241272	chr1:4626267	AJAP1	chr1:4715105-4843850:+	-0.34	-4.78	2.97E-6	Anxiety disorder	
KIRP	cis	1	rs2413748	chr22:43530982	MCAT	chr22:43528212-43539403:-	-0.22	-3.89	0.000128	Prostate cancer	
KIRP	cis	1	rs2414884	chr15:66075872	DPP8	chr15:65737999-65810035:-	-0.13	-4.74	3.46E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs2414885	chr15:66034624	DPP8	chr15:65737999-65810035:-	-0.13	-4.62	5.98E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs2415253	chr15:75375699	MAN2C1	chr15:75648135-75660941:-	0.25	4.77	3.06E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.33	4.97	1.19E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs2415255	chr15:75332412	MAN2C1	chr15:75648135-75660941:-	0.22	3.88	0.000134	Blood trace element (Zn levels)	
KIRP	cis	1	rs2415255	chr15:75332412	SCAMP5	chr15:75287901-75313836:+	0.37	5.46	1.12E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.39	5.03	9.02E-7	Metabolite levels	
KIRP	cis	1	rs2424700	chr20:25266513	ENTPD6	chr20:25176339-25207360:+	-0.35	-6	6.38E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424700	chr20:25266513	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.45E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424704	chr20:25273929	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.78	2.09E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424704	chr20:25273929	FAM182B	chr20:25744102-25848786:-	0.29	3.97	9.26E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424710	chr20:25283886	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.08	4.28E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424710	chr20:25283886	FAM182B	chr20:25744102-25848786:-	0.28	3.86	0.000144	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424712	chr20:25416942	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424712	chr20:25416942	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424713	chr20:25418482	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.74	2.59E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424713	chr20:25418482	FAM182B	chr20:25744102-25848786:-	0.3	3.97	9.19E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424716	chr20:25423538	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.34	9.87E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2424716	chr20:25423538	FAM182B	chr20:25744102-25848786:-	0.31	4.32	2.25E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2431349	chr5:75921330	F2RL2	chr5:75911308-75919240:-	-0.28	-5.11	6.22E-7	Hearing impairment	
KIRP	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.76	10.46	1.16E-21	Type 2 diabetes	
KIRP	cis	1	rs2432871	chr6:143733908	ADAT2	chr6:143743970-143771841:-	0.16	4.06	6.58E-5	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
KIRP	cis	1	rs2432872	chr6:143734156	ADAT2	chr6:143743970-143771841:-	0.16	3.96	9.45E-5	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
KIRP	cis	1	rs2439209	chr4:46274771	GABRA2	chr4:46251581-46392421:-	-0.23	-3.82	0.000164	Epilepsy	
KIRP	cis	1	rs244295	chr17:53242899	COX11	chr17:53029259-53046064:-	-0.23	-3.85	0.000147	Menarche (age at onset)	
KIRP	cis	1	rs244296	chr17:53242878	COX11	chr17:53029259-53046064:-	-0.22	-3.83	0.000161	Menarche (age at onset)	
KIRP	cis	1	rs2444240	chr11:120040442	OAF	chr11:120081747-120100649:+	0.31	5.14	5.34E-7	Corneal curvature	
KIRP	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.44	6.36	8.66E-10	Tumor biomarkers	
KIRP	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.44	7.32	2.93E-12	Tumor biomarkers	
KIRP	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.43	-6.16	2.67E-9	Tumor biomarkers	
KIRP	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.5	9.53E-13	Tumor biomarkers	
KIRP	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.45	-6.58	2.54E-10	Tumor biomarkers	
KIRP	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.42	-6.93	3.25E-11	Tumor biomarkers	
KIRP	cis	1	rs2447211	chr15:43936351	LCMT2	chr15:43619976-43622891:-	-0.33	-4.02	7.67E-5	Tumor biomarkers	
KIRP	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.31	4.76	3.19E-6	Homocysteine levels	
KIRP	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.29	4.55	8.05E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs244899	chr5:167911040	FBLL1	chr5:167956582-167957638:+	0.33	4.54	8.56E-6	Response to platinum-based chemotherapy (carboplatin)	
KIRP	cis	1	rs2455219	chr5:75922581	F2RL2	chr5:75911308-75919240:-	-0.27	-5.01	9.83E-7	Hearing impairment	
KIRP	cis	1	rs2456009	chr15:65840082	DPP8	chr15:65737999-65810035:-	0.13	4.86	2.03E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs2458413	chr8:105359432	TM7SF4	chr8:105352054-105368916:+	0.23	4.38	1.71E-5	Paget's disease	
KIRP	cis	1	rs2458414	chr8:105355840	TM7SF4	chr8:105352054-105368916:+	0.23	4.25	2.96E-5	Paget's disease	
KIRP	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.22	-4.01	7.77E-5	Diabetic kidney disease	
KIRP	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.44	6.12	3.37E-9	Tumor biomarkers	
KIRP	cis	1	rs2470134	chr15:43849886	CATSPER2	chr15:43922774-43959900:-	0.4	6.38	7.65E-10	Tumor biomarkers	
KIRP	cis	1	rs2471884	chr11:117010320	PCSK7	chr11:117075789-117102811:-	-0.4	-4.35	1.94E-5	Protein quantitative trait loci	
KIRP	cis	1	rs2472476	chr9:107531956	NIPSNAP3A	chr9:107509969-107535189:+	0.26	4.12	5.1E-5	Obesity-related traits	
KIRP	cis	1	rs2472478	chr9:107531361	NIPSNAP3A	chr9:107509969-107535189:+	0.26	3.97	9.24E-5	Obesity-related traits	
KIRP	cis	1	rs2474777	chr20:25272633	ENTPD6	chr20:25176339-25207360:+	-0.33	-5.65	4.06E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2474777	chr20:25272633	FAM182B	chr20:25744102-25848786:-	0.31	4.32	2.16E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482427	chr9:107532425	NIPSNAP3A	chr9:107509969-107535189:+	0.26	4.12	5.1E-5	Obesity-related traits	
KIRP	cis	1	rs2482911	chr20:25395528	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482911	chr20:25395528	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482919	chr20:25299756	ENTPD6	chr20:25176339-25207360:+	0.33	5.63	4.54E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482919	chr20:25299756	FAM182B	chr20:25744102-25848786:-	-0.29	-3.89	0.000127	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482927	chr20:25327151	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.34E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482927	chr20:25327151	FAM182B	chr20:25744102-25848786:-	-0.29	-3.95	0.000101	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482928	chr20:25331530	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482928	chr20:25331530	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482930	chr20:25334115	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482930	chr20:25334115	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482931	chr20:25334445	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482931	chr20:25334445	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482937	chr20:25340786	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482937	chr20:25340786	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482940	chr20:25349830	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482940	chr20:25349830	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482941	chr20:25361216	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482941	chr20:25361216	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482943	chr20:25380593	ENTPD6	chr20:25176339-25207360:+	0.34	5.65	4.18E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2482943	chr20:25380593	FAM182B	chr20:25744102-25848786:-	-0.3	-4	8.12E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.32	1.13E-9	Body mass index	
KIRP	cis	1	rs2487715	chr9:107532394	NIPSNAP3A	chr9:107509969-107535189:+	0.26	3.92	0.000111	Obesity-related traits	
KIRP	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.18	-4.12	5.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.18	-4.16	4.36E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.18	-4.12	5.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.19	4.11	5.25E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.18	-4.02	7.68E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.22	-4.88	1.8E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.16	-3.84	0.000157	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.18	-4	8.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.18	-3.81	0.000176	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.19	4.37	1.8E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.17	-3.81	0.000174	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.2	-4.33	2.1E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.18	-4.09	5.76E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.23	-4.95	1.3E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.2	-4.4	1.55E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.17	-4.07	6.21E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.16	-3.86	0.000145	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.17	-3.85	0.000146	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.18	-4.01	7.83E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.19	-4.01	7.99E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.18	-4.01	7.83E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.21	-4.56	7.85E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.21	-4.54	8.37E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.22	-4.5	1.03E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs2496588	chr6:143733124	ADAT2	chr6:143743970-143771841:-	0.18	4.36	1.9E-5	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
KIRP	cis	1	rs2496589	chr6:143733576	ADAT2	chr6:143743970-143771841:-	0.19	4.56	7.72E-6	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
KIRP	cis	1	rs2496655	chr6:41494367	APOBEC2	chr6:41020940-41032629:+	-0.38	-3.88	0.000134	EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs2500404	chr20:25359758	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500404	chr20:25359758	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500405	chr20:25360826	ENTPD6	chr20:25176339-25207360:+	0.34	5.69	3.43E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500405	chr20:25360826	FAM182B	chr20:25744102-25848786:-	-0.29	-3.94	0.000104	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500418	chr20:25382268	ENTPD6	chr20:25176339-25207360:+	0.33	5.63	4.51E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500418	chr20:25382268	FAM182B	chr20:25744102-25848786:-	-0.29	-3.9	0.000124	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500424	chr20:25391969	ENTPD6	chr20:25176339-25207360:+	0.34	5.68	3.46E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500424	chr20:25391969	FAM182B	chr20:25744102-25848786:-	-0.3	-4.07	6.19E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500432	chr20:25290512	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.1	3.73E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500436	chr20:25406366	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500436	chr20:25406366	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500443	chr20:25331442	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500443	chr20:25331442	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500446	chr20:25339664	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500446	chr20:25339664	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500448	chr20:25404027	ENTPD6	chr20:25176339-25207360:+	0.34	5.67	3.64E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2500448	chr20:25404027	FAM182B	chr20:25744102-25848786:-	-0.3	-3.99	8.55E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.28	4.48	1.12E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.14	-3.86	0.000141	Folate pathway vitamin levels	
KIRP	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.28	4.45	1.27E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.33	-4.65	5.36E-6	Asthma	
KIRP	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.54	6.15	2.81E-9	Bipolar disorder and schizophrenia	
KIRP	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.76	10.46	1.19E-21	Type 2 diabetes	
KIRP	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.8	10.87	5.12E-23	Type 2 diabetes	
KIRP	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.8	10.88	4.96E-23	Type 2 diabetes	
KIRP	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.8	10.87	5.12E-23	Type 2 diabetes	
KIRP	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.81	10.89	4.53E-23	Type 2 diabetes	
KIRP	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.81	-11.02	1.68E-23	Type 2 diabetes	
KIRP	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.76	10.46	1.16E-21	Type 2 diabetes	
KIRP	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.8	10.87	5.12E-23	Type 2 diabetes	
KIRP	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.76	10.65	2.89E-22	Type 2 diabetes	
KIRP	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.76	10.65	2.89E-22	Type 2 diabetes	
KIRP	cis	1	rs2530664	chr22:30038152	MTMR3	chr22:30279158-30426855:+	-0.24	-3.86	0.000145	Lipid traits	
KIRP	cis	1	rs2530664	chr22:30038152	NF2	chr22:29999545-30094583:+	-0.33	-4.09	5.72E-5	Lipid traits	
KIRP	cis	1	rs2531848	chr22:30032484	NF2	chr22:29999545-30094583:+	-0.32	-4.07	6.23E-5	Lipid traits	
KIRP	cis	1	rs2531849	chr22:30037900	MTMR3	chr22:30279158-30426855:+	-0.27	-4.27	2.74E-5	Lipid traits	
KIRP	cis	1	rs2531849	chr22:30037900	NF2	chr22:29999545-30094583:+	-0.35	-4.36	1.9E-5	Lipid traits	
KIRP	cis	1	rs2531849	chr22:30037900	SF3A1	chr22:30727979-30752913:-	-0.24	-3.91	0.000117	Lipid traits	
KIRP	cis	1	rs2541161	chr9:131884802	PPP2R4	chr9:131873244-131911223:+	-0.28	-4.39	1.63E-5	Blood metabolite ratios	
KIRP	cis	1	rs2541164	chr9:131876908	PPP2R4	chr9:131873244-131911223:+	0.3	4.39	1.61E-5	Blood metabolite ratios	
KIRP	cis	1	rs2543384	chr14:76627301	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs2543387	chr14:76629046	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.4	6.14	2.95E-9	Height	
KIRP	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.4	-6.03	5.49E-9	Height	
KIRP	cis	1	rs2564956	chr3:53070462	SFMBT1	chr3:52938628-53080070:-	-0.42	-6.76	8.72E-11	Ulcerative colitis	
KIRP	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.36	4.95	1.32E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2572910	chr8:143770135	LYNX1	chr8:143845758-143859640:-	-0.28	-4.46	1.21E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.38	-5.86	1.39E-8	Height	
KIRP	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.38	-5.86	1.39E-8	Height	
KIRP	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.39	-5.97	7.6E-9	Height	
KIRP	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.36	-5.43	1.26E-7	Height	
KIRP	cis	1	rs2581794	chr3:53036206	RFT1	chr3:53122503-53164470:-	-0.27	-3.94	0.000103	Schizophrenia	
KIRP	cis	1	rs2581794	chr3:53036206	SFMBT1	chr3:52938628-53080070:-	-0.29	-4.34	2.03E-5	Schizophrenia	
KIRP	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.38	-5.84	1.54E-8	Height	
KIRP	cis	1	rs2581817	chr3:53071797	SFMBT1	chr3:52938628-53080070:-	-0.41	-6.59	2.36E-10	Ulcerative colitis	
KIRP	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.35	4.94	1.39E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2585179	chr8:143774193	LYNX1	chr8:143845758-143859640:-	-0.28	-4.46	1.21E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2591092	chr14:76630133	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs2591094	chr14:76632335	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.41	4.28	2.61E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.43	-4.52	9.53E-6	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs2602836	chr4:100014805	ADH4	chr4:100044835-100065449:-	0.26	4.01	8.01E-5	HDL cholesterol	
KIRP	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.42	-5.76	2.38E-8	Tumor biomarkers	
KIRP	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.44	-6.97	2.52E-11	Tumor biomarkers	
KIRP	cis	1	rs2614811	chr15:43913487	LCMT2	chr15:43619976-43622891:-	-0.33	-3.81	0.000175	Tumor biomarkers	
KIRP	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.93	13.85	3.51E-33	Diastolic blood pressure	
KIRP	cis	1	rs2628313	chr17:53235352	COX11	chr17:53029259-53046064:-	-0.23	-4	8.29E-5	Menarche (age at onset)	
KIRP	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.3	4.49	1.08E-5	Cocaine dependence	
KIRP	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.23	5.46	1.12E-7	Ulcerative colitis	
KIRP	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.43	-4.52	9.53E-6	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.43	-4.52	9.53E-6	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.45	-6.02	5.9E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs2665826	chr17:61944924	FTSJ3	chr17:61896795-61905031:-	0.29	4.2	3.6E-5	Body mass index	
KIRP	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.94	14.18	2.49E-34	Diastolic blood pressure	
KIRP	cis	1	rs271621	chr19:18631332	LRRC25	chr19:18501955-18508421:-	-0.12	-3.9	0.00012	Breast cancer	
KIRP	cis	1	rs271621	chr19:18631332	SSBP4	chr19:18530221-18545371:+	-0.16	-4.22	3.37E-5	Breast cancer	
KIRP	cis	1	rs271623	chr19:18628947	LRRC25	chr19:18501955-18508421:-	-0.12	-3.91	0.000115	Breast cancer	
KIRP	cis	1	rs271623	chr19:18628947	SSBP4	chr19:18530221-18545371:+	-0.16	-4.24	3.05E-5	Breast cancer	
KIRP	cis	1	rs271674	chr17:47978986	SLC35B1	chr17:47778690-47785528:-	0.25	4.03	7.31E-5	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	
KIRP	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.36	5.03	9.26E-7	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.28	-4.37	1.79E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2727099	chr15:66063428	DPP8	chr15:65737999-65810035:-	-0.12	-4.57	7.5E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.33	-5.22	3.6E-7	Information processing speed	
KIRP	cis	1	rs2736345	chr8:11352485	AMAC1L2	chr8:11188495-11189695:+	-0.25	-3.82	0.000168	Systemic lupus erythematosus	
KIRP	cis	1	rs2736345	chr8:11352485	BLK	chr8:11351521-11422107:+	-0.34	-5.27	2.77E-7	Systemic lupus erythematosus	
KIRP	cis	1	rs2738413	chr14:64679960	MTHFD1	chr14:64854759-64926727:+	-0.2	-3.95	0.000102	Atrial fibrillation	
KIRP	cis	1	rs2740544	chr13:50617640	EBPL	chr13:50234811-50265623:-	-0.28	-4.08	6.07E-5	Height	
KIRP	cis	1	rs2740545	chr13:50626759	EBPL	chr13:50234811-50265623:-	-0.29	-4.26	2.88E-5	Height	
KIRP	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.42	-8.86	1.17E-16	Ankylosing spondylitis	
KIRP	cis	1	rs2760914	chr13:50600027	EBPL	chr13:50234811-50265623:-	-0.29	-4.2	3.66E-5	Height	
KIRP	cis	1	rs2768630	chr9:131866388	PPP2R4	chr9:131873244-131911223:+	-0.3	-4.16	4.32E-5	Blood metabolite ratios	
KIRP	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.43	9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.3	-3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs2802727	chr1:243483326	SDCCAG8	chr1:243419320-243663392:+	0.4	4.04	6.92E-5	Obesity (early onset extreme)	
KIRP	cis	1	rs2803839	chr13:50573919	EBPL	chr13:50234811-50265623:-	-0.29	-4.2	3.66E-5	Height	
KIRP	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.43	-5.72	2.84E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.48	-6.42	6.14E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.54	-8.6	7.32E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.55	-8.54	1.08E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.55	-8.6	6.93E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs2832065	chr21:30135362	N6AMT1	chr21:30244513-30257693:-	-0.32	-3.86	0.000144	Cognitive test performance	
KIRP	cis	1	rs2832077	chr21:30141021	N6AMT1	chr21:30244513-30257693:-	-0.32	-3.89	0.000128	Cognitive test performance	
KIRP	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.45	-8.06	2.64E-14	Eye color traits	
KIRP	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.45	-8.06	2.64E-14	Eye color traits	
KIRP	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.37	4.74	3.57E-6	Atopic dermatitis	
KIRP	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.22	3.98	8.97E-5	Cognitive function	
KIRP	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.22	3.91	0.000115	Cognitive function	
KIRP	cis	1	rs28371676	chr10:96702363	C10orf129	chr10:96953957-96988685:+	1.07	9.57	7.7E-19	Blood metabolite levels	
KIRP	cis	1	rs28371682	chr10:96703109	C10orf129	chr10:96953957-96988685:+	1.07	9.57	7.7E-19	Blood metabolite levels	
KIRP	cis	1	rs28379681	chr7:1070539	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.4	-5.41	1.41E-7	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRP	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.29	-4.65	5.25E-6	Testicular germ cell tumor	
KIRP	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.35	-5.51	8.51E-8	Testicular germ cell tumor	
KIRP	cis	1	rs28399511	chr10:96580140	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.38	5.02	9.41E-7	Atopic dermatitis	
KIRP	cis	1	rs28399710	chr7:1070631	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs28409655	chr4:48391379	CNGA1	chr4:47937996-48018610:-	-0.24	-3.87	0.000138	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs28444423	chr15:65982141	DPP8	chr15:65737999-65810035:-	-0.13	-4.72	3.79E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs28444611	chr6:11040767	ELOVL2	chr6:10980995-11044624:-	-0.33	-4.07	6.25E-5	Blood metabolite ratios	
KIRP	cis	1	rs28448438	chr4:56416665	SRD5A3	chr4:56212409-56237866:+	-0.29	-4.65	5.19E-6	Personality dimensions	
KIRP	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.29	4.2	3.7E-5	Body mass index	
KIRP	cis	1	rs28463765	chr4:56412434	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.64	5.56E-6	Personality dimensions	
KIRP	cis	1	rs2847218	chr11:60333721	MS4A8B	chr11:60467047-60483282:+	-0.7	-6.19	2.29E-9	Metabolite levels  (X-11787)	
KIRP	cis	1	rs28485881	chr17:80690014	FN3K	chr17:80693452-80709073:+	-0.22	-4.43	1.37E-5	Glycated hemoglobin levels	
KIRP	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.45	-5.86	1.38E-8	Glycated hemoglobin levels	
KIRP	cis	1	rs28514423	chr4:56429239	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.91	1.62E-6	Personality dimensions	
KIRP	cis	1	rs28514423	chr4:56429239	TMEM165	chr4:56262090-56292342:+	0.25	3.96	9.48E-5	Personality dimensions	
KIRP	cis	1	rs28517362	chr6:151876387	C6orf97	chr6:151815175-151942327:+	0.54	4.78	2.9E-6	Bone mineral density (spine)	
KIRP	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.17	-3.99	8.57E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs28528096	chr7:1070912	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.28	4.22	3.3E-5	Body mass index	
KIRP	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.28	4.05	6.83E-5	Body mass index	
KIRP	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.28	4.05	6.61E-5	Body mass index	
KIRP	cis	1	rs2854223	chr17:61939014	TCAM1P	chr17:61934376-61941738:+	-0.31	-3.96	9.74E-5	Body mass index	
KIRP	cis	1	rs28556680	chr15:66023799	DPP8	chr15:65737999-65810035:-	-0.12	-4.54	8.51E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs2856	chr20:25433536	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.44	5.54E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs2856	chr20:25433536	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.46E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs28572116	chr4:56424344	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.36	1.88E-5	Personality dimensions	
KIRP	cis	1	rs28572537	chr19:18552208	LRRC25	chr19:18501955-18508421:-	-0.12	-3.97	9.19E-5	Breast cancer	
KIRP	cis	1	rs28572537	chr19:18552208	SSBP4	chr19:18530221-18545371:+	-0.17	-4.81	2.52E-6	Breast cancer	
KIRP	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.43	-4.63	5.71E-6	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs28582059	chr4:56408404	SRD5A3	chr4:56212409-56237866:+	-0.31	-5.03	8.97E-7	Personality dimensions	
KIRP	cis	1	rs28582059	chr4:56408404	TMEM165	chr4:56262090-56292342:+	0.25	3.99	8.48E-5	Personality dimensions	
KIRP	cis	1	rs28602663	chr1:76235355	ACADM	chr1:76190043-76229353:+	0.19	4.58	7.18E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs28605789	chr6:118889952	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000167	Renal cell carcinoma	
KIRP	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.2	4.15	4.53E-5	Height	
KIRP	cis	1	rs28626045	chr14:75589195	RPS6KL1	chr14:75372347-75389958:-	0.22	3.86	0.000144	Height	
KIRP	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.37	5.24	3.35E-7	Forced vital capacity	
KIRP	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.37	5.25	3.13E-7	Forced vital capacity	
KIRP	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.37	-5.24	3.35E-7	Forced vital capacity	
KIRP	cis	1	rs28640237	chr15:66070962	DPP8	chr15:65737999-65810035:-	-0.12	-4.47	1.18E-5	Mean corpuscular hemoglobin	
KIRP	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.28	-4.14	4.58E-5	Bone mineral density	
KIRP	cis	1	rs28670674	chr4:56407103	SRD5A3	chr4:56212409-56237866:+	-0.31	-4.73	3.6E-6	Personality dimensions	
KIRP	cis	1	rs2867109	chr2:651030	SNTG2	chr2:946555-1371382:+	0.38	3.95	9.94E-5	Body mass index	
KIRP	cis	1	rs2867110	chr2:651105	SNTG2	chr2:946555-1371382:+	-0.39	-4.16	4.26E-5	Body mass index	
KIRP	cis	1	rs2867112	chr2:651349	SNTG2	chr2:946555-1371382:+	0.4	4.19	3.8E-5	Body mass index	
KIRP	cis	1	rs2867113	chr2:651365	SNTG2	chr2:946555-1371382:+	0.37	3.86	0.000143	Body mass index	
KIRP	cis	1	rs2867114	chr2:651380	SNTG2	chr2:946555-1371382:+	0.4	4.16	4.33E-5	Body mass index	
KIRP	cis	1	rs2867115	chr2:651382	SNTG2	chr2:946555-1371382:+	0.4	4.16	4.33E-5	Body mass index	
KIRP	cis	1	rs2867122	chr2:624581	SNTG2	chr2:946555-1371382:+	-0.41	-3.98	8.9E-5	Body mass index	
KIRP	cis	1	rs2867125	chr2:622827	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000137	Body mass index	
KIRP	cis	1	rs28683528	chr12:123845351	PITPNM2	chr12:123468027-123635285:-	-0.28	-3.86	0.000144	Educational attainment;Height;Head circumference (infant)	
KIRP	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.93	13.29	3.02E-31	Diastolic blood pressure	
KIRP	cis	1	rs2873853	chr22:49573628	ZBED4	chr22:50247497-50283726:+	-0.25	-4.13	4.92E-5	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	
KIRP	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.3	4.25	2.9E-5	Body mass index	
KIRP	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.29	-4.51	9.86E-6	Bone mineral density	
KIRP	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.29	-4.51	9.86E-6	Bone mineral density	
KIRP	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.91	10.87	5.43E-23	Diastolic blood pressure	
KIRP	cis	1	rs2877649	chr14:24954002	SDR39U1	chr14:24908974-24912064:-	0.36	4.26	2.83E-5	Smooth-surface caries	
KIRP	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.26	5.85	1.43E-8	Longevity	
KIRP	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.35	6.44	5.57E-10	Height	
KIRP	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.32	4.94	1.4E-6	Height	
KIRP	cis	1	rs2897770	chr13:50325070	EBPL	chr13:50234811-50265623:-	-0.37	-5.05	8.27E-7	Obesity-related traits	
KIRP	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.38	5.03	8.84E-7	Metabolite levels	
KIRP	cis	1	rs2903492	chr2:624678	SNTG2	chr2:946555-1371382:+	-0.4	-3.81	0.000173	Body mass index	
KIRP	cis	1	rs2916068	chr19:19516433	HAPLN4	chr19:19366453-19384074:-	0.24	3.93	0.00011	Schizophrenia	
KIRP	cis	1	rs2920280	chr8:143761144	LY6K	chr8:143781529-143785582:+	0.37	4.87	1.92E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920280	chr8:143761144	LYNX1	chr8:143845758-143859640:-	-0.27	-3.98	9.0E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920282	chr8:143757763	LY6K	chr8:143781529-143785582:+	0.34	4.64	5.38E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920282	chr8:143757763	LYNX1	chr8:143845758-143859640:-	-0.26	-4.14	4.63E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920283	chr8:143757037	LY6K	chr8:143781529-143785582:+	0.33	4.6	6.64E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920283	chr8:143757037	LYNX1	chr8:143845758-143859640:-	-0.26	-4.14	4.58E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920292	chr8:143765699	LY6K	chr8:143781529-143785582:+	0.35	4.92	1.49E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920292	chr8:143765699	LYNX1	chr8:143845758-143859640:-	-0.26	-4.21	3.55E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.35	4.92	1.49E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920293	chr8:143765414	LYNX1	chr8:143845758-143859640:-	-0.26	-4.21	3.55E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920294	chr8:143765326	LY6K	chr8:143781529-143785582:+	0.35	4.92	1.49E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920294	chr8:143765326	LYNX1	chr8:143845758-143859640:-	-0.26	-4.21	3.55E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.32	4.5	1.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920295	chr8:143764937	LYNX1	chr8:143845758-143859640:-	-0.27	-4.27	2.74E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920296	chr8:143763109	LY6K	chr8:143781529-143785582:+	0.35	4.9	1.69E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920296	chr8:143763109	LYNX1	chr8:143845758-143859640:-	-0.26	-4.12	5.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920297	chr8:143763083	LY6K	chr8:143781529-143785582:+	0.35	4.9	1.69E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920297	chr8:143763083	LYNX1	chr8:143845758-143859640:-	-0.26	-4.12	5.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920298	chr8:143763043	LY6K	chr8:143781529-143785582:+	0.35	4.9	1.69E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920298	chr8:143763043	LYNX1	chr8:143845758-143859640:-	-0.26	-4.12	5.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.46	-6.55	3.02E-10	Tumor biomarkers	
KIRP	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.44	-7.28	3.74E-12	Tumor biomarkers	
KIRP	cis	1	rs2920781	chr15:43924682	LCMT2	chr15:43619976-43622891:-	-0.32	-3.85	0.000149	Tumor biomarkers	
KIRP	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.46	-6.55	3.02E-10	Tumor biomarkers	
KIRP	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.44	-7.28	3.74E-12	Tumor biomarkers	
KIRP	cis	1	rs2927072	chr15:43922398	LCMT2	chr15:43619976-43622891:-	-0.32	-3.85	0.000149	Tumor biomarkers	
KIRP	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.37	-4.31	2.35E-5	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.26	4.47	1.17E-5	Obesity-related traits	
KIRP	cis	1	rs2951308	chr7:143767149	OR2A9P	chr7:143991573-143997832:+;chr7	0.28	5.18	4.36E-7	Obesity-related traits	
KIRP	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.43	1.37E-5	Obesity-related traits	
KIRP	cis	1	rs2951353	chr7:143761116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5.16	4.85E-7	Obesity-related traits	
KIRP	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs2951354	chr7:143761001	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.41	1.53E-5	Obesity-related traits	
KIRP	cis	1	rs2951360	chr7:143757349	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.11	6.22E-7	Obesity-related traits	
KIRP	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.03	8.92E-7	Obesity-related traits	
KIRP	cis	1	rs2951363	chr7:143754724	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.49	9.38E-8	Obesity-related traits	
KIRP	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.18	4.41E-7	Obesity-related traits	
KIRP	cis	1	rs2951364	chr7:143754483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.61	5.16E-8	Obesity-related traits	
KIRP	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.06	7.8E-7	Obesity-related traits	
KIRP	cis	1	rs2951368	chr7:143752821	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.52	7.96E-8	Obesity-related traits	
KIRP	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.21	3.83E-7	Obesity-related traits	
KIRP	cis	1	rs2951369	chr7:143752638	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.64	4.36E-8	Obesity-related traits	
KIRP	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.06	7.8E-7	Obesity-related traits	
KIRP	cis	1	rs2951372	chr7:143749503	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.52	7.96E-8	Obesity-related traits	
KIRP	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.03	8.92E-7	Obesity-related traits	
KIRP	cis	1	rs2961115	chr7:143753371	OR2A9P	chr7:143991573-143997832:+;chr7	-0.3	-5.49	9.38E-8	Obesity-related traits	
KIRP	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.24	-4.06	6.41E-5	Obesity-related traits	
KIRP	cis	1	rs2961117	chr7:143755253	OR2A7	chr7:143955790-143974852:-	0.26	3.92	0.000111	Obesity-related traits	
KIRP	cis	1	rs2961117	chr7:143755253	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.05	8.17E-7	Obesity-related traits	
KIRP	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.35	1.92E-5	Obesity-related traits	
KIRP	cis	1	rs2961118	chr7:143755443	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.07	7.49E-7	Obesity-related traits	
KIRP	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs2961119	chr7:143755852	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.41	1.53E-5	Obesity-related traits	
KIRP	cis	1	rs2961120	chr7:143756585	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.11	6.22E-7	Obesity-related traits	
KIRP	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs2961125	chr7:143761770	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs2961126	chr7:143762736	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.27	-4.5	1.01E-5	Obesity-related traits	
KIRP	cis	1	rs2961128	chr7:143763483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	4.17E-7	Obesity-related traits	
KIRP	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.25	-4.2	3.62E-5	Obesity-related traits	
KIRP	cis	1	rs2961132	chr7:143768128	OR2A7	chr7:143955790-143974852:-	0.26	3.96	9.75E-5	Obesity-related traits	
KIRP	cis	1	rs2961132	chr7:143768128	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5.2	4.08E-7	Obesity-related traits	
KIRP	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.25	-4.29	2.5E-5	Obesity-related traits	
KIRP	cis	1	rs2961134	chr7:143771062	OR2A7	chr7:143955790-143974852:-	0.27	4.13	4.9E-5	Obesity-related traits	
KIRP	cis	1	rs2961134	chr7:143771062	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.88	1.87E-6	Obesity-related traits	
KIRP	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.3	5.24	3.3E-7	Obesity-related traits	
KIRP	cis	1	rs2961144	chr7:143747870	OR2A9P	chr7:143991573-143997832:+;chr7	0.3	5.5	8.81E-8	Obesity-related traits	
KIRP	cis	1	rs2965188	chr19:19522557	HAPLN4	chr19:19366453-19384074:-	0.24	3.86	0.000141	Schizophrenia	
KIRP	cis	1	rs2976388	chr8:143760256	LY6K	chr8:143781529-143785582:+	0.38	5	1.07E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976392	chr8:143762932	LY6K	chr8:143781529-143785582:+	0.35	4.87	1.92E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976392	chr8:143762932	LYNX1	chr8:143845758-143859640:-	-0.26	-4.06	6.45E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976394	chr8:143763622	LY6K	chr8:143781529-143785582:+	0.35	4.9	1.69E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976394	chr8:143763622	LYNX1	chr8:143845758-143859640:-	-0.26	-4.12	5.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976396	chr8:143764001	LY6K	chr8:143781529-143785582:+	-0.35	-4.82	2.43E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976396	chr8:143764001	LYNX1	chr8:143845758-143859640:-	0.26	4.08	5.92E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976398	chr8:143764879	LY6K	chr8:143781529-143785582:+	0.35	4.95	1.32E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2976398	chr8:143764879	LYNX1	chr8:143845758-143859640:-	-0.27	-4.2	3.65E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2977993	chr9:131608786	C9orf114	chr9:131584346-131592085:-	0.28	4.33	2.11E-5	Schizophrenia	
KIRP	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.22	4.82	2.38E-6	Schizophrenia	
KIRP	cis	1	rs2978982	chr8:143763490	LY6K	chr8:143781529-143785582:+	0.35	4.88	1.84E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2978982	chr8:143763490	LYNX1	chr8:143845758-143859640:-	-0.26	-4.07	6.28E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRP	cis	1	rs2985684	chr14:50101682	RPL36AL	chr14:50085407-50087349:-	0.21	4.1	5.48E-5	Carotid intima media thickness	
KIRP	cis	1	rs2985687	chr14:50100386	RPL36AL	chr14:50085407-50087349:-	0.22	4.25	3.0E-5	Carotid intima media thickness	
KIRP	cis	1	rs2985696	chr14:50094913	PPIL5	chr14:50065415-50081389:+	0.23	4.11	5.23E-5	Carotid intima media thickness	
KIRP	cis	1	rs2985696	chr14:50094913	RPL36AL	chr14:50085407-50087349:-	0.29	5.74	2.64E-8	Carotid intima media thickness	
KIRP	cis	1	rs2985697	chr14:50092902	PPIL5	chr14:50065415-50081389:+	0.23	4.11	5.36E-5	Carotid intima media thickness	
KIRP	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.29	5.7	3.26E-8	Carotid intima media thickness	
KIRP	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-1.01	-20.33	5.03E-56	Homocysteine levels	
KIRP	cis	1	rs3002702	chr20:25268920	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.2	2.18E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs3002702	chr20:25268920	FAM182B	chr20:25744102-25848786:-	0.31	4.3	2.4E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs3007030	chr14:50086563	PPIL5	chr14:50065415-50081389:+	0.22	3.83	0.000159	Carotid intima media thickness	
KIRP	cis	1	rs3007030	chr14:50086563	RPL36AL	chr14:50085407-50087349:-	0.28	5.41	1.43E-7	Carotid intima media thickness	
KIRP	cis	1	rs3007031	chr14:50102269	RPL36AL	chr14:50085407-50087349:-	0.21	4.07	6.14E-5	Carotid intima media thickness	
KIRP	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.48	-6.39	7.53E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.43	-5.93	9.34E-9	Tumor biomarkers	
KIRP	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.44	-7.04	1.65E-11	Tumor biomarkers	
KIRP	cis	1	rs3101443	chr15:43912372	LCMT2	chr15:43619976-43622891:-	-0.33	-3.9	0.000123	Tumor biomarkers	
KIRP	cis	1	rs3104767	chr16:52624738	AKTIP	chr16:53525193-53537170:-	-0.22	-4.01	7.89E-5	Breast cancer	
KIRP	cis	1	rs3104768	chr16:52626396	AKTIP	chr16:53525193-53537170:-	0.23	4.06	6.4E-5	Breast cancer	
KIRP	cis	1	rs3104769	chr16:52627231	AKTIP	chr16:53525193-53537170:-	0.23	4.06	6.4E-5	Breast cancer	
KIRP	cis	1	rs3104772	chr16:52629326	AKTIP	chr16:53525193-53537170:-	0.23	3.95	0.000101	Breast cancer	
KIRP	cis	1	rs3104774	chr16:52629702	AKTIP	chr16:53525193-53537170:-	-0.22	-3.92	0.000112	Breast cancer	
KIRP	cis	1	rs3104782	chr16:52636177	AKTIP	chr16:53525193-53537170:-	0.24	4.08	6.03E-5	Breast cancer	
KIRP	cis	1	rs3104784	chr16:52636365	AKTIP	chr16:53525193-53537170:-	-0.23	-4.08	6.06E-5	Breast cancer	
KIRP	cis	1	rs3104787	chr16:52637543	AKTIP	chr16:53525193-53537170:-	0.23	3.98	8.9E-5	Breast cancer	
KIRP	cis	1	rs3104788	chr16:52638503	AKTIP	chr16:53525193-53537170:-	-0.23	-4.13	4.95E-5	Breast cancer	
KIRP	cis	1	rs3104789	chr16:52638548	AKTIP	chr16:53525193-53537170:-	0.23	3.98	8.9E-5	Breast cancer	
KIRP	cis	1	rs3104793	chr16:52641186	AKTIP	chr16:53525193-53537170:-	0.24	4.16	4.29E-5	Breast cancer	
KIRP	cis	1	rs3104796	chr16:52642377	AKTIP	chr16:53525193-53537170:-	0.24	4.1	5.48E-5	Breast cancer	
KIRP	cis	1	rs3104798	chr16:52644895	AKTIP	chr16:53525193-53537170:-	0.22	3.89	0.000129	Breast cancer	
KIRP	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.44	-5.89	1.18E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs3106598	chr13:61678912	TDRD3	chr13:60970591-61148012:+	-0.24	-3.96	9.78E-5	Longevity	
KIRP	cis	1	rs3110496	chr17:27917771	TP53I13	chr17:27895739-27900174:+	0.19	4.65	5.23E-6	Height	
KIRP	cis	1	rs3112612	chr16:52635164	AKTIP	chr16:53525193-53537170:-	0.23	3.98	8.8E-5	Breast cancer	
KIRP	cis	1	rs3112613	chr16:52634163	AKTIP	chr16:53525193-53537170:-	0.25	4.26	2.83E-5	Breast cancer	
KIRP	cis	1	rs3112615	chr16:52632350	AKTIP	chr16:53525193-53537170:-	0.23	3.91	0.000116	Breast cancer	
KIRP	cis	1	rs3112617	chr16:52631717	AKTIP	chr16:53525193-53537170:-	0.22	3.89	0.000126	Breast cancer	
KIRP	cis	1	rs3112618	chr16:52631186	AKTIP	chr16:53525193-53537170:-	0.23	3.91	0.000116	Breast cancer	
KIRP	cis	1	rs3112621	chr16:52630349	AKTIP	chr16:53525193-53537170:-	0.25	4.19	3.82E-5	Breast cancer	
KIRP	cis	1	rs3112622	chr16:52629503	AKTIP	chr16:53525193-53537170:-	0.23	3.95	0.000101	Breast cancer	
KIRP	cis	1	rs3112623	chr16:52627526	AKTIP	chr16:53525193-53537170:-	0.23	4.06	6.4E-5	Breast cancer	
KIRP	cis	1	rs3112624	chr16:52626551	AKTIP	chr16:53525193-53537170:-	0.23	4.06	6.4E-5	Breast cancer	
KIRP	cis	1	rs3112625	chr16:52625552	AKTIP	chr16:53525193-53537170:-	0.24	4.18	3.95E-5	Breast cancer	
KIRP	cis	1	rs3112626	chr16:52625200	AKTIP	chr16:53525193-53537170:-	0.23	3.96	9.69E-5	Breast cancer	
KIRP	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.44	-5.82	1.67E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs3116494	chr2:204592021	CD28	chr2:204571198-204602556:+	0.22	4.11	5.27E-5	Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs3118625	chr9:131873256	PPP2R4	chr9:131873244-131911223:+	-0.3	-4.36	1.88E-5	Blood metabolite ratios	
KIRP	cis	1	rs3118632	chr9:131901284	PPP2R4	chr9:131873244-131911223:+	-0.28	-4.35	1.97E-5	Blood metabolite ratios	
KIRP	cis	1	rs3120662	chr1:152302865	HRNR	chr1:152184558-152196669:-	-0.43	-5.12	6.0E-7	Atopic dermatitis	
KIRP	cis	1	rs3124510	chr9:131899690	PPP2R4	chr9:131873244-131911223:+	-0.29	-4.51	9.6E-6	Blood metabolite ratios	
KIRP	cis	1	rs3124511	chr9:131901458	PPP2R4	chr9:131873244-131911223:+	-0.3	-4.39	1.64E-5	Blood metabolite ratios	
KIRP	cis	1	rs3124512	chr9:131903881	PPP2R4	chr9:131873244-131911223:+	-0.34	-5.12	5.98E-7	Blood metabolite ratios	
KIRP	cis	1	rs3124513	chr9:131904593	PPP2R4	chr9:131873244-131911223:+	-0.28	-4.31	2.3E-5	Blood metabolite ratios	
KIRP	cis	1	rs3124514	chr9:131904608	PPP2R4	chr9:131873244-131911223:+	-0.28	-4.31	2.3E-5	Blood metabolite ratios	
KIRP	cis	1	rs3126085	chr1:152300817	HRNR	chr1:152184558-152196669:-	-0.44	-5.23	3.52E-7	Atopic dermatitis	
KIRP	cis	1	rs3126092	chr1:152307955	HRNR	chr1:152184558-152196669:-	-0.44	-5.23	3.52E-7	Atopic dermatitis	
KIRP	cis	1	rs3126095	chr1:152309683	HRNR	chr1:152184558-152196669:-	-0.44	-5.23	3.52E-7	Atopic dermatitis	
KIRP	cis	1	rs3126098	chr1:152311923	HRNR	chr1:152184558-152196669:-	-0.44	-5.23	3.52E-7	Atopic dermatitis	
KIRP	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.27	3.94	0.000104	Diabetic kidney disease	
KIRP	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.27	4.07	6.18E-5	Diabetic kidney disease	
KIRP	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.27	4.04	6.95E-5	Diabetic kidney disease	
KIRP	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.27	4.04	6.95E-5	Diabetic kidney disease	
KIRP	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.27	4.07	6.18E-5	Diabetic kidney disease	
KIRP	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.28	4.03	7.26E-5	Diabetic kidney disease	
KIRP	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.27	4.07	6.18E-5	Diabetic kidney disease	
KIRP	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.28	4.27	2.76E-5	Diabetic kidney disease	
KIRP	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.26	4.31	2.33E-5	Diabetic kidney disease	
KIRP	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.26	4.31	2.35E-5	Diabetic kidney disease	
KIRP	cis	1	rs313839	chr19:47221557	PRKD2	chr19:47177574-47220384:-	0.29	4.12	4.98E-5	Type 1 diabetes	
KIRP	cis	1	rs315135	chr12:69762987	YEATS4	chr12:69753532-69784575:+	0.5	5.2	4.02E-7	Response to diuretic therapy	
KIRP	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.26	4.13	4.82E-5	Diabetic kidney disease	
KIRP	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.28	4.02	7.58E-5	Diabetic kidney disease	
KIRP	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.27	-3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.27	3.98	9.01E-5	Diabetic kidney disease	
KIRP	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.32	-4.9	1.68E-6	Narcolepsy	
KIRP	cis	1	rs3197999	chr3:49721532	DOCK3	chr3:50712672-51421628:+	-0.31	-4.48	1.1E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs3197999	chr3:49721532	RBM6	chr3:49977592-50137484:+	0.15	4.22	3.3E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs3197999	chr3:49721532	UBA7	chr3:49842639-49851391:-	0.36	6.15	2.91E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.59	-6.25	1.63E-9	Dental caries	
KIRP	cis	1	rs3204270	chr17:79682051	TSPAN10	chr17:79609349-79615778:+	-0.52	-4.37	1.78E-5	Dental caries	
KIRP	cis	1	rs3206817	chr17:65892834	LOC440461	chr17:66194801-66196436:+	0.31	3.85	0.000146	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs320700	chr7:137049477	PTN	chr7:136912092-137028546:-	0.32	3.87	0.000138	Educational attainment (years of education)	
KIRP	cis	1	rs3213446	chr22:51015674	CPT1B	chr22:51007291-51017096:-	-0.33	-4.88	1.79E-6	Narcolepsy	
KIRP	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.54	-9.74	2.3E-19	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.27	-6.09	3.95E-9	Longevity	
KIRP	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.38	5.39	1.59E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.28	5.12	5.85E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.76	10.65	2.89E-22	Type 2 diabetes	
KIRP	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.37	6.05	4.84E-9	Cognitive performance	
KIRP	cis	1	rs34055941	chr9:131895076	PPP2R4	chr9:131873244-131911223:+	0.26	4.03	7.18E-5	Blood metabolite ratios	
KIRP	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.39	6.34	1.01E-9	Cognitive performance	
KIRP	cis	1	rs34088794	chr15:40665420	C15orf23	chr15:40674922-40686488:+	0.99	11.13	7.46E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs34088794	chr15:40665420	IVD	chr15:40697686-40713512:+	-0.34	-3.86	0.000141	Heschl's gyrus morphology	
KIRP	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.5	-7.48	1.09E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.16	8.08E-12	Subjective well-being	
KIRP	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.61	6.07	4.41E-9	Crohn's disease	
KIRP	cis	1	rs34171762	chr19:18559410	LRRC25	chr19:18501955-18508421:-	-0.12	-4.18	3.97E-5	Breast cancer	
KIRP	cis	1	rs34171762	chr19:18559410	SSBP4	chr19:18530221-18545371:+	-0.16	-4.26	2.87E-5	Breast cancer	
KIRP	cis	1	rs34180939	chr5:148618964	AFAP1L1	chr5:148651401-148721365:+	0.32	4.21	3.47E-5	Body mass index	
KIRP	cis	1	rs34182248	chr17:45321359	LOC100272146	chr17:45500843-45504056:+	-0.2	-4.33	2.08E-5	Body mass index	
KIRP	cis	1	rs34227865	chr4:76546525	CDKL2	chr4:76501705-76555721:-	0.29	4.16	4.28E-5	Magnesium levels	
KIRP	cis	1	rs34237279	chr15:75361121	MAN2C1	chr15:75648135-75660941:-	0.25	4.61	6.21E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.35	5.21	3.76E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs34246550	chr8:89585399	MMP16	chr8:89049462-89339717:-	0.31	4.45	1.24E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs34252323	chr2:135486302	TMEM163	chr2:135213331-135525334:-	-0.41	-5.46	1.11E-7	Gut microbiome composition (winter)	
KIRP	cis	1	rs34256197	chr19:18606472	LRRC25	chr19:18501955-18508421:-	-0.12	-4.09	5.81E-5	Breast cancer	
KIRP	cis	1	rs34256197	chr19:18606472	SSBP4	chr19:18530221-18545371:+	-0.17	-4.54	8.61E-6	Breast cancer	
KIRP	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.56	-8.27	6.47E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs34333482	chr6:116855952	FAM26F	chr6:116782556-116784933:+	0.23	5.96	7.98E-9	Pelvic organ prolapse (moderate/severe)	
KIRP	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.31	-4.95	1.33E-6	Educational attainment (years of education)	
KIRP	cis	1	rs34373625	chr10:4981201	AKR1C2	chr10:4964715-5060207:-	0.89	8.25	7.58E-15	Height	
KIRP	cis	1	rs34405766	chr2:135486189	TMEM163	chr2:135213331-135525334:-	-0.41	-5.46	1.11E-7	Gut microbiome composition (winter)	
KIRP	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.3	-4.98	1.14E-6	Bone mineral density	
KIRP	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.29	-4.74	3.54E-6	Bone mineral density	
KIRP	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.29	-4.74	3.54E-6	Bone mineral density	
KIRP	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.33	5.31	2.32E-7	Body mass index	
KIRP	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.31	4.35	1.91E-5	Inflammatory skin disease	
KIRP	cis	1	rs34453673	chr5:434722	C5orf55	chr5:441645-443258:-	0.37	5.57	6.22E-8	Cystic fibrosis severity	
KIRP	cis	1	rs3448	chr3:49396751	NCKIPSD	chr3:48711280-48723334:-	0.32	4.39	1.65E-5	Menarche (age at onset)	
KIRP	cis	1	rs3448	chr3:49396751	P4HTM	chr3:49027341-49044579:+	0.24	4.27	2.7E-5	Menarche (age at onset)	
KIRP	cis	1	rs34492688	chr17:45321622	LOC100272146	chr17:45500843-45504056:+	-0.19	-4.39	1.63E-5	Body mass index	
KIRP	cis	1	rs34530577	chr3:53103796	RFT1	chr3:53122503-53164470:-	-0.39	-5.82	1.66E-8	Height	
KIRP	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.26	3.88	0.000132	Diabetic kidney disease	
KIRP	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.37	-5.69	3.37E-8	Schizophrenia	
KIRP	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.56	-8.27	6.47E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.49	-7.22	5.34E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.39	-3.89	0.000129	Bronchopulmonary dysplasia	
KIRP	cis	1	rs34645895	chr20:25368373	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs34645895	chr20:25368373	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs34684276	chr15:78813155	CHRNA5	chr15:78857906-78886458:+	-0.23	-3.83	0.00016	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
KIRP	cis	1	rs34746918	chr19:18539744	LRRC25	chr19:18501955-18508421:-	-0.12	-4.24	3.05E-5	Breast cancer	
KIRP	cis	1	rs34746918	chr19:18539744	SSBP4	chr19:18530221-18545371:+	-0.15	-4.28	2.66E-5	Breast cancer	
KIRP	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.41	-6.06	4.67E-9	Schizophrenia	
KIRP	cis	1	rs34762726	chr3:49689210	RBM6	chr3:49977592-50137484:+	0.15	4.42	1.46E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs34762726	chr3:49689210	UBA7	chr3:49842639-49851391:-	0.35	6.21	2.02E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs34785390	chr4:76534481	CDKL2	chr4:76501705-76555721:-	0.28	3.84	0.000152	Magnesium levels	
KIRP	cis	1	rs34792	chr16:15587497	NDE1	chr16:15737124-15820206:+	-0.2	-3.98	8.82E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
KIRP	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.42	-4.52	9.18E-6	Menarche (age at onset)	
KIRP	cis	1	rs34847072	chr5:437862	C5orf55	chr5:441645-443258:-	0.36	5.54	7.16E-8	Cystic fibrosis severity	
KIRP	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.49	5.35	1.89E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs34849118	chr2:240919912	NDUFA10	chr2:240900158-240964798:-	0.22	3.94	0.000104	Odorant perception (isobutyraldehyde)	
KIRP	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.5	-7.54	7.34E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs34897410	chr2:239182123	LOC151174	chr2:239133754-239140318:-	0.49	4.48	1.1E-5	Irritable bowel syndrome	
KIRP	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.4	-6.13	3.09E-9	Schizophrenia	
KIRP	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs34910028	chr11:47758449	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs34947476	chr2:135486150	TMEM163	chr2:135213331-135525334:-	-0.4	-5.41	1.41E-7	Gut microbiome composition (winter)	
KIRP	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.42	5.62	4.86E-8	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs35025342	chr6:151876661	C6orf97	chr6:151815175-151942327:+	0.54	4.76	3.14E-6	Bone mineral density (spine)	
KIRP	cis	1	rs35056702	chr6:109736326	AKD1	chr6:109814059-110012415:-	-0.23	-4.03	7.33E-5	Height	
KIRP	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.28	5.37	1.68E-7	Height	
KIRP	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.39	-5.61	5.1E-8	Forced vital capacity	
KIRP	cis	1	rs35099099	chr6:39284857	KCNK17	chr6:39266778-39282237:-	-0.34	-4.94	1.41E-6	Type 2 diabetes	
KIRP	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.18	-4.25	2.93E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs35184688	chr17:40272406	DHX58	chr17:40253422-40264751:-	-0.24	-4.14	4.72E-5	Fibrinogen levels	
KIRP	cis	1	rs352476	chr15:65805389	DPP8	chr15:65737999-65810035:-	0.13	4.9	1.66E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs352479	chr15:65803428	DPP8	chr15:65737999-65810035:-	0.13	4.86	1.99E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.26	3.85	0.00015	Diabetic kidney disease	
KIRP	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.41	-6.03	5.5E-9	Schizophrenia	
KIRP	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.37	-5.76	2.38E-8	Schizophrenia	
KIRP	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.37	-3.83	0.000159	Bronchopulmonary dysplasia	
KIRP	cis	1	rs353464	chr5:176403023	PRR7	chr5:176873796-176883283:+	-0.22	-3.9	0.00012	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs353467	chr5:176445698	PRR7	chr5:176873796-176883283:+	-0.21	-3.88	0.000134	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs353468	chr5:176445494	PRR7	chr5:176873796-176883283:+	-0.21	-3.88	0.000134	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs353478	chr5:176370988	PRR7	chr5:176873796-176883283:+	-0.21	-3.86	0.000145	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs353490	chr5:176433063	PRR7	chr5:176873796-176883283:+	-0.21	-3.82	0.000166	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs353493	chr5:176432585	PRR7	chr5:176873796-176883283:+	-0.22	-3.89	0.000126	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.27	4.15	4.56E-5	Diabetic kidney disease	
KIRP	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.56	-8.27	6.47E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.26	3.85	0.00015	Diabetic kidney disease	
KIRP	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.5	8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs35464459	chr10:4964640	AKR1C2	chr10:4964715-5060207:-	0.91	7.85	1.01E-13	Height	
KIRP	cis	1	rs35468197	chr10:4978256	AKR1C2	chr10:4964715-5060207:-	0.88	8.2	1.05E-14	Height	
KIRP	cis	1	rs35468353	chr16:31056433	HSD3B7	chr16:30996519-31000473:+	0.29	5.69	3.39E-8	Response to metformin (IC50)	
KIRP	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.2	4.18	4.04E-5	Response to metformin (IC50)	
KIRP	cis	1	rs35485559	chr12:81441066	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.4	-6.13	3.09E-9	Schizophrenia	
KIRP	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.37	-4.11	5.35E-5	Menarche (age at onset)	
KIRP	cis	1	rs35564624	chr6:151876494	C6orf97	chr6:151815175-151942327:+	0.54	4.78	2.9E-6	Bone mineral density (spine)	
KIRP	cis	1	rs35577967	chr15:75354621	MAN2C1	chr15:75648135-75660941:-	0.24	4.3	2.44E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.31	4.53	9.09E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs35602488	chr3:94246319	STX19	chr3:93733215-93747454:-	0.57	6.24	1.68E-9	Blood pressure measurement (high sodium intervention)	
KIRP	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.51	-6.69	1.34E-10	Subjective well-being	
KIRP	cis	1	rs35624992	chr11:47615798	PSMC3	chr11:47440320-47448024:-	0.2	3.84	0.000151	Subjective well-being	
KIRP	cis	1	rs35628463	chr2:653581	SNTG2	chr2:946555-1371382:+	0.41	4.2	3.61E-5	Body mass index	
KIRP	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.37	-5.58	5.9E-8	Schizophrenia	
KIRP	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.41	-6.06	4.67E-9	Schizophrenia	
KIRP	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.41	-6.02	5.85E-9	Schizophrenia	
KIRP	cis	1	rs35672725	chr8:89581838	MMP16	chr8:89049462-89339717:-	0.3	4.07	6.12E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs35703976	chr2:135486350	TMEM163	chr2:135213331-135525334:-	-0.41	-5.46	1.11E-7	Gut microbiome composition (winter)	
KIRP	cis	1	rs35715471	chr8:89582284	MMP16	chr8:89049462-89339717:-	0.31	4.34	2.0E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.38	4	8.26E-5	Immune reponse to smallpox (secreted IL-2)	
KIRP	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.37	-5.68	3.45E-8	Schizophrenia	
KIRP	cis	1	rs35728690	chr4:76546789	CDKL2	chr4:76501705-76555721:-	0.29	4.16	4.28E-5	Magnesium levels	
KIRP	cis	1	rs35736167	chr15:75332002	MAN2C1	chr15:75648135-75660941:-	0.22	3.88	0.000134	Blood trace element (Zn levels)	
KIRP	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.37	5.46	1.12E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.56	-7.66	3.49E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs35767091	chr4:56346723	SRD5A3	chr4:56212409-56237866:+	0.29	4.66	5.04E-6	Personality dimensions	
KIRP	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.53	-7.9	7.63E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.4	-5.82	1.7E-8	Schizophrenia	
KIRP	cis	1	rs35883214	chr4:76508861	CDKL2	chr4:76501705-76555721:-	0.28	3.85	0.000148	Magnesium levels	
KIRP	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs35902101	chr11:47795169	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs35949897	chr12:15346379	RERG	chr12:15260718-15374304:-	0.35	5.04	8.55E-7	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.37	-5.68	3.45E-8	Schizophrenia	
KIRP	cis	1	rs35977534	chr5:176335231	PRR7	chr5:176873796-176883283:+	-0.22	-4.06	6.56E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.37	6.05	4.84E-9	Cognitive performance	
KIRP	cis	1	rs35993975	chr3:10067794	LOC401052	chr3:10048102-10052779:-	0.32	3.96	9.79E-5	Alzheimer's disease	
KIRP	cis	1	rs36000835	chr10:4979788	AKR1C2	chr10:4964715-5060207:-	0.97	8.36	3.57E-15	Height	
KIRP	cis	1	rs36006749	chr3:38443312	EXOG	chr3:38537763-38567796:+	-0.17	-4.14	4.71E-5	Electrocardiographic conduction measures	
KIRP	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.26	3.88	0.000132	Diabetic kidney disease	
KIRP	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.38	-5.76	2.37E-8	Schizophrenia	
KIRP	cis	1	rs36035949	chr6:109736614	AKD1	chr6:109814059-110012415:-	-0.26	-4.57	7.43E-6	Height	
KIRP	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.3	5.48	9.85E-8	Height	
KIRP	cis	1	rs36053186	chr8:89583242	MMP16	chr8:89049462-89339717:-	0.31	4.43	1.4E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs36096746	chr10:4975353	AKR1C2	chr10:4964715-5060207:-	0.84	7.77	1.77E-13	Height	
KIRP	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.5	-7.4	1.8E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.5	-8.1	2.03E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs365132	chr5:176378574	PRR7	chr5:176873796-176883283:+	-0.22	-3.89	0.000126	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	0.4	5.31	2.35E-7	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRP	cis	1	rs3729931	chr3:12626516	SYN2	chr3:12045862-12233530:+	-0.29	-3.95	0.0001	Cardiac hypertrophy	
KIRP	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.37	6.05	4.84E-9	Cognitive performance	
KIRP	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs3734618	chr6:39284184	KCNK17	chr6:39266778-39282237:-	-0.37	-5.36	1.8E-7	Type 2 diabetes	
KIRP	cis	1	rs3736544	chr4:56309992	SRD5A3	chr4:56212409-56237866:+	0.3	4.67	4.8E-6	Personality dimensions	
KIRP	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.38	5.02	9.56E-7	Metabolite levels	
KIRP	cis	1	rs3739034	chr2:135483381	TMEM163	chr2:135213331-135525334:-	0.41	5.6	5.22E-8	Gut microbiome composition (winter)	
KIRP	cis	1	rs3739036	chr2:135483534	TMEM163	chr2:135213331-135525334:-	0.41	5.66	3.95E-8	Gut microbiome composition (winter)	
KIRP	cis	1	rs3739847	chr9:131911574	PPP2R4	chr9:131873244-131911223:+	-0.3	-4.64	5.4E-6	Blood metabolite ratios	
KIRP	cis	1	rs3740367	chr10:96495266	C10orf129	chr10:96953957-96988685:+	0.98	8.9	8.97E-17	Blood metabolite levels	
KIRP	cis	1	rs3741489	chr12:133417802	EP400NL	chr12:132568828-132600084:+;chr12	-0.46	-4.66	4.98E-6	Cognitive function	
KIRP	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.42	-7.97	4.6E-14	IgG glycosylation	
KIRP	cis	1	rs3745565	chr19:6690982	GPR108	chr19:6729927-6737633:-	-0.45	-4.5	1.02E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs3745566	chr19:6690966	GPR108	chr19:6729927-6737633:-	0.41	4.07	6.23E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.6	9.65	4.32E-19	Schizophrenia	
KIRP	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.46	5.04	8.65E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs3749237	chr3:49770032	UBA7	chr3:49842639-49851391:-	-0.3	-5.4	1.49E-7	Resting heart rate	
KIRP	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.22	-4.87	1.91E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.2	-4.51	9.64E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.18	-4.08	5.88E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.17	-4.03	7.38E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.2	-4.46	1.22E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.18	-3.87	0.000139	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.18	-4.04	7.06E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.34	5.59	5.53E-8	Fractional exhaled nitric oxide (childhood)	
KIRP	cis	1	rs3751972	chr17:26206414	NOS2	chr17:26083793-26220409:-	-0.91	-12.51	1.58E-28	Fractional exhaled nitric oxide (childhood)	
KIRP	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs3758581	chr10:96602623	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs3760891	chr19:33599708	RHPN2	chr19:33469499-33555824:-	-0.23	-3.9	0.000122	Bone properties (heel)	
KIRP	cis	1	rs3761117	chr20:25388070	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs3761117	chr20:25388070	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.22	-4.87	1.91E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3767627	chr1:149938898	MTMR11	chr1:149900544-149908791:-	0.32	3.93	0.000109	Height	
KIRP	cis	1	rs3769825	chr2:202111380	STRADB	chr2:202316392-202345573:+	-0.2	-4.06	6.42E-5	Chronic lymphocytic leukemia	
KIRP	cis	1	rs3770066	chr2:86392350	LOC90784	chr2:86247339-86250991:-	-0.47	-4.68	4.48E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs3770087	chr2:86267068	LOC90784	chr2:86247339-86250991:-	-0.52	-5.48	1.01E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs3770087	chr2:86267068	POLR1A	chr2:86253453-86333278:-	0.36	5.27	2.79E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs3771175	chr2:102960210	IL1RL1	chr2:102927962-102968497:+	-0.43	-5.33	2.1E-7	Asthma	
KIRP	cis	1	rs3771180	chr2:102953617	IL1RL1	chr2:102927962-102968497:+	0.41	5.07	7.46E-7	Asthma	
KIRP	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.38	6.3	1.22E-9	Cognitive performance	
KIRP	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.38	6.29	1.31E-9	Cognitive performance	
KIRP	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.85	10.73	1.47E-22	Diastolic blood pressure	
KIRP	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.25	-5.42	1.37E-7	Longevity	
KIRP	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.16	-3.88	0.000134	QRS complex (Sokolow-Lyon)	
KIRP	cis	1	rs3780480	chr9:33163486	B4GALT1	chr9:33110639-33167356:-	-0.37	-4.35	1.95E-5	IgG glycosylation	
KIRP	cis	1	rs3780486	chr9:33139453	B4GALT1	chr9:33110639-33167356:-	-0.37	-4.39	1.67E-5	IgG glycosylation	
KIRP	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.35	4.26	2.88E-5	Multiple sclerosis	
KIRP	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.33	-6.15	2.9E-9	Multiple sclerosis	
KIRP	cis	1	rs3782130	chr12:58161898	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.04	7.09E-5	Multiple sclerosis	
KIRP	cis	1	rs3785162	chr16:55603226	LPCAT2	chr16:55542913-55620581:+	-0.21	-4.05	6.77E-5	Thyroid hormone levels	
KIRP	cis	1	rs3786933	chr19:33602881	RHPN2	chr19:33469499-33555824:-	-0.23	-3.9	0.000122	Bone properties (heel)	
KIRP	cis	1	rs3788332	chr22:22171567	TOP3B	chr22:22311404-22337193:-	-0.21	-4.64	5.37E-6	Multiple sclerosis	
KIRP	cis	1	rs3790012	chr13:36773489	SOHLH2	chr13:36742347-36871992:-	0.46	6.1	3.79E-9	Glucose homeostasis traits	
KIRP	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.49	-8.03	3.26E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.48	-7.82	1.25E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.5	-8.08	2.27E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.49	-7.99	4.19E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs3792527	chr3:38493212	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000138	Electrocardiographic conduction measures	
KIRP	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.18	4.25	2.97E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.47	-5.14	5.45E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.42	-7.71	2.52E-13	Kawasaki disease	
KIRP	cis	1	rs3805152	chr4:56359658	SRD5A3	chr4:56212409-56237866:+	0.3	4.66	5.05E-6	Personality dimensions	
KIRP	cis	1	rs3805154	chr4:56363927	SRD5A3	chr4:56212409-56237866:+	0.3	4.69	4.3E-6	Personality dimensions	
KIRP	cis	1	rs3805157	chr4:56364103	SRD5A3	chr4:56212409-56237866:+	0.31	4.99	1.11E-6	Personality dimensions	
KIRP	cis	1	rs3805157	chr4:56364103	TMEM165	chr4:56262090-56292342:+	-0.25	-3.96	9.78E-5	Personality dimensions	
KIRP	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.16	4.46	1.24E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs3810429	chr19:18543270	LRRC25	chr19:18501955-18508421:-	-0.12	-4.12	5.01E-5	Breast cancer	
KIRP	cis	1	rs3810429	chr19:18543270	SSBP4	chr19:18530221-18545371:+	-0.16	-4.52	9.14E-6	Breast cancer	
KIRP	cis	1	rs3810610	chr22:22115498	TOP3B	chr22:22311404-22337193:-	-0.18	-4.2	3.6E-5	Multiple sclerosis	
KIRP	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.35	-4.59	6.77E-6	Metabolite levels	
KIRP	cis	1	rs3816063	chr8:142161064	DENND3	chr8:142138720-142205906:+	0.22	4.41	1.51E-5	Obesity-related traits	
KIRP	cis	1	rs3816587	chr4:25417244	ANAPC4	chr4:25378848-25420119:+	-0.18	-4.39	1.62E-5	Rheumatoid arthritis	
KIRP	cis	1	rs3817181	chr17:61776538	FTSJ3	chr17:61896795-61905031:-	0.27	3.81	0.000172	Body mass index	
KIRP	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.27	-4.34	2.03E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.15	4.16	4.27E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs3825018	chr11:64358809	SLC22A12	chr11:64358282-64369820:+	-0.23	-4.09	5.8E-5	Urate levels in obese individuals	
KIRP	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.33	3.93	0.00011	Multiple sclerosis	
KIRP	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.33	-6.12	3.39E-9	Multiple sclerosis	
KIRP	cis	1	rs3825079	chr12:58203354	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-3.88	0.000132	Multiple sclerosis	
KIRP	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.56	10.52	7.37E-22	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.57	-5.17	4.57E-7	Abdominal aortic aneurysm	
KIRP	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.52	-8.2	1.04E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs3828496	chr4:48388292	CNGA1	chr4:47937996-48018610:-	-0.23	-3.86	0.000141	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.37	6.74	9.57E-11	Height	
KIRP	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.31	4.76	3.15E-6	Height	
KIRP	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs3850304	chr14:59895019	JKAMP	chr14:59951161-59972080:+	0.56	4.2	3.63E-5	Schizophrenia	
KIRP	cis	1	rs3853750	chr5:110154309	TMEM232	chr5:109624934-110062381:-	0.29	4.01	8.03E-5	Asthma and hay fever	
KIRP	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs3862008	chr10:96619002	C10orf129	chr10:96953957-96988685:+	0.72	7.02	1.83E-11	Blood metabolite levels	
KIRP	cis	1	rs3862009	chr10:96619025	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs3866330	chr3:49582994	NCKIPSD	chr3:48711280-48723334:-	0.29	4.25	2.94E-5	Menarche (age at onset)	
KIRP	cis	1	rs3866330	chr3:49582994	P4HTM	chr3:49027341-49044579:+	0.24	4.59	6.8E-6	Menarche (age at onset)	
KIRP	cis	1	rs3870339	chr3:49536863	NCKIPSD	chr3:48711280-48723334:-	0.29	4.27	2.71E-5	Menarche (age at onset)	
KIRP	cis	1	rs3870339	chr3:49536863	P4HTM	chr3:49027341-49044579:+	0.24	4.46	1.2E-5	Menarche (age at onset)	
KIRP	cis	1	rs3870341	chr3:49584745	NCKIPSD	chr3:48711280-48723334:-	0.29	4.3	2.42E-5	Menarche (age at onset)	
KIRP	cis	1	rs3870341	chr3:49584745	P4HTM	chr3:49027341-49044579:+	0.24	4.55	8.12E-6	Menarche (age at onset)	
KIRP	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.3	4.35	1.96E-5	Diabetic kidney disease	
KIRP	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.95	13.68	1.31E-32	Diastolic blood pressure	
KIRP	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.58	6.76	8.93E-11	Red blood cell traits	
KIRP	cis	1	rs389404	chr19:6693387	GPR108	chr19:6729927-6737633:-	-0.44	-4.56	7.79E-6	Complement C3 and C4 levels	
KIRP	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.5	-5.03	9.14E-7	Crohn's disease	
KIRP	cis	1	rs3905330	chr3:49550774	NCKIPSD	chr3:48711280-48723334:-	0.29	4.36	1.86E-5	Menarche (age at onset)	
KIRP	cis	1	rs3905330	chr3:49550774	P4HTM	chr3:49027341-49044579:+	0.24	4.58	7.07E-6	Menarche (age at onset)	
KIRP	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.45	-6.02	5.66E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.36	6.57	2.67E-10	Height	
KIRP	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.31	4.72	3.77E-6	Height	
KIRP	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.95	-13.75	7.47E-33	Diastolic blood pressure	
KIRP	cis	1	rs3934135	chr15:84583799	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.5	8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs3935969	chr17:65881959	LOC440461	chr17:66194801-66196436:+	0.3	3.99	8.43E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.51	-8.04	2.98E-14	Urinary metabolites	
KIRP	cis	1	rs3960018	chr15:90383307	ANPEP	chr15:90328127-90358072:-	0.21	3.95	0.0001	Type 2 diabetes	
KIRP	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.77	-12.08	4.5E-27	Type 2 diabetes	
KIRP	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.41	-7.57	6.06E-13	Schizophrenia	
KIRP	cis	1	rs397119	chr20:25440187	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.36	8.83E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs397119	chr20:25440187	FAM182B	chr20:25744102-25848786:-	0.31	4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs398036	chr20:25439850	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.36	8.83E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs398036	chr20:25439850	FAM182B	chr20:25744102-25848786:-	0.31	4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.31	5.36	1.8E-7	Obesity-related traits	
KIRP	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.39	-7.35	2.47E-12	Inflammatory skin disease	
KIRP	cis	1	rs401166	chr20:25446308	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs401166	chr20:25446308	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.27	4.03	7.36E-5	Diabetic kidney disease	
KIRP	cis	1	rs402511	chr5:176434440	PRR7	chr5:176873796-176883283:+	-0.22	-3.89	0.000126	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs404394	chr20:25447896	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs404394	chr20:25447896	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs406900	chr6:88085447	C6orf162	chr6:88032306-88052043:+	-0.28	-4.16	4.24E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.4	6.17	2.51E-9	Body mass index	
KIRP	cis	1	rs4073846	chr1:46462881	MUTYH	chr1:45794915-45806142:-	-0.17	-3.95	0.0001	Body mass index	
KIRP	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.49	-8.34	4.14E-15	Eye color traits	
KIRP	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.5	-8.46	1.8E-15	Eye color traits	
KIRP	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.31	-4.19	3.87E-5	Urate levels in lean individuals	
KIRP	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.28	3.84	0.000156	Diabetic kidney disease	
KIRP	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.57	5.08	7.09E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-1.14	-7.74	2.04E-13	Schizophrenia	
KIRP	cis	1	rs41266839	chr6:26409890	LOC100270746	chr6:26987146-26988085:-	0.5	4.03	7.4E-5	Schizophrenia	
KIRP	cis	1	rs41288262	chr13:79174187	SLAIN1	chr13:78272470-78338377:+	-0.47	-4.01	7.82E-5	Serum thyroid-stimulating hormone levels	
KIRP	cis	1	rs4129956	chr4:302008	ZNF718	chr4:53272-156488:+	0.29	4.29	2.46E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs4130590	chr9:130107964	ZNF79	chr9:130186653-130207650:+	0.29	4.67	4.89E-6	Bipolar disorder	
KIRP	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.29	1.27E-9	Body mass index	
KIRP	cis	1	rs414013	chr6:88085866	C6orf162	chr6:88032306-88052043:+	-0.28	-4.16	4.24E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.22	3.82	0.000164	Pulse pressure	
KIRP	cis	1	rs4144743	chr17:45323125	LOC100272146	chr17:45500843-45504056:+	-0.16	-4.1	5.41E-5	Body mass index	
KIRP	cis	1	rs4144744	chr17:45323262	LOC100272146	chr17:45500843-45504056:+	-0.16	-3.91	0.000117	Body mass index	
KIRP	cis	1	rs4144745	chr17:45323349	LOC100272146	chr17:45500843-45504056:+	-0.16	-3.91	0.000117	Body mass index	
KIRP	cis	1	rs4144746	chr17:45323355	LOC100272146	chr17:45500843-45504056:+	-0.16	-3.91	0.000117	Body mass index	
KIRP	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.16	-3.81	0.000173	QRS complex (Sokolow-Lyon)	
KIRP	cis	1	rs4147025	chr3:38456531	EXOG	chr3:38537763-38567796:+	-0.16	-3.85	0.00015	Electrocardiographic conduction measures	
KIRP	cis	1	rs4149547	chr2:240933308	NDUFA10	chr2:240900158-240964798:-	0.23	4.05	6.6E-5	Odorant perception (isobutyraldehyde)	
KIRP	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.25	4.09	5.78E-5	Pancreatic cancer	
KIRP	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.25	4.11	5.18E-5	Pancreatic cancer	
KIRP	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.25	4.11	5.18E-5	Pancreatic cancer	
KIRP	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.25	4.09	5.78E-5	Pancreatic cancer	
KIRP	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.25	4.15	4.55E-5	Pancreatic cancer	
KIRP	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.26	4.17	4.17E-5	Pancreatic cancer	
KIRP	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.25	-3.98	8.83E-5	Pancreatic cancer	
KIRP	cis	1	rs416451	chr5:75922072	F2RL2	chr5:75911308-75919240:-	-0.28	-5.21	3.72E-7	Hearing impairment	
KIRP	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.34	-4.92	1.49E-6	Bipolar disorder	
KIRP	cis	1	rs421147	chr19:6691424	GPR108	chr19:6729927-6737633:-	-0.41	-4.23	3.24E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs422424	chr20:25445446	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs422424	chr20:25445446	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs422844	chr20:25445591	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs422844	chr20:25445591	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.38	5.31	2.27E-7	Forced vital capacity	
KIRP	cis	1	rs4241407	chr3:49600319	NCKIPSD	chr3:48711280-48723334:-	0.3	4.18	4.0E-5	Menarche (age at onset)	
KIRP	cis	1	rs4241407	chr3:49600319	P4HTM	chr3:49027341-49044579:+	0.24	4.36	1.89E-5	Menarche (age at onset)	
KIRP	cis	1	rs4242434	chr8:22501830	BIN3	chr8:22477949-22526661:-	0.22	3.95	9.93E-5	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
KIRP	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.19	-4.26	2.82E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.51	7.85	1.05E-13	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
KIRP	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.45	-5.67	3.64E-8	Cholesterol, total;LDL cholesterol	
KIRP	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.44	-4.15	4.46E-5	Cholesterol, total;LDL cholesterol	
KIRP	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.29	-3.99	8.62E-5	Urate levels in lean individuals	
KIRP	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.39	-6.08	4.08E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRP	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.33	5.29	2.62E-7	Folate pathway vitamin levels	
KIRP	cis	1	rs4268415	chr10:4983590	AKR1C2	chr10:4964715-5060207:-	0.55	5.48	9.71E-8	Height	
KIRP	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.75E-5	Diabetic kidney disease	
KIRP	cis	1	rs4271626	chr17:65930133	LOC440461	chr17:66194801-66196436:+	0.31	3.98	8.88E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs4274254	chr12:81458128	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.44	-6.59	2.41E-10	Longevity	
KIRP	cis	1	rs4283605	chr3:49678651	RBM6	chr3:49977592-50137484:+	0.16	4.48	1.09E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs4283605	chr3:49678651	UBA7	chr3:49842639-49851391:-	0.35	6.23	1.82E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs4285028	chr3:121660664	IQCB1	chr3:121488610-121553926:-	-0.32	-4.65	5.3E-6	Multiple sclerosis	
KIRP	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.46	6.67	1.52E-10	Urinary metabolites	
KIRP	cis	1	rs429657	chr15:65813764	DPP8	chr15:65737999-65810035:-	0.13	4.82	2.47E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs4297570	chr13:36755179	SOHLH2	chr13:36742347-36871992:-	-0.5	-6.68	1.36E-10	Glucose homeostasis traits	
KIRP	cis	1	rs4300818	chr2:228713255	WDR69	chr2:228736327-228789026:+	0.3	4.56	7.83E-6	Blood pressure	
KIRP	cis	1	rs4304957	chr14:76647572	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.35	6.45	5.16E-10	Height	
KIRP	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.28	4.26	2.84E-5	Height	
KIRP	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.27	3.89	0.000129	Diabetic kidney disease	
KIRP	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.5	7.96	5.06E-14	Urinary metabolites	
KIRP	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.27	3.96	9.5E-5	Diabetic kidney disease	
KIRP	cis	1	rs4315635	chr22:49571530	ZBED4	chr22:50247497-50283726:+	0.3	4.96	1.25E-6	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	
KIRP	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.82	11.1	9.06E-24	Type 2 diabetes	
KIRP	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.2	4.23	3.23E-5	Height	
KIRP	cis	1	rs4322591	chr14:75600697	RPS6KL1	chr14:75372347-75389958:-	0.22	3.82	0.000169	Height	
KIRP	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.41	-6.09	4.0E-9	Rheumatoid arthritis	
KIRP	cis	1	rs4326865	chr12:81458579	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs4332428	chr10:4965434	AKR1C2	chr10:4964715-5060207:-	0.76	6.81	6.71E-11	Height	
KIRP	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.31	5.54	7.33E-8	Height	
KIRP	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.3	4.57	7.56E-6	Height	
KIRP	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.45	8.5	1.35E-15	Schizophrenia	
KIRP	cis	1	rs4341440	chr10:4965293	AKR1C2	chr10:4964715-5060207:-	0.8	7.15	8.21E-12	Height	
KIRP	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.5	8.03	3.21E-14	Urinary metabolites	
KIRP	cis	1	rs4351285	chr6:159384673	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4351999	chr15:65992380	DPP8	chr15:65737999-65810035:-	-0.13	-4.84	2.17E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.25	4.04	6.93E-5	Pancreatic cancer	
KIRP	cis	1	rs4356975	chr4:69972463	UGT2A3	chr4:69794177-69817509:-	0.32	6.01	6.21E-9	Obesity-related traits	
KIRP	cis	1	rs4356975	chr4:69972463	UGT2B11	chr4:70066053-70080449:-	0.57	9.74	2.29E-19	Obesity-related traits	
KIRP	cis	1	rs436041	chr19:6692796	GPR108	chr19:6729927-6737633:-	-0.43	-4.45	1.27E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs4366490	chr11:62912854	SLC22A24	chr11:62847414-62911693:-	0.5	7.63	4.25E-13	Conotruncal heart defects	
KIRP	cis	1	rs4366668	chr15:65903398	DPP8	chr15:65737999-65810035:-	-0.12	-4.49	1.08E-5	Mean corpuscular hemoglobin	
KIRP	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.34	6.25	1.6E-9	Height	
KIRP	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.29	4.48	1.11E-5	Height	
KIRP	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.86	1.36E-8	Height	
KIRP	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.79E-6	Height	
KIRP	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.64	4.35E-8	Body mass index	
KIRP	cis	1	rs437298	chr1:76113770	ACADM	chr1:76190043-76229353:+	-0.22	-5.18	4.38E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs4376778	chr1:46288846	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.27	4.03	7.36E-5	Diabetic kidney disease	
KIRP	cis	1	rs438703	chr19:6692790	GPR108	chr19:6729927-6737633:-	-0.43	-4.45	1.27E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.29	-4.74	3.54E-6	Bone mineral density	
KIRP	cis	1	rs4393318	chr11:62912785	SLC22A24	chr11:62847414-62911693:-	-0.51	-7.78	1.62E-13	Conotruncal heart defects	
KIRP	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.49	6.46	4.85E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs4394894	chr12:81464831	LIN7A	chr12:81191171-81331694:-	0.27	3.9	0.000123	Neuroticism	
KIRP	cis	1	rs4394895	chr12:81464942	LIN7A	chr12:81191171-81331694:-	0.27	3.9	0.000123	Neuroticism	
KIRP	cis	1	rs4397735	chr10:4965543	AKR1C2	chr10:4964715-5060207:-	0.91	7.87	9.35E-14	Height	
KIRP	cis	1	rs4399664	chr19:21778026	ZNF429	chr19:21688437-21739068:+	0.33	4.4	1.56E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.39	6.19	2.34E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
KIRP	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.9	11.75	6.23E-26	Diastolic blood pressure	
KIRP	cis	1	rs441109	chr1:76120430	ACADM	chr1:76190043-76229353:+	-0.22	-5.21	3.78E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.35	6.44	5.73E-10	Height	
KIRP	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.28	4.31	2.29E-5	Height	
KIRP	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	0.42	5.54	7.35E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRP	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.51	8.45E-8	Height	
KIRP	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.31	-4.69	4.47E-6	Height	
KIRP	cis	1	rs4452188	chr2:648810	SNTG2	chr2:946555-1371382:+	0.39	4.05	6.75E-5	Body mass index	
KIRP	cis	1	rs4460230	chr6:159369990	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4465650	chr17:28396721	SSH2	chr17:27952965-28257018:-	0.19	4.18	4.04E-5	Coffee consumption (cups per day)	
KIRP	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.48	-6.36	8.56E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.29	-4.59	6.88E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs4473887	chr6:159369470	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs447722	chr20:25443510	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs447722	chr20:25443510	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs448396	chr20:25440269	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs448396	chr20:25440269	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4487084	chr2:228713179	WDR69	chr2:228736327-228789026:+	0.3	4.56	7.83E-6	Blood pressure	
KIRP	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.25	-5.41	1.38E-7	Longevity	
KIRP	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.35	-4.63	5.62E-6	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRP	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.47	-7.73	2.28E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.35	6.18	2.37E-9	Height	
KIRP	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.33	4.92	1.52E-6	Height	
KIRP	cis	1	rs4502963	chr6:159369462	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4508401	chr15:91514721	UNC45A	chr15:91473410-91497322:+	0.23	4.42	1.46E-5	Type 2 diabetes	
KIRP	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.75E-5	Diabetic kidney disease	
KIRP	cis	1	rs453329	chr20:25440593	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.08	4.24E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs453329	chr20:25440593	FAM182B	chr20:25744102-25848786:-	0.32	4.4	1.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.58	5.9E-8	Height	
KIRP	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.29	-4.37	1.79E-5	Height	
KIRP	cis	1	rs4541130	chr17:45321037	LOC100272146	chr17:45500843-45504056:+	-0.2	-4.33	2.08E-5	Body mass index	
KIRP	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.06	4.55E-9	Body mass index	
KIRP	cis	1	rs4545281	chr1:46360054	MUTYH	chr1:45794915-45806142:-	0.16	3.83	0.000162	Body mass index	
KIRP	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.33	-5.56	6.63E-8	Body mass index	
KIRP	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.24	3.85	0.00015	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs45559033	chr14:74341124	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs455804	chr21:31146169	USP16	chr21:30396938-30426805:+	0.24	3.88	0.000133	Hepatocellular carcinoma	
KIRP	cis	1	rs4559448	chr1:76203456	ACADM	chr1:76190043-76229353:+	0.21	4.97	1.21E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.41	6.68	1.38E-10	Hematology traits	
KIRP	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.86	1.36E-8	Height	
KIRP	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.79E-6	Height	
KIRP	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.75	6.21	2.0E-9	Crohn's disease	
KIRP	cis	1	rs4580704	chr4:56326707	SRD5A3	chr4:56212409-56237866:+	-0.29	-4.46	1.21E-5	Personality dimensions	
KIRP	cis	1	rs458196	chr22:29978026	NF2	chr22:29999545-30094583:+	-0.31	-3.87	0.000135	Lipid traits	
KIRP	cis	1	rs4582105	chr4:246342	ZNF718	chr4:53272-156488:+	0.29	4.31	2.34E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.27	4.04	6.95E-5	Diabetic kidney disease	
KIRP	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.31	4.02	7.45E-5	Atopic dermatitis	
KIRP	cis	1	rs4595905	chr19:18547305	LRRC25	chr19:18501955-18508421:-	-0.12	-4.09	5.83E-5	Breast cancer	
KIRP	cis	1	rs4595905	chr19:18547305	SSBP4	chr19:18530221-18545371:+	-0.16	-4.43	1.4E-5	Breast cancer	
KIRP	cis	1	rs4604732	chr1:247623872	LOC148824	chr1:247687982-247694106:-	0.34	4.11	5.35E-5	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
KIRP	cis	1	rs4604928	chr11:117044203	PCSK7	chr11:117075789-117102811:-	-0.41	-4.44	1.33E-5	Protein quantitative trait loci	
KIRP	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.33	5.03	9.22E-7	Height	
KIRP	cis	1	rs4606360	chr1:173699007	SERPINC1	chr1:173872943-173886516:-	0.36	4.78	2.94E-6	Subjective well-being	
KIRP	cis	1	rs4613321	chr2:650647	SNTG2	chr2:946555-1371382:+	-0.38	-3.88	0.000131	Body mass index	
KIRP	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.25	4.1	5.6E-5	Diabetic kidney disease	
KIRP	cis	1	rs4628584	chr10:4972697	AKR1C2	chr10:4964715-5060207:-	0.87	8.12	1.81E-14	Height	
KIRP	cis	1	rs4638245	chr10:96500563	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.32	-5.34	1.98E-7	Body mass index	
KIRP	cis	1	rs4643132	chr12:81458555	LIN7A	chr12:81191171-81331694:-	0.27	3.95	0.000101	Neuroticism	
KIRP	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.37	-5.76	2.38E-8	Schizophrenia	
KIRP	cis	1	rs4646486	chr1:47278997	CYP4A22	chr1:47603107-47614526:+	0.45	5.08	7.07E-7	Blood metabolite levels	
KIRP	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.37	4.66	4.91E-6	Multiple sclerosis	
KIRP	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.3	-5.76	2.38E-8	Multiple sclerosis	
KIRP	cis	1	rs4646961	chr1:76217169	ACADM	chr1:76190043-76229353:+	0.2	4.75	3.27E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.31	4.48	1.1E-5	Diabetic kidney disease	
KIRP	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.25	4.1	5.6E-5	Diabetic kidney disease	
KIRP	cis	1	rs465742	chr22:29959335	NF2	chr22:29999545-30094583:+	0.37	4.07	6.27E-5	Lipid traits	
KIRP	cis	1	rs4660303	chr1:40060473	OXCT2	chr1:40235197-40237020:-	0.38	4.86	1.98E-6	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRP	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.98	18.99	2.32E-51	Homocysteine levels	
KIRP	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs4660317	chr1:46326226	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs4660319	chr1:46341623	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.06	4.72E-9	Body mass index	
KIRP	cis	1	rs4660321	chr1:46366760	MUTYH	chr1:45794915-45806142:-	0.16	3.96	9.82E-5	Body mass index	
KIRP	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.83	-15.72	8.39E-40	Homocysteine levels	
KIRP	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.3	1.27E-9	Body mass index	
KIRP	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs4663300	chr2:239181491	LOC151174	chr2:239133754-239140318:-	0.49	4.48	1.1E-5	Irritable bowel syndrome	
KIRP	cis	1	rs4663865	chr2:239145960	LOC151174	chr2:239133754-239140318:-	-0.47	-4.42	1.45E-5	Irritable bowel syndrome	
KIRP	cis	1	rs4663866	chr2:239150815	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.27E-6	Irritable bowel syndrome	
KIRP	cis	1	rs4663867	chr2:239159964	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.27E-6	Irritable bowel syndrome	
KIRP	cis	1	rs4663868	chr2:239161091	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.27E-6	Irritable bowel syndrome	
KIRP	cis	1	rs4664308	chr2:160917497	LY75	chr2:160625141-160761262:-	0.32	4.5	1.01E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs4665147	chr2:160917062	LY75	chr2:160625141-160761262:-	0.32	4.5	1.01E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.33	-5.53	7.58E-8	Body mass index	
KIRP	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.66	3.94E-8	Body mass index	
KIRP	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.27	3.92	0.000112	Diabetic kidney disease	
KIRP	cis	1	rs4671400	chr2:61472632	C2orf74	chr2:61372243-61391964:+	0.46	4.04	7.1E-5	3-hydroxypropylmercapturic acid levels in smokers	
KIRP	cis	1	rs4675361	chr2:204589944	CD28	chr2:204571198-204602556:+	0.21	4.03	7.19E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs4675860	chr2:241840417	C2orf54	chr2:241825466-241835573:-	0.45	6.93	3.15E-11	Urinary metabolites	
KIRP	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.5	8.09	2.16E-14	Urinary metabolites	
KIRP	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.5	8.09	2.16E-14	Urinary metabolites	
KIRP	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.45	-6.57	2.7E-10	Urinary metabolites	
KIRP	cis	1	rs4679198	chr3:124693299	HEG1	chr3:124684555-124774802:-	-0.22	-4.25	2.99E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs4687697	chr3:53090490	SFMBT1	chr3:52938628-53080070:-	0.42	6.71	1.15E-10	Ulcerative colitis	
KIRP	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.41	6.19	2.24E-9	Height	
KIRP	cis	1	rs468852	chr22:29956156	NF2	chr22:29999545-30094583:+	0.32	3.92	0.000111	Lipid traits	
KIRP	cis	1	rs4693089	chr4:84373622	MRPS18C	chr4:84377118-84389352:+	-0.21	-5.17	4.71E-7	Menopause (age at onset)	
KIRP	cis	1	rs4694744	chr4:70326656	UGT2B11	chr4:70066053-70080449:-	-0.28	-3.98	8.86E-5	Bacteremia	
KIRP	cis	1	rs4694745	chr4:70334776	UGT2B11	chr4:70066053-70080449:-	0.29	4.07	6.25E-5	Bacteremia	
KIRP	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.43	-9.11	2.08E-17	Ankylosing spondylitis	
KIRP	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.3	3.81	0.000174	Ankylosing spondylitis	
KIRP	cis	1	rs4699055	chr4:104154500	BDH2	chr4:103998783-104021024:-	0.2	3.88	0.000134	Testicular germ cell tumor	
KIRP	cis	1	rs470606	chr11:120028202	OAF	chr11:120081747-120100649:+	0.3	5.06	7.75E-7	Corneal curvature	
KIRP	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.55	-8.6	7.25E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs4709248	chr6:159355637	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4709251	chr6:159380322	RSPH3	chr6:159398268-159421198:-	0.37	4.56	7.83E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4709252	chr6:159380384	RSPH3	chr6:159398268-159421198:-	0.36	4.46	1.2E-5	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4709254	chr6:159408597	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4709256	chr6:159409058	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4709258	chr6:159412010	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4709259	chr6:159419584	RSPH3	chr6:159398268-159421198:-	0.39	4.71	3.97E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs4711346	chr6:33730996	WDR46	chr6:33246886-33256991:-	-0.28	-3.99	8.59E-5	Body mass index	
KIRP	cis	1	rs4713858	chr6:35402785	ZNF76	chr6:35226686-35263760:+	-0.29	-3.84	0.000154	Height	
KIRP	cis	1	rs4713	chr9:131910805	PPP2R4	chr9:131873244-131911223:+	-0.3	-4.69	4.33E-6	Blood metabolite ratios	
KIRP	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.17	4.83	2.32E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.19	5.24	3.26E-7	Folate pathway vitamin levels	
KIRP	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.23	-3.95	0.0001	Diabetic kidney disease	
KIRP	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.28	4.12	5.06E-5	Diabetic kidney disease	
KIRP	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.26	-4.35	1.92E-5	Obesity-related traits	
KIRP	cis	1	rs4726669	chr7:143758191	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.07	7.49E-7	Obesity-related traits	
KIRP	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.27	-4.01	7.84E-5	Interstitial lung disease	
KIRP	cis	1	rs4727845	chr7:116914651	CFTR	chr7:117120017-117308716:+	0.28	4.04	7.09E-5	Dupuytren's disease	
KIRP	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.37	6.71	1.18E-10	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs473005	chr4:56288125	SRD5A3	chr4:56212409-56237866:+	0.26	4.22	3.34E-5	Personality dimensions	
KIRP	cis	1	rs473005	chr4:56288125	TMEM165	chr4:56262090-56292342:+	-0.24	-3.97	9.37E-5	Personality dimensions	
KIRP	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.39	9.34	4.23E-18	Response to temozolomide	
KIRP	cis	1	rs4733384	chr8:29985381	MBOAT4	chr8:29989188-30002200:-	0.45	4.84	2.24E-6	Migraine	
KIRP	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.39	9.2	1.09E-17	Response to temozolomide	
KIRP	cis	1	rs4746112	chr10:74042995	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.41E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs4747241	chr10:74036429	DNAJB12	chr10:74092588-74114907:-	0.29	4.99	1.11E-6	Heschl's gyrus morphology	
KIRP	cis	1	rs4747242	chr10:74037193	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.45E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.39	-9.27	6.85E-18	Response to temozolomide	
KIRP	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.52	-6.94	2.95E-11	Subjective well-being	
KIRP	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.54	-7.07	1.41E-11	Subjective well-being	
KIRP	cis	1	rs4752856	chr11:47648042	PSMC3	chr11:47440320-47448024:-	0.22	4.31	2.32E-5	Subjective well-being	
KIRP	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.53	-6.88	4.4E-11	Subjective well-being	
KIRP	cis	1	rs4752857	chr11:47655752	PSMC3	chr11:47440320-47448024:-	0.2	4.01	7.86E-5	Subjective well-being	
KIRP	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.51	-6.92	3.46E-11	Subjective well-being	
KIRP	cis	1	rs4752873	chr11:47857520	PSMC3	chr11:47440320-47448024:-	0.2	3.93	0.00011	Subjective well-being	
KIRP	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.38	-5.33	2.08E-7	Forced vital capacity	
KIRP	cis	1	rs4758623	chr11:3014953	NAP1L4	chr11:2965661-3013607:-	0.24	3.83	0.000162	Calcium levels	
KIRP	cis	1	rs4758889	chr12:133475533	EP400NL	chr12:132568828-132600084:+;chr12	-0.45	-4.44	1.32E-5	Cognitive function	
KIRP	cis	1	rs4758915	chr12:133477147	EP400NL	chr12:132568828-132600084:+;chr12	-0.45	-4.42	1.43E-5	Cognitive function	
KIRP	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.51	-7.66	3.46E-13	Cognitive function	
KIRP	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.28	-5.09	6.74E-7	Type 1 diabetes	
KIRP	cis	1	rs4768	chr3:49758764	UBA7	chr3:49842639-49851391:-	-0.3	-5.44	1.19E-7	Resting heart rate	
KIRP	cis	1	rs4771996	chr13:98053792	RAP2A	chr13:98086475-98120251:+	0.28	4.36	1.84E-5	Obesity-related traits	
KIRP	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.39	9.34	4.22E-18	Response to temozolomide	
KIRP	cis	1	rs4783720	chr16:69559696	EXOSC6	chr16:70284134-70285833:-	-0.35	-3.95	0.000101	Urate levels	
KIRP	cis	1	rs4783896	chr16:55606360	LPCAT2	chr16:55542913-55620581:+	-0.21	-4.03	7.35E-5	Thyroid hormone levels	
KIRP	cis	1	rs4787491	chr16:30015337	TBX6	chr16:30097117-30103208:-	0.18	3.88	0.000133	Body mass index	
KIRP	cis	1	rs4788187	chr16:29845685	LOC440356	chr16:29875004-29879374:+	0.31	4.23	3.19E-5	Multiple sclerosis	
KIRP	cis	1	rs4788188	chr16:29860863	LOC440356	chr16:29875004-29879374:+	-0.33	-4.22	3.32E-5	Multiple sclerosis	
KIRP	cis	1	rs4790908	chr17:65852907	LOC440461	chr17:66194801-66196436:+	0.29	3.86	0.000141	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs4791212	chr17:65975385	LOC440461	chr17:66194801-66196436:+	0.33	4.19	3.77E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs4791299	chr17:65930937	LOC440461	chr17:66194801-66196436:+	0.31	4.21	3.44E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.39	9.34	4.23E-18	Response to temozolomide	
KIRP	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.55	-10.33	3.11E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.56	-10.34	2.74E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.57	-10.77	1.1E-22	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.56	-10.31	3.42E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.56	-10.31	3.42E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.55	-10.33	3.11E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs479879	chr10:105945985	C10orf79	chr10:105889647-105992120:-	0.22	5.2	3.94E-7	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.6	9.43	2.17E-18	Schizophrenia	
KIRP	cis	1	rs4803774	chr19:45450872	APOC2	chr19:45449243-45452817:+	-0.41	-9.31	4.94E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRP	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.37	8.63	5.75E-16	Response to temozolomide	
KIRP	cis	1	rs4808133	chr19:18608518	LRRC25	chr19:18501955-18508421:-	-0.13	-4.24	3.11E-5	Breast cancer	
KIRP	cis	1	rs4808133	chr19:18608518	SSBP4	chr19:18530221-18545371:+	-0.16	-4.29	2.51E-5	Breast cancer	
KIRP	cis	1	rs4808134	chr19:18608579	LRRC25	chr19:18501955-18508421:-	-0.13	-4.24	3.11E-5	Breast cancer	
KIRP	cis	1	rs4808134	chr19:18608579	SSBP4	chr19:18530221-18545371:+	-0.16	-4.29	2.51E-5	Breast cancer	
KIRP	cis	1	rs4808136	chr19:18618867	SSBP4	chr19:18530221-18545371:+	0.15	4.06	6.36E-5	Breast cancer	
KIRP	cis	1	rs4808200	chr19:19554803	HAPLN4	chr19:19366453-19384074:-	0.24	3.95	9.87E-5	Schizophrenia	
KIRP	cis	1	rs4808801	chr19:18571141	LRRC25	chr19:18501955-18508421:-	-0.12	-4.22	3.32E-5	Breast cancer	
KIRP	cis	1	rs4808801	chr19:18571141	SLC27A1	chr19:17581300-17616977:+	0.18	3.83	0.000161	Breast cancer	
KIRP	cis	1	rs4808801	chr19:18571141	SSBP4	chr19:18530221-18545371:+	-0.16	-4.35	1.98E-5	Breast cancer	
KIRP	cis	1	rs4808804	chr19:18585325	LRRC25	chr19:18501955-18508421:-	-0.12	-3.91	0.000119	Breast cancer	
KIRP	cis	1	rs4813562	chr20:25352588	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4813562	chr20:25352588	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4813563	chr20:25365340	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4813563	chr20:25365340	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4813566	chr20:25386465	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4813566	chr20:25386465	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815404	chr20:25301845	ENTPD6	chr20:25176339-25207360:+	0.35	6.09	3.85E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815404	chr20:25301845	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.14E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815405	chr20:25317492	ENTPD6	chr20:25176339-25207360:+	0.34	5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815405	chr20:25317492	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815406	chr20:25341316	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815406	chr20:25341316	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815407	chr20:25341478	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815407	chr20:25341478	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815408	chr20:25346678	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815408	chr20:25346678	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815409	chr20:25346697	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815409	chr20:25346697	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815411	chr20:25350223	ENTPD6	chr20:25176339-25207360:+	0.38	6.61	2.14E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815411	chr20:25350223	FAM182B	chr20:25744102-25848786:-	-0.31	-4.22	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815412	chr20:25350325	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815412	chr20:25350325	FAM182B	chr20:25744102-25848786:-	0.3	4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815417	chr20:25379526	ENTPD6	chr20:25176339-25207360:+	0.35	6.17	2.57E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815417	chr20:25379526	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.08E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815418	chr20:25382211	ENTPD6	chr20:25176339-25207360:+	0.37	6.43	5.87E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815418	chr20:25382211	FAM182B	chr20:25744102-25848786:-	-0.31	-4.18	3.99E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815420	chr20:25383979	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815420	chr20:25383979	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815421	chr20:25386509	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815421	chr20:25386509	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815424	chr20:25390284	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815424	chr20:25390284	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815426	chr20:25405186	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4815426	chr20:25405186	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs4821544	chr22:37258503	NCF4	chr22:37257030-37274058:+	0.1	4.84	2.21E-6	Atopic dermatitis	
KIRP	cis	1	rs4823087	chr22:30693581	MTP18	chr22:30805176-30825041:+	0.38	3.98	9.05E-5	Coronary artery calcification	
KIRP	cis	1	rs4842838	chr15:84582124	LOC388152	chr15:84867600-84898920:-	0.24	4.01	7.87E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs4842924	chr15:84587607	LOC388152	chr15:84867600-84898920:-	0.23	3.92	0.000111	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs4845756	chr1:152254919	HRNR	chr1:152184558-152196669:-	0.44	5.49	9.51E-8	Atopic dermatitis	
KIRP	cis	1	rs4853461	chr2:192119298	MYO1B	chr2:192110107-192290115:+	0.31	4.99	1.09E-6	Obesity-related traits	
KIRP	cis	1	rs4853462	chr2:192123804	MYO1B	chr2:192110107-192290115:+	0.32	5.09	6.96E-7	Obesity-related traits	
KIRP	cis	1	rs4853561	chr2:192107706	MYO1B	chr2:192110107-192290115:+	0.33	5.45	1.13E-7	Obesity-related traits	
KIRP	cis	1	rs4853562	chr2:192118422	MYO1B	chr2:192110107-192290115:+	0.31	4.99	1.09E-6	Obesity-related traits	
KIRP	cis	1	rs4853563	chr2:192119534	MYO1B	chr2:192110107-192290115:+	0.31	4.98	1.14E-6	Obesity-related traits	
KIRP	cis	1	rs4853564	chr2:192123665	MYO1B	chr2:192110107-192290115:+	0.32	5.09	6.96E-7	Obesity-related traits	
KIRP	cis	1	rs4853565	chr2:192123746	MYO1B	chr2:192110107-192290115:+	0.32	5.09	6.96E-7	Obesity-related traits	
KIRP	cis	1	rs4853568	chr2:192126190	MYO1B	chr2:192110107-192290115:+	0.29	4.62	6.07E-6	Obesity-related traits	
KIRP	cis	1	rs4854058	chr2:240923677	NDUFA10	chr2:240900158-240964798:-	0.23	4	8.22E-5	Odorant perception (isobutyraldehyde)	
KIRP	cis	1	rs4854339	chr2:623212	SNTG2	chr2:946555-1371382:+	-0.41	-3.83	0.000161	Body mass index	
KIRP	cis	1	rs4854340	chr2:623216	SNTG2	chr2:946555-1371382:+	-0.41	-3.83	0.000161	Body mass index	
KIRP	cis	1	rs4854343	chr2:638107	SNTG2	chr2:946555-1371382:+	-0.41	-3.97	9.39E-5	Body mass index	
KIRP	cis	1	rs4854344	chr2:638144	SNTG2	chr2:946555-1371382:+	-0.43	-4.25	2.92E-5	Body mass index	
KIRP	cis	1	rs4854345	chr2:638190	SNTG2	chr2:946555-1371382:+	0.41	4.06	6.46E-5	Body mass index	
KIRP	cis	1	rs4854346	chr2:638918	SNTG2	chr2:946555-1371382:+	-0.4	-3.89	0.000127	Body mass index	
KIRP	cis	1	rs4854347	chr2:641159	SNTG2	chr2:946555-1371382:+	-0.43	-4.26	2.79E-5	Body mass index	
KIRP	cis	1	rs4854348	chr2:647760	SNTG2	chr2:946555-1371382:+	-0.37	-3.9	0.000122	Body mass index	
KIRP	cis	1	rs4854349	chr2:647861	SNTG2	chr2:946555-1371382:+	-0.37	-3.9	0.000122	Body mass index	
KIRP	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.39	9.34	4.22E-18	Response to temozolomide	
KIRP	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.24	5.13	5.66E-7	Longevity	
KIRP	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.27	5.79	2.01E-8	Longevity	
KIRP	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.41	5.98	7.29E-9	Longevity	
KIRP	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.45	-6.71	1.21E-10	Longevity	
KIRP	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.45	-6.71	1.18E-10	Longevity	
KIRP	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.47	9.12	1.99E-17	Kawasaki disease	
KIRP	cis	1	rs4864998	chr4:56332606	SRD5A3	chr4:56212409-56237866:+	0.3	4.67	4.89E-6	Personality dimensions	
KIRP	cis	1	rs4865008	chr4:56410855	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.67	4.84E-6	Personality dimensions	
KIRP	cis	1	rs4865010	chr4:56414962	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.81	2.5E-6	Personality dimensions	
KIRP	cis	1	rs4868644	chr5:175947051	UIMC1	chr5:176332006-176433732:-	0.23	3.9	0.000124	Venous thromboembolism (SNP x SNP interaction)	
KIRP	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.05	-23.23	7.35E-66	Pediatric autoimmune diseases	
KIRP	cis	1	rs4870040	chr6:151872090	C6orf97	chr6:151815175-151942327:+	0.45	4.15	4.52E-5	Bone mineral density (spine)	
KIRP	cis	1	rs4870041	chr6:151872324	C6orf97	chr6:151815175-151942327:+	0.45	4.13	4.88E-5	Bone mineral density (spine)	
KIRP	cis	1	rs487965	chr4:46232957	GABRA2	chr4:46251581-46392421:-	-0.24	-3.93	0.000107	Epilepsy	
KIRP	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.3	-6.73	1.02E-10	Lewy body disease	
KIRP	cis	1	rs4886238	chr13:61113739	TDRD3	chr13:60970591-61148012:+	0.29	4.57	7.38E-6	Menopause (age at onset)	
KIRP	cis	1	rs4886615	chr15:75131661	MPI	chr15:75182410-75190565:+	0.24	3.85	0.000149	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
KIRP	cis	1	rs4887783	chr16:74700743	MLKL	chr16:74705753-74734789:-	0.33	5.54	7.2E-8	Testicular germ cell tumor	
KIRP	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.22	-3.89	0.000126	Testicular germ cell tumor	
KIRP	cis	1	rs4888262	chr16:74670458	MLKL	chr16:74705753-74734789:-	0.29	4.99	1.1E-6	Testicular germ cell tumor	
KIRP	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.21	-3.89	0.000129	Testicular germ cell tumor	
KIRP	cis	1	rs4888264	chr16:74681632	MLKL	chr16:74705753-74734789:-	0.33	5.51	8.46E-8	Testicular germ cell tumor	
KIRP	cis	1	rs4888265	chr16:74683737	MLKL	chr16:74705753-74734789:-	0.32	5.48	9.79E-8	Testicular germ cell tumor	
KIRP	cis	1	rs4889609	chr16:31026427	HSD3B7	chr16:30996519-31000473:+	0.29	5.76	2.37E-8	Response to metformin (IC50)	
KIRP	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.2	4.27	2.71E-5	Response to metformin (IC50)	
KIRP	cis	1	rs489266	chr4:46214525	GABRA2	chr4:46251581-46392421:-	-0.24	-4.01	7.82E-5	Epilepsy	
KIRP	cis	1	rs4894785	chr3:171632051	FNDC3B	chr3:171757418-172118490:+	-0.18	-3.87	0.000135	Response to angiotensin II receptor blocker therapy	
KIRP	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.2	4.15	4.53E-5	Height	
KIRP	cis	1	rs4899546	chr14:75594946	RPS6KL1	chr14:75372347-75389958:-	0.22	3.86	0.000144	Height	
KIRP	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.29	-6.62	1.93E-10	Common traits (Other)	
KIRP	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.29	-6.6	2.27E-10	Common traits (Other)	
KIRP	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.29	-6.6	2.27E-10	Common traits (Other)	
KIRP	cis	1	rs490967	chr4:46265033	GABRA2	chr4:46251581-46392421:-	-0.22	-3.82	0.000166	Epilepsy	
KIRP	cis	1	rs4918798	chr10:96750543	C10orf129	chr10:96953957-96988685:+	0.38	4.81	2.55E-6	Warfarin maintenance dose	
KIRP	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.22	-4.77	3.03E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.22	-4.73	3.6E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.19	-4.1	5.45E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.18	-4.04	7.07E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.48	7.38	2.04E-12	Arsenic metabolism	
KIRP	cis	1	rs4924986	chr17:19242467	RNF112	chr17:19314523-19320587:+	-0.5	-5.76	2.29E-8	Schizophrenia	
KIRP	cis	1	rs4932143	chr15:90372067	ANPEP	chr15:90328127-90358072:-	0.2	3.89	0.000125	Type 2 diabetes	
KIRP	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.72	-10.93	3.43E-23	Type 2 diabetes	
KIRP	cis	1	rs4932148	chr15:90394356	ANPEP	chr15:90328127-90358072:-	0.2	3.92	0.000113	Type 2 diabetes	
KIRP	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.75	-11.86	2.69E-26	Type 2 diabetes	
KIRP	cis	1	rs493459	chr4:46251032	GABRA2	chr4:46251581-46392421:-	-0.23	-3.87	0.000139	Epilepsy	
KIRP	cis	1	rs493674	chr4:46214726	GABRA2	chr4:46251581-46392421:-	-0.22	-3.83	0.000162	Epilepsy	
KIRP	cis	1	rs4947534	chr7:56079094	VOPP1	chr7:55538307-55640200:-	-0.24	-4.14	4.66E-5	Blood metabolite levels;Amino acid levels	
KIRP	cis	1	rs4948102	chr7:56097265	VOPP1	chr7:55538307-55640200:-	-0.24	-4.14	4.59E-5	Plasma homocysteine levels (post-methionine load test)	
KIRP	cis	1	rs494965	chr11:120053650	OAF	chr11:120081747-120100649:+	0.28	4.68	4.5E-6	Corneal curvature	
KIRP	cis	1	rs4949674	chr1:76213715	ACADM	chr1:76190043-76229353:+	0.2	4.78	2.96E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4949872	chr1:76131392	ACADM	chr1:76190043-76229353:+	0.21	5.05	8.19E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4949874	chr1:76161889	ACADM	chr1:76190043-76229353:+	0.23	5.42	1.32E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4949875	chr1:76173080	ACADM	chr1:76190043-76229353:+	0.23	5.42	1.33E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4949876	chr1:76173377	ACADM	chr1:76190043-76229353:+	0.23	5.45	1.13E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4949879	chr1:76237143	ACADM	chr1:76190043-76229353:+	0.19	4.51	9.72E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs4953911	chr2:135068794	TMEM163	chr2:135213331-135525334:-	0.22	3.81	0.000171	Multiple sclerosis (severity)	
KIRP	cis	1	rs4953925	chr2:135471290	TMEM163	chr2:135213331-135525334:-	-0.34	-4.91	1.56E-6	Gut microbiome composition (winter)	
KIRP	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.32	5.79	2.01E-8	Height	
KIRP	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.31	4.66	5.04E-6	Height	
KIRP	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.35	6.4	6.84E-10	Height	
KIRP	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.81E-5	Height	
KIRP	cis	1	rs495818	chr4:46247898	GABRA2	chr4:46251581-46392421:-	-0.23	-3.83	0.00016	Epilepsy	
KIRP	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.82	6.49	4.25E-10	Crohn's disease	
KIRP	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.6	6.1	3.68E-9	Crohn's disease	
KIRP	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.79	6.11	3.5E-9	Crohn's disease	
KIRP	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.78	7.42	1.56E-12	Crohn's disease	
KIRP	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.6	6.1	3.68E-9	Crohn's disease	
KIRP	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.7	5.89	1.19E-8	Crohn's disease	
KIRP	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.4	-5.84	1.5E-8	Tumor biomarkers	
KIRP	cis	1	rs496584	chr15:43831923	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.16	4.85E-7	Tumor biomarkers	
KIRP	cis	1	rs496584	chr15:43831923	TUBGCP4	chr15:43663313-43698238:+	0.19	4.04	7.15E-5	Tumor biomarkers	
KIRP	cis	1	rs496650	chr4:46264385	GABRA2	chr4:46251581-46392421:-	-0.22	-3.82	0.000166	Epilepsy	
KIRP	cis	1	rs4973380	chr2:228725402	WDR69	chr2:228736327-228789026:+	0.29	4.36	1.89E-5	Blood pressure	
KIRP	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.96	-14.54	1.27E-35	Diastolic blood pressure	
KIRP	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.34	6.38	7.73E-10	Height	
KIRP	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.76E-5	Height	
KIRP	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.32	5.76	2.28E-8	Height	
KIRP	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.3	4.61	6.37E-6	Height	
KIRP	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.34	6.29	1.29E-9	Height	
KIRP	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.29	4.41	1.49E-5	Height	
KIRP	cis	1	rs497517	chr1:4624505	AJAP1	chr1:4715105-4843850:+	-0.36	-5.15	5.18E-7	Anxiety disorder	
KIRP	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.47	-6.28	1.4E-9	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.48	-6.39	7.61E-10	Chronic obstructive pulmonary disease (moderate to severe)	
KIRP	cis	1	rs4990365	chr6:159375553	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs5011018	chr10:4967006	AKR1C2	chr10:4964715-5060207:-	0.85	8.01	3.57E-14	Height	
KIRP	cis	1	rs5017300	chr2:631099	SNTG2	chr2:946555-1371382:+	-0.4	-3.83	0.00016	Body mass index	
KIRP	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.38	8.92	8.07E-17	Response to temozolomide	
KIRP	cis	1	rs504696	chr4:46229571	GABRA2	chr4:46251581-46392421:-	-0.22	-3.84	0.000151	Epilepsy	
KIRP	cis	1	rs505802	chr11:64357072	SLC22A12	chr11:64358282-64369820:+	0.24	4.26	2.81E-5	Urate levels in obese individuals	
KIRP	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.38	9.1	2.21E-17	Response to temozolomide	
KIRP	cis	1	rs506644	chr4:46239450	GABRA2	chr4:46251581-46392421:-	-0.23	-3.92	0.000113	Epilepsy	
KIRP	cis	1	rs507646	chr4:46239579	GABRA2	chr4:46251581-46392421:-	-0.23	-3.93	0.00011	Epilepsy	
KIRP	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.39	-9.12	1.89E-17	Response to temozolomide	
KIRP	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.37	8.5	1.35E-15	Response to temozolomide	
KIRP	cis	1	rs515910	chr10:105966404	C10orf79	chr10:105889647-105992120:-	0.21	4.94	1.38E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.38	9.04	3.44E-17	Response to temozolomide	
KIRP	cis	1	rs517134	chr4:46279117	GABRA2	chr4:46251581-46392421:-	-0.24	-4.03	7.29E-5	Epilepsy	
KIRP	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.39	-9.26	7.05E-18	Response to temozolomide	
KIRP	cis	1	rs524023	chr11:64358265	SLC22A12	chr11:64358282-64369820:+	0.23	4.05	6.79E-5	Urate levels in obese individuals	
KIRP	cis	1	rs527154	chr10:105943683	C10orf79	chr10:105889647-105992120:-	0.21	4.93	1.44E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs527710	chr4:46209845	GABRA2	chr4:46251581-46392421:-	-0.26	-4.22	3.34E-5	Epilepsy	
KIRP	cis	1	rs530329	chr4:46281119	GABRA2	chr4:46251581-46392421:-	-0.24	-4.03	7.29E-5	Epilepsy	
KIRP	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.39	9.53	1.04E-18	Response to temozolomide	
KIRP	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.39	-9.32	4.84E-18	Response to temozolomide	
KIRP	cis	1	rs534459	chr4:46256805	GABRA2	chr4:46251581-46392421:-	-0.22	-3.82	0.000166	Epilepsy	
KIRP	cis	1	rs535066	chr4:46240287	GABRA2	chr4:46251581-46392421:-	-0.23	-3.94	0.000105	Epilepsy	
KIRP	cis	1	rs537246	chr11:64360630	SLC22A12	chr11:64358282-64369820:+	0.22	3.94	0.000102	Urate levels in obese individuals	
KIRP	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.38	9.12	1.88E-17	Response to temozolomide	
KIRP	cis	1	rs540363	chr4:46274246	GABRA2	chr4:46251581-46392421:-	-0.22	-3.82	0.000165	Epilepsy	
KIRP	cis	1	rs540708	chr4:46246715	GABRA2	chr4:46251581-46392421:-	-0.22	-3.84	0.000154	Epilepsy	
KIRP	cis	1	rs542432	chr4:46246540	GABRA2	chr4:46251581-46392421:-	-0.24	-4.01	7.93E-5	Epilepsy	
KIRP	cis	1	rs546131	chr11:34851760	APIP	chr11:34896714-34937939:-	0.2	4.23	3.19E-5	Lung disease severity in cystic fibrosis	
KIRP	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.38	8.91	8.46E-17	Response to temozolomide	
KIRP	cis	1	rs551905	chr4:46278365	GABRA2	chr4:46251581-46392421:-	-0.23	-3.83	0.000158	Epilepsy	
KIRP	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.38	8.97	5.36E-17	Response to temozolomide	
KIRP	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.37	8.96	5.9E-17	Response to temozolomide	
KIRP	cis	1	rs555017	chr6:20185051	MBOAT1	chr6:20100935-20212670:-	0.25	4.83	2.36E-6	Anger	
KIRP	cis	1	rs556292	chr10:105961957	C10orf79	chr10:105889647-105992120:-	0.21	4.92	1.54E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs55661361	chr11:124613957	NRGN	chr11:124609829-124617102:+	0.31	5.32	2.18E-7	Schizophrenia	
KIRP	cis	1	rs55674647	chr17:61794195	FTSJ3	chr17:61896795-61905031:-	0.3	3.82	0.000167	Body mass index	
KIRP	cis	1	rs55697388	chr6:118891544	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000167	Renal cell carcinoma	
KIRP	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.47	-7.77	1.75E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs55788133	chr15:40664239	C15orf23	chr15:40674922-40686488:+	0.96	10.64	3.1E-22	Heschl's gyrus morphology	
KIRP	cis	1	rs55805503	chr10:96534043	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.32	5.3	2.44E-7	Body mass index	
KIRP	cis	1	rs55842567	chr5:437586	C5orf55	chr5:441645-443258:-	0.36	5.54	7.16E-8	Cystic fibrosis severity	
KIRP	cis	1	rs55868506	chr17:61851686	FTSJ3	chr17:61896795-61905031:-	0.31	4.44	1.33E-5	Body mass index	
KIRP	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.37	-8.77	2.2E-16	Response to temozolomide	
KIRP	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.25	-4.06	6.59E-5	Inflammatory skin disease	
KIRP	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.58	8.97	5.39E-17	Inflammatory skin disease	
KIRP	cis	1	rs55896768	chr17:65913358	C17orf58	chr17:65987218-65989765:-	0.26	4	8.33E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs55896768	chr17:65913358	LOC440461	chr17:66194801-66196436:+	0.3	4.15	4.44E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs55905547	chr20:57589995	TH1L	chr20:57556311-57570186:+	-0.35	-4.12	5.13E-5	Mean platelet volume	
KIRP	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.35	6.4	6.84E-10	Height	
KIRP	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.81E-5	Height	
KIRP	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.6	5.12	5.84E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.49	-7.97	4.62E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.5	-8.07	2.43E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs55962025	chr4:3112109	C4orf44	chr4:3250767-3265839:+	-0.26	-3.99	8.63E-5	Parental longevity (mother's age at death)	
KIRP	cis	1	rs55979739	chr16:31049155	HSD3B7	chr16:30996519-31000473:+	0.28	5.24	3.35E-7	Response to metformin (IC50)	
KIRP	cis	1	rs559946	chr11:64358605	SLC22A12	chr11:64358282-64369820:+	0.23	4.07	6.14E-5	Urate levels in obese individuals	
KIRP	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.26	3.88	0.000132	Diabetic kidney disease	
KIRP	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.4	5.7	3.2E-8	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRP	cis	1	rs56042615	chr5:437667	C5orf55	chr5:441645-443258:-	0.36	5.54	7.16E-8	Cystic fibrosis severity	
KIRP	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.42	-7.14	9.23E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.23	-4.06	6.46E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs56098064	chr14:50105849	RPL36AL	chr14:50085407-50087349:-	0.22	4.26	2.82E-5	Carotid intima media thickness	
KIRP	cis	1	rs56104203	chr2:86336256	LOC90784	chr2:86247339-86250991:-	-0.45	-4.3	2.37E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs56104584	chr5:437542	C5orf55	chr5:441645-443258:-	0.36	5.54	7.16E-8	Cystic fibrosis severity	
KIRP	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs56127630	chr3:49438036	NCKIPSD	chr3:48711280-48723334:-	-0.33	-4.54	8.4E-6	Menarche (age at onset)	
KIRP	cis	1	rs56127630	chr3:49438036	P4HTM	chr3:49027341-49044579:+	-0.25	-4.41	1.49E-5	Menarche (age at onset)	
KIRP	cis	1	rs56148300	chr17:65892752	C17orf58	chr17:65987218-65989765:-	0.26	3.93	0.000107	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs56148300	chr17:65892752	LOC440461	chr17:66194801-66196436:+	0.31	4.23	3.2E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.3	3.98	8.97E-5	Metabolite levels	
KIRP	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.5	-8.07	2.47E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.87	9.81	1.38E-19	Diastolic blood pressure	
KIRP	cis	1	rs56249692	chr3:124723760	HEG1	chr3:124684555-124774802:-	0.22	4.11	5.3E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs56256440	chr10:79698207	DLG5	chr10:79550551-79686348:-	0.26	4.35	1.95E-5	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.26	3.88	0.000132	Diabetic kidney disease	
KIRP	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.32	4.45	1.24E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.4	6.58	2.49E-10	Cognitive performance	
KIRP	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.47	-7.63	4.26E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.21E-5	Body mass index	
KIRP	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.23	-3.93	0.000109	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs56393562	chr17:65933918	LOC440461	chr17:66194801-66196436:+	0.31	3.85	0.000146	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs56404791	chr17:65893019	C17orf58	chr17:65987218-65989765:-	0.26	3.93	0.000107	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs56404791	chr17:65893019	LOC440461	chr17:66194801-66196436:+	0.31	4.23	3.2E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.37	8.96	5.9E-17	Response to temozolomide	
KIRP	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.39	5.19	4.19E-7	Metabolite levels	
KIRP	cis	1	rs566776	chr4:46241929	GABRA2	chr4:46251581-46392421:-	0.23	3.96	9.52E-5	Epilepsy	
KIRP	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.37	8.96	5.9E-17	Response to temozolomide	
KIRP	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.92	13.11	1.33E-30	Diastolic blood pressure	
KIRP	cis	1	rs567926	chr4:46241769	GABRA2	chr4:46251581-46392421:-	-0.23	-3.83	0.00016	Epilepsy	
KIRP	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.58	-11.39	9.74E-25	Crohn's disease	
KIRP	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.36	-5.42	1.32E-7	Schizophrenia	
KIRP	cis	1	rs56871534	chr4:76510197	CDKL2	chr4:76501705-76555721:-	0.28	3.85	0.000148	Magnesium levels	
KIRP	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.56	-10.31	3.42E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.38	9.1	2.21E-17	Response to temozolomide	
KIRP	cis	1	rs569856	chr10:105942304	C10orf79	chr10:105889647-105992120:-	0.2	4.82	2.44E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs56987357	chr14:88824363	SPATA7	chr14:88852012-88904802:+	-0.27	-3.89	0.000126	Coronary artery calcification	
KIRP	cis	1	rs569967	chr10:105942337	C10orf79	chr10:105889647-105992120:-	0.2	4.82	2.44E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.35	4.56	7.79E-6	Atopic dermatitis	
KIRP	cis	1	rs571576	chr4:46236233	GABRA2	chr4:46251581-46392421:-	-0.24	-3.93	0.000109	Epilepsy	
KIRP	cis	1	rs57262132	chr5:116537883	SEMA6A	chr5:115779252-115910551:-	-0.41	-4.02	7.61E-5	Periodontitis (DPAL)	
KIRP	cis	1	rs57311533	chr8:89582889	MMP16	chr8:89049462-89339717:-	0.31	4.43	1.4E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs573211	chr11:120044762	OAF	chr11:120081747-120100649:+	0.31	5.14	5.42E-7	Corneal curvature	
KIRP	cis	1	rs573400	chr4:46252066	GABRA2	chr4:46251581-46392421:-	0.23	3.92	0.000111	Epilepsy	
KIRP	cis	1	rs57406211	chr5:150170966	LOC134466	chr5:150310000-150326146:-	0.85	6.74	9.88E-11	Crohn's disease	
KIRP	cis	1	rs574091	chr4:46228078	GABRA2	chr4:46251581-46392421:-	-0.24	-3.93	0.000107	Epilepsy	
KIRP	cis	1	rs57433322	chr17:19141582	RNF112	chr17:19314523-19320587:+	0.46	4.86	2.03E-6	Schizophrenia	
KIRP	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.95	13.77	6.6E-33	Diastolic blood pressure	
KIRP	cis	1	rs5749806	chr22:22106618	TOP3B	chr22:22311404-22337193:-	-0.19	-4.34	1.99E-5	Multiple sclerosis	
KIRP	cis	1	rs5749986	chr22:22157661	TOP3B	chr22:22311404-22337193:-	0.18	4.21	3.45E-5	Multiple sclerosis	
KIRP	cis	1	rs575100	chr4:46228221	GABRA2	chr4:46251581-46392421:-	-0.24	-3.93	0.000107	Epilepsy	
KIRP	cis	1	rs5751255	chr22:42648408	C22orf32	chr22:42475699-42480287:+	0.17	4.14	4.68E-5	Cognitive function	
KIRP	cis	1	rs5751255	chr22:42648408	NAGA	chr22:42454339-42466846:-	0.35	5.14	5.23E-7	Cognitive function	
KIRP	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.5	-7.94	5.65E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs5756813	chr22:38175477	TRIOBP	chr22:38082344-38172562:+	-0.31	-5.5	8.88E-8	Optic cup area;Vertical cup-disc ratio	
KIRP	cis	1	rs57576577	chr16:31036367	HSD3B7	chr16:30996519-31000473:+	0.29	5.61	4.99E-8	Response to metformin (IC50)	
KIRP	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.2	4.1	5.4E-5	Response to metformin (IC50)	
KIRP	cis	1	rs5758659	chr22:42622003	C22orf32	chr22:42475699-42480287:+	0.18	4.4	1.56E-5	Cognitive function	
KIRP	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.19	-3.85	0.00015	Cognitive function	
KIRP	cis	1	rs5758659	chr22:42622003	NAGA	chr22:42454339-42466846:-	0.34	5.01	9.79E-7	Cognitive function	
KIRP	cis	1	rs5758660	chr22:42623718	C22orf32	chr22:42475699-42480287:+	0.17	4.33	2.15E-5	Cognitive function	
KIRP	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.2	-4.06	6.37E-5	Cognitive function	
KIRP	cis	1	rs5758660	chr22:42623718	NAGA	chr22:42454339-42466846:-	0.34	4.95	1.35E-6	Cognitive function	
KIRP	cis	1	rs5758677	chr22:42643039	C22orf32	chr22:42475699-42480287:+	0.17	4.22	3.35E-5	Cognitive function	
KIRP	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.19	-3.98	8.93E-5	Cognitive function	
KIRP	cis	1	rs5758677	chr22:42643039	NAGA	chr22:42454339-42466846:-	0.34	4.96	1.25E-6	Cognitive function	
KIRP	cis	1	rs5758677	chr22:42643039	WBP2NL	chr22:42120334-42454460:+	0.27	3.85	0.000149	Cognitive function	
KIRP	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.58	4.67	4.73E-6	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.58	4.13	4.86E-5	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.56	4.72	3.9E-6	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs576779	chr4:56274307	SRD5A3	chr4:56212409-56237866:+	0.3	5.06	8.0E-7	Personality dimensions	
KIRP	cis	1	rs576779	chr4:56274307	TMEM165	chr4:56262090-56292342:+	-0.24	-3.89	0.000126	Personality dimensions	
KIRP	cis	1	rs5770911	chr22:51011241	CPT1B	chr22:51007291-51017096:-	-0.38	-4.49	1.08E-5	Narcolepsy	
KIRP	cis	1	rs5770917	chr22:51017353	CPT1B	chr22:51007291-51017096:-	-0.36	-4.71	3.98E-6	Narcolepsy	
KIRP	cis	1	rs5770922	chr22:51023408	CPT1B	chr22:51007291-51017096:-	-0.38	-4.44	1.32E-5	Narcolepsy	
KIRP	cis	1	rs5770924	chr22:51024542	CPT1B	chr22:51007291-51017096:-	-0.38	-4.61	6.26E-6	Narcolepsy	
KIRP	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.38	9.07	2.67E-17	Response to temozolomide	
KIRP	cis	1	rs577544	chr4:46278859	GABRA2	chr4:46251581-46392421:-	-0.23	-3.97	9.37E-5	Epilepsy	
KIRP	cis	1	rs579890	chr11:116798963	PCSK7	chr11:117075789-117102811:-	-0.38	-4.02	7.48E-5	Protein quantitative trait loci	
KIRP	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.38	8.8	1.74E-16	Response to temozolomide	
KIRP	cis	1	rs581686	chr10:105983356	C10orf79	chr10:105889647-105992120:-	0.22	5.18	4.44E-7	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs58189451	chr6:149921388	NUP43	chr6:150045453-150067688:-	-0.33	-4.73	3.65E-6	Lung cancer	
KIRP	cis	1	rs58204112	chr14:74359417	LIN52	chr14:74551656-74667117:+	0.24	3.83	0.000158	Morning vs. evening chronotype	
KIRP	cis	1	rs58349349	chr10:96553499	C10orf129	chr10:96953957-96988685:+	0.73	7.44	1.41E-12	Blood metabolite levels	
KIRP	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.36	5.25	3.08E-7	Schizophrenia (negative symptoms)	
KIRP	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.4	-6.06	4.7E-9	Schizophrenia	
KIRP	cis	1	rs584309	chr10:105956776	C10orf79	chr10:105889647-105992120:-	0.21	4.95	1.32E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.49	-7.99	4.04E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.39	5.09	6.8E-7	Metabolite levels	
KIRP	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.62	5.86	1.41E-8	Crohn's disease	
KIRP	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.47	-4.66	5.05E-6	Abdominal aortic aneurysm	
KIRP	cis	1	rs59032271	chr5:148618749	AFAP1L1	chr5:148651401-148721365:+	0.32	4.21	3.47E-5	Body mass index	
KIRP	cis	1	rs59043558	chr5:150334662	LOC134466	chr5:150310000-150326146:-	0.5	4.93	1.48E-6	Crohn's disease	
KIRP	cis	1	rs590958	chr15:65735707	DPP8	chr15:65737999-65810035:-	-0.13	-4.84	2.25E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs591784	chr10:105936290	C10orf79	chr10:105889647-105992120:-	0.21	4.93	1.44E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.28	-4.12	5.11E-5	Bone mineral density	
KIRP	cis	1	rs59278974	chr10:96389786	C10orf129	chr10:96953957-96988685:+	0.77	7.06	1.45E-11	Blood metabolite levels	
KIRP	cis	1	rs593151	chr10:105935979	C10orf79	chr10:105889647-105992120:-	0.21	4.93	1.44E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs59321715	chr5:150313480	LOC134466	chr5:150310000-150326146:-	0.77	5.83	1.57E-8	Crohn's disease	
KIRP	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.24	3.91	0.000118	Morning vs. evening chronotype	
KIRP	cis	1	rs59375902	chr12:81441561	LIN7A	chr12:81191171-81331694:-	0.26	3.87	0.000135	Neuroticism	
KIRP	cis	1	rs59428599	chr10:4970849	AKR1C2	chr10:4964715-5060207:-	0.84	7.77	1.77E-13	Height	
KIRP	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.78	6.7	1.26E-10	Crohn's disease	
KIRP	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.82	6.49	4.25E-10	Crohn's disease	
KIRP	cis	1	rs59757169	chr5:148618752	AFAP1L1	chr5:148651401-148721365:+	0.32	4.21	3.47E-5	Body mass index	
KIRP	cis	1	rs59770215	chr6:159371062	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs59804446	chr4:56429541	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.68	4.63E-6	Personality dimensions	
KIRP	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.55	-10.33	3.11E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.48	-7.83	1.21E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs5995481	chr22:38004202	SH3BP1	chr22:38030661-38062939:+	0.29	4.07	6.16E-5	Response to anti-depressant treatment in major depressive disorder	
KIRP	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.6	5.9	1.13E-8	Crohn's disease	
KIRP	cis	1	rs5999515	chr22:22145101	TOP3B	chr22:22311404-22337193:-	0.19	4.41	1.51E-5	Multiple sclerosis	
KIRP	cis	1	rs5999521	chr22:22146399	TOP3B	chr22:22311404-22337193:-	-0.18	-4.22	3.4E-5	Multiple sclerosis	
KIRP	cis	1	rs5999750	chr22:22188009	TOP3B	chr22:22311404-22337193:-	-0.18	-4.05	6.77E-5	Multiple sclerosis	
KIRP	cis	1	rs6000842	chr22:38006253	SH3BP1	chr22:38030661-38062939:+	0.28	3.94	0.000103	Response to anti-depressant treatment in major depressive disorder	
KIRP	cis	1	rs600193	chr15:65729409	DPP8	chr15:65737999-65810035:-	0.13	4.8	2.68E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs6005807	chr22:28934313	CHEK2	chr22:29083731-29137822:-	0.42	4.21	3.53E-5	Cerebrospinal fluid p-Tau181p:AB1-42 ratio;Cerebrospinal P-tau181p levels;Cerebrospinal T-tau levels	
KIRP	cis	1	rs601019	chr10:105976452	C10orf79	chr10:105889647-105992120:-	-0.21	-4.93	1.46E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs601338	chr19:49206674	FUT2	chr19:49199228-49209190:+	-0.26	-4.26	2.85E-5	Blood metabolite levels;Blood metabolite ratios	
KIRP	cis	1	rs601338	chr19:49206674	NTN5	chr19:49164666-49176264:-	0.25	4.57	7.4E-6	Blood metabolite levels;Blood metabolite ratios	
KIRP	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.49	4.86	2.06E-6	Crohn's disease	
KIRP	cis	1	rs60146975	chr6:159358206	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.5	-7.96	4.97E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs601923	chr5:176417386	PRR7	chr5:176873796-176883283:+	-0.21	-3.91	0.000116	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs6027072	chr20:37284070	LOC388796	chr20:37049239-37064018:-	0.51	4.44	1.3E-5	Modified Stumvoll Insulin Sensitivity Index (interaction with BMI)	
KIRP	cis	1	rs60310240	chr14:88822709	SPATA7	chr14:88852012-88904802:+	-0.27	-4.01	8.0E-5	Coronary artery calcification	
KIRP	cis	1	rs6037086	chr20:25306338	ENTPD6	chr20:25176339-25207360:+	0.33	5.63	4.54E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037086	chr20:25306338	FAM182B	chr20:25744102-25848786:-	-0.29	-3.89	0.000127	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037095	chr20:25335687	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037095	chr20:25335687	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037099	chr20:25356876	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037099	chr20:25356876	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037105	chr20:25374199	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037105	chr20:25374199	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037121	chr20:25428311	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037121	chr20:25428311	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000158	IFN-related cytopenia	
KIRP	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000161	IFN-related cytopenia	
KIRP	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000158	IFN-related cytopenia	
KIRP	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.23	-3.95	9.91E-5	IFN-related cytopenia	
KIRP	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.23	-3.95	9.91E-5	IFN-related cytopenia	
KIRP	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.00016	IFN-related cytopenia	
KIRP	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.22	-3.82	0.000167	IFN-related cytopenia	
KIRP	cis	1	rs60378628	chr10:96683734	C10orf129	chr10:96953957-96988685:+	0.78	7.35	2.45E-12	Blood metabolite levels	
KIRP	cis	1	rs6039450	chr20:9352254	PAK7	chr20:9518037-9819687:-	0.39	4.05	6.87E-5	Neutrophil count	
KIRP	cis	1	rs60425110	chr15:75333000	MAN2C1	chr15:75648135-75660941:-	0.22	3.88	0.000134	Blood trace element (Zn levels)	
KIRP	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.37	5.46	1.12E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs60432293	chr17:65860407	LOC440461	chr17:66194801-66196436:+	0.3	4.04	6.92E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.51	-8.12	1.78E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs6050542	chr20:25318879	ENTPD6	chr20:25176339-25207360:+	0.34	5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050542	chr20:25318879	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050544	chr20:25320228	ENTPD6	chr20:25176339-25207360:+	0.35	6.15	2.79E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050544	chr20:25320228	FAM182B	chr20:25744102-25848786:-	-0.31	-4.23	3.28E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050547	chr20:25326012	ENTPD6	chr20:25176339-25207360:+	0.36	6.11	3.52E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050547	chr20:25326012	FAM182B	chr20:25744102-25848786:-	-0.32	-4.32	2.25E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050555	chr20:25328543	ENTPD6	chr20:25176339-25207360:+	0.38	6.46	5.04E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050555	chr20:25328543	FAM182B	chr20:25744102-25848786:-	-0.31	-4.19	3.88E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050559	chr20:25329915	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.12	3.34E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050559	chr20:25329915	FAM182B	chr20:25744102-25848786:-	0.32	4.4	1.6E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050561	chr20:25334855	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050561	chr20:25334855	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050562	chr20:25336186	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050562	chr20:25336186	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050564	chr20:25344231	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050564	chr20:25344231	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050565	chr20:25347563	ENTPD6	chr20:25176339-25207360:+	0.36	6.33	1.01E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050565	chr20:25347563	FAM182B	chr20:25744102-25848786:-	-0.3	-4.19	3.84E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050566	chr20:25351071	ENTPD6	chr20:25176339-25207360:+	0.36	6.31	1.19E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050566	chr20:25351071	FAM182B	chr20:25744102-25848786:-	-0.31	-4.3	2.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050573	chr20:25366065	ENTPD6	chr20:25176339-25207360:+	-0.38	-6.61	2.14E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050573	chr20:25366065	FAM182B	chr20:25744102-25848786:-	0.31	4.22	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050590	chr20:25384994	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050590	chr20:25384994	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050598	chr20:25397257	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050598	chr20:25397257	FAM182B	chr20:25744102-25848786:-	0.3	4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050599	chr20:25400240	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050599	chr20:25400240	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050602	chr20:25401203	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050602	chr20:25401203	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050609	chr20:25411751	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050609	chr20:25411751	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050617	chr20:25421648	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050617	chr20:25421648	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050626	chr20:25428261	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.48	4.49E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050626	chr20:25428261	FAM182B	chr20:25744102-25848786:-	0.3	4.19	3.85E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050629	chr20:25430680	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050629	chr20:25430680	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050630	chr20:25430745	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050630	chr20:25430745	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050631	chr20:25431749	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.34	9.87E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050631	chr20:25431749	FAM182B	chr20:25744102-25848786:-	0.31	4.32	2.25E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050632	chr20:25432601	ENTPD6	chr20:25176339-25207360:+	-0.37	-6.45	5.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6050632	chr20:25432601	FAM182B	chr20:25744102-25848786:-	0.31	4.21	3.57E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6051080	chr20:25975674	ENTPD6	chr20:25176339-25207360:+	-0.23	-3.8	0.000177	Colorectal or endometrial cancer	
KIRP	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.47	6.92	3.35E-11	Colorectal or endometrial cancer	
KIRP	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.25	-5.41	1.38E-7	Longevity	
KIRP	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000158	IFN-related cytopenia	
KIRP	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.24	-4.11	5.33E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.23	4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.22	-3.87	0.000138	IFN-related cytopenia	
KIRP	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000161	IFN-related cytopenia	
KIRP	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.22	-3.87	0.000138	IFN-related cytopenia	
KIRP	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.22	-3.87	0.000138	IFN-related cytopenia	
KIRP	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.22	-3.83	0.000161	IFN-related cytopenia	
KIRP	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.23	-4.02	7.74E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.25	4.45	1.26E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.23	-3.93	0.000106	IFN-related cytopenia	
KIRP	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.23	-4	8.31E-5	IFN-related cytopenia	
KIRP	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.23	-3.92	0.000112	IFN-related cytopenia	
KIRP	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.23	-3.87	0.000139	IFN-related cytopenia	
KIRP	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.23	-3.87	0.000139	IFN-related cytopenia	
KIRP	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.23	-3.87	0.000139	IFN-related cytopenia	
KIRP	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.22	3.85	0.000149	IFN-related cytopenia	
KIRP	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.24	-4.15	4.48E-5	IFN-related cytopenia	
KIRP	cis	1	rs60571765	chr4:76549046	CDKL2	chr4:76501705-76555721:-	0.29	4.15	4.46E-5	Magnesium levels	
KIRP	cis	1	rs60622165	chr8:89599455	MMP16	chr8:89049462-89339717:-	0.31	4.45	1.24E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs6063312	chr20:47343059	KCNB1	chr20:47988505-48100490:-	-0.36	-3.83	0.00016	Tonometry	
KIRP	cis	1	rs6063313	chr20:47343532	KCNB1	chr20:47988505-48100490:-	-0.37	-3.92	0.000115	Tonometry	
KIRP	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.34	4.42	1.45E-5	Atopic dermatitis	
KIRP	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.38	-4.13	4.77E-5	Mean platelet volume	
KIRP	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.35	-4.24	3.12E-5	Mean platelet volume	
KIRP	cis	1	rs6076336	chr20:25319212	ENTPD6	chr20:25176339-25207360:+	0.34	5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6076336	chr20:25319212	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6076339	chr20:25348712	ENTPD6	chr20:25176339-25207360:+	0.34	5.95	8.65E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6076339	chr20:25348712	FAM182B	chr20:25744102-25848786:-	-0.31	-4.21	3.48E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6076345	chr20:25381895	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6076345	chr20:25381895	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083804	chr20:25317060	ENTPD6	chr20:25176339-25207360:+	0.34	5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083804	chr20:25317060	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083805	chr20:25317356	ENTPD6	chr20:25176339-25207360:+	0.35	6.09	3.85E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083805	chr20:25317356	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.14E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083809	chr20:25329309	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083809	chr20:25329309	FAM182B	chr20:25744102-25848786:-	-0.31	-4.21	3.52E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083813	chr20:25337671	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083813	chr20:25337671	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083825	chr20:25366424	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083825	chr20:25366424	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083828	chr20:25369918	ENTPD6	chr20:25176339-25207360:+	0.38	6.68	1.43E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083828	chr20:25369918	FAM182B	chr20:25744102-25848786:-	-0.32	-4.48	1.13E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083844	chr20:25386832	ENTPD6	chr20:25176339-25207360:+	0.35	6.08	4.22E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083844	chr20:25386832	FAM182B	chr20:25744102-25848786:-	-0.3	-4.15	4.49E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083856	chr20:25407585	ENTPD6	chr20:25176339-25207360:+	0.36	6.13	3.17E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083856	chr20:25407585	FAM182B	chr20:25744102-25848786:-	-0.29	-3.91	0.000119	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083862	chr20:25411086	ENTPD6	chr20:25176339-25207360:+	0.29	5.01	9.97E-7	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6083862	chr20:25411086	FAM182B	chr20:25744102-25848786:-	-0.32	-4.58	7.18E-6	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.48	-7.57	6.05E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.39	5.19	4.19E-7	Metabolite levels	
KIRP	cis	1	rs6095261	chr20:47346494	KCNB1	chr20:47988505-48100490:-	-0.37	-3.92	0.000115	Tonometry	
KIRP	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.38	-5.81	1.83E-8	Schizophrenia	
KIRP	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.35	-5.01	9.8E-7	Forced vital capacity	
KIRP	cis	1	rs6107033	chr20:25363591	ENTPD6	chr20:25176339-25207360:+	0.35	6.05	4.8E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107033	chr20:25363591	FAM182B	chr20:25744102-25848786:-	-0.3	-4.11	5.36E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107045	chr20:25441936	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.04	5.08E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107045	chr20:25441936	FAM182B	chr20:25744102-25848786:-	0.3	3.97	9.43E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107046	chr20:25442049	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.04	5.08E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107046	chr20:25442049	FAM182B	chr20:25744102-25848786:-	0.3	3.97	9.43E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107047	chr20:25442097	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.04	5.08E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6107047	chr20:25442097	FAM182B	chr20:25744102-25848786:-	0.3	3.97	9.43E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.19	2.3E-9	Body mass index	
KIRP	cis	1	rs61102033	chr1:46382441	MUTYH	chr1:45794915-45806142:-	0.17	4	8.07E-5	Body mass index	
KIRP	cis	1	rs6115140	chr20:25285507	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.08	4.28E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115140	chr20:25285507	FAM182B	chr20:25744102-25848786:-	0.28	3.86	0.000144	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115146	chr20:25304507	ENTPD6	chr20:25176339-25207360:+	0.35	6.05	4.89E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115146	chr20:25304507	FAM182B	chr20:25744102-25848786:-	-0.31	-4.26	2.86E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115153	chr20:25325567	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115153	chr20:25325567	FAM182B	chr20:25744102-25848786:-	-0.31	-4.21	3.52E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115159	chr20:25350944	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115159	chr20:25350944	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115168	chr20:25372891	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115168	chr20:25372891	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115182	chr20:25410259	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.26E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115182	chr20:25410259	FAM182B	chr20:25744102-25848786:-	-0.3	-4.2	3.7E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115191	chr20:25440478	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.04	5.08E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6115191	chr20:25440478	FAM182B	chr20:25744102-25848786:-	0.3	3.97	9.43E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs61153799	chr10:96547356	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs61189394	chr10:96675513	C10orf129	chr10:96953957-96988685:+	0.81	7.52	8.67E-13	Blood metabolite levels	
KIRP	cis	1	rs611960	chr11:118034228	C2CD2L	chr11:118978093-118987826:+	-0.37	-3.83	0.000158	Preeclampsia	
KIRP	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.46	-5.65	4.05E-8	Triglycerides	
KIRP	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.61	6.07	4.41E-9	Crohn's disease	
KIRP	cis	1	rs613089	chr1:147081187	ACP6	chr1:147119168-147142634:-	-0.41	-5.68	3.59E-8	Schizophrenia (negative symptoms)	
KIRP	cis	1	rs61312893	chr17:45325023	LOC100272146	chr17:45500843-45504056:+	-0.18	-4.08	6.07E-5	Body mass index	
KIRP	cis	1	rs6132835	chr20:25434667	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.15	2.84E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6132835	chr20:25434667	FAM182B	chr20:25744102-25848786:-	0.32	4.31	2.3E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.23	-3.87	0.000139	IFN-related cytopenia	
KIRP	cis	1	rs61360320	chr17:61800392	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs6138572	chr20:25435934	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.61	5.19E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6138572	chr20:25435934	FAM182B	chr20:25744102-25848786:-	0.3	4	8.37E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6138575	chr20:25438952	ENTPD6	chr20:25176339-25207360:+	-0.34	-5.61	5.19E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6138575	chr20:25438952	FAM182B	chr20:25744102-25848786:-	0.3	4	8.37E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	6.76E-5	IFN-related cytopenia	
KIRP	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.22	-3.87	0.000138	IFN-related cytopenia	
KIRP	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.27	-4.52	9.38E-6	IFN-related cytopenia	
KIRP	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.89	-7.42	1.63E-12	Blood metabolite levels	
KIRP	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.46	7.13	9.75E-12	Metabolite levels (small molecules and protein measures)	
KIRP	cis	1	rs615284	chr13:28192930	POLR1D	chr13:28194895-28241547:+	-0.26	-4.92	1.51E-6	Large B-cell lymphoma	
KIRP	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.62	5.59	5.61E-8	Crohn's disease	
KIRP	cis	1	rs61561636	chr5:116524843	SEMA6A	chr5:115779252-115910551:-	-0.38	-3.81	0.000171	Periodontitis (DPAL)	
KIRP	cis	1	rs61604699	chr10:96696903	C10orf129	chr10:96953957-96988685:+	1.05	9.67	3.92E-19	Blood metabolite levels	
KIRP	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.9	11.86	2.53E-26	Diastolic blood pressure	
KIRP	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.9	11.86	2.53E-26	Diastolic blood pressure	
KIRP	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs61783200	chr1:46297403	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs61783220	chr1:46335312	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.24	3.84	0.000152	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61792116	chr4:301077	ZNF718	chr4:53272-156488:+	0.28	4	8.18E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.27	3.96	9.51E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.27	3.94	0.000103	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.27	4.01	7.84E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.28	4.07	6.19E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.26	4.21	3.55E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.26	4.21	3.55E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs61803655	chr1:153769332	CREB3L4	chr1:153940379-153946832:+	-0.23	-4.5	1.04E-5	Lentiform nucleus volume	
KIRP	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.46	4.82	2.4E-6	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs61835260	chr1:227703336	JMJD4	chr1:227918891-227923112:-	0.24	4.6	6.44E-6	Height	
KIRP	cis	1	rs61856137	chr10:5087978	AKR1C2	chr10:4964715-5060207:-	0.35	4.2	3.6E-5	Longevity	
KIRP	cis	1	rs61934658	chr12:81445968	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs61977049	chr14:88827000	SPATA7	chr14:88852012-88904802:+	-0.26	-3.84	0.000151	Coronary artery calcification	
KIRP	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.38	-5.82	1.73E-8	Schizophrenia	
KIRP	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.38	-5.82	1.67E-8	Schizophrenia	
KIRP	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.4	-6.13	3.09E-9	Schizophrenia	
KIRP	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.41	-6.03	5.5E-9	Schizophrenia	
KIRP	cis	1	rs62084240	chr17:65859233	LOC440461	chr17:66194801-66196436:+	0.32	3.89	0.000129	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs62085992	chr17:65923083	LOC440461	chr17:66194801-66196436:+	0.33	3.96	9.56E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs62085993	chr17:65923152	LOC440461	chr17:66194801-66196436:+	0.31	3.85	0.000146	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs62103177	chr18:77624479	HSBP1L1	chr18:77724582-77730820:+	0.32	4.18	4.0E-5	Opioid sensitivity	
KIRP	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.48	-7.43	1.48E-12	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.51	-8.17	1.31E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.5	-8.2	1.04E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.5	-8.07	2.43E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.5	-7.81	1.36E-13	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.4	-3.97	9.14E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.3	3.93	0.000107	Metabolite levels	
KIRP	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.32	4.45	1.29E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.32	4.42	1.45E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs62184315	chr2:190771945	ASNSD1	chr2:190526125-190535556:+	-0.33	-3.95	9.88E-5	Alcohol dependence (age at onset)	
KIRP	cis	1	rs62229266	chr21:37460271	SETD4	chr21:37406840-37451687:-	-0.27	-5.73	2.72E-8	Mitral valve prolapse	
KIRP	cis	1	rs62259933	chr3:49469703	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.22	3.43E-5	Menarche (age at onset)	
KIRP	cis	1	rs62259933	chr3:49469703	P4HTM	chr3:49027341-49044579:+	-0.24	-4.33	2.11E-5	Menarche (age at onset)	
KIRP	cis	1	rs62259944	chr3:49430883	NCKIPSD	chr3:48711280-48723334:-	-0.31	-3.95	9.84E-5	Menarche (age at onset)	
KIRP	cis	1	rs62259944	chr3:49430883	P4HTM	chr3:49027341-49044579:+	-0.27	-4.48	1.11E-5	Menarche (age at onset)	
KIRP	cis	1	rs62259947	chr3:49439924	NCKIPSD	chr3:48711280-48723334:-	-0.32	-4.13	4.8E-5	Menarche (age at onset)	
KIRP	cis	1	rs62259947	chr3:49439924	P4HTM	chr3:49027341-49044579:+	-0.25	-4.2	3.71E-5	Menarche (age at onset)	
KIRP	cis	1	rs62261249	chr3:49594060	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.06	6.44E-5	Menarche (age at onset)	
KIRP	cis	1	rs62261249	chr3:49594060	P4HTM	chr3:49027341-49044579:+	-0.25	-4.35	1.96E-5	Menarche (age at onset)	
KIRP	cis	1	rs62265556	chr3:94243253	STX19	chr3:93733215-93747454:-	0.59	6.5	3.99E-10	Blood pressure measurement (high sodium intervention)	
KIRP	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.39	6.49	4.18E-10	Cognitive performance	
KIRP	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.51	8.45E-8	Height	
KIRP	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.31	-4.69	4.47E-6	Height	
KIRP	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.51	8.45E-8	Height	
KIRP	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.31	-4.69	4.47E-6	Height	
KIRP	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.31	5.51	8.62E-8	Height	
KIRP	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.29	4.39	1.61E-5	Height	
KIRP	cis	1	rs624159	chr10:105939451	C10orf79	chr10:105889647-105992120:-	0.21	4.93	1.44E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs62422189	chr6:118907053	NUS1	chr6:117996617-118031884:+	0.25	3.89	0.000126	Renal cell carcinoma	
KIRP	cis	1	rs62422220	chr6:118923731	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000163	Renal cell carcinoma	
KIRP	cis	1	rs627804	chr15:65734040	DPP8	chr15:65737999-65810035:-	-0.13	-4.84	2.19E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs629301	chr1:109818306	PSRC1	chr1:109822179-109825808:-	-0.37	-6.28	1.39E-9	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
KIRP	cis	1	rs637511	chr6:20184997	MBOAT1	chr6:20100935-20212670:-	-0.25	-4.82	2.46E-6	Anger	
KIRP	cis	1	rs638893	chr11:118698537	TTC36	chr11:118398210-118401740:+	-0.38	-4.23	3.19E-5	Vitiligo	
KIRP	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.58	-11.39	9.74E-25	Crohn's disease	
KIRP	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.36	6.19	2.26E-9	Height	
KIRP	cis	1	rs6429082	chr1:235600129	B3GALNT2	chr1:235610533-235667781:-	0.23	4.27	2.77E-5	Adiposity	
KIRP	cis	1	rs6429082	chr1:235600129	TBCE	chr1:235530728-235612280:+	0.2	4.02	7.63E-5	Adiposity	
KIRP	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-1.01	-20.59	6.27E-57	Homocysteine levels	
KIRP	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.8	-14.43	3.16E-35	Homocysteine levels	
KIRP	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.35	5.32	2.22E-7	Body mass index	
KIRP	cis	1	rs6429582	chr1:46321843	MUTYH	chr1:45794915-45806142:-	-0.17	-4.03	7.38E-5	Body mass index	
KIRP	cis	1	rs6436741	chr2:228714598	WDR69	chr2:228736327-228789026:+	0.3	4.42	1.41E-5	Blood pressure	
KIRP	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.35	6.44	5.47E-10	Height	
KIRP	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.28	4.34	2.07E-5	Height	
KIRP	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.29	-4.57	7.63E-6	Bone mineral density	
KIRP	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	5.76	2.3E-8	Longevity	
KIRP	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.26	-5.89	1.14E-8	Longevity	
KIRP	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.26	-5.94	9.16E-9	Longevity	
KIRP	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.25	-5.42	1.37E-7	Longevity	
KIRP	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.25	-5.41	1.38E-7	Longevity	
KIRP	cis	1	rs6445358	chr3:52308845	GNL3	chr3:52719936-52728508:+	-0.25	-4.71	4.02E-6	Electroencephalogram traits	
KIRP	cis	1	rs6446262	chr3:49401153	NCKIPSD	chr3:48711280-48723334:-	0.32	4.13	4.8E-5	Menarche (age at onset)	
KIRP	cis	1	rs6446262	chr3:49401153	P4HTM	chr3:49027341-49044579:+	0.25	4.2	3.71E-5	Menarche (age at onset)	
KIRP	cis	1	rs6446275	chr3:49466871	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.22	3.43E-5	Menarche (age at onset)	
KIRP	cis	1	rs6446275	chr3:49466871	P4HTM	chr3:49027341-49044579:+	-0.24	-4.33	2.11E-5	Menarche (age at onset)	
KIRP	cis	1	rs6447634	chr4:48413511	CNGA1	chr4:47937996-48018610:-	0.24	3.87	0.000138	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.79	10.64	3.01E-22	Type 2 diabetes	
KIRP	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.65	8.96	5.86E-17	Type 2 diabetes	
KIRP	cis	1	rs6453278	chr5:76417042	LOC728723	chr5:76382623-76444175:+	0.31	4.87	1.91E-6	Autism	
KIRP	cis	1	rs6453279	chr5:76417074	LOC728723	chr5:76382623-76444175:+	-0.34	-5.24	3.26E-7	Autism	
KIRP	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.54	8.59	7.38E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.18	4.91	1.57E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.29	-4.59	6.88E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.28	-4.01	7.92E-5	Diabetic kidney disease	
KIRP	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.28	-4.01	7.92E-5	Diabetic kidney disease	
KIRP	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.3	5.17	4.51E-7	Obesity-related traits	
KIRP	cis	1	rs6464573	chr7:143748098	OR2A9P	chr7:143991573-143997832:+;chr7	0.31	5.8	1.92E-8	Obesity-related traits	
KIRP	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.28	-4.49	1.05E-5	Obesity-related traits	
KIRP	cis	1	rs6464574	chr7:143748257	OR2A7	chr7:143955790-143974852:-	0.28	4	8.32E-5	Obesity-related traits	
KIRP	cis	1	rs6464574	chr7:143748257	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5	1.04E-6	Obesity-related traits	
KIRP	cis	1	rs646776	chr1:109818530	PSRC1	chr1:109822179-109825808:-	-0.37	-6.32	1.13E-9	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
KIRP	cis	1	rs6468131	chr8:29981020	MBOAT4	chr8:29989188-30002200:-	-0.37	-4.05	6.66E-5	Migraine	
KIRP	cis	1	rs6474359	chr8:41549194	SLC20A2	chr8:42273995-42397068:-	-0.46	-3.95	0.0001	Glycated hemoglobin levels	
KIRP	cis	1	rs6477998	chr9:115997249	CDC26	chr9:116029290-116037869:-	0.41	6.46	4.95E-10	Hematology traits	
KIRP	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.41	-6.12	3.36E-9	Rheumatoid arthritis	
KIRP	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.41	-5.95	8.39E-9	Rheumatoid arthritis	
KIRP	cis	1	rs6478867	chr9:131903923	PPP2R4	chr9:131873244-131911223:+	-0.29	-4.47	1.18E-5	Blood metabolite ratios	
KIRP	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.33	-4.68	4.64E-6	Forced vital capacity	
KIRP	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.43	6.41	6.45E-10	Forced vital capacity	
KIRP	cis	1	rs6485784	chr11:47832260	NUP160	chr11:47799671-47870057:-	-0.22	-3.88	0.000133	Intraocular pressure	
KIRP	cis	1	rs6487679	chr12:9371332	LOC642846	chr12:9436253-9466684:+	0.27	3.9	0.000121	Non-alcoholic fatty liver disease histology (AST)	
KIRP	cis	1	rs6494521	chr15:65739928	DPP8	chr15:65737999-65810035:-	-0.13	-4.83	2.34E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs6494528	chr15:65865632	DPP8	chr15:65737999-65810035:-	-0.13	-4.73	3.69E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs6494529	chr15:65902922	DPP8	chr15:65737999-65810035:-	-0.13	-4.79	2.78E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs6494532	chr15:65975798	DPP8	chr15:65737999-65810035:-	-0.12	-4.56	7.66E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs6494537	chr15:66051345	DPP8	chr15:65737999-65810035:-	-0.12	-4.55	8.29E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.76	-11.94	1.41E-26	Type 2 diabetes	
KIRP	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.55	-10.33	3.11E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs6504168	chr17:61697469	FTSJ3	chr17:61896795-61905031:-	0.31	4.16	4.38E-5	Body mass index	
KIRP	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.31	4.43	1.37E-5	Body mass index	
KIRP	cis	1	rs6504170	chr17:61709168	FTSJ3	chr17:61896795-61905031:-	0.3	4.24	3.06E-5	Body mass index	
KIRP	cis	1	rs6504171	chr17:61710010	FTSJ3	chr17:61896795-61905031:-	0.28	3.92	0.000112	Body mass index	
KIRP	cis	1	rs6504171	chr17:61710010	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.32	2.23E-5	Body mass index	
KIRP	cis	1	rs6504173	chr17:61735056	FTSJ3	chr17:61896795-61905031:-	0.29	4.02	7.65E-5	Body mass index	
KIRP	cis	1	rs6504173	chr17:61735056	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.39	1.61E-5	Body mass index	
KIRP	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.29	4.13	4.93E-5	Body mass index	
KIRP	cis	1	rs6504542	chr17:65836642	LOC440461	chr17:66194801-66196436:+	0.29	3.88	0.00013	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504543	chr17:65837659	LOC440461	chr17:66194801-66196436:+	0.29	3.95	0.000101	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504548	chr17:65886048	C17orf58	chr17:65987218-65989765:-	0.25	3.84	0.000153	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504548	chr17:65886048	LOC440461	chr17:66194801-66196436:+	0.3	4.12	5.13E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504549	chr17:65888784	C17orf58	chr17:65987218-65989765:-	0.25	3.85	0.000151	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504549	chr17:65888784	LOC440461	chr17:66194801-66196436:+	0.3	4.08	6.07E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504555	chr17:65940727	C17orf58	chr17:65987218-65989765:-	-0.26	-3.93	0.000107	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6504555	chr17:65940727	LOC440461	chr17:66194801-66196436:+	-0.31	-4.23	3.2E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs6510348	chr19:33601946	RHPN2	chr19:33469499-33555824:-	-0.23	-3.9	0.000122	Bone properties (heel)	
KIRP	cis	1	rs6515651	chr20:25414539	ENTPD6	chr20:25176339-25207360:+	0.36	6.34	9.87E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6515651	chr20:25414539	FAM182B	chr20:25744102-25848786:-	-0.31	-4.32	2.25E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs6518986	chr22:22185347	TOP3B	chr22:22311404-22337193:-	-0.18	-4.07	6.17E-5	Multiple sclerosis	
KIRP	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.44	-6.59	2.41E-10	Longevity	
KIRP	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.12	-4.29	2.49E-5	Tuberculosis	
KIRP	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.47	8.29	5.75E-15	Tuberculosis	
KIRP	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.38	5.05	8.37E-7	Metabolite levels	
KIRP	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.32	4.18	4.01E-5	Metabolite levels	
KIRP	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.38	5.03	9.15E-7	Metabolite levels	
KIRP	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.38	5.04	8.57E-7	Metabolite levels	
KIRP	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.38	5.03	9.15E-7	Metabolite levels	
KIRP	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.35	-5.9	1.13E-8	Body mass index	
KIRP	cis	1	rs6554286	chr4:56400304	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.44	1.3E-5	Personality dimensions	
KIRP	cis	1	rs6563380	chr13:36770422	SOHLH2	chr13:36742347-36871992:-	0.47	6.27	1.44E-9	Glucose homeostasis traits	
KIRP	cis	1	rs6563943	chr16:83639335	SLC38A8	chr16:84043389-84075762:-	-0.23	-4.2	3.64E-5	Height	
KIRP	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.58	-11.44	6.79E-25	Crohn's disease	
KIRP	cis	1	rs6570043	chr6:136134098	C6orf217	chr6:135818939-136037192:+	-0.28	-5.13	5.68E-7	Phosphorus levels	
KIRP	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.47	-5.63	4.6E-8	Cholesterol, total	
KIRP	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.56	5.56	6.7E-8	Crohn's disease	
KIRP	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.56	5.56	6.7E-8	Crohn's disease	
KIRP	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.45	4.54	8.7E-6	Crohn's disease	
KIRP	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.36	4.56	7.69E-6	Multiple sclerosis	
KIRP	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.31	-6.08	4.12E-9	Multiple sclerosis	
KIRP	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.16	-3.82	0.000166	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs6593585	chr1:76140273	ACADM	chr1:76190043-76229353:+	0.22	5.24	3.33E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs6594480	chr5:110173859	TMEM232	chr5:109624934-110062381:-	0.32	4.5	1.03E-5	Asthma and hay fever	
KIRP	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.94	13.5	5.88E-32	Diastolic blood pressure	
KIRP	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.91	-13.51	5.49E-32	Diastolic blood pressure	
KIRP	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.88	-12.97	4.06E-30	Diastolic blood pressure	
KIRP	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.94	14.2	2.07E-34	Diastolic blood pressure	
KIRP	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.94	14.2	2.07E-34	Diastolic blood pressure	
KIRP	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.29	4.25	3.02E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs6603003	chr15:84565602	LOC388152	chr15:84867600-84898920:-	-0.24	-3.97	9.24E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs6603004	chr15:84568504	LOC388152	chr15:84867600-84898920:-	0.24	4.03	7.32E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs662099	chr15:65726693	DPP8	chr15:65737999-65810035:-	-0.13	-4.75	3.35E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs66492340	chr20:14362996	FLRT3	chr20:14304643-14318270:-	-0.26	-4.06	6.54E-5	Mean platelet volume	
KIRP	cis	1	rs6650153	chr10:5019320	AKR1C2	chr10:4964715-5060207:-	0.84	7.61	4.81E-13	Height	
KIRP	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.93	9.2E-9	Body mass index	
KIRP	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.39	-6	6.62E-9	Body mass index	
KIRP	cis	1	rs6661910	chr1:46290632	MUTYH	chr1:45794915-45806142:-	0.17	3.98	8.8E-5	Body mass index	
KIRP	cis	1	rs66624122	chr10:4981039	AKR1C2	chr10:4964715-5060207:-	0.89	8.25	7.58E-15	Height	
KIRP	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.32	1.13E-9	Body mass index	
KIRP	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-1.01	-20.74	1.96E-57	Homocysteine levels	
KIRP	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.04	5.15E-9	Body mass index	
KIRP	cis	1	rs6668284	chr1:46354510	MUTYH	chr1:45794915-45806142:-	0.17	3.98	9.08E-5	Body mass index	
KIRP	cis	1	rs6669236	chr1:227813909	JMJD4	chr1:227918891-227923112:-	0.21	3.99	8.68E-5	Height	
KIRP	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.34	9.87E-10	Body mass index	
KIRP	cis	1	rs6672180	chr1:76123973	ACADM	chr1:76190043-76229353:+	0.22	5.17	4.53E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs6672267	chr1:12054911	MFN2	chr1:12040238-12073571:+	-0.23	-4.02	7.58E-5	Platelet count	
KIRP	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs6672898	chr1:46290588	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs66738981	chr17:45325538	LOC100272146	chr17:45500843-45504056:+	-0.2	-4.52	9.26E-6	Body mass index	
KIRP	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.99	6.8E-9	Body mass index	
KIRP	cis	1	rs6675946	chr1:46371774	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000145	Body mass index	
KIRP	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.3	1.27E-9	Body mass index	
KIRP	cis	1	rs66775662	chr6:151876216	C6orf97	chr6:151815175-151942327:+	0.55	4.83	2.28E-6	Bone mineral density (spine)	
KIRP	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.48	5.27	2.8E-7	Diastolic blood pressure;Blood pressure	
KIRP	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs6680380	chr1:46300189	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs66885174	chr10:4975650	AKR1C2	chr10:4964715-5060207:-	0.95	8.25	7.66E-15	Height	
KIRP	cis	1	rs6689375	chr1:227721627	JMJD4	chr1:227918891-227923112:-	0.22	4.17	4.11E-5	Height	
KIRP	cis	1	rs6692376	chr1:227716069	JMJD4	chr1:227918891-227923112:-	0.21	4.12	5.14E-5	Height	
KIRP	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.04	5.08E-9	Body mass index	
KIRP	cis	1	rs6695809	chr1:46285461	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000145	Body mass index	
KIRP	cis	1	rs6696239	chr1:227750068	JMJD4	chr1:227918891-227923112:-	0.23	4.23	3.29E-5	Height	
KIRP	cis	1	rs6698409	chr1:227768358	JMJD4	chr1:227918891-227923112:-	0.23	4.29	2.47E-5	Height	
KIRP	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.37	-6.32	1.08E-9	Height	
KIRP	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.44E-9	Body mass index	
KIRP	cis	1	rs6700597	chr1:46284246	MUTYH	chr1:45794915-45806142:-	0.16	3.87	0.000139	Body mass index	
KIRP	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs6701614	chr1:46309420	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs6702653	chr1:227703919	JMJD4	chr1:227918891-227923112:-	0.21	4.2	3.66E-5	Height	
KIRP	cis	1	rs6704784	chr2:192109558	MYO1B	chr2:192110107-192290115:+	0.33	5.36	1.86E-7	Obesity-related traits	
KIRP	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.33	4.4	1.57E-5	Metabolite levels	
KIRP	cis	1	rs67059283	chr10:79683235	DLG5	chr10:79550551-79686348:-	0.27	4.53	8.86E-6	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.39	6.19	2.34E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
KIRP	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.34	4.83	2.31E-6	Idiopathic membranous nephropathy	
KIRP	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.37	4.95	1.31E-6	Metabolite levels	
KIRP	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.36	-6.13	3.17E-9	Body mass index	
KIRP	cis	1	rs67080286	chr17:45322248	LOC100272146	chr17:45500843-45504056:+	-0.18	-4.17	4.17E-5	Body mass index	
KIRP	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.19	-3.85	0.000151	Venous thromboembolism (SNP x SNP interaction)	
KIRP	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.5	-8.12	1.79E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.32	-5.34	1.98E-7	Body mass index	
KIRP	cis	1	rs6711012	chr2:624034	SNTG2	chr2:946555-1371382:+	-0.42	-4.05	6.76E-5	Body mass index	
KIRP	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.3	3.97	9.15E-5	Metabolite levels	
KIRP	cis	1	rs6711039	chr2:624084	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000139	Body mass index	
KIRP	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.71	-6.4	6.99E-10	Rheumatoid arthritis	
KIRP	cis	1	rs6711254	chr2:624210	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000139	Body mass index	
KIRP	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.61	-6.45	5.24E-10	Rheumatoid arthritis	
KIRP	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.46	-5.48	9.88E-8	Rheumatoid arthritis	
KIRP	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.71	-6.4	6.99E-10	Rheumatoid arthritis	
KIRP	cis	1	rs6717005	chr2:621910	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000137	Body mass index	
KIRP	cis	1	rs6719518	chr2:623935	SNTG2	chr2:946555-1371382:+	0.41	3.87	0.000137	Body mass index	
KIRP	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.33	4.5	1.01E-5	Idiopathic membranous nephropathy	
KIRP	cis	1	rs6719883	chr2:651482	SNTG2	chr2:946555-1371382:+	0.39	4.04	6.98E-5	Body mass index	
KIRP	cis	1	rs6719980	chr2:651507	SNTG2	chr2:946555-1371382:+	0.39	4.04	6.98E-5	Body mass index	
KIRP	cis	1	rs67212247	chr5:116535428	SEMA6A	chr5:115779252-115910551:-	-0.41	-4.04	7.01E-5	Periodontitis (DPAL)	
KIRP	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.3	-5.07	7.31E-7	Obesity-related traits	
KIRP	cis	1	rs67239267	chr7:143745116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.7	3.27E-8	Obesity-related traits	
KIRP	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.51	8.04	3.02E-14	Urinary metabolites	
KIRP	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.38	5.03	9.15E-7	Metabolite levels	
KIRP	cis	1	rs6728726	chr2:623976	SNTG2	chr2:946555-1371382:+	-0.4	-3.81	0.000173	Body mass index	
KIRP	cis	1	rs6730157	chr2:135907088	TMEM163	chr2:135213331-135525334:-	0.34	5.56	6.44E-8	Body mass index;Blood metabolite levels;Cholesterol, total	
KIRP	cis	1	rs6731348	chr2:630339	SNTG2	chr2:946555-1371382:+	-0.42	-4.19	3.75E-5	Body mass index	
KIRP	cis	1	rs6731688	chr2:630662	SNTG2	chr2:946555-1371382:+	-0.4	-3.83	0.000158	Body mass index	
KIRP	cis	1	rs6734363	chr2:635200	SNTG2	chr2:946555-1371382:+	-0.42	-4.02	7.74E-5	Body mass index	
KIRP	cis	1	rs6735024	chr2:630509	SNTG2	chr2:946555-1371382:+	-0.42	-3.97	9.4E-5	Body mass index	
KIRP	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.32	3.94	0.000104	Metabolite levels	
KIRP	cis	1	rs6738964	chr2:228739135	WDR69	chr2:228736327-228789026:+	0.3	4.76	3.13E-6	Blood pressure	
KIRP	cis	1	rs6739303	chr2:628749	SNTG2	chr2:946555-1371382:+	-0.39	-3.86	0.000145	Body mass index	
KIRP	cis	1	rs67401267	chr22:30750209	MTP18	chr22:30805176-30825041:+	0.37	3.81	0.000173	Coronary artery calcification	
KIRP	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.38	5.12	5.76E-7	Metabolite levels	
KIRP	cis	1	rs6741269	chr2:239179418	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.29E-6	Irritable bowel syndrome	
KIRP	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.12	-4.02	7.58E-5	Tuberculosis	
KIRP	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.42	7.25	4.63E-12	Tuberculosis	
KIRP	cis	1	rs6743060	chr2:629510	SNTG2	chr2:946555-1371382:+	-0.42	-3.97	9.4E-5	Body mass index	
KIRP	cis	1	rs6744308	chr2:228711816	WDR69	chr2:228736327-228789026:+	0.3	4.56	7.83E-6	Blood pressure	
KIRP	cis	1	rs67445790	chr6:151876730	C6orf97	chr6:151815175-151942327:+	0.54	4.76	3.14E-6	Bone mineral density (spine)	
KIRP	cis	1	rs6744646	chr2:628504	SNTG2	chr2:946555-1371382:+	-0.41	-4.17	4.16E-5	Body mass index	
KIRP	cis	1	rs6744653	chr2:628524	SNTG2	chr2:946555-1371382:+	-0.41	-4.17	4.16E-5	Body mass index	
KIRP	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.29	3.81	0.000171	Metabolite levels	
KIRP	cis	1	rs6746275	chr2:635857	SNTG2	chr2:946555-1371382:+	-0.42	-3.95	9.87E-5	Body mass index	
KIRP	cis	1	rs67466576	chr10:4977394	AKR1C2	chr10:4964715-5060207:-	0.88	8.2	1.05E-14	Height	
KIRP	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.47	7.44	1.42E-12	Urinary metabolites	
KIRP	cis	1	rs6748821	chr2:629601	SNTG2	chr2:946555-1371382:+	-0.42	-3.97	9.4E-5	Body mass index	
KIRP	cis	1	rs6749232	chr2:192115052	MYO1B	chr2:192110107-192290115:+	0.32	5.37	1.71E-7	Obesity-related traits	
KIRP	cis	1	rs6749375	chr2:636017	SNTG2	chr2:946555-1371382:+	-0.43	-4.05	6.85E-5	Body mass index	
KIRP	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.44	6.25	1.64E-9	Urinary metabolites	
KIRP	cis	1	rs6751993	chr2:635864	SNTG2	chr2:946555-1371382:+	-0.42	-3.95	9.87E-5	Body mass index	
KIRP	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.33	-4.37	1.78E-5	Metabolite levels	
KIRP	cis	1	rs67544533	chr15:75361539	MAN2C1	chr15:75648135-75660941:-	0.25	4.65	5.22E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.34	5.1	6.37E-7	Blood trace element (Zn levels)	
KIRP	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.35	4.4	1.54E-5	Metabolite levels	
KIRP	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.33	4.3	2.42E-5	Metabolite levels	
KIRP	cis	1	rs6755502	chr2:635721	SNTG2	chr2:946555-1371382:+	-0.41	-3.91	0.000119	Body mass index	
KIRP	cis	1	rs6756518	chr2:651483	SNTG2	chr2:946555-1371382:+	0.39	4.04	6.98E-5	Body mass index	
KIRP	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.35	4.59	6.84E-6	Metabolite levels	
KIRP	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.79	-9.98	4.04E-20	Triptolide cytotoxicity	
KIRP	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.33	4.55	8.29E-6	Idiopathic membranous nephropathy	
KIRP	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.33	4.54	8.45E-6	Idiopathic membranous nephropathy	
KIRP	cis	1	rs6760274	chr2:652272	SNTG2	chr2:946555-1371382:+	0.41	4.01	7.95E-5	Body mass index	
KIRP	cis	1	rs6760543	chr2:622388	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000137	Body mass index	
KIRP	cis	1	rs6761514	chr2:202227549	ALS2CR12	chr2:202153148-202222101:-	-0.26	-4.24	3.05E-5	Basal cell carcinoma	
KIRP	cis	1	rs67615769	chr17:45325478	LOC100272146	chr17:45500843-45504056:+	-0.2	-4.52	9.26E-6	Body mass index	
KIRP	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.89	1.14E-8	Height	
KIRP	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.82E-6	Height	
KIRP	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs67640320	chr14:52511596	NID2	chr14:52471521-52535946:-	-0.32	-4.91	1.62E-6	Pulmonary function	
KIRP	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.34	6.38	7.98E-10	Height	
KIRP	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.28	4.4	1.56E-5	Height	
KIRP	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.34	6.29	1.29E-9	Height	
KIRP	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.29	4.41	1.49E-5	Height	
KIRP	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.34	5.89	1.17E-8	Height	
KIRP	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.35	5.22	3.62E-7	Height	
KIRP	cis	1	rs6768080	chr3:135536448	MSL2	chr3:135867760-135914688:-	0.28	3.92	0.000112	Anticoagulant levels	
KIRP	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.93	12.5	1.69E-28	Diastolic blood pressure	
KIRP	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.93	12.5	1.69E-28	Diastolic blood pressure	
KIRP	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.96	12.75	2.41E-29	Diastolic blood pressure	
KIRP	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.34	6.25	1.6E-9	Height	
KIRP	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.29	4.48	1.11E-5	Height	
KIRP	cis	1	rs6770152	chr3:53100214	SFMBT1	chr3:52938628-53080070:-	-0.37	-5.98	7.35E-9	Ulcerative colitis	
KIRP	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.27	-5.88	1.24E-8	Longevity	
KIRP	cis	1	rs6770670	chr3:49686682	RBM6	chr3:49977592-50137484:+	0.15	4.42	1.46E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs6770670	chr3:49686682	UBA7	chr3:49842639-49851391:-	0.35	6.21	2.02E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs6772046	chr3:38479660	EXOG	chr3:38537763-38567796:+	-0.18	-4.35	1.98E-5	Electrocardiographic conduction measures	
KIRP	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.34	6.11	3.49E-9	Height	
KIRP	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.32	4.88	1.81E-6	Height	
KIRP	cis	1	rs6774724	chr3:49381911	NCKIPSD	chr3:48711280-48723334:-	0.33	4.42	1.44E-5	Menarche (age at onset)	
KIRP	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.43	5.42	1.31E-7	Inflammatory skin disease	
KIRP	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.24	-5.21	3.88E-7	Longevity	
KIRP	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.38	-5.54	7.42E-8	Schizophrenia (negative symptoms)	
KIRP	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.92	13.25	4.18E-31	Diastolic blood pressure	
KIRP	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.51	8.42E-8	Height	
KIRP	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.31	-4.67	4.75E-6	Height	
KIRP	cis	1	rs678292	chr10:105957561	C10orf79	chr10:105889647-105992120:-	0.21	4.92	1.54E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.94	14.19	2.14E-34	Diastolic blood pressure	
KIRP	cis	1	rs6783003	chr3:49524778	NCKIPSD	chr3:48711280-48723334:-	-0.29	-3.85	0.000151	Menarche (age at onset)	
KIRP	cis	1	rs6783003	chr3:49524778	P4HTM	chr3:49027341-49044579:+	-0.24	-4.08	5.96E-5	Menarche (age at onset)	
KIRP	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.26	-5.71	3.1E-8	Longevity	
KIRP	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.35	-6.56	2.87E-10	Height	
KIRP	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.29	-4.59	6.72E-6	Height	
KIRP	cis	1	rs6785045	chr3:49435243	NCKIPSD	chr3:48711280-48723334:-	-0.33	-4.54	8.4E-6	Menarche (age at onset)	
KIRP	cis	1	rs6785045	chr3:49435243	P4HTM	chr3:49027341-49044579:+	-0.25	-4.41	1.49E-5	Menarche (age at onset)	
KIRP	cis	1	rs67865942	chr8:89596642	MMP16	chr8:89049462-89339717:-	0.31	4.45	1.24E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.31E-10	Height	
KIRP	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.28	4.35	1.91E-5	Height	
KIRP	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.28	-4.39	1.61E-5	Bone mineral density	
KIRP	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.89	10.7	1.99E-22	Diastolic blood pressure	
KIRP	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.35	6.18	2.37E-9	Height	
KIRP	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.33	4.92	1.52E-6	Height	
KIRP	cis	1	rs6790637	chr3:56438617	SPATA12	chr3:57094469-57109460:+	0.23	4.01	7.8E-5	Night sleep phenotypes	
KIRP	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.94	14.11	4.23E-34	Diastolic blood pressure	
KIRP	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.42	7.17	7.54E-12	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.51	8.42E-8	Height	
KIRP	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.31	-4.67	4.75E-6	Height	
KIRP	cis	1	rs6794457	chr3:124703693	HEG1	chr3:124684555-124774802:-	0.21	4.1	5.59E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.26	-5.51	8.63E-8	Longevity	
KIRP	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.94	14.2	2.07E-34	Diastolic blood pressure	
KIRP	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs68005215	chr10:4977435	AKR1C2	chr10:4964715-5060207:-	0.88	8.18	1.21E-14	Height	
KIRP	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.34	6.38	7.73E-10	Height	
KIRP	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.76E-5	Height	
KIRP	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.96	13.71	1.08E-32	Diastolic blood pressure	
KIRP	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.34	6.19	2.34E-9	Height	
KIRP	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.29	4.49	1.07E-5	Height	
KIRP	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.94	14.12	3.78E-34	Diastolic blood pressure	
KIRP	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.94	14.12	3.78E-34	Diastolic blood pressure	
KIRP	cis	1	rs6804655	chr3:49738945	UBA7	chr3:49842639-49851391:-	-0.3	-5.48	1.0E-7	Resting heart rate	
KIRP	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs6805609	chr3:49471522	TREX1	chr3:48501186-48509043:+	0.2	3.85	0.000146	Menarche (age at onset)	
KIRP	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.93	12.5	1.69E-28	Diastolic blood pressure	
KIRP	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.35	-6.62	2.02E-10	Height	
KIRP	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.27	-4.19	3.75E-5	Height	
KIRP	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.27	-5.88	1.24E-8	Longevity	
KIRP	cis	1	rs6811520	chr4:56315178	SRD5A3	chr4:56212409-56237866:+	0.3	4.67	4.77E-6	Personality dimensions	
KIRP	cis	1	rs6812042	chr4:56396079	SRD5A3	chr4:56212409-56237866:+	0.31	4.91	1.62E-6	Personality dimensions	
KIRP	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.54	-7.86	9.7E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs6819660	chr4:56374577	SRD5A3	chr4:56212409-56237866:+	0.31	5	1.04E-6	Personality dimensions	
KIRP	cis	1	rs6819660	chr4:56374577	TMEM165	chr4:56262090-56292342:+	-0.25	-3.96	9.73E-5	Personality dimensions	
KIRP	cis	1	rs6824057	chr4:56367278	SRD5A3	chr4:56212409-56237866:+	0.3	4.66	5.05E-6	Personality dimensions	
KIRP	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.44	-6.59	2.41E-10	Longevity	
KIRP	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.37	-5.37	1.73E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs6832503	chr4:48028442	NIPAL1	chr4:48018791-48039078:+	-0.3	-5.52	8.16E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs6832769	chr4:56298194	SRD5A3	chr4:56212409-56237866:+	0.26	4.23	3.21E-5	Personality dimensions	
KIRP	cis	1	rs6834676	chr4:56298414	SRD5A3	chr4:56212409-56237866:+	0.29	4.63	5.65E-6	Personality dimensions	
KIRP	cis	1	rs6837710	chr4:56374455	SRD5A3	chr4:56212409-56237866:+	0.3	4.68	4.54E-6	Personality dimensions	
KIRP	cis	1	rs6848395	chr4:48394593	CNGA1	chr4:47937996-48018610:-	-0.25	-3.98	8.73E-5	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs6851838	chr4:56420747	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.92	1.52E-6	Personality dimensions	
KIRP	cis	1	rs6851838	chr4:56420747	TMEM165	chr4:56262090-56292342:+	0.25	3.97	9.11E-5	Personality dimensions	
KIRP	cis	1	rs6852678	chr4:76542749	CDKL2	chr4:76501705-76555721:-	-0.28	-3.99	8.66E-5	Magnesium levels	
KIRP	cis	1	rs6853192	chr4:56409254	SRD5A3	chr4:56212409-56237866:+	-0.31	-5	1.04E-6	Personality dimensions	
KIRP	cis	1	rs6853192	chr4:56409254	TMEM165	chr4:56262090-56292342:+	0.25	3.99	8.51E-5	Personality dimensions	
KIRP	cis	1	rs6860540	chr5:156938327	NIPAL4	chr5:156887027-156901729:+	-0.32	-5.19	4.19E-7	Inflammatory skin disease	
KIRP	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.56	5.77	2.23E-8	Crohn's disease	
KIRP	cis	1	rs686441	chr10:105950233	C10orf79	chr10:105889647-105992120:-	0.21	4.92	1.54E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.82	6.49	4.25E-10	Crohn's disease	
KIRP	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.78	6.82	6.17E-11	Crohn's disease	
KIRP	cis	1	rs687557	chr10:105989509	C10orf79	chr10:105889647-105992120:-	0.22	5.31	2.3E-7	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.58	11.35	1.33E-24	Crohn's disease	
KIRP	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.8	10.89	4.44E-23	Type 2 diabetes	
KIRP	cis	1	rs6904133	chr6:151881805	C6orf97	chr6:151815175-151942327:+	0.49	4.4	1.58E-5	Bone mineral density (spine)	
KIRP	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.55	-8.6	6.93E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.3	-4.54	8.46E-6	Homocysteine levels	
KIRP	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.25	-3.85	0.000149	Homocysteine levels	
KIRP	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.18	5.07	7.4E-7	Folate pathway vitamin levels	
KIRP	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.54	8.47	1.67E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.46	5.52	7.88E-8	Diabetic kidney disease	
KIRP	cis	1	rs6928	chr22:22115004	TOP3B	chr22:22311404-22337193:-	-0.18	-4.08	5.98E-5	Multiple sclerosis	
KIRP	cis	1	rs6930076	chr6:88088654	C6orf162	chr6:88032306-88052043:+	-0.28	-4.19	3.85E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.41	6.35	9.26E-10	Response to antipsychotic treatment	
KIRP	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.5	-7.41	1.75E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.58	-11.39	9.74E-25	Crohn's disease	
KIRP	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.48	-7.12	1.04E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs694609	chr13:28194806	POLR1D	chr13:28194895-28241547:+	-0.24	-4.52	9.18E-6	Large B-cell lymphoma	
KIRP	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.59	-11.35	1.31E-24	Crohn's disease	
KIRP	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.32	3.91	0.000115	Crohn's disease	
KIRP	cis	1	rs6950776	chr7:116913823	CFTR	chr7:117120017-117308716:+	0.28	4.01	7.88E-5	Dupuytren's disease	
KIRP	cis	1	rs6951125	chr7:116914043	CFTR	chr7:117120017-117308716:+	-0.28	-4	8.08E-5	Dupuytren's disease	
KIRP	cis	1	rs6951245	chr7:1058193	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.74	3.5E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.27	-4.07	6.32E-5	Interstitial lung disease	
KIRP	cis	1	rs7000361	chr8:121018318	MRPL13	chr8:121408084-121457647:-	0.26	3.81	0.00017	HIV-1 viral setpoint	
KIRP	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	1.02	21.96	1.39E-61	Bone mineral density	
KIRP	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	1.02	21.91	2.01E-61	Bone mineral density	
KIRP	cis	1	rs7018	chr20:25278261	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.09	3.85E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7018	chr20:25278261	FAM182B	chr20:25744102-25848786:-	0.3	4.17	4.14E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7019	chr20:25278278	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.08	4.28E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7019	chr20:25278278	FAM182B	chr20:25744102-25848786:-	0.28	3.86	0.000144	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7020	chr20:25278600	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.1	3.7E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7020	chr20:25278600	FAM182B	chr20:25744102-25848786:-	0.3	4.2	3.72E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7021449	chr9:131899312	PPP2R4	chr9:131873244-131911223:+	0.28	4.32	2.25E-5	Blood metabolite ratios	
KIRP	cis	1	rs7021663	chr9:136676014	C9orf96	chr9:136243284-136271219:+	-0.28	-3.9	0.000124	IgG glycosylation	
KIRP	cis	1	rs7021946	chr9:136676275	C9orf96	chr9:136243284-136271219:+	0.3	4.07	6.3E-5	IgG glycosylation	
KIRP	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.39	-6.27	1.48E-9	Hematology traits	
KIRP	cis	1	rs7023900	chr9:131891152	PPP2R4	chr9:131873244-131911223:+	0.27	4.1	5.44E-5	Blood metabolite ratios	
KIRP	cis	1	rs7036114	chr9:131893406	PPP2R4	chr9:131873244-131911223:+	0.26	4.06	6.5E-5	Blood metabolite ratios	
KIRP	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.41	-5.98	7.31E-9	Rheumatoid arthritis	
KIRP	cis	1	rs7037163	chr9:131894340	PPP2R4	chr9:131873244-131911223:+	0.27	3.99	8.66E-5	Blood metabolite ratios	
KIRP	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.37	-4.71	4.07E-6	Multiple sclerosis	
KIRP	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.29	5.49	9.2E-8	Multiple sclerosis	
KIRP	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.39	-6.27	1.48E-9	Hematology traits	
KIRP	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.54	7.68	3.08E-13	Cognitive function	
KIRP	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.18	-4.12	5.15E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.22	-4.87	1.91E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.69	13.05	2.21E-30	Metabolite levels	
KIRP	cis	1	rs7078003	chr10:99359412	C10orf62	chr10:99349484-99350690:+	-0.42	-4.87	1.95E-6	Metabolite levels (small molecules and protein measures)	
KIRP	cis	1	rs7078012	chr10:81705433	LOC283050	chr10:80703084-80828536:-	-0.29	-4.45	1.28E-5	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.17	-3.98	9.0E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.19	-4.29	2.53E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.17	-4.02	7.52E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.55	-10.16	1.09E-20	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs7097	chr13:28197436	POLR1D	chr13:28194895-28241547:+	0.24	4.54	8.4E-6	Large B-cell lymphoma	
KIRP	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.54	-7.26	4.43E-12	Subjective well-being	
KIRP	cis	1	rs7105282	chr11:47805614	PSMC3	chr11:47440320-47448024:-	0.2	4.04	7.11E-5	Subjective well-being	
KIRP	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.18	-3.87	0.000136	Brain structure	
KIRP	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.18	-3.87	0.000137	Brain structure	
KIRP	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.75	-11.75	6.33E-26	Type 2 diabetes	
KIRP	cis	1	rs7112513	chr11:117037361	PCSK7	chr11:117075789-117102811:-	-0.38	-4.19	3.78E-5	Protein quantitative trait loci	
KIRP	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.35	-5.01	9.8E-7	Forced vital capacity	
KIRP	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.54	-7.2	6.12E-12	Subjective well-being	
KIRP	cis	1	rs7120333	chr11:47817441	PSMC3	chr11:47440320-47448024:-	0.2	3.92	0.000114	Subjective well-being	
KIRP	cis	1	rs7122944	chr11:117034619	PCSK7	chr11:117075789-117102811:-	-0.42	-4.44	1.3E-5	Protein quantitative trait loci	
KIRP	cis	1	rs7123517	chr11:117027755	PCSK7	chr11:117075789-117102811:-	-0.41	-4.44	1.33E-5	Protein quantitative trait loci	
KIRP	cis	1	rs7132119	chr12:81549675	LIN7A	chr12:81191171-81331694:-	-0.27	-4.11	5.32E-5	Response to antidepressant treatment (citalopram)	
KIRP	cis	1	rs713219	chr9:131900920	PPP2R4	chr9:131873244-131911223:+	0.28	4.32	2.25E-5	Blood metabolite ratios	
KIRP	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.49	4.4	1.56E-5	Metabolite levels (HVA/5-HIAA ratio)	
KIRP	cis	1	rs7133079	chr12:81439523	LIN7A	chr12:81191171-81331694:-	0.26	3.92	0.000112	Neuroticism	
KIRP	cis	1	rs71391092	chr16:74567075	MLKL	chr16:74705753-74734789:-	-0.39	-4.41	1.51E-5	Schizophrenia	
KIRP	cis	1	rs7141087	chr14:101036052	BEGAIN	chr14:101003486-101036131:-	-0.37	-5.34	1.96E-7	Menarche (age at onset)	
KIRP	cis	1	rs7142457	chr14:50097862	RPL36AL	chr14:50085407-50087349:-	0.22	4.25	3.0E-5	Carotid intima media thickness	
KIRP	cis	1	rs71426508	chr2:239137767	LOC151174	chr2:239133754-239140318:-	0.47	3.83	0.000161	Irritable bowel syndrome	
KIRP	cis	1	rs71426509	chr2:239175334	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.29E-6	Irritable bowel syndrome	
KIRP	cis	1	rs71426510	chr2:239178909	LOC151174	chr2:239133754-239140318:-	0.5	4.61	6.29E-6	Irritable bowel syndrome	
KIRP	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.37	4.55	8.11E-6	Atopic dermatitis	
KIRP	cis	1	rs7145588	chr14:88826796	SPATA7	chr14:88852012-88904802:+	-0.26	-3.84	0.000151	Coronary artery calcification	
KIRP	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.21	4.51	9.85E-6	Height	
KIRP	cis	1	rs7147118	chr14:75610170	RPS6KL1	chr14:75372347-75389958:-	0.23	4.13	4.87E-5	Height	
KIRP	cis	1	rs7148538	chr14:74392342	LIN52	chr14:74551656-74667117:+	0.24	3.91	0.000118	Morning vs. evening chronotype	
KIRP	cis	1	rs71526949	chr8:89582882	MMP16	chr8:89049462-89339717:-	0.3	4.14	4.64E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs71526953	chr8:89595818	MMP16	chr8:89049462-89339717:-	0.3	4.22	3.31E-5	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.24	5.29	2.57E-7	Common traits (Other)	
KIRP	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.27	6.16	2.73E-9	Common traits (Other)	
KIRP	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.34	4.35	1.98E-5	Atopic dermatitis	
KIRP	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.39	4.79	2.81E-6	Atopic dermatitis	
KIRP	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.35	-3.97	9.45E-5	Menarche (age at onset)	
KIRP	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.42	-4.54	8.66E-6	Menarche (age at onset)	
KIRP	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.26	-5.97	7.56E-9	Common traits (Other)	
KIRP	cis	1	rs7162129	chr15:84566444	LOC388152	chr15:84867600-84898920:-	-0.24	-3.99	8.55E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs7162900	chr15:75368017	MAN2C1	chr15:75648135-75660941:-	0.25	4.74	3.45E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.33	4.95	1.32E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7163482	chr15:65739683	DPP8	chr15:65737999-65810035:-	-0.13	-4.83	2.34E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.94	11.26	2.8E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs7164132	chr15:40675155	IVD	chr15:40697686-40713512:+	-0.35	-4.25	2.96E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs7165102	chr15:65888359	DPP8	chr15:65737999-65810035:-	-0.13	-4.71	3.92E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs7166453	chr15:66013143	DPP8	chr15:65737999-65810035:-	-0.12	-4.6	6.56E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.94	11.42	7.82E-25	Heschl's gyrus morphology	
KIRP	cis	1	rs7166991	chr15:40671957	IVD	chr15:40697686-40713512:+	-0.34	-4.2	3.58E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs7167285	chr15:75368769	MAN2C1	chr15:75648135-75660941:-	0.25	4.74	3.45E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.33	4.95	1.32E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7168680	chr15:75369212	MAN2C1	chr15:75648135-75660941:-	0.25	4.74	3.45E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.33	4.95	1.32E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.94	11.26	2.8E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs7169404	chr15:40675443	IVD	chr15:40697686-40713512:+	-0.35	-4.25	2.96E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs7170930	chr15:66580853	DIS3L	chr15:66585633-66626235:+	0.44	4.49	1.07E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.23	-4.01	7.89E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRP	cis	1	rs7172335	chr15:65977204	DPP8	chr15:65737999-65810035:-	-0.13	-4.63	5.71E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs7173833	chr15:75369618	MAN2C1	chr15:75648135-75660941:-	0.21	3.95	0.000102	Blood trace element (Zn levels)	
KIRP	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.33	4.92	1.52E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs7175659	chr15:39315897	THBS1	chr15:39873280-39889667:+	0.33	5.44	1.23E-7	Cardiac hypertrophy	
KIRP	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.31	-4.41	1.49E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs717658	chr7:150503637	TMEM176A	chr7:150497854-150502208:+	0.18	3.81	0.000176	Forced expiratory volume in 1 second (environmental interaction)	
KIRP	cis	1	rs7178584	chr15:65795200	DPP8	chr15:65737999-65810035:-	0.13	4.86	1.99E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs7178962	chr15:84573248	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs7181333	chr15:66039826	DPP8	chr15:65737999-65810035:-	0.12	4.52	9.15E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs7183263	chr15:84573041	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs7186128	chr16:16957915	LOC339047	chr16:16422508-16444437:+;chr16	0.19	3.85	0.000149	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	
KIRP	cis	1	rs7186227	chr16:55609568	LPCAT2	chr16:55542913-55620581:+	-0.2	-3.89	0.000125	Thyroid hormone levels	
KIRP	cis	1	rs7186553	chr16:55604471	LPCAT2	chr16:55542913-55620581:+	-0.21	-4.12	5.17E-5	Thyroid hormone levels	
KIRP	cis	1	rs7186721	chr16:55609474	LPCAT2	chr16:55542913-55620581:+	-0.2	-3.89	0.000125	Thyroid hormone levels	
KIRP	cis	1	rs718834	chr9:114844799	DNAJC25	chr9:114393632-114416629:+	-0.24	-3.83	0.000158	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs7189550	chr16:29911260	TBX6	chr16:30097117-30103208:-	-0.21	-4.26	2.87E-5	Response to taxane treatment (placlitaxel)	
KIRP	cis	1	rs7191665	chr16:74688948	MLKL	chr16:74705753-74734789:-	0.33	5.51	8.46E-8	Testicular germ cell tumor	
KIRP	cis	1	rs7193778	chr16:69563890	EXOSC6	chr16:70284134-70285833:-	-0.37	-4.05	6.75E-5	Urate levels	
KIRP	cis	1	rs7201320	chr16:74694058	MLKL	chr16:74705753-74734789:-	0.33	5.59	5.54E-8	Testicular germ cell tumor	
KIRP	cis	1	rs7202229	chr16:75165256	CLEC18B	chr16:74442531-74455649:-	-0.67	-4.45	1.26E-5	Crohn's disease (time to surgery)	
KIRP	cis	1	rs7203315	chr16:10188060	GRIN2A	chr16:9847267-10276611:-	0.57	6.27	1.46E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRP	cis	1	rs7203671	chr16:52630145	AKTIP	chr16:53525193-53537170:-	0.21	3.82	0.000168	Breast cancer	
KIRP	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.38	5.53	7.55E-8	Height	
KIRP	cis	1	rs7208663	chr17:65885171	LOC440461	chr17:66194801-66196436:+	0.3	3.99	8.43E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.5	8.54	1.05E-15	Eye color traits	
KIRP	cis	1	rs7209435	chr17:61712964	FTSJ3	chr17:61896795-61905031:-	0.28	3.92	0.000112	Body mass index	
KIRP	cis	1	rs7209435	chr17:61712964	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.32	2.23E-5	Body mass index	
KIRP	cis	1	rs7209675	chr17:65831258	LOC440461	chr17:66194801-66196436:+	0.3	3.93	0.000108	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7209758	chr17:61913621	FTSJ3	chr17:61896795-61905031:-	0.32	4.66	5.11E-6	Body mass index	
KIRP	cis	1	rs7210027	chr17:65977053	C17orf58	chr17:65987218-65989765:-	-0.24	-3.81	0.000171	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7210027	chr17:65977053	LOC440461	chr17:66194801-66196436:+	-0.29	-4.12	4.98E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7212293	chr17:65847325	LOC440461	chr17:66194801-66196436:+	0.29	4.05	6.86E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.5	8.54	1.05E-15	Eye color traits	
KIRP	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.55	-10.33	3.11E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs7214312	chr17:61870863	FTSJ3	chr17:61896795-61905031:-	0.31	4.44	1.33E-5	Body mass index	
KIRP	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.26	-4.54	8.38E-6	Fibrinogen levels	
KIRP	cis	1	rs7216064	chr17:65898809	LOC440461	chr17:66194801-66196436:+	0.31	3.98	8.88E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs7216798	chr17:61740963	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs7217982	chr17:61832150	FTSJ3	chr17:61896795-61905031:-	0.32	4.51	9.79E-6	Body mass index	
KIRP	cis	1	rs7219014	chr17:37624790	PGAP3	chr17:37827376-37844310:-	-0.28	-4.04	7.14E-5	Urinary metabolites	
KIRP	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.25	-4.4	1.55E-5	Fibrinogen levels	
KIRP	cis	1	rs7220821	chr17:61704147	FTSJ3	chr17:61896795-61905031:-	0.27	3.82	0.000164	Body mass index	
KIRP	cis	1	rs7220821	chr17:61704147	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.32	2.18E-5	Body mass index	
KIRP	cis	1	rs7220892	chr17:61908316	FTSJ3	chr17:61896795-61905031:-	0.32	4.65	5.28E-6	Body mass index	
KIRP	cis	1	rs7221223	chr17:53059007	TOM1L1	chr17:52978052-53039328:+	-0.23	-3.91	0.000116	Breast cancer	
KIRP	cis	1	rs7222060	chr17:61868279	FTSJ3	chr17:61896795-61905031:-	0.31	4.44	1.33E-5	Body mass index	
KIRP	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.5	8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs7223003	chr17:45324293	LOC100272146	chr17:45500843-45504056:+	-0.17	-4.02	7.48E-5	Body mass index	
KIRP	cis	1	rs7223412	chr17:61808172	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.5	-8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.3	4.24	3.07E-5	Body mass index	
KIRP	cis	1	rs7223930	chr17:65842186	LOC440461	chr17:66194801-66196436:+	0.29	3.81	0.000174	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs7223966	chr17:61893398	FTSJ3	chr17:61896795-61905031:-	0.32	4.51	9.84E-6	Body mass index	
KIRP	cis	1	rs7224610	chr17:53364788	HLF	chr17:53342321-53402426:+	0.54	7.42	1.63E-12	Urate levels	
KIRP	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.25	4.49	1.08E-5	Fibrinogen levels	
KIRP	cis	1	rs7225151	chr17:5137047	CHRNE	chr17:4801064-4806369:-	0.29	3.88	0.000131	Alzheimer's disease (late onset)	
KIRP	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.39	-4.04	6.88E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs7251653	chr19:18608283	LRRC25	chr19:18501955-18508421:-	-0.13	-4.26	2.9E-5	Breast cancer	
KIRP	cis	1	rs7251653	chr19:18608283	SSBP4	chr19:18530221-18545371:+	-0.17	-4.56	7.72E-6	Breast cancer	
KIRP	cis	1	rs7252707	chr19:18612257	SSBP4	chr19:18530221-18545371:+	-0.15	-4.25	2.95E-5	Breast cancer	
KIRP	cis	1	rs7252848	chr19:18612351	SSBP4	chr19:18530221-18545371:+	-0.16	-4.35	1.96E-5	Breast cancer	
KIRP	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.26	5.85	1.44E-8	Longevity	
KIRP	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.27	5.94	8.9E-9	Longevity	
KIRP	cis	1	rs7254758	chr19:33608047	RHPN2	chr19:33469499-33555824:-	-0.22	-3.82	0.000168	Bone properties (heel)	
KIRP	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.61	9.79	1.64E-19	Schizophrenia	
KIRP	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.37	-4.03	7.41E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs7258465	chr19:18533642	LRRC25	chr19:18501955-18508421:-	-0.12	-4.14	4.66E-5	Breast cancer	
KIRP	cis	1	rs7258465	chr19:18533642	SSBP4	chr19:18530221-18545371:+	-0.16	-4.3	2.4E-5	Breast cancer	
KIRP	cis	1	rs72627117	chr14:74355233	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627119	chr14:74356274	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627120	chr14:74363480	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627122	chr14:74368236	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627123	chr14:74368331	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627124	chr14:74369128	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627125	chr14:74369623	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627126	chr14:74370024	LIN52	chr14:74551656-74667117:+	0.24	3.91	0.000118	Morning vs. evening chronotype	
KIRP	cis	1	rs72627127	chr14:74370098	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627129	chr14:74374805	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72627130	chr14:74374897	LIN52	chr14:74551656-74667117:+	0.24	3.88	0.00013	Morning vs. evening chronotype	
KIRP	cis	1	rs72644211	chr10:81781695	LOC219347	chr10:81805991-81838949:-	1.05	9.34	4.16E-18	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	1.01	9.5	1.35E-18	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs72645460	chr11:116771375	PCSK7	chr11:117075789-117102811:-	0.39	4.06	6.59E-5	Protein quantitative trait loci	
KIRP	cis	1	rs72665924	chr4:106095505	PPA2	chr4:106290235-106395227:-	-0.24	-3.89	0.000126	Melanoma	
KIRP	cis	1	rs7267979	chr20:25298087	ENTPD6	chr20:25176339-25207360:+	-0.34	-6.02	5.66E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7267979	chr20:25298087	FAM182B	chr20:25744102-25848786:-	0.3	4.21	3.46E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7268053	chr20:25328286	ENTPD6	chr20:25176339-25207360:+	0.37	6.42	6.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7268053	chr20:25328286	FAM182B	chr20:25744102-25848786:-	-0.31	-4.21	3.52E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs72686191	chr1:76218319	ACADM	chr1:76190043-76229353:+	0.21	4.8	2.67E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs726967	chr4:56421713	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.67	4.78E-6	Personality dimensions	
KIRP	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.46	-4.88	1.86E-6	Abdominal aortic aneurysm	
KIRP	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.32	5.32	2.24E-7	Body mass index	
KIRP	cis	1	rs72800847	chr16:31022639	HSD3B7	chr16:30996519-31000473:+	0.25	4.26	2.83E-5	Response to metformin (IC50)	
KIRP	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.43	-7.17	7.53E-12	Esophageal cancer (squamous cell)	
KIRP	cis	1	rs72823473	chr17:45321775	LOC100272146	chr17:45500843-45504056:+	-0.18	-4.17	4.17E-5	Body mass index	
KIRP	cis	1	rs72823474	chr17:45321776	LOC100272146	chr17:45500843-45504056:+	-0.18	-4.17	4.17E-5	Body mass index	
KIRP	cis	1	rs72823619	chr2:102924615	IL1RL1	chr2:102927962-102968497:+	0.37	4.48	1.09E-5	Asthma	
KIRP	cis	1	rs72823621	chr2:102925435	IL1RL1	chr2:102927962-102968497:+	0.38	4.58	7.3E-6	Asthma	
KIRP	cis	1	rs72823632	chr2:102931534	IL1RL1	chr2:102927962-102968497:+	0.39	4.92	1.53E-6	Asthma	
KIRP	cis	1	rs72823635	chr2:102931612	IL1RL1	chr2:102927962-102968497:+	0.39	4.92	1.53E-6	Asthma	
KIRP	cis	1	rs72823646	chr2:102954213	IL1RL1	chr2:102927962-102968497:+	0.41	5.07	7.46E-7	Asthma	
KIRP	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-1.11	-7.42	1.58E-12	Schizophrenia	
KIRP	cis	1	rs72843784	chr6:26498758	LOC100270746	chr6:26987146-26988085:-	0.48	3.8	0.000177	Schizophrenia	
KIRP	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.42	-4.48	1.1E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.28	4.05	6.83E-5	Body mass index	
KIRP	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.6	-6.31	1.16E-9	Rheumatoid arthritis	
KIRP	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.71	-6.4	6.99E-10	Rheumatoid arthritis	
KIRP	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.71	-6.4	6.99E-10	Rheumatoid arthritis	
KIRP	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.69	-6.19	2.32E-9	Rheumatoid arthritis	
KIRP	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.69	-6.19	2.32E-9	Rheumatoid arthritis	
KIRP	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.69	-6.19	2.32E-9	Rheumatoid arthritis	
KIRP	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.7	-6.17	2.53E-9	Rheumatoid arthritis	
KIRP	cis	1	rs7298108	chr12:9376168	LOC642846	chr12:9436253-9466684:+	-0.26	-3.91	0.000118	Non-alcoholic fatty liver disease histology (AST)	
KIRP	cis	1	rs7302787	chr12:15344066	RERG	chr12:15260718-15374304:-	0.37	5.25	3.08E-7	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs73036062	chr11:133828187	IGSF9B	chr11:133785186-133826880:-	0.29	3.94	0.000104	Schizophrenia	
KIRP	cis	1	rs73036063	chr11:133828758	IGSF9B	chr11:133785186-133826880:-	0.29	3.91	0.000116	Schizophrenia	
KIRP	cis	1	rs73036064	chr11:133829442	IGSF9B	chr11:133785186-133826880:-	0.29	3.88	0.000132	Schizophrenia	
KIRP	cis	1	rs73036735	chr1:179426268	C1orf125	chr1:179335107-179523868:+	0.45	4.07	6.17E-5	Multiple sclerosis (age of onset)	
KIRP	cis	1	rs730532	chr14:52518811	NID2	chr14:52471521-52535946:-	0.34	5.6	5.43E-8	Pulmonary function	
KIRP	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.87	11.09	1.03E-23	Diastolic blood pressure	
KIRP	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.94	13.57	3.2E-32	Diastolic blood pressure	
KIRP	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.94	13.57	3.2E-32	Diastolic blood pressure	
KIRP	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.93	13.73	9.25E-33	Diastolic blood pressure	
KIRP	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.96	14.25	1.34E-34	Diastolic blood pressure	
KIRP	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.9	11.06	1.23E-23	Diastolic blood pressure	
KIRP	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.93	13.17	8.48E-31	Diastolic blood pressure	
KIRP	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.89	10.95	2.9E-23	Diastolic blood pressure	
KIRP	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.89	10.95	2.9E-23	Diastolic blood pressure	
KIRP	cis	1	rs73088137	chr3:49448423	NCKIPSD	chr3:48711280-48723334:-	-0.32	-4.13	4.91E-5	Menarche (age at onset)	
KIRP	cis	1	rs73088137	chr3:49448423	P4HTM	chr3:49027341-49044579:+	-0.25	-4.15	4.41E-5	Menarche (age at onset)	
KIRP	cis	1	rs73088137	chr3:49448423	TREX1	chr3:48501186-48509043:+	0.22	3.89	0.000127	Menarche (age at onset)	
KIRP	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.27	-4.58	7.31E-6	Colorectal cancer	
KIRP	cis	1	rs731152	chr17:40279680	DHX58	chr17:40253422-40264751:-	-0.25	-4.3	2.41E-5	Fibrinogen levels	
KIRP	cis	1	rs73128528	chr20:44582187	WFDC3	chr20:44402847-44420547:-	-0.53	-4.59	6.92E-6	Abdominal aortic aneurysm	
KIRP	cis	1	rs73140069	chr7:75986790	UPK3B	chr7:76139745-76157197:+	-0.3	-4.11	5.35E-5	Multiple sclerosis	
KIRP	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.27	3.94	0.000105	Diabetic kidney disease	
KIRP	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.27	3.86	0.000143	Diabetic kidney disease	
KIRP	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.27	3.86	0.000143	Diabetic kidney disease	
KIRP	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.26	3.81	0.000174	Diabetic kidney disease	
KIRP	cis	1	rs732172	chr16:31050033	HSD3B7	chr16:30996519-31000473:+	0.27	5.12	5.87E-7	Response to metformin (IC50)	
KIRP	cis	1	rs732173	chr16:31050023	HSD3B7	chr16:30996519-31000473:+	0.26	4.95	1.33E-6	Response to metformin (IC50)	
KIRP	cis	1	rs7322160	chr13:61061456	TDRD3	chr13:60970591-61148012:+	0.28	4.26	2.82E-5	Menopause (age at onset)	
KIRP	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.76	6.55	2.92E-10	Crohn's disease	
KIRP	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.78	6.83	5.96E-11	Crohn's disease	
KIRP	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.6	6.1	3.68E-9	Crohn's disease	
KIRP	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.43	-4.2	3.7E-5	Schizophrenia	
KIRP	cis	1	rs73301712	chr14:59898245	JKAMP	chr14:59951161-59972080:+	0.53	5	1.06E-6	Schizophrenia	
KIRP	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.47	-4.39	1.62E-5	Schizophrenia	
KIRP	cis	1	rs73301725	chr14:59902159	JKAMP	chr14:59951161-59972080:+	0.52	4.69	4.28E-6	Schizophrenia	
KIRP	cis	1	rs73301741	chr14:59908444	C14orf149	chr14:59939406-59951126:-	-0.46	-4.3	2.37E-5	Schizophrenia	
KIRP	cis	1	rs73301741	chr14:59908444	JKAMP	chr14:59951161-59972080:+	0.59	5.27	2.84E-7	Schizophrenia	
KIRP	cis	1	rs73301746	chr14:59908485	C14orf149	chr14:59939406-59951126:-	-0.46	-4.3	2.37E-5	Schizophrenia	
KIRP	cis	1	rs73301746	chr14:59908485	JKAMP	chr14:59951161-59972080:+	0.59	5.27	2.84E-7	Schizophrenia	
KIRP	cis	1	rs733115	chr10:96619086	C10orf129	chr10:96953957-96988685:+	0.72	7.21	5.84E-12	Blood metabolite levels	
KIRP	cis	1	rs7332189	chr13:36755610	SOHLH2	chr13:36742347-36871992:-	-0.5	-6.76	8.89E-11	Glucose homeostasis traits	
KIRP	cis	1	rs7332932	chr13:36755636	SOHLH2	chr13:36742347-36871992:-	-0.5	-6.76	8.89E-11	Glucose homeostasis traits	
KIRP	cis	1	rs73337598	chr17:61732576	FTSJ3	chr17:61896795-61905031:-	0.32	4.58	7.23E-6	Body mass index	
KIRP	cis	1	rs73343333	chr5:125913560	ALDH7A1	chr5:125878918-125931082:-	0.26	3.83	0.000157	Osteoporosis	
KIRP	cis	1	rs73352808	chr17:65875157	LOC440461	chr17:66194801-66196436:+	0.3	4.08	5.9E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs73421524	chr15:54777457	CCPG1	chr15:55647438-55790782:-	0.35	3.83	0.000161	Post-traumatic stress disorder	
KIRP	cis	1	rs7343481	chr20:25300113	ENTPD6	chr20:25176339-25207360:+	0.34	5.89	1.15E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs7343481	chr20:25300113	FAM182B	chr20:25744102-25848786:-	-0.3	-4.17	4.11E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs73484234	chr11:22822211	SVIP	chr11:22843600-22851382:-	0.33	3.87	0.000135	Dialysis-related mortality	
KIRP	cis	1	rs73552468	chr19:21772097	ZNF429	chr19:21688437-21739068:+	0.32	4.37	1.76E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs73552479	chr19:21778816	ZNF429	chr19:21688437-21739068:+	0.33	4.45	1.27E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.36	6.61	2.13E-10	Height	
KIRP	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.28	4.33	2.11E-5	Height	
KIRP	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.31E-10	Height	
KIRP	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.28	4.35	1.91E-5	Height	
KIRP	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.96	-14.19	2.28E-34	Diastolic blood pressure	
KIRP	cis	1	rs7373805	chr3:38455439	EXOG	chr3:38537763-38567796:+	-0.16	-3.85	0.00015	Electrocardiographic conduction measures	
KIRP	cis	1	rs7373816	chr3:38490443	EXOG	chr3:38537763-38567796:+	-0.16	-3.87	0.000138	Electrocardiographic conduction measures	
KIRP	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.35	6.44	5.67E-10	Height	
KIRP	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.28	4.27	2.71E-5	Height	
KIRP	cis	1	rs73842702	chr4:120611013	PDE5A	chr4:120415552-120549981:-	-0.43	-4.17	4.21E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRP	cis	1	rs739451	chr9:136678954	C9orf96	chr9:136243284-136271219:+	0.31	3.84	0.000152	IgG glycosylation	
KIRP	cis	1	rs739637	chr17:40280944	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs7396835	chr11:116684028	PCSK7	chr11:117075789-117102811:-	-0.39	-4.28	2.63E-5	Quantitative traits	
KIRP	cis	1	rs7402778	chr15:24774948	PWRN1	chr15:24778839-24832924:+	0.29	3.96	9.66E-5	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs7402804	chr15:24836600	PWRN1	chr15:24778839-24832924:+	0.26	3.85	0.000146	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs7402908	chr15:24836980	PWRN1	chr15:24778839-24832924:+	0.27	3.94	0.000104	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.49	8.13	1.7E-14	Eye color traits	
KIRP	cis	1	rs74071851	chr14:88882202	SPATA7	chr14:88852012-88904802:+	-0.28	-4.01	7.81E-5	Coronary artery calcification	
KIRP	cis	1	rs74140304	chr1:227730539	JMJD4	chr1:227918891-227923112:-	0.21	4.12	5.14E-5	Height	
KIRP	cis	1	rs74150870	chr10:96406166	C10orf129	chr10:96953957-96988685:+	0.77	7.25	4.65E-12	Blood metabolite levels	
KIRP	cis	1	rs74152357	chr10:96508039	C10orf129	chr10:96953957-96988685:+	0.73	7.44	1.41E-12	Blood metabolite levels	
KIRP	cis	1	rs74152360	chr10:96512547	C10orf129	chr10:96953957-96988685:+	0.73	7.44	1.41E-12	Blood metabolite levels	
KIRP	cis	1	rs74154119	chr10:96632871	C10orf129	chr10:96953957-96988685:+	0.72	7.35	2.43E-12	Blood metabolite levels	
KIRP	cis	1	rs74154124	chr10:96651789	C10orf129	chr10:96953957-96988685:+	0.8	7.53	8.13E-13	Blood metabolite levels	
KIRP	cis	1	rs7418348	chr1:227720778	JMJD4	chr1:227918891-227923112:-	-0.23	-4.56	7.68E-6	Height	
KIRP	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.22	-4.73	3.6E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.45	-3.91	0.000116	Plasma clusterin levels	
KIRP	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.08	4.11E-9	Height	
KIRP	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.87E-6	Height	
KIRP	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.38	6.31	1.16E-9	Cognitive performance	
KIRP	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.36	6.62	2.0E-10	Height	
KIRP	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.28	4.31	2.34E-5	Height	
KIRP	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs74298052	chr6:159405298	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs74298057	chr6:159417303	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs74298058	chr6:159419953	RSPH3	chr6:159398268-159421198:-	0.39	4.71	3.97E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.07	4.41E-9	Height	
KIRP	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.3	-4.53	8.8E-6	Height	
KIRP	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.35	6.41	6.48E-10	Height	
KIRP	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.29	4.37	1.8E-5	Height	
KIRP	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.35	6.48	4.5E-10	Height	
KIRP	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.29	4.49	1.05E-5	Height	
KIRP	cis	1	rs7433707	chr3:38443180	EXOG	chr3:38537763-38567796:+	-0.16	-3.85	0.00015	Electrocardiographic conduction measures	
KIRP	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.31	5.51	8.62E-8	Height	
KIRP	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.29	4.39	1.61E-5	Height	
KIRP	cis	1	rs74347384	chr7:1072440	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.45	-6.61	2.05E-10	Longevity	
KIRP	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.63	5.69E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs74369356	chr7:1071711	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs74372131	chr10:81787214	LOC219347	chr10:81805991-81838949:-	1	9.32	4.62E-18	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs7438704	chr4:48363245	CNGA1	chr4:47937996-48018610:-	0.23	3.86	0.000141	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs74403477	chr1:179424380	C1orf125	chr1:179335107-179523868:+	0.46	4.14	4.62E-5	Multiple sclerosis (age of onset)	
KIRP	cis	1	rs74410979	chr6:159361089	RSPH3	chr6:159398268-159421198:-	0.39	4.65	5.31E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs74419074	chr10:96424439	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs74471041	chr3:49542543	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.17	4.07E-5	Menarche (age at onset)	
KIRP	cis	1	rs74471041	chr3:49542543	P4HTM	chr3:49027341-49044579:+	-0.24	-4.35	1.95E-5	Menarche (age at onset)	
KIRP	cis	1	rs74508437	chr10:96514363	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-1.06	-9.21	1.03E-17	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs74544416	chr8:82657745	IMPA1	chr8:82569151-82598589:-	0.51	3.84	0.000152	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs74549782	chr10:96482852	C10orf129	chr10:96953957-96988685:+	1.03	8.98	5.02E-17	Blood metabolite levels	
KIRP	cis	1	rs74627839	chr10:96682129	C10orf129	chr10:96953957-96988685:+	0.78	7.35	2.45E-12	Blood metabolite levels	
KIRP	cis	1	rs74636383	chr10:96546697	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.19	-4.18	3.91E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.33	-4.01	7.96E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs74676797	chr2:633063	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.39	-9.26	7.39E-18	Response to temozolomide	
KIRP	cis	1	rs74758321	chr8:82667320	CHMP4C	chr8:82644688-82671746:+	-1.11	-10.08	1.91E-20	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.22	-4.87	1.91E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs747782	chr11:47940925	NUP160	chr11:47799671-47870057:-	-0.23	-4.04	6.87E-5	Intraocular pressure	
KIRP	cis	1	rs7477	chr17:16246016	ADORA2B	chr17:15848231-15879210:+	-0.35	-5.51	8.41E-8	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.63	5.69E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs74799213	chr7:100467739	AGFG2	chr7:100136834-100165842:+	-0.42	-3.86	0.000143	Type 2 diabetes	
KIRP	cis	1	rs74803483	chr10:96713372	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs74804603	chr10:96566698	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs74883200	chr10:96390079	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.9	1.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7494918	chr15:24833624	PWRN1	chr15:24778839-24832924:+	0.27	3.91	0.000118	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs7495122	chr15:24833611	PWRN1	chr15:24778839-24832924:+	0.27	3.91	0.000118	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs74955473	chr5:150174558	LOC134466	chr5:150310000-150326146:-	0.81	6.3	1.21E-9	Crohn's disease	
KIRP	cis	1	rs7496335	chr15:65758868	DPP8	chr15:65737999-65810035:-	-0.13	-4.82	2.41E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs74963911	chr10:96706316	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs74967207	chr10:96468755	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs7496814	chr15:84584959	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.29	4.25	3.02E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs74996264	chr10:96713995	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs75016635	chr7:1094121	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.77	3.03E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.5	8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs75059851	chr11:133822569	IGSF9B	chr11:133785186-133826880:-	0.32	4.06	6.56E-5	Schizophrenia	
KIRP	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.6	6.1	3.68E-9	Crohn's disease	
KIRP	cis	1	rs75075655	chr10:96666317	C10orf129	chr10:96953957-96988685:+	0.78	7.35	2.45E-12	Blood metabolite levels	
KIRP	cis	1	rs75079001	chr19:21757375	ZNF429	chr19:21688437-21739068:+	0.31	4.24	3.11E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs7513559	chr1:76173744	ACADM	chr1:76190043-76229353:+	0.23	5.34	2.01E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs7515491	chr1:46355079	MUTYH	chr1:45794915-45806142:-	0.18	4.25	2.98E-5	Body mass index	
KIRP	cis	1	rs75159543	chr15:40665228	C15orf23	chr15:40674922-40686488:+	0.99	11.13	7.46E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs75159543	chr15:40665228	IVD	chr15:40697686-40713512:+	-0.34	-3.86	0.000141	Heschl's gyrus morphology	
KIRP	cis	1	rs7516226	chr1:76234257	ACADM	chr1:76190043-76229353:+	0.2	4.67	4.75E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs751702	chr13:51848377	GUCY1B2	chr13:51568649-51654998:-	-0.27	-3.81	0.000174	Cerebrospinal fluid clusterin levels	
KIRP	cis	1	rs7518038	chr1:76154430	ACADM	chr1:76190043-76229353:+	0.24	5.58	6.06E-8	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs75193300	chr7:100518940	AGFG2	chr7:100136834-100165842:+	-0.41	-3.81	0.000176	Type 2 diabetes	
KIRP	cis	1	rs75211977	chr19:21760201	ZNF429	chr19:21688437-21739068:+	0.31	4.27	2.77E-5	Colorectal or endometrial cancer	
KIRP	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.29	1.29E-9	Body mass index	
KIRP	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.69	11.91	1.75E-26	Homocysteine levels	
KIRP	cis	1	rs7524467	chr1:76194054	ACADM	chr1:76190043-76229353:+	0.21	4.82	2.41E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.44E-9	Body mass index	
KIRP	cis	1	rs7524495	chr1:46266932	MUTYH	chr1:45794915-45806142:-	0.16	3.87	0.000139	Body mass index	
KIRP	cis	1	rs75254631	chr10:96560911	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.3	4.23	3.17E-5	Body mass index	
KIRP	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.94	11.26	2.8E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs75278386	chr15:40678312	IVD	chr15:40697686-40713512:+	-0.35	-4.25	2.96E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs75280500	chr10:96582914	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.79	5.81	1.76E-8	Crohn's disease	
KIRP	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.45	-3.83	0.000159	Plasma clusterin levels	
KIRP	cis	1	rs7533888	chr1:76160449	ACADM	chr1:76190043-76229353:+	0.23	5.42	1.32E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-1	-20.38	3.41E-56	Homocysteine levels	
KIRP	cis	1	rs7534754	chr1:76185308	ACADM	chr1:76190043-76229353:+	0.21	4.98	1.15E-6	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.83	-15.5	5.31E-39	Homocysteine levels	
KIRP	cis	1	rs7538893	chr1:227728803	JMJD4	chr1:227918891-227923112:-	0.21	4.12	5.14E-5	Height	
KIRP	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.39	-6.03	5.51E-9	Body mass index	
KIRP	cis	1	rs7539932	chr1:46292354	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.96	7.91E-9	Body mass index	
KIRP	cis	1	rs7540325	chr1:46338217	MUTYH	chr1:45794915-45806142:-	0.16	3.86	0.000143	Body mass index	
KIRP	cis	1	rs75404862	chr10:96441082	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs754466	chr10:79680434	DLG5	chr10:79550551-79686348:-	0.24	4.29	2.46E-5	Liver enzyme levels (gamma-glutamyl transferase)	
KIRP	cis	1	rs75470184	chr10:96392186	C10orf129	chr10:96953957-96988685:+	0.77	7.25	4.65E-12	Blood metabolite levels	
KIRP	cis	1	rs7547921	chr1:38602073	MEAF6	chr1:37958176-37980364:-	-0.44	-3.87	0.000139	Visceral adipose tissue/subcutaneous adipose tissue ratio	
KIRP	cis	1	rs75488469	chr7:1102122	ZFAND2A	chr7:1192544-1199855:-	-0.41	-5.02	9.42E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7548962	chr1:76139266	ACADM	chr1:76190043-76229353:+	0.22	5.24	3.33E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.99	6.68E-9	Body mass index	
KIRP	cis	1	rs7550746	chr1:46351719	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.54E-5	Body mass index	
KIRP	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.36	6.02	5.67E-9	Height	
KIRP	cis	1	rs7552404	chr1:76135946	ACADM	chr1:76190043-76229353:+	0.22	5.22	3.59E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.39	6.06	4.76E-9	Body mass index	
KIRP	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.42	-6.43	5.8E-10	Body mass index	
KIRP	cis	1	rs7558910	chr2:645122	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs7559018	chr2:645203	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs7559447	chr2:645646	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs7560127	chr2:643315	SNTG2	chr2:946555-1371382:+	-0.4	-3.96	9.66E-5	Body mass index	
KIRP	cis	1	rs75602228	chr10:96427354	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs7560246	chr2:643469	SNTG2	chr2:946555-1371382:+	-0.43	-4.27	2.74E-5	Body mass index	
KIRP	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.38	-6.35	9.28E-10	Melanoma;Esophageal squamous cell carcinoma	
KIRP	cis	1	rs7561317	chr2:644953	SNTG2	chr2:946555-1371382:+	-0.41	-4.12	5.09E-5	Body mass index	
KIRP	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.32	5.27	2.77E-7	Body mass index	
KIRP	cis	1	rs75642445	chr10:96507575	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs75645849	chr10:96698970	C10orf129	chr10:96953957-96988685:+	1.05	9.67	3.92E-19	Blood metabolite levels	
KIRP	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.33	4.39	1.65E-5	Metabolite levels	
KIRP	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.49	-8.01	3.74E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs7567368	chr2:645082	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs756777	chr9:136679080	C9orf96	chr9:136243284-136271219:+	0.31	4.3	2.36E-5	IgG glycosylation	
KIRP	cis	1	rs7568069	chr2:71584485	ZNF638	chr2:71503723-71662187:+	-0.23	-4.65	5.3E-6	Height	
KIRP	cis	1	rs756920	chr11:2310870	C11orf21	chr11:2317507-2323143:-	0.29	3.9	0.000124	Obesity-related traits	
KIRP	cis	1	rs7569210	chr2:631462	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs7570971	chr2:135837906	TMEM163	chr2:135213331-135525334:-	-0.33	-5.45	1.13E-7	Body mass index;Blood metabolite levels;Cholesterol, total	
KIRP	cis	1	rs7570993	chr2:652565	SNTG2	chr2:946555-1371382:+	0.4	4.14	4.63E-5	Body mass index	
KIRP	cis	1	rs7571967	chr2:646839	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs7571970	chr2:646849	SNTG2	chr2:946555-1371382:+	-0.42	-4.23	3.16E-5	Body mass index	
KIRP	cis	1	rs75724251	chr10:96676190	C10orf129	chr10:96953957-96988685:+	1.01	8.81	1.62E-16	Blood metabolite levels	
KIRP	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.31	4.06	6.47E-5	Metabolite levels	
KIRP	cis	1	rs7574255	chr2:228699884	WDR69	chr2:228736327-228789026:+	-0.29	-4.35	1.96E-5	Blood pressure	
KIRP	cis	1	rs7574359	chr2:652542	SNTG2	chr2:946555-1371382:+	0.4	4.14	4.63E-5	Body mass index	
KIRP	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.41	5.35	1.9E-7	Metabolite levels	
KIRP	cis	1	rs7576624	chr2:625029	SNTG2	chr2:946555-1371382:+	-0.4	-3.81	0.000173	Body mass index	
KIRP	cis	1	rs7576635	chr2:625057	SNTG2	chr2:946555-1371382:+	-0.4	-3.81	0.000173	Body mass index	
KIRP	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.68	6.48	4.48E-10	Crohn's disease	
KIRP	cis	1	rs7578456	chr2:202235348	ALS2CR12	chr2:202153148-202222101:-	-0.26	-4.09	5.74E-5	Basal cell carcinoma	
KIRP	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.37	-6.37	8.35E-10	Body mass index	
KIRP	cis	1	rs75794524	chr10:96694591	C10orf129	chr10:96953957-96988685:+	1.05	9.67	3.92E-19	Blood metabolite levels	
KIRP	cis	1	rs75799196	chr10:96675093	C10orf129	chr10:96953957-96988685:+	1.01	8.81	1.62E-16	Blood metabolite levels	
KIRP	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.4	6.13	3.17E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
KIRP	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.37	4.93	1.45E-6	Metabolite levels	
KIRP	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.26	5.95	8.41E-9	Common traits (Other)	
KIRP	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.29	3.81	0.000173	Metabolite levels	
KIRP	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.3	3.95	0.0001	Metabolite levels	
KIRP	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.38	5.07	7.39E-7	Metabolite levels	
KIRP	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.38	5.05	8.25E-7	Metabolite levels	
KIRP	cis	1	rs7585056	chr2:631528	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.3	3.95	0.0001	Metabolite levels	
KIRP	cis	1	rs7588007	chr2:631255	SNTG2	chr2:946555-1371382:+	-0.42	-4	8.14E-5	Body mass index	
KIRP	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.35	4.52	9.51E-6	Atopic dermatitis	
KIRP	cis	1	rs758944	chr7:75953297	UPK3B	chr7:76139745-76157197:+	-0.3	-4.13	4.96E-5	Multiple sclerosis	
KIRP	cis	1	rs7591067	chr2:642846	SNTG2	chr2:946555-1371382:+	-0.43	-4.26	2.79E-5	Body mass index	
KIRP	cis	1	rs7591163	chr2:228715375	WDR69	chr2:228736327-228789026:+	0.3	4.56	7.83E-6	Blood pressure	
KIRP	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.99	8.94	6.59E-17	Chronic obstructive pulmonary disease-related biomarkers	
KIRP	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.78	-9.84	1.1E-19	Triptolide cytotoxicity	
KIRP	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.57	5.08	7.09E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.3	3.93	0.000107	Metabolite levels	
KIRP	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.5	-8.1	2.03E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.4	6.42	6.28E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs7597155	chr2:69985435	ANXA4	chr2:69969127-70053594:+	-0.28	-4.28	2.64E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7597156	chr2:203194062	FZD7	chr2:202899310-202903160:+	-0.4	-3.91	0.000116	Urate levels	
KIRP	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.31	4.1	5.42E-5	Metabolite levels	
KIRP	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.31	3.97	9.1E-5	Metabolite levels	
KIRP	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.33	-5.53	7.69E-8	Body mass index	
KIRP	cis	1	rs7601028	chr2:642499	SNTG2	chr2:946555-1371382:+	-0.43	-4.26	2.79E-5	Body mass index	
KIRP	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.5	8.06	2.55E-14	Urinary metabolites	
KIRP	cis	1	rs7604609	chr2:643303	SNTG2	chr2:946555-1371382:+	-0.39	-4.04	6.88E-5	Body mass index	
KIRP	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.37	4.95	1.3E-6	Metabolite levels	
KIRP	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.48	7.9	7.38E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs76063586	chr10:96642431	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.31	-4.07	6.18E-5	Metabolite levels	
KIRP	cis	1	rs76074552	chr10:96725037	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs76076565	chr10:96747206	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs7608050	chr2:652247	SNTG2	chr2:946555-1371382:+	0.4	4.13	4.81E-5	Body mass index	
KIRP	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.18	3.94	0.000103	Obesity-related traits	
KIRP	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.37	6.18	2.38E-9	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.4	-6.88	4.31E-11	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRP	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.3	-4.94	1.4E-6	Bone mineral density	
KIRP	cis	1	rs761025	chr20:25426968	ENTPD6	chr20:25176339-25207360:+	-0.36	-6.34	9.87E-10	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs761025	chr20:25426968	FAM182B	chr20:25744102-25848786:-	0.31	4.32	2.25E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs76110720	chr10:96641794	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.31	5.51	8.62E-8	Height	
KIRP	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.29	4.39	1.61E-5	Height	
KIRP	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.76	3.25E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7613491	chr3:49508976	NCKIPSD	chr3:48711280-48723334:-	-0.29	-3.85	0.000151	Menarche (age at onset)	
KIRP	cis	1	rs7613491	chr3:49508976	P4HTM	chr3:49027341-49044579:+	-0.24	-4.08	5.96E-5	Menarche (age at onset)	
KIRP	cis	1	rs76135795	chr13:79161205	SLAIN1	chr13:78272470-78338377:+	-0.45	-4.14	4.63E-5	Serum thyroid-stimulating hormone levels	
KIRP	cis	1	rs7614727	chr3:52295895	GNL3	chr3:52719936-52728508:+	-0.22	-4.17	4.11E-5	Electroencephalogram traits	
KIRP	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.93	13.91	2.18E-33	Diastolic blood pressure	
KIRP	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.27	-4.09	5.73E-5	Bone mineral density	
KIRP	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.33	5.7	3.17E-8	Height	
KIRP	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.29	4.26	2.85E-5	Height	
KIRP	cis	1	rs76194	chr19:18630580	LRRC25	chr19:18501955-18508421:-	-0.12	-3.9	0.00012	Breast cancer	
KIRP	cis	1	rs76194	chr19:18630580	SSBP4	chr19:18530221-18545371:+	-0.16	-4.22	3.37E-5	Breast cancer	
KIRP	cis	1	rs7619789	chr3:49476263	NCKIPSD	chr3:48711280-48723334:-	0.29	4.27	2.71E-5	Menarche (age at onset)	
KIRP	cis	1	rs7619789	chr3:49476263	P4HTM	chr3:49027341-49044579:+	0.24	4.46	1.2E-5	Menarche (age at onset)	
KIRP	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.27	-4.17	4.07E-5	Bone mineral density	
KIRP	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs7625821	chr3:51513236	HEMK1	chr3:50606583-50622419:+	0.23	3.92	0.000111	Melanoma	
KIRP	cis	1	rs76265521	chr10:96514016	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.32	-4.9	1.68E-6	Narcolepsy	
KIRP	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.32	-4.9	1.68E-6	Narcolepsy	
KIRP	cis	1	rs76277863	chr15:40649863	C15orf23	chr15:40674922-40686488:+	0.98	10.85	6.1E-23	Heschl's gyrus morphology	
KIRP	cis	1	rs7629072	chr3:52305633	GNL3	chr3:52719936-52728508:+	-0.22	-4.12	5.03E-5	Electroencephalogram traits	
KIRP	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.38	5.56	6.6E-8	Height	
KIRP	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.25	-5.42	1.35E-7	Longevity	
KIRP	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.33	-5.86	1.36E-8	Height	
KIRP	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.3	-4.51	9.79E-6	Height	
KIRP	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.89	11.87	2.38E-26	Diastolic blood pressure	
KIRP	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.26	-5.8	1.92E-8	Longevity	
KIRP	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.28	-6.19	2.28E-9	Longevity	
KIRP	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.25	-5.41	1.38E-7	Longevity	
KIRP	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.27	-6.1	3.76E-9	Longevity	
KIRP	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.35	6.43	5.79E-10	Height	
KIRP	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.29	4.47	1.15E-5	Height	
KIRP	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.3	-4.83	2.34E-6	Bone mineral density	
KIRP	cis	1	rs76429909	chr13:79161195	SLAIN1	chr13:78272470-78338377:+	-0.45	-4.14	4.63E-5	Serum thyroid-stimulating hormone levels	
KIRP	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.75	6.26	1.54E-9	Crohn's disease	
KIRP	cis	1	rs7644148	chr3:49545241	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.17	4.07E-5	Menarche (age at onset)	
KIRP	cis	1	rs7644148	chr3:49545241	P4HTM	chr3:49027341-49044579:+	-0.24	-4.35	1.95E-5	Menarche (age at onset)	
KIRP	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.29	5.01	9.84E-7	Height	
KIRP	cis	1	rs7645611	chr3:53125297	RFT1	chr3:53122503-53164470:-	0.37	3.91	0.000117	Immune reponse to smallpox (secreted IL-2)	
KIRP	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.91	11.96	1.21E-26	Diastolic blood pressure	
KIRP	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.96	13.97	1.35E-33	Diastolic blood pressure	
KIRP	cis	1	rs7647973	chr3:49510931	NCKIPSD	chr3:48711280-48723334:-	-0.29	-3.82	0.000168	Menarche (age at onset)	
KIRP	cis	1	rs7647973	chr3:49510931	P4HTM	chr3:49027341-49044579:+	-0.24	-4.06	6.49E-5	Menarche (age at onset)	
KIRP	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.94	14.04	7.72E-34	Diastolic blood pressure	
KIRP	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.93	14.19	2.16E-34	Diastolic blood pressure	
KIRP	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs7648995	chr3:49438803	NCKIPSD	chr3:48711280-48723334:-	-0.33	-4.54	8.4E-6	Menarche (age at onset)	
KIRP	cis	1	rs7648995	chr3:49438803	P4HTM	chr3:49027341-49044579:+	-0.25	-4.41	1.49E-5	Menarche (age at onset)	
KIRP	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.91	13.11	1.37E-30	Diastolic blood pressure	
KIRP	cis	1	rs7651039	chr3:15648004	BTD	chr3:15643140-15687324:+	-0.24	-4.42	1.43E-5	Coronary heart disease	
KIRP	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.25	-5.4	1.51E-7	Longevity	
KIRP	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.26	5.76	2.34E-8	Longevity	
KIRP	cis	1	rs76541158	chr10:96383524	C10orf129	chr10:96953957-96988685:+	1	8.64	5.49E-16	Blood metabolite levels	
KIRP	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.44	-6.52	3.64E-10	Tumor biomarkers	
KIRP	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.43	-7.38	2.07E-12	Tumor biomarkers	
KIRP	cis	1	rs76542740	chr15:43891512	LCMT2	chr15:43619976-43622891:-	-0.31	-3.85	0.000146	Tumor biomarkers	
KIRP	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.6	6.09	4.0E-9	Crohn's disease	
KIRP	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.38	-6.05	4.97E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRP	cis	1	rs76579763	chr14:59935971	JKAMP	chr14:59951161-59972080:+	0.61	4.53	9.08E-6	Schizophrenia	
KIRP	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.4	-6.27	1.45E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRP	cis	1	rs76635824	chr16:20606442	ACSM1	chr16:20634559-20709066:-	0.46	3.91	0.000118	Schizophrenia	
KIRP	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.29	4.28	2.66E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs7667849	chr4:56388199	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.71	3.94E-6	Personality dimensions	
KIRP	cis	1	rs7668147	chr4:56339384	SRD5A3	chr4:56212409-56237866:+	0.3	4.96	1.25E-6	Personality dimensions	
KIRP	cis	1	rs7668147	chr4:56339384	TMEM165	chr4:56262090-56292342:+	-0.24	-3.98	8.89E-5	Personality dimensions	
KIRP	cis	1	rs76683169	chr10:102358397	SFXN3	chr10:102790996-102800997:+	0.36	3.85	0.00015	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs7670225	chr4:56368018	SRD5A3	chr4:56212409-56237866:+	0.3	4.69	4.3E-6	Personality dimensions	
KIRP	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.58	5.24	3.3E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs7673908	chr4:56394819	SRD5A3	chr4:56212409-56237866:+	-0.31	-5.09	6.79E-7	Personality dimensions	
KIRP	cis	1	rs7673908	chr4:56394819	TMEM165	chr4:56262090-56292342:+	0.25	4.07	6.1E-5	Personality dimensions	
KIRP	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.25	4.17	4.09E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs7677526	chr4:56349908	SRD5A3	chr4:56212409-56237866:+	0.31	4.99	1.08E-6	Personality dimensions	
KIRP	cis	1	rs7677526	chr4:56349908	TMEM165	chr4:56262090-56292342:+	-0.25	-3.98	8.9E-5	Personality dimensions	
KIRP	cis	1	rs7679608	chr4:76514201	CDKL2	chr4:76501705-76555721:-	0.28	3.95	9.87E-5	Magnesium levels	
KIRP	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.59	6.88E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.57	4.87	1.96E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs76828799	chr10:96611177	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs76833820	chr7:1070278	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs76841360	chr1:40060025	OXCT2	chr1:40235197-40237020:-	0.39	4.93	1.44E-6	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRP	cis	1	rs76852223	chr6:159370432	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.28	4.04	7.08E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs76872831	chr5:150171559	LOC134466	chr5:150310000-150326146:-	0.85	6.75	9.17E-11	Crohn's disease	
KIRP	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.39	-6.12	3.26E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRP	cis	1	rs768994	chr6:159399348	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs7690734	chr4:76537889	CDKL2	chr4:76501705-76555721:-	0.31	4.24	3.05E-5	Magnesium levels	
KIRP	cis	1	rs76937928	chr10:96649690	C10orf129	chr10:96953957-96988685:+	1.04	9.08	2.6E-17	Blood metabolite levels	
KIRP	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.94	11.06	1.26E-23	Heschl's gyrus morphology	
KIRP	cis	1	rs76994419	chr15:40714150	IVD	chr15:40697686-40713512:+	-0.34	-4.13	4.84E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.07	24.56	3.06E-70	Birdshot chorioretinopathy	
KIRP	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.63	6.44	5.6E-10	Crohn's disease	
KIRP	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.26	4.21	3.55E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs77083167	chr7:1071823	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.56	5.77	2.23E-8	Crohn's disease	
KIRP	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.61	5.98	7.16E-9	Crohn's disease	
KIRP	cis	1	rs77097088	chr6:159354815	RSPH3	chr6:159398268-159421198:-	0.41	4.66	4.93E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs77122985	chr10:96680701	C10orf129	chr10:96953957-96988685:+	0.78	7.35	2.45E-12	Blood metabolite levels	
KIRP	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.48	4.92	1.52E-6	Crohn's disease	
KIRP	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.45	4.51	9.76E-6	Crohn's disease	
KIRP	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.46	4.48	1.11E-5	Crohn's disease	
KIRP	cis	1	rs7716219	chr5:54955071	SLC38A9	chr5:54921676-55008554:-	-0.33	-3.95	9.91E-5	Height	
KIRP	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.76	6.15	2.85E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs7718874	chr5:176358065	PRR7	chr5:176873796-176883283:+	-0.22	-4.06	6.56E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
KIRP	cis	1	rs77225875	chr6:159418145	RSPH3	chr6:159398268-159421198:-	0.4	4.71	3.92E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs77234191	chr4:258294	ZNF718	chr4:53272-156488:+	0.29	4.3	2.38E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.49	-5.18	4.5E-7	Crohn's disease	
KIRP	cis	1	rs7724558	chr5:150328866	LOC134466	chr5:150310000-150326146:-	0.76	6.82	6.28E-11	Crohn's disease	
KIRP	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.46	4.52	9.42E-6	Crohn's disease	
KIRP	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs77344981	chr19:6692145	GPR108	chr19:6729927-6737633:-	-0.43	-3.98	8.82E-5	Complement C3 and C4 levels	
KIRP	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.57	5.63	4.63E-8	Crohn's disease	
KIRP	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.56	5.56	6.7E-8	Crohn's disease	
KIRP	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.45	4.43	1.36E-5	Crohn's disease	
KIRP	cis	1	rs7740107	chr6:130374461	L3MBTL3	chr6:130339734-130462584:+	-0.28	-4.33	2.15E-5	Height	
KIRP	cis	1	rs77419080	chr10:96546020	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs7742626	chr6:136132496	C6orf217	chr6:135818939-136037192:+	0.28	4.87	1.89E-6	Phosphorus levels	
KIRP	cis	1	rs774356	chr9:27559721	C9orf72	chr9:27546544-27573842:-	0.23	4.05	6.79E-5	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs774359	chr9:27561049	C9orf72	chr9:27546544-27573842:-	0.23	4.05	6.79E-5	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs77446828	chr6:159414034	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs77467078	chr10:96734466	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.38	4.81	2.49E-6	Atopic dermatitis	
KIRP	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.54	-8.4	2.78E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.26	-4	8.25E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.17	4.38	1.73E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.89	11.2	4.35E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.49	-7.08	1.32E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.31	-4.8	2.66E-6	Homocysteine levels	
KIRP	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.53	-7.94	5.6E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs77605770	chr6:159370528	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.58	5.68	3.59E-8	Crohn's disease	
KIRP	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.63	5.69E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.49	-7.08	1.32E-11	Response to antipsychotic treatment	
KIRP	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.59	6.88E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.31	-5.21	3.83E-7	Obesity-related traits	
KIRP	cis	1	rs7777389	chr7:143744802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.54	7.22E-8	Obesity-related traits	
KIRP	cis	1	rs77784224	chr11:60378652	MS4A8B	chr11:60467047-60483282:+	0.84	6.58	2.49E-10	Metabolite levels  (X-11787)	
KIRP	cis	1	rs77789667	chr14:59940418	JKAMP	chr14:59951161-59972080:+	0.61	4.47	1.17E-5	Schizophrenia	
KIRP	cis	1	rs77819408	chr10:96552188	C10orf129	chr10:96953957-96988685:+	0.73	7.44	1.41E-12	Blood metabolite levels	
KIRP	cis	1	rs77868187	chr7:1093968	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.77	3.03E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.13	-4.56	7.75E-6	Tuberculosis	
KIRP	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.43	7.3	3.32E-12	Tuberculosis	
KIRP	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.13	-4.3	2.36E-5	Tuberculosis	
KIRP	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.4	6.91	3.65E-11	Tuberculosis	
KIRP	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.14	-4.74	3.54E-6	Tuberculosis	
KIRP	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.43	7.33	2.83E-12	Tuberculosis	
KIRP	cis	1	rs77876414	chr6:159414811	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs7789940	chr7:75951230	UPK3B	chr7:76139745-76157197:+	-0.29	-4.03	7.19E-5	Multiple sclerosis	
KIRP	cis	1	rs77921213	chr10:96546246	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.53	4.32	2.19E-5	Renal underexcretion gout;Gout	
KIRP	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.55	4.45	1.27E-5	Renal underexcretion gout;Gout	
KIRP	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.57	5.08	7.09E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.48	-4.74	3.55E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRP	cis	1	rs7806994	chr7:56139505	ZNF713	chr7:55955162-56008433:+	-0.28	-4.61	6.34E-6	PR interval in Tripanosoma cruzi seropositivity	
KIRP	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.75E-5	Diabetic kidney disease	
KIRP	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.27	3.94	0.000104	Diabetic kidney disease	
KIRP	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.75E-5	Diabetic kidney disease	
KIRP	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.26	3.96	9.8E-5	Diabetic kidney disease	
KIRP	cis	1	rs78143408	chr7:1096846	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs78144779	chr10:96735342	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs78150064	chr10:96388665	C10orf129	chr10:96953957-96988685:+	0.77	7.25	4.65E-12	Blood metabolite levels	
KIRP	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.89	11.18	4.96E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.76	3.25E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.28	3.93	0.000109	Body mass index	
KIRP	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.34	-4.24	3.13E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs78185801	chr7:1096367	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.78	2.88E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7819570	chr8:89588626	MMP16	chr8:89049462-89339717:-	0.31	4.44	1.32E-5	Schizophrenia	
KIRP	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.32	4.13	4.96E-5	Atopic dermatitis	
KIRP	cis	1	rs78261998	chr10:96630716	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs78308415	chr7:1072634	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.58	7.15E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.29	4.3	2.4E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs78373114	chr10:96643896	C10orf129	chr10:96953957-96988685:+	0.79	7.45	1.32E-12	Blood metabolite levels	
KIRP	cis	1	rs7838490	chr8:89585048	MMP16	chr8:89049462-89339717:-	0.31	4.52	9.28E-6	Body mass index and cholesterol (psychopharmacological treatment)	
KIRP	cis	1	rs78397134	chr10:96549486	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs78441737	chr10:96693563	C10orf129	chr10:96953957-96988685:+	1.04	9.36	3.66E-18	Blood metabolite levels	
KIRP	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.76	3.25E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.54	3.08E-10	Body mass index	
KIRP	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.36	9.0E-10	Body mass index	
KIRP	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.21	2.06E-9	Body mass index	
KIRP	cis	1	rs785479	chr1:46492144	MUTYH	chr1:45794915-45806142:-	0.17	3.96	9.51E-5	Body mass index	
KIRP	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.5	3.99E-10	Body mass index	
KIRP	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.32	1.13E-9	Body mass index	
KIRP	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.26	1.53E-9	Body mass index	
KIRP	cis	1	rs785495	chr1:46587887	MUTYH	chr1:45794915-45806142:-	0.16	3.88	0.000133	Body mass index	
KIRP	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.55	2.91E-10	Body mass index	
KIRP	cis	1	rs78552657	chr6:159417840	RSPH3	chr6:159398268-159421198:-	0.39	4.72	3.82E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.17	-3.85	0.000146	Blood metabolite ratios	
KIRP	cis	1	rs7855278	chr9:131921365	PPP2R4	chr9:131873244-131911223:+	-0.33	-5.31	2.34E-7	Blood metabolite ratios	
KIRP	cis	1	rs78572295	chr10:96675470	C10orf129	chr10:96953957-96988685:+	1.01	8.81	1.62E-16	Blood metabolite levels	
KIRP	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.94	11.26	2.8E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs78604110	chr15:40681854	IVD	chr15:40697686-40713512:+	-0.35	-4.25	2.96E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs78609324	chr10:96603745	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs78628466	chr7:1068453	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.56	7.71E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs786425	chr12:124085502	ATP6V0A2	chr12:124196865-124246299:+	-0.28	-4.58	7.24E-6	Pubertal anthropometrics	
KIRP	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.25	5.34	2.0E-7	Pubertal anthropometrics	
KIRP	cis	1	rs78679088	chr21:33910827	TCP10L	chr21:33947152-33957845:-	-0.36	-3.94	0.000106	Gastritis	
KIRP	cis	1	rs7868408	chr9:131917864	PPP2R4	chr9:131873244-131911223:+	0.25	3.96	9.6E-5	Blood metabolite ratios	
KIRP	cis	1	rs7870381	chr9:4970909	MLANA	chr9:5890909-5909822:+	0.3	4.49	1.08E-5	Oropharynx cancer	
KIRP	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-1.11	-10.22	6.73E-21	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-1.09	-9.44	1.99E-18	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs78740005	chr8:82659306	IMPA1	chr8:82569151-82598589:-	0.52	3.89	0.000126	Epithelial ovarian cancer;Ovarian cancer	
KIRP	cis	1	rs7877	chr1:171254890	FMO4	chr1:171283486-171311222:+	0.25	3.84	0.000156	Sudden cardiac arrest	
KIRP	cis	1	rs78811622	chr6:51630065	TRAM2	chr6:52362202-52441862:-	-0.26	-3.87	0.000138	Prostate cancer	
KIRP	cis	1	rs78831378	chr10:96713686	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs78835984	chr10:96689543	C10orf129	chr10:96953957-96988685:+	1.01	8.81	1.62E-16	Blood metabolite levels	
KIRP	cis	1	rs78836001	chr10:4981992	AKR1C2	chr10:4964715-5060207:-	0.97	8.36	3.57E-15	Height	
KIRP	cis	1	rs78861357	chr7:1095418	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.77	3.05E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.59	6.91E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs78909326	chr10:96679176	C10orf129	chr10:96953957-96988685:+	0.79	7.36	2.25E-12	Blood metabolite levels	
KIRP	cis	1	rs78919131	chr10:96638446	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs789208	chr10:105935096	C10orf79	chr10:105889647-105992120:-	0.2	4.81	2.5E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs7893456	chr10:5007862	AKR1C2	chr10:4964715-5060207:-	0.79	7.3	3.46E-12	Height	
KIRP	cis	1	rs7898235	chr10:74038181	DNAJB12	chr10:74092588-74114907:-	0.25	4.1	5.45E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	0.21	4.94	1.38E-6	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs7899746	chr10:96787859	CYP2C9	chr10:96698415-96749147:+	0.26	3.84	0.000151	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs79021324	chr14:59941424	JKAMP	chr14:59951161-59972080:+	0.65	4.77	3.0E-6	Schizophrenia	
KIRP	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.94	11.26	2.8E-24	Heschl's gyrus morphology	
KIRP	cis	1	rs79044944	chr15:40676285	IVD	chr15:40697686-40713512:+	-0.35	-4.25	2.96E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs7907195	chr10:96515341	C10orf129	chr10:96953957-96988685:+	0.72	7.15	8.67E-12	Blood metabolite levels	
KIRP	cis	1	rs7908994	chr10:5008383	AKR1C2	chr10:4964715-5060207:-	0.74	7.05	1.58E-11	Height	
KIRP	cis	1	rs79103432	chr10:96545475	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs79172815	chr10:96389784	C10orf129	chr10:96953957-96988685:+	1.02	8.5	1.38E-15	Blood metabolite levels	
KIRP	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.54	8.4	2.76E-15	Response to antipsychotic treatment	
KIRP	cis	1	rs79187906	chr10:96560695	C10orf129	chr10:96953957-96988685:+	0.71	6.96	2.6E-11	Blood metabolite levels	
KIRP	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.35	4.56	7.79E-6	Atopic dermatitis	
KIRP	cis	1	rs7921185	chr10:4976430	AKR1C2	chr10:4964715-5060207:-	0.84	7.77	1.77E-13	Height	
KIRP	cis	1	rs79219523	chr10:96493750	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs79220007	chr6:26098474	BTN2A1	chr6:26458189-26469865:+	-0.48	-3.92	0.000113	Mean corpuscular hemoglobin;Mean corpuscular volume;Iron status biomarkers (iron levels);Hematocrit;Cardiovascular disease risk factors;Alcohol consumption (transferrin glycosylation);Cholesterol, total;Hematological parameters;Red blood cell traits;Iron status biomarkers;Hemoglobin;Iron status biom	
KIRP	cis	1	rs7924699	chr11:47893120	NUP160	chr11:47799671-47870057:-	-0.22	-3.94	0.000104	Intraocular pressure	
KIRP	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.59	5.35	1.89E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs7927771	chr11:47781306	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.4	-5.96	7.9E-9	Schizophrenia	
KIRP	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs79357647	chr6:159402432	RSPH3	chr6:159398268-159421198:-	0.4	4.77	3.06E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.29	4.3	2.4E-5	Immune response to smallpox vaccine (IL-6)	
KIRP	cis	1	rs7940310	chr11:117024481	PCSK7	chr11:117075789-117102811:-	-0.38	-4.2	3.67E-5	Protein quantitative trait loci	
KIRP	cis	1	rs7942031	chr11:47868474	NUP160	chr11:47799671-47870057:-	-0.22	-3.94	0.000104	Intraocular pressure	
KIRP	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.59	6.91E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs79429965	chr10:96494912	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.35	4.56	7.79E-6	Atopic dermatitis	
KIRP	cis	1	rs7944004	chr11:2311152	CD81	chr11:2398547-2418649:+	-0.2	-3.9	0.000124	Chronic lymphocytic leukemia	
KIRP	cis	1	rs79442859	chr5:150171210	LOC134466	chr5:150310000-150326146:-	0.85	6.74	9.88E-11	Crohn's disease	
KIRP	cis	1	rs79443843	chr7:1075245	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.59	6.91E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.26	4.13	4.78E-5	Pancreatic cancer	
KIRP	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs7947730	chr11:47786184	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs7948969	chr11:62907048	SLC22A24	chr11:62847414-62911693:-	0.5	7.67	3.32E-13	Conotruncal heart defects	
KIRP	cis	1	rs79517882	chr10:96424148	C10orf129	chr10:96953957-96988685:+	1	8.65	5.17E-16	Blood metabolite levels	
KIRP	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.95	13.86	3.09E-33	Diastolic blood pressure	
KIRP	cis	1	rs7956634	chr12:15321194	RERG	chr12:15260718-15374304:-	-0.38	-5.46	1.11E-7	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs7956773	chr12:15321301	RERG	chr12:15260718-15374304:-	0.37	5.18	4.37E-7	Glomerular filtration rate (creatinine)	
KIRP	cis	1	rs79579293	chr14:88822068	SPATA7	chr14:88852012-88904802:+	-0.28	-4.15	4.51E-5	Coronary artery calcification	
KIRP	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.67	5.63	4.68E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs79611756	chr10:96387031	C10orf129	chr10:96953957-96988685:+	1	8.64	5.49E-16	Blood metabolite levels	
KIRP	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.77	6.16	2.65E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs79678941	chr10:96449450	C10orf129	chr10:96953957-96988685:+	1.03	9	4.49E-17	Blood metabolite levels	
KIRP	cis	1	rs79683221	chr7:1096139	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.78	2.88E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.33	4.3	2.39E-5	Atopic dermatitis	
KIRP	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.5	-8.12	1.77E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.27	4.71	3.92E-6	IgG glycosylation	
KIRP	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.58	7.15E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs7977534	chr12:112717920	TMEM116	chr12:112369103-112450989:-	0.21	3.85	0.000147	Oral cavity and pharyngeal cancer	
KIRP	cis	1	rs79780973	chr5:150174810	LOC134466	chr5:150310000-150326146:-	0.81	6.3	1.21E-9	Crohn's disease	
KIRP	cis	1	rs79800397	chr10:96714425	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.27	-4.09	5.81E-5	Educational attainment;Height;Head circumference (infant)	
KIRP	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.57	5.15	5.17E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.31	4.02	7.45E-5	Atopic dermatitis	
KIRP	cis	1	rs79950930	chr10:96429130	C10orf129	chr10:96953957-96988685:+	1.01	9.03	3.59E-17	Blood metabolite levels	
KIRP	cis	1	rs8002861	chr13:44474517	C13orf31	chr13:44453420-44468067:+	-0.22	-4.21	3.51E-5	Leprosy	
KIRP	cis	1	rs80031817	chr7:1096793	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs8003506	chr14:75586288	RPS6KL1	chr14:75372347-75389958:-	-0.23	-4.06	6.47E-5	Height	
KIRP	cis	1	rs8005686	chr14:76633967	ESRRB	chr14:76837690-76968178:+	0.36	3.82	0.000168	Blood pressure	
KIRP	cis	1	rs80059054	chr10:96483008	C10orf129	chr10:96953957-96988685:+	1.03	8.98	5.02E-17	Blood metabolite levels	
KIRP	cis	1	rs8006176	chr14:101033288	BEGAIN	chr14:101003486-101036131:-	-0.38	-5.54	7.37E-8	Menarche (age at onset)	
KIRP	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.6	6.1	3.68E-9	Crohn's disease	
KIRP	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.64E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.55	4.45	1.27E-5	Renal underexcretion gout;Gout	
KIRP	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.41	-7.87	8.86E-14	IgG glycosylation	
KIRP	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.31	4.02	7.45E-5	Atopic dermatitis	
KIRP	cis	1	rs8014170	chr14:50071694	RPL36AL	chr14:50085407-50087349:-	0.28	5.58	6.06E-8	Carotid intima media thickness	
KIRP	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.76	6.15	2.85E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.8	2.7E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRP	cis	1	rs8023716	chr15:65744861	DPP8	chr15:65737999-65810035:-	-0.13	-4.71	4.04E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs8024039	chr15:24826345	PWRN1	chr15:24778839-24832924:+	0.27	3.96	9.53E-5	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs8024418	chr15:84586308	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs8024628	chr15:84586463	LOC388152	chr15:84867600-84898920:-	-0.23	-3.82	0.000168	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.57	5.08	7.09E-7	Renal underexcretion gout;Gout	
KIRP	cis	1	rs80259168	chr10:96543753	C10orf129	chr10:96953957-96988685:+	1.03	8.96	5.75E-17	Blood metabolite levels	
KIRP	cis	1	rs8026212	chr15:96053612	LOC145820	chr15:95976322-96051074:+	0.27	3.81	0.000173	Alcoholism (alcohol dependence factor score)	
KIRP	cis	1	rs8027260	chr15:65955172	DPP8	chr15:65737999-65810035:-	0.12	4.64	5.39E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs8028182	chr15:75718669	SNUPN	chr15:75890426-75918719:-	0.25	4.11	5.35E-5	Sudden cardiac arrest	
KIRP	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.64	5.3	2.5E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs8029016	chr15:84586464	LOC388152	chr15:84867600-84898920:-	-0.23	-3.82	0.000168	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs8030379	chr15:84590910	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs8031179	chr15:65952034	DPP8	chr15:65737999-65810035:-	-0.12	-4.55	8.04E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs80313145	chr6:26194965	HIST1H3E	chr6:26224427-26226589:+	0.61	5.54	7.24E-8	Renal underexcretion gout;Gout	
KIRP	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.82	6.5	3.97E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRP	cis	1	rs8031576	chr15:90380214	ANPEP	chr15:90328127-90358072:-	0.2	3.9	0.000121	Type 2 diabetes	
KIRP	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.76	-11.92	1.66E-26	Type 2 diabetes	
KIRP	cis	1	rs8031915	chr15:91519291	UNC45A	chr15:91473410-91497322:+	0.23	4.4	1.59E-5	Type 2 diabetes	
KIRP	cis	1	rs8033837	chr15:75353975	MAN2C1	chr15:75648135-75660941:-	0.22	4.01	7.84E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.3	4.43	1.36E-5	Blood trace element (Zn levels)	
KIRP	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.95	11.47	5.37E-25	Heschl's gyrus morphology	
KIRP	cis	1	rs8033938	chr15:40703114	IVD	chr15:40697686-40713512:+	-0.33	-4.02	7.61E-5	Heschl's gyrus morphology	
KIRP	cis	1	rs8035639	chr15:65944548	DPP8	chr15:65737999-65810035:-	-0.12	-4.42	1.44E-5	Mean corpuscular hemoglobin	
KIRP	cis	1	rs8035639	chr15:65944548	SLC24A1	chr15:65903704-65953256:+	-0.2	-3.81	0.000173	Mean corpuscular hemoglobin	
KIRP	cis	1	rs8036197	chr15:75370232	MAN2C1	chr15:75648135-75660941:-	0.25	4.69	4.3E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.33	5.01	1.02E-6	Blood trace element (Zn levels)	
KIRP	cis	1	rs8037254	chr15:91520099	UNC45A	chr15:91473410-91497322:+	0.23	4.42	1.46E-5	Type 2 diabetes	
KIRP	cis	1	rs8041056	chr15:84564817	LOC388152	chr15:84867600-84898920:-	-0.24	-3.97	9.24E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs8042366	chr15:66012443	DPP8	chr15:65737999-65810035:-	-0.12	-4.57	7.58E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs8042680	chr15:91521337	UNC45A	chr15:91473410-91497322:+	-0.25	-4.63	5.73E-6	Type 2 diabetes	
KIRP	cis	1	rs8042807	chr15:66012444	DPP8	chr15:65737999-65810035:-	-0.12	-4.62	6.02E-6	Mean corpuscular hemoglobin	
KIRP	cis	1	rs8042970	chr15:84586368	LOC388152	chr15:84867600-84898920:-	-0.24	-4.12	5.16E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs8044653	chr16:55615757	LPCAT2	chr16:55542913-55620581:+	-0.2	-3.86	0.00014	Thyroid hormone levels	
KIRP	cis	1	rs8046697	chr16:75442144	TMEM170A	chr16:75477144-75498584:-	-0.26	-3.98	8.79E-5	Migraine	
KIRP	cis	1	rs8047014	chr16:69135049	TMED6	chr16:69377160-69385689:-	-0.24	-4.05	6.85E-5	Attention deficit hyperactivity disorder	
KIRP	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.3	4.29	2.46E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRP	cis	1	rs8062783	chr16:74691264	MLKL	chr16:74705753-74734789:-	-0.32	-5.41	1.42E-7	Testicular germ cell tumor	
KIRP	cis	1	rs8064261	chr17:61705212	FTSJ3	chr17:61896795-61905031:-	0.3	4.26	2.87E-5	Body mass index	
KIRP	cis	1	rs8066719	chr17:61825764	FTSJ3	chr17:61896795-61905031:-	0.33	4.77	3.11E-6	Body mass index	
KIRP	cis	1	rs8067064	chr17:61825984	FTSJ3	chr17:61896795-61905031:-	0.33	4.77	3.11E-6	Body mass index	
KIRP	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.29	4.01	7.99E-5	Body mass index	
KIRP	cis	1	rs8067892	chr17:65837983	LOC440461	chr17:66194801-66196436:+	0.29	3.87	0.000139	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs8068603	chr17:61755211	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs8068748	chr17:40532701	ARL4D	chr17:41476353-41478503:+	0.25	4	8.26E-5	Crohn's disease;Multiple sclerosis	
KIRP	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.33	-4.73	3.64E-6	Body mass index	
KIRP	cis	1	rs8070446	chr17:40285879	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.56	-10.31	3.42E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.55E-5	Body mass index	
KIRP	cis	1	rs8071463	chr17:65938655	LOC440461	chr17:66194801-66196436:+	-0.29	-3.96	9.82E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs8072225	chr17:65912960	C17orf58	chr17:65987218-65989765:-	0.26	3.91	0.000119	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs8072225	chr17:65912960	LOC440461	chr17:66194801-66196436:+	0.3	4.11	5.26E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs8073373	chr17:61703320	FTSJ3	chr17:61896795-61905031:-	0.27	3.82	0.000164	Body mass index	
KIRP	cis	1	rs8073373	chr17:61703320	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.32	2.18E-5	Body mass index	
KIRP	cis	1	rs8074078	chr17:65838743	LOC440461	chr17:66194801-66196436:+	0.3	4	8.09E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.26	4.55	8.3E-6	Fibrinogen levels	
KIRP	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.55E-5	Body mass index	
KIRP	cis	1	rs8075061	chr17:61804723	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs8075257	chr17:61728750	FTSJ3	chr17:61896795-61905031:-	0.31	4.56	7.85E-6	Body mass index	
KIRP	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.28	3.95	0.000101	Body mass index	
KIRP	cis	1	rs8075422	chr17:61804686	TCAM1P	chr17:61934376-61941738:+	-0.31	-3.94	0.000103	Body mass index	
KIRP	cis	1	rs8075521	chr17:61804954	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.41	-7.36	2.25E-12	Metabolite levels	
KIRP	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.26	-4.78	2.97E-6	Metabolite levels	
KIRP	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.29	-4.09	5.61E-5	Body mass index	
KIRP	cis	1	rs8077265	chr17:61732727	FTSJ3	chr17:61896795-61905031:-	0.28	4	8.14E-5	Body mass index	
KIRP	cis	1	rs8077265	chr17:61732727	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.4	1.56E-5	Body mass index	
KIRP	cis	1	rs8078462	chr17:61857937	FTSJ3	chr17:61896795-61905031:-	0.31	4.44	1.33E-5	Body mass index	
KIRP	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.55	-10.28	4.47E-21	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRP	cis	1	rs8078862	chr17:61854068	FTSJ3	chr17:61896795-61905031:-	0.31	4.44	1.33E-5	Body mass index	
KIRP	cis	1	rs8081517	chr17:65845697	LOC440461	chr17:66194801-66196436:+	0.29	3.86	0.000141	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs8081541	chr17:61812483	FTSJ3	chr17:61896795-61905031:-	0.32	4.48	1.13E-5	Body mass index	
KIRP	cis	1	rs8081612	chr17:61724695	TCAM1P	chr17:61934376-61941738:+	0.31	3.94	0.000105	Body mass index	
KIRP	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.54	3.08E-10	Body mass index	
KIRP	cis	1	rs8103622	chr19:18572834	LRRC25	chr19:18501955-18508421:-	-0.12	-4.24	3.05E-5	Breast cancer	
KIRP	cis	1	rs8103622	chr19:18572834	SSBP4	chr19:18530221-18545371:+	-0.17	-4.62	5.94E-6	Breast cancer	
KIRP	cis	1	rs8105994	chr19:18593553	LRRC25	chr19:18501955-18508421:-	-0.13	-4.27	2.69E-5	Breast cancer	
KIRP	cis	1	rs8105994	chr19:18593553	SSBP4	chr19:18530221-18545371:+	-0.15	-4.04	6.97E-5	Breast cancer	
KIRP	cis	1	rs8107367	chr19:18564705	LRRC25	chr19:18501955-18508421:-	-0.12	-4.11	5.17E-5	Breast cancer	
KIRP	cis	1	rs8107367	chr19:18564705	SSBP4	chr19:18530221-18545371:+	-0.15	-4.26	2.82E-5	Breast cancer	
KIRP	cis	1	rs8109573	chr19:18617151	LRRC25	chr19:18501955-18508421:-	-0.12	-3.81	0.000175	Breast cancer	
KIRP	cis	1	rs8109573	chr19:18617151	SSBP4	chr19:18530221-18545371:+	-0.17	-4.5	1.01E-5	Breast cancer	
KIRP	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.36	-3.82	0.000168	Bronchopulmonary dysplasia	
KIRP	cis	1	rs8125868	chr20:25324410	ENTPD6	chr20:25176339-25207360:+	0.35	6.15	2.79E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs8125868	chr20:25324410	FAM182B	chr20:25744102-25848786:-	-0.31	-4.23	3.28E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.31	-4.7	4.19E-6	Narcolepsy	
KIRP	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.49	4.76	3.23E-6	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.49	-4.89	1.74E-6	Amyotrophic lateral sclerosis	
KIRP	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.37	4.54	8.48E-6	Multiple sclerosis	
KIRP	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.32	-6.02	5.76E-9	Multiple sclerosis	
KIRP	cis	1	rs8181644	chr12:58173466	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-4.26	2.8E-5	Multiple sclerosis	
KIRP	cis	1	rs823144	chr1:205744546	PM20D1	chr1:205797154-205819245:-	-0.36	-4.2	3.68E-5	Parkinson's disease	
KIRP	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.23	4.21	3.51E-5	Parkinson's disease	
KIRP	cis	1	rs823156	chr1:205764640	PM20D1	chr1:205797154-205819245:-	-0.34	-3.81	0.000173	Parkinson's disease	
KIRP	cis	1	rs830124	chr12:122395777	WDR66	chr12:122356480-122441830:+	0.43	4.27	2.68E-5	Urinary metabolites	
KIRP	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.76	10.46	1.16E-21	Type 2 diabetes	
KIRP	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.75	10.34	2.89E-21	Type 2 diabetes	
KIRP	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.81	11.09	1.01E-23	Type 2 diabetes	
KIRP	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.76	10.73	1.57E-22	Type 2 diabetes	
KIRP	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.8	-10.95	2.9E-23	Type 2 diabetes	
KIRP	cis	1	rs833087	chr13:28177227	POLR1D	chr13:28194895-28241547:+	-0.26	-4.82	2.42E-6	Large B-cell lymphoma	
KIRP	cis	1	rs836135	chr11:34548906	CAT	chr11:34460478-34493603:+	0.28	4.25	2.9E-5	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	
KIRP	cis	1	rs836137	chr11:34548424	CAT	chr11:34460478-34493603:+	0.25	3.89	0.000129	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	
KIRP	cis	1	rs842361	chr2:135340840	TMEM163	chr2:135213331-135525334:-	-0.39	-6.96	2.59E-11	Neuroticism	
KIRP	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.25	-3.84	0.000151	Homocysteine levels	
KIRP	cis	1	rs859767	chr2:135341200	TMEM163	chr2:135213331-135525334:-	-0.43	-7.58	5.68E-13	Neuroticism	
KIRP	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.78	-10.92	3.57E-23	Type 2 diabetes	
KIRP	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.73	9.6	6.46E-19	Type 2 diabetes	
KIRP	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.8	11.05	1.31E-23	Type 2 diabetes	
KIRP	cis	1	rs868698	chr17:19185211	RNF112	chr17:19314523-19320587:+	0.36	4.2	3.61E-5	Schizophrenia	
KIRP	cis	1	rs872842	chr22:43530631	MCAT	chr22:43528212-43539403:-	0.22	3.87	0.000136	Prostate cancer	
KIRP	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.43	8.19	1.13E-14	Kawasaki disease	
KIRP	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.19	-4	8.33E-5	Height	
KIRP	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.2	4.23	3.23E-5	Height	
KIRP	cis	1	rs876403	chr14:75602834	RPS6KL1	chr14:75372347-75389958:-	0.22	3.82	0.000169	Height	
KIRP	cis	1	rs876719	chr17:53366566	HLF	chr17:53342321-53402426:+	0.5	5.91	1.05E-8	QRS duration	
KIRP	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.58	-9.15	1.61E-17	Cognitive function	
KIRP	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.41	-6.12	3.36E-9	Rheumatoid arthritis	
KIRP	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.84	-15.56	3.22E-39	Homocysteine levels	
KIRP	cis	1	rs883180	chr16:55612277	LPCAT2	chr16:55542913-55620581:+	-0.21	-3.98	8.76E-5	Thyroid hormone levels	
KIRP	cis	1	rs884272	chr11:12455682	USP47	chr11:11862970-11980870:+	-0.25	-4.24	3.11E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs884613	chr20:25288505	ENTPD6	chr20:25176339-25207360:+	0.33	5.63	4.54E-8	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs884613	chr20:25288505	FAM182B	chr20:25744102-25848786:-	-0.29	-3.89	0.000127	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.5	-7.59	5.63E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs884951	chr3:124699915	HEG1	chr3:124684555-124774802:-	-0.22	-4.28	2.67E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.49	6.54	3.2E-10	Breast cancer (early onset);Breast cancer	
KIRP	cis	1	rs889398	chr16:69556715	EXOSC6	chr16:70284134-70285833:-	0.23	3.83	0.000159	Body mass index	
KIRP	cis	1	rs889399	chr16:69556583	EXOSC6	chr16:70284134-70285833:-	0.23	3.81	0.000172	Body mass index	
KIRP	cis	1	rs8897	chr3:49460407	NCKIPSD	chr3:48711280-48723334:-	0.27	4.07	6.09E-5	Menarche (age at onset)	
KIRP	cis	1	rs8897	chr3:49460407	P4HTM	chr3:49027341-49044579:+	0.22	4.28	2.64E-5	Menarche (age at onset)	
KIRP	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.38	-5.86	1.39E-8	Height	
KIRP	cis	1	rs892974	chr3:49398514	NCKIPSD	chr3:48711280-48723334:-	0.32	4.13	4.9E-5	Menarche (age at onset)	
KIRP	cis	1	rs892974	chr3:49398514	P4HTM	chr3:49027341-49044579:+	0.24	4.04	6.93E-5	Menarche (age at onset)	
KIRP	cis	1	rs895958	chr12:122378206	WDR66	chr12:122356480-122441830:+	-0.47	-4.19	3.77E-5	Urinary metabolites	
KIRP	cis	1	rs895959	chr12:122320352	WDR66	chr12:122356480-122441830:+	-0.41	-4.06	6.37E-5	Urinary metabolites	
KIRP	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.26	5.63	4.53E-8	Longevity	
KIRP	cis	1	rs909341	chr20:62328742	SLC2A4RG	chr20:62371211-62375401:+	-0.19	-3.86	0.00014	Atopic dermatitis	
KIRP	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.19	3.88	0.000131	Height	
KIRP	cis	1	rs910997	chr20:25267301	ENTPD6	chr20:25176339-25207360:+	-0.35	-6.03	5.38E-9	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs910997	chr20:25267301	FAM182B	chr20:25744102-25848786:-	0.3	4.13	4.95E-5	Liver enzyme levels (alkaline phosphatase)	
KIRP	cis	1	rs9174	chr4:25419283	ANAPC4	chr4:25378848-25420119:+	-0.19	-4.59	6.75E-6	Rheumatoid arthritis	
KIRP	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.5	-8.13	1.64E-14	Spherical equivalent (joint main effects and education interaction)	
KIRP	cis	1	rs9217	chr17:7363088	RANGRF	chr17:8191989-8193408:+	-0.19	-4.27	2.69E-5	Height	
KIRP	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.26	5.69	3.4E-8	Longevity	
KIRP	cis	1	rs922483	chr8:11351912	BLK	chr8:11351521-11422107:+	-0.35	-5.42	1.31E-7	Systemic lupus erythematosus	
KIRP	cis	1	rs922664	chr15:84569555	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs923372	chr4:48410454	CNGA1	chr4:47937996-48018610:-	0.23	3.83	0.00016	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.35	-4.93	1.44E-6	Idiopathic membranous nephropathy	
KIRP	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.8	10.94	3.12E-23	Type 2 diabetes	
KIRP	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.39	6.68	1.4E-10	Melanoma;Esophageal squamous cell carcinoma	
KIRP	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.36	6.82	6.31E-11	Height	
KIRP	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.29	4.52	9.32E-6	Height	
KIRP	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.35	6.42	6.23E-10	Height	
KIRP	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.29	4.5	1.03E-5	Height	
KIRP	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.34	6.22	1.96E-9	Height	
KIRP	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.29	4.48	1.11E-5	Height	
KIRP	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.34	6.19	2.34E-9	Height	
KIRP	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.29	4.48	1.1E-5	Height	
KIRP	cis	1	rs9294377	chr6:88084839	C6orf162	chr6:88032306-88052043:+	-0.27	-4.12	5.17E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.56	-9.05	3.27E-17	Plasma homocysteine levels (post-methionine load test)	
KIRP	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.37	5.77	2.17E-8	Plasma homocysteine levels (post-methionine load test)	
KIRP	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.16	3.81	0.000171	QRS complex (Sokolow-Lyon)	
KIRP	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.16	3.9	0.000122	QRS complex (Sokolow-Lyon)	
KIRP	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.19	5.24	3.26E-7	Folate pathway vitamin levels	
KIRP	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.26	-4.07	6.24E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.17	4.66	5.02E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs929843	chr16:70045748	EXOSC6	chr16:70284134-70285833:-	-0.35	-4.66	5.0E-6	Menarche (age at onset)	
KIRP	cis	1	rs9304742	chr19:53451291	ZNF320	chr19:53367119-53400946:-	0.24	4.28	2.6E-5	Psoriasis	
KIRP	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.45	-6.61	2.05E-10	Longevity	
KIRP	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.37	5.04	8.65E-7	Inflammatory skin disease	
KIRP	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.3	3.9	0.000122	Metabolite levels	
KIRP	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.67	5.69	3.31E-8	Crohn's disease	
KIRP	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.94	13.98	1.19E-33	Diastolic blood pressure	
KIRP	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.26	-5.8	1.92E-8	Longevity	
KIRP	cis	1	rs9311474	chr3:52338852	GNL3	chr3:52719936-52728508:+	-0.21	-3.82	0.000168	Electroencephalogram traits	
KIRP	cis	1	rs9312662	chr4:56386371	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.73	3.59E-6	Personality dimensions	
KIRP	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.32	6.17	2.52E-9	Height	
KIRP	cis	1	rs9322193	chr6:149919143	NUP43	chr6:150045453-150067688:-	-0.31	-4.4	1.59E-5	Lung cancer	
KIRP	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.56	5.54	7.26E-8	Crohn's disease	
KIRP	cis	1	rs9325473	chr10:96734582	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs932835	chr9:131887071	PPP2R4	chr9:131873244-131911223:+	0.27	4.16	4.22E-5	Blood metabolite ratios	
KIRP	cis	1	rs9332092	chr10:96696529	C10orf129	chr10:96953957-96988685:+	1.04	9.3	5.59E-18	Blood metabolite levels	
KIRP	cis	1	rs9332093	chr10:96696555	C10orf129	chr10:96953957-96988685:+	-1.02	-9.33	4.32E-18	Blood metabolite levels	
KIRP	cis	1	rs9332137	chr10:96712978	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs9332147	chr10:96722552	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs9332157	chr10:96724115	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs9332160	chr10:96724395	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332169	chr10:96731310	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332175	chr10:96732484	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332177	chr10:96734790	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs9332187	chr10:96737177	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs9332188	chr10:96737210	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332214	chr10:96743108	C10orf129	chr10:96953957-96988685:+	1.09	9.89	7.76E-20	Blood metabolite levels	
KIRP	cis	1	rs9332217	chr10:96743228	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332227	chr10:96745180	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332230	chr10:96745984	C10orf129	chr10:96953957-96988685:+	1.08	9.52	1.17E-18	Blood metabolite levels	
KIRP	cis	1	rs9332245	chr10:96749181	C10orf129	chr10:96953957-96988685:+	-1.03	-9.21	1.05E-17	Blood metabolite levels	
KIRP	cis	1	rs933770	chr15:96052722	LOC145820	chr15:95976322-96051074:+	-0.28	-4.1	5.45E-5	Alcoholism (alcohol dependence factor score)	
KIRP	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.36	6.47	4.8E-10	Height	
KIRP	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.32	4.83	2.29E-6	Height	
KIRP	cis	1	rs9355256	chr6:159375477	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs936228	chr15:75132164	MPI	chr15:75182410-75190565:+	0.24	3.83	0.00016	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
KIRP	cis	1	rs936229	chr15:75132319	MPI	chr15:75182410-75190565:+	0.24	3.9	0.000122	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
KIRP	cis	1	rs9362395	chr6:87854341	C6orf162	chr6:88032306-88052043:+	0.55	4.48	1.12E-5	Schizophrenia	
KIRP	cis	1	rs9364505	chr6:159375426	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs9365012	chr6:159373408	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs9365013	chr6:159373446	RSPH3	chr6:159398268-159421198:-	0.4	4.72	3.77E-6	Bladder cancer (smoking interaction)	
KIRP	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.39	-4.04	6.88E-5	Bronchopulmonary dysplasia	
KIRP	cis	1	rs9366716	chr6:11042418	ELOVL2	chr6:10980995-11044624:-	-0.33	-4.04	6.96E-5	Blood metabolite ratios	
KIRP	cis	1	rs9368564	chr6:11060283	ELOVL2	chr6:10980995-11044624:-	-0.33	-4.11	5.21E-5	Blood metabolite ratios	
KIRP	cis	1	rs9371221	chr6:151885986	C6orf97	chr6:151815175-151942327:+	0.49	4.38	1.68E-5	Bone mineral density (spine)	
KIRP	cis	1	rs9371537	chr6:151872500	C6orf97	chr6:151815175-151942327:+	-0.46	-4.27	2.76E-5	Bone mineral density (spine)	
KIRP	cis	1	rs9377228	chr6:149921998	NUP43	chr6:150045453-150067688:-	-0.35	-5.16	4.79E-7	Lung cancer	
KIRP	cis	1	rs9377229	chr6:149928791	NUP43	chr6:150045453-150067688:-	-0.33	-4.6	6.56E-6	Lung cancer	
KIRP	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.16	-3.89	0.000125	QRS complex (Sokolow-Lyon)	
KIRP	cis	1	rs9383693	chr6:154474871	RBM16	chr6:155054512-155155192:+	-0.18	-4.03	7.39E-5	Chronic lymphocytic leukemia	
KIRP	cis	1	rs9393903	chr6:11042909	ELOVL2	chr6:10980995-11044624:-	0.33	4.1	5.42E-5	Blood metabolite ratios	
KIRP	cis	1	rs9393915	chr6:11072322	ELOVL2	chr6:10980995-11044624:-	-0.38	-5.04	8.57E-7	Blood metabolite ratios	
KIRP	cis	1	rs9394931	chr6:42873245	GNMT	chr6:42928500-42931617:+	0.41	5.86	1.39E-8	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
KIRP	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.27	-3.92	0.000112	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
KIRP	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.3	-4.55	8.07E-6	Homocysteine levels	
KIRP	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.94	-14.28	1.06E-34	Diastolic blood pressure	
KIRP	cis	1	rs939581	chr2:623224	SNTG2	chr2:946555-1371382:+	-0.41	-3.83	0.000161	Body mass index	
KIRP	cis	1	rs939582	chr2:622723	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000137	Body mass index	
KIRP	cis	1	rs939584	chr2:621558	SNTG2	chr2:946555-1371382:+	-0.41	-3.87	0.000137	Body mass index	
KIRP	cis	1	rs9397424	chr6:151872791	C6orf97	chr6:151815175-151942327:+	0.45	4.13	4.88E-5	Bone mineral density (spine)	
KIRP	cis	1	rs9397425	chr6:151873024	C6orf97	chr6:151815175-151942327:+	0.43	3.95	9.88E-5	Bone mineral density (spine)	
KIRP	cis	1	rs9397429	chr6:151877569	C6orf97	chr6:151815175-151942327:+	0.54	4.7	4.12E-6	Bone mineral density (spine)	
KIRP	cis	1	rs9397431	chr6:151883930	C6orf97	chr6:151815175-151942327:+	0.49	4.4	1.58E-5	Bone mineral density (spine)	
KIRP	cis	1	rs9399693	chr6:149933854	NUP43	chr6:150045453-150067688:-	-0.36	-5.29	2.51E-7	Lung cancer	
KIRP	cis	1	rs940045	chr3:49449638	NCKIPSD	chr3:48711280-48723334:-	0.32	4.61	6.41E-6	Menarche (age at onset)	
KIRP	cis	1	rs940045	chr3:49449638	P4HTM	chr3:49027341-49044579:+	0.24	4.52	9.18E-6	Menarche (age at onset)	
KIRP	cis	1	rs940341	chr2:228724726	WDR69	chr2:228736327-228789026:+	0.28	4.23	3.24E-5	Blood pressure	
KIRP	cis	1	rs940934	chr15:84575528	LOC388152	chr15:84867600-84898920:-	-0.24	-4.05	6.72E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRP	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.38	4.99	1.11E-6	Atopic dermatitis	
KIRP	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.17	-4.04	6.93E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRP	cis	1	rs942270	chr1:76177332	ACADM	chr1:76190043-76229353:+	0.22	5.17	4.55E-7	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.34	4.53	9.1E-6	Life satisfaction	
KIRP	cis	1	rs9426935	chr1:153769400	CREB3L4	chr1:153940379-153946832:+	-0.23	-4.5	1.04E-5	Lentiform nucleus volume	
KIRP	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.4	-6.54	3.08E-10	Body mass index	
KIRP	cis	1	rs9436116	chr1:150454724	ADAMTSL4	chr1:150521898-150533410:+	0.29	4.48	1.11E-5	Morning vs. evening chronotype	
KIRP	cis	1	rs9436116	chr1:150454724	MRPS21	chr1:150266269-150280818:+	0.18	5.28	2.68E-7	Morning vs. evening chronotype	
KIRP	cis	1	rs9450662	chr6:88088593	C6orf162	chr6:88032306-88052043:+	-0.28	-4.12	5.12E-5	Depressive episodes in bipolar disorder	
KIRP	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.25	3.87	0.000137	Folate pathway vitamin levels	
KIRP	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.17	-4.63	5.77E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.17	4.76	3.23E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.33	1.07E-9	Body mass index	
KIRP	cis	1	rs947211	chr1:205752665	PM20D1	chr1:205797154-205819245:-	-0.35	-4.11	5.21E-5	Parkinson's disease	
KIRP	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.23	4.23	3.25E-5	Parkinson's disease	
KIRP	cis	1	rs9472202	chr6:44021286	XPO5	chr6:43490069-43543812:-	-0.29	-3.87	0.000137	Behavioral disturbance or psychiatric symptoms in prion disease	
KIRP	cis	1	rs9472202	chr6:44021286	YIPF3	chr6:43479565-43484702:-	-0.25	-3.98	8.83E-5	Behavioral disturbance or psychiatric symptoms in prion disease	
KIRP	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.19	5.12	5.82E-7	Folate pathway vitamin levels	
KIRP	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.17	4.61	6.14E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.17	4.61	6.35E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.17	4.78	2.95E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.26	-4.07	6.24E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.17	4.66	5.02E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.26	-4.18	3.94E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.17	4.72	3.79E-6	Folate pathway vitamin levels	
KIRP	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.27	-4.13	4.9E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.15	4.04	6.96E-5	Folate pathway vitamin levels	
KIRP	cis	1	rs947583	chr6:136133659	C6orf217	chr6:135818939-136037192:+	-0.28	-4.82	2.38E-6	Phosphorus levels	
KIRP	cis	1	rs9479767	chr6:154476528	RBM16	chr6:155054512-155155192:+	-0.2	-4.33	2.13E-5	Chronic lymphocytic leukemia	
KIRP	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.31	6	6.34E-9	Height	
KIRP	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.32	6.22	1.98E-9	Height	
KIRP	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.32	6.17	2.52E-9	Height	
KIRP	cis	1	rs9481821	chr6:118846022	NUS1	chr6:117996617-118031884:+	0.24	3.98	9.0E-5	Renal cell carcinoma	
KIRP	cis	1	rs9481833	chr6:118919631	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000163	Renal cell carcinoma	
KIRP	cis	1	rs9487043	chr6:109610474	SMPD2	chr6:109761931-109765121:+	0.21	3.86	0.000141	Red blood cell traits	
KIRP	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.32	6.22	1.98E-9	Height	
KIRP	cis	1	rs9489447	chr6:118900846	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000167	Renal cell carcinoma	
KIRP	cis	1	rs9489450	chr6:118904385	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000167	Renal cell carcinoma	
KIRP	cis	1	rs9489452	chr6:118910868	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000163	Renal cell carcinoma	
KIRP	cis	1	rs9489457	chr6:118920285	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000163	Renal cell carcinoma	
KIRP	cis	1	rs9489458	chr6:118920503	NUS1	chr6:117996617-118031884:+	0.23	3.82	0.000163	Renal cell carcinoma	
KIRP	cis	1	rs950027	chr15:45801035	SPATA5L1	chr15:45694519-45713614:+	-0.24	-3.83	0.000158	Response to fenofibrate (adiponectin levels)	
KIRP	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.39	-5.91	1.03E-8	Schizophrenia	
KIRP	cis	1	rs950880	chr2:102932562	IL1RL1	chr2:102927962-102968497:+	-0.29	-4.12	4.98E-5	Serum protein levels (sST2)	
KIRP	cis	1	rs951084	chr1:227700252	JMJD4	chr1:227918891-227923112:-	0.25	4.73	3.7E-6	Height	
KIRP	cis	1	rs9512760	chr13:28173662	POLR1D	chr13:28194895-28241547:+	0.27	5.18	4.37E-7	Large B-cell lymphoma	
KIRP	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.49	-7.86	9.77E-14	Arsenic metabolism	
KIRP	cis	1	rs9528136	chr13:61013615	TDRD3	chr13:60970591-61148012:+	0.29	4.55	8.06E-6	Menopause (age at onset)	
KIRP	cis	1	rs9535307	chr13:50291842	EBPL	chr13:50234811-50265623:-	-0.35	-4.87	1.94E-6	Obesity-related traits	
KIRP	cis	1	rs9538719	chr13:61052747	TDRD3	chr13:60970591-61148012:+	0.27	4.29	2.5E-5	Menopause (age at onset)	
KIRP	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.51	7.28	3.82E-12	Response to antipsychotic treatment	
KIRP	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.54	-7.78	1.61E-13	Response to antipsychotic treatment	
KIRP	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.57	-7.9	7.58E-14	Response to antipsychotic treatment	
KIRP	cis	1	rs957970	chr17:40519890	ARL4D	chr17:41476353-41478503:+	0.25	3.95	0.000101	Crohn's disease;Multiple sclerosis	
KIRP	cis	1	rs958283	chr6:151887150	C6orf97	chr6:151815175-151942327:+	0.49	4.38	1.68E-5	Bone mineral density (spine)	
KIRP	cis	1	rs9596219	chr13:50563447	EBPL	chr13:50234811-50265623:-	-0.3	-4.35	1.97E-5	Height	
KIRP	cis	1	rs9596220	chr13:50570191	EBPL	chr13:50234811-50265623:-	-0.29	-4.2	3.66E-5	Height	
KIRP	cis	1	rs9607287	chr22:22163425	TOP3B	chr22:22311404-22337193:-	-0.2	-4.57	7.51E-6	Multiple sclerosis	
KIRP	cis	1	rs962587	chr13:98061465	RAP2A	chr13:98086475-98120251:+	0.29	4.28	2.65E-5	Obesity-related traits	
KIRP	cis	1	rs963427	chr1:67609347	IL23R	chr1:67604590-67725648:+	-0.27	-3.81	0.00017	Psoriasis	
KIRP	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.41	5.56	6.63E-8	Blood metabolite levels;Blood metabolite ratios	
KIRP	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.55	-8.59	7.83E-16	Response to antipsychotic treatment	
KIRP	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.3	3.95	0.0001	Metabolite levels	
KIRP	cis	1	rs9662166	chr1:76235906	ACADM	chr1:76190043-76229353:+	0.18	4.41	1.51E-5	Blood metabolite levels;Acylcarnitine levels	
KIRP	cis	1	rs9665846	chr11:62907832	SLC22A24	chr11:62847414-62911693:-	0.5	7.63	4.25E-13	Conotruncal heart defects	
KIRP	cis	1	rs9668191	chr12:122305295	WDR66	chr12:122356480-122441830:+	-0.4	-3.9	0.000121	Urinary metabolites	
KIRP	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.51	8.57	8.78E-16	Eye color traits	
KIRP	cis	1	rs9684708	chr4:56430381	SRD5A3	chr4:56212409-56237866:+	-0.29	-4.55	8.18E-6	Personality dimensions	
KIRP	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	1.23	15.5	5.4E-39	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
KIRP	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.28	3.96	9.6E-5	Erythrocyte sedimentation rate	
KIRP	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.51	-8.8	1.75E-16	Erythrocyte sedimentation rate	
KIRP	cis	1	rs9697030	chr9:131920181	PPP2R4	chr9:131873244-131911223:+	0.31	4.9	1.64E-6	Blood metabolite ratios	
KIRP	cis	1	rs9719540	chr7:139370544	C7orf55	chr7:139025897-139030539:+	-0.16	-4.67	4.83E-6	Neuroticism	
KIRP	cis	1	rs9734313	chr11:64358311	SLC22A12	chr11:64358282-64369820:+	-0.22	-3.84	0.000155	Urate levels in obese individuals	
KIRP	cis	1	rs974015	chr4:48409347	CNGA1	chr4:47937996-48018610:-	0.25	4.08	6.06E-5	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs974016	chr4:48409315	CNGA1	chr4:47937996-48018610:-	0.23	3.83	0.00016	Crohn's disease;Inflammatory bowel disease	
KIRP	cis	1	rs974495	chr3:49400482	NCKIPSD	chr3:48711280-48723334:-	0.31	4.46	1.19E-5	Menarche (age at onset)	
KIRP	cis	1	rs974495	chr3:49400482	P4HTM	chr3:49027341-49044579:+	0.24	4.47	1.15E-5	Menarche (age at onset)	
KIRP	cis	1	rs9747164	chr17:61864787	FTSJ3	chr17:61896795-61905031:-	0.29	4.11	5.23E-5	Body mass index	
KIRP	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.5	8.53	1.13E-15	Eye color traits	
KIRP	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.5	8.58	8.06E-16	Eye color traits	
KIRP	cis	1	rs975459	chr6:151876909	C6orf97	chr6:151815175-151942327:+	0.55	4.86	2.0E-6	Bone mineral density (spine)	
KIRP	cis	1	rs9767077	chr6:150109615	NUP43	chr6:150045453-150067688:-	-0.33	-4.7	4.14E-6	Lung cancer	
KIRP	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.37	5.24	3.35E-7	Forced vital capacity	
KIRP	cis	1	rs9788767	chr15:24761453	PWRN1	chr15:24778839-24832924:+	0.3	4.03	7.41E-5	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
KIRP	cis	1	rs979455	chr5:150594802	ARSI	chr5:149675909-149682525:-	-0.35	-4.35	1.92E-5	Obesity-related traits	
KIRP	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.24	4.33	2.13E-5	Colorectal cancer	
KIRP	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.35	6.4	6.84E-10	Height	
KIRP	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.81E-5	Height	
KIRP	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.29	6.29	1.31E-9	Longevity	
KIRP	cis	1	rs9812791	chr3:49682311	RBM6	chr3:49977592-50137484:+	0.15	4.44	1.34E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9812791	chr3:49682311	UBA7	chr3:49842639-49851391:-	0.35	6.15	2.79E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.35	6.59	2.43E-10	Height	
KIRP	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.28	4.39	1.66E-5	Height	
KIRP	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.1	3.8E-9	Height	
KIRP	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.31	-4.7	4.15E-6	Height	
KIRP	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.24	-5.28	2.74E-7	Longevity	
KIRP	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.87	10.58	4.86E-22	Diastolic blood pressure	
KIRP	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.26	-5.62	4.75E-8	Longevity	
KIRP	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.93	13.28	3.36E-31	Diastolic blood pressure	
KIRP	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.35	6.4	6.84E-10	Height	
KIRP	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.28	4.37	1.81E-5	Height	
KIRP	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs9822268	chr3:49719729	DOCK3	chr3:50712672-51421628:+	-0.28	-4.25	2.94E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9822268	chr3:49719729	RBM6	chr3:49977592-50137484:+	0.16	4.55	8.21E-6	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9822268	chr3:49719729	UBA7	chr3:49842639-49851391:-	0.35	6.21	2.01E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.89	10.95	2.9E-23	Diastolic blood pressure	
KIRP	cis	1	rs9823546	chr3:49705512	RBM6	chr3:49977592-50137484:+	0.15	4.36	1.84E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9823546	chr3:49705512	UBA7	chr3:49842639-49851391:-	0.36	6.24	1.71E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.93	-13.64	1.87E-32	Diastolic blood pressure	
KIRP	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.97	14.01	9.87E-34	Diastolic blood pressure	
KIRP	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.27	-5.9	1.09E-8	Longevity	
KIRP	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.34	6.29	1.33E-9	Height	
KIRP	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.28	4.26	2.8E-5	Height	
KIRP	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.36	6.62	2.0E-10	Height	
KIRP	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.28	4.31	2.34E-5	Height	
KIRP	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.32	5.76	2.28E-8	Height	
KIRP	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.3	4.61	6.37E-6	Height	
KIRP	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.93	13.82	4.3E-33	Diastolic blood pressure	
KIRP	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.96	13.77	6.46E-33	Diastolic blood pressure	
KIRP	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.34	6.29	1.29E-9	Height	
KIRP	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.29	4.41	1.49E-5	Height	
KIRP	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.94	13.9	2.39E-33	Diastolic blood pressure	
KIRP	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.35	6.32	1.1E-9	Height	
KIRP	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.31	4.75	3.33E-6	Height	
KIRP	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs9836291	chr3:49697459	RBM6	chr3:49977592-50137484:+	0.15	4.35	1.96E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9836291	chr3:49697459	UBA7	chr3:49842639-49851391:-	0.36	6.62	2.0E-10	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.21	-4.02	7.65E-5	Multiple sclerosis (severity)	
KIRP	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.26	-5.67	3.69E-8	Longevity	
KIRP	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.31E-35	Diastolic blood pressure	
KIRP	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.31E-35	Diastolic blood pressure	
KIRP	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.94	13.89	2.54E-33	Diastolic blood pressure	
KIRP	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.32	5.72	2.91E-8	Height	
KIRP	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.3	4.58	7.19E-6	Height	
KIRP	cis	1	rs9842132	chr3:49427933	NCKIPSD	chr3:48711280-48723334:-	-0.32	-4.38	1.69E-5	Menarche (age at onset)	
KIRP	cis	1	rs9842132	chr3:49427933	P4HTM	chr3:49027341-49044579:+	-0.25	-4.32	2.21E-5	Menarche (age at onset)	
KIRP	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.41	-6.37	8.34E-10	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
KIRP	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.89	-11.67	1.18E-25	Diastolic blood pressure	
KIRP	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.96	-14.29	9.55E-35	Diastolic blood pressure	
KIRP	cis	1	rs9844598	chr3:56438859	SPATA12	chr3:57094469-57109460:+	0.23	3.98	9.01E-5	Night sleep phenotypes	
KIRP	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.93	13.21	5.79E-31	Diastolic blood pressure	
KIRP	cis	1	rs9847710	chr3:53062661	SFMBT1	chr3:52938628-53080070:-	-0.41	-6.64	1.79E-10	Ulcerative colitis	
KIRP	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.86	10.26	5.26E-21	Diastolic blood pressure	
KIRP	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.91	10.67	2.38E-22	Diastolic blood pressure	
KIRP	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.25	-5.41	1.38E-7	Longevity	
KIRP	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.36	6.62	2.0E-10	Height	
KIRP	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.28	4.31	2.34E-5	Height	
KIRP	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.33	6.07	4.5E-9	Height	
KIRP	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.3	4.6	6.65E-6	Height	
KIRP	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.94	13.67	1.53E-32	Diastolic blood pressure	
KIRP	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.36	6.61	2.11E-10	Height	
KIRP	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.31	4.73	3.68E-6	Height	
KIRP	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.9	10.69	2.06E-22	Diastolic blood pressure	
KIRP	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.93	13.81	4.9E-33	Diastolic blood pressure	
KIRP	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.93	13.28	3.36E-31	Diastolic blood pressure	
KIRP	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.93	13.28	3.36E-31	Diastolic blood pressure	
KIRP	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.92	13.69	1.27E-32	Diastolic blood pressure	
KIRP	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.31	5.54	7.33E-8	Height	
KIRP	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.3	4.57	7.56E-6	Height	
KIRP	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.93	13.79	5.54E-33	Diastolic blood pressure	
KIRP	cis	1	rs9858213	chr3:49731861	DOCK3	chr3:50712672-51421628:+	-0.31	-4.52	9.37E-6	Educational attainment	
KIRP	cis	1	rs9858213	chr3:49731861	RBM6	chr3:49977592-50137484:+	0.15	4.36	1.83E-5	Educational attainment	
KIRP	cis	1	rs9858213	chr3:49731861	UBA7	chr3:49842639-49851391:-	0.36	6.29	1.3E-9	Educational attainment	
KIRP	cis	1	rs9858542	chr3:49701983	RBM6	chr3:49977592-50137484:+	-0.15	-4.28	2.64E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9858542	chr3:49701983	UBA7	chr3:49842639-49851391:-	-0.35	-6.12	3.29E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9860055	chr3:49506900	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.17	4.07E-5	Menarche (age at onset)	
KIRP	cis	1	rs9860055	chr3:49506900	P4HTM	chr3:49027341-49044579:+	-0.24	-4.35	1.95E-5	Menarche (age at onset)	
KIRP	cis	1	rs9861998	chr3:124699246	HEG1	chr3:124684555-124774802:-	-0.22	-4.28	2.67E-5	Age-related hearing impairment (interaction)	
KIRP	cis	1	rs9862534	chr3:49598064	NCKIPSD	chr3:48711280-48723334:-	0.28	4.19	3.86E-5	Menarche (age at onset)	
KIRP	cis	1	rs9862534	chr3:49598064	P4HTM	chr3:49027341-49044579:+	0.24	4.52	9.25E-6	Menarche (age at onset)	
KIRP	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.95	13.68	1.31E-32	Diastolic blood pressure	
KIRP	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.91	10.98	2.31E-23	Diastolic blood pressure	
KIRP	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.32	5.74	2.63E-8	Height	
KIRP	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.28	4.24	3.12E-5	Height	
KIRP	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.25	-5.53	7.48E-8	Longevity	
KIRP	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.32	5.79	2.01E-8	Height	
KIRP	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.31	4.66	5.04E-6	Height	
KIRP	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.94	14.06	6.5E-34	Diastolic blood pressure	
KIRP	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.93	13.86	3.31E-33	Diastolic blood pressure	
KIRP	cis	1	rs9866430	chr3:51591265	HEMK1	chr3:50606583-50622419:+	0.24	4.25	2.93E-5	Melanoma	
KIRP	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.93	13.21	5.79E-31	Diastolic blood pressure	
KIRP	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.85	-11.28	2.27E-24	Diastolic blood pressure	
KIRP	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.93	13.91	2.18E-33	Diastolic blood pressure	
KIRP	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.93	13.21	5.79E-31	Diastolic blood pressure	
KIRP	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.96	13.75	7.58E-33	Diastolic blood pressure	
KIRP	cis	1	rs9869723	chr3:123954355	ADCY5	chr3:123003399-123167392:-	0.47	3.94	0.000104	PR interval in Tripanosoma cruzi seropositivity	
KIRP	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.35	6.57	2.64E-10	Height	
KIRP	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.29	4.5	1.03E-5	Height	
KIRP	cis	1	rs9871024	chr3:49554241	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.27	2.78E-5	Menarche (age at onset)	
KIRP	cis	1	rs9871024	chr3:49554241	P4HTM	chr3:49027341-49044579:+	-0.25	-4.48	1.13E-5	Menarche (age at onset)	
KIRP	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.32	5.76	2.28E-8	Height	
KIRP	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.3	4.61	6.37E-6	Height	
KIRP	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.85	10.68	2.25E-22	Diastolic blood pressure	
KIRP	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.89	10.95	2.9E-23	Diastolic blood pressure	
KIRP	cis	1	rs9874517	chr3:53128371	RFT1	chr3:53122503-53164470:-	0.37	4.02	7.74E-5	Immune reponse to smallpox (secreted IL-2)	
KIRP	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	0.94	13.5	5.88E-32	Diastolic blood pressure	
KIRP	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.9	10.69	2.06E-22	Diastolic blood pressure	
KIRP	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.94	13.82	4.41E-33	Diastolic blood pressure	
KIRP	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.97	7.75E-9	Height	
KIRP	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.26	-4.16	4.32E-5	Height	
KIRP	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.27	-5.86	1.34E-8	Longevity	
KIRP	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.95	-14.39	4.43E-35	Diastolic blood pressure	
KIRP	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.24	-5.21	3.74E-7	Longevity	
KIRP	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	0.94	13.5	5.88E-32	Diastolic blood pressure	
KIRP	cis	1	rs9882740	chr3:49702484	RBM6	chr3:49977592-50137484:+	0.15	4.36	1.84E-5	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9882740	chr3:49702484	UBA7	chr3:49842639-49851391:-	0.36	6.24	1.71E-9	Crohn's disease;Ulcerative colitis	
KIRP	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.34	6.19	2.34E-9	Height	
KIRP	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.29	4.49	1.07E-5	Height	
KIRP	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.25	-5.42	1.37E-7	Longevity	
KIRP	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.26	-5.62	4.78E-8	Longevity	
KIRP	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.35	6.58	2.46E-10	Height	
KIRP	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.28	4.36	1.86E-5	Height	
KIRP	cis	1	rs9885413	chr5:110176128	TMEM232	chr5:109624934-110062381:-	0.35	3.87	0.000135	Mortality in heart failure	
KIRP	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.25	-4.29	2.53E-5	Fibrinogen levels	
KIRP	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.25	-4.29	2.53E-5	Fibrinogen levels	
KIRP	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.32	4.53	9.09E-6	Body mass index	
KIRP	cis	1	rs9891119	chr17:40507980	ARL4D	chr17:41476353-41478503:+	0.25	3.93	0.000108	Crohn's disease;Multiple sclerosis	
KIRP	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.49	8.13	1.7E-14	Eye color traits	
KIRP	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.28	4	8.15E-5	Body mass index	
KIRP	cis	1	rs9897982	chr17:65879592	LOC440461	chr17:66194801-66196436:+	0.3	4.09	5.66E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs9899491	chr17:61934384	FTSJ3	chr17:61896795-61905031:-	0.33	4.77	3.07E-6	Body mass index	
KIRP	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs9899788	chr17:61756384	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs9901112	chr17:61730617	FTSJ3	chr17:61896795-61905031:-	0.3	4.21	3.57E-5	Body mass index	
KIRP	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs9901507	chr17:61765524	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs9903204	chr17:40288062	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs9903897	chr17:61716705	FTSJ3	chr17:61896795-61905031:-	0.28	3.92	0.000112	Body mass index	
KIRP	cis	1	rs9903897	chr17:61716705	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.32	2.23E-5	Body mass index	
KIRP	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs9903903	chr17:61762044	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.29	4.03	7.25E-5	Body mass index	
KIRP	cis	1	rs9908044	chr17:61747032	TCAM1P	chr17:61934376-61941738:+	-0.34	-4.42	1.46E-5	Body mass index	
KIRP	cis	1	rs9908102	chr17:12896553	ELAC2	chr17:12895703-12921359:-	0.26	4.94	1.42E-6	Schizophrenia	
KIRP	cis	1	rs9909940	chr17:80689036	FN3K	chr17:80693452-80709073:+	-0.22	-4.49	1.06E-5	Glycated hemoglobin levels	
KIRP	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.45	-5.87	1.32E-8	Glycated hemoglobin levels	
KIRP	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.3	4.25	2.9E-5	Body mass index	
KIRP	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.53	-7.22	5.38E-12	Subjective well-being	
KIRP	cis	1	rs9909	chr11:47799775	PSMC3	chr11:47440320-47448024:-	0.19	3.89	0.000125	Subjective well-being	
KIRP	cis	1	rs9912084	chr17:65868035	LOC440461	chr17:66194801-66196436:+	0.3	4.04	6.92E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs9912088	chr17:40288278	DHX58	chr17:40253422-40264751:-	-0.25	-4.32	2.23E-5	Fibrinogen levels	
KIRP	cis	1	rs9912770	chr17:65868233	LOC440461	chr17:66194801-66196436:+	0.3	4.04	6.92E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.55E-5	Body mass index	
KIRP	cis	1	rs9913471	chr17:65874495	LOC440461	chr17:66194801-66196436:+	0.3	3.99	8.43E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs9915108	chr17:65874463	LOC440461	chr17:66194801-66196436:+	0.3	3.99	8.43E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
KIRP	cis	1	rs9915255	chr17:40284191	DHX58	chr17:40253422-40264751:-	-0.27	-4.63	5.62E-6	Fibrinogen levels	
KIRP	cis	1	rs9919599	chr11:116745484	PCSK7	chr11:117075789-117102811:-	-0.38	-3.85	0.000148	Protein quantitative trait loci	
KIRP	cis	1	rs9923145	chr16:74686166	MLKL	chr16:74705753-74734789:-	0.33	5.51	8.46E-8	Testicular germ cell tumor	
KIRP	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.3	4.29	2.55E-5	Body mass index	
KIRP	cis	1	rs9925964	chr16:31129895	MYST1	chr16:31128985-31142713:+	-0.22	-4.39	1.66E-5	Body mass index	
KIRP	cis	1	rs9929496	chr16:74668473	MLKL	chr16:74705753-74734789:-	0.31	5.16	4.76E-7	Testicular germ cell tumor	
KIRP	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.22	-3.98	8.75E-5	Testicular germ cell tumor	
KIRP	cis	1	rs9931225	chr16:74699293	MLKL	chr16:74705753-74734789:-	0.32	5.41	1.41E-7	Testicular germ cell tumor	
KIRP	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.21	-3.84	0.000156	Testicular germ cell tumor	
KIRP	cis	1	rs9934609	chr16:83638578	SLC38A8	chr16:84043389-84075762:-	0.26	4.71	3.95E-6	Height	
KIRP	cis	1	rs9934700	chr16:83638734	SLC38A8	chr16:84043389-84075762:-	0.27	5.01	1.02E-6	Height	
KIRP	cis	1	rs9938630	chr16:29837108	LOC440356	chr16:29875004-29879374:+	-0.31	-4.08	6.06E-5	Multiple sclerosis	
KIRP	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.22	1.91E-9	Height	
KIRP	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.31	-4.71	4.08E-6	Height	
KIRP	cis	1	rs9983229	chr21:30137674	N6AMT1	chr21:30244513-30257693:-	0.31	3.86	0.000143	Cognitive test performance	
KIRP	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.31	-5.79	1.99E-8	Height	
KIRP	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.28	-4.46	1.24E-5	Height	
KIRP	cis	1	rs9988450	chr1:62924448	DOCK7	chr1:62920398-63153969:-	-0.2	-4.92	1.54E-6	Triglycerides	
KIRP	cis	1	rs9989419	chr16:56985139	CETP	chr16:56995835-57017756:+	-0.21	-4.48	1.12E-5	HDL cholesterol;Lipid traits	
KIRP	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.34	6.18	2.45E-9	Height	
KIRP	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.29	4.51	9.84E-6	Height	
KIRP	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.32	-5.82	1.68E-8	Height	
KIRP	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.28	-4.23	3.26E-5	Height	
KIRP	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.44	-6.45	5.34E-10	Longevity	
KIRP	cis	1	rs9997288	chr4:56347227	SRD5A3	chr4:56212409-56237866:+	0.28	4.39	1.67E-5	Personality dimensions	
KIRP	cis	1	rs9998146	chr4:56397977	SRD5A3	chr4:56212409-56237866:+	-0.3	-4.74	3.55E-6	Personality dimensions	
KIRP	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.35	-6.85	5.1E-11	Migraine without aura	
KIRP	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.53	7.88	8.5E-14	Educational attainment	
KIRP	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.53	7.98	4.55E-14	Educational attainment	
KIRP	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.52	7.7	2.76E-13	Educational attainment	
KIRP	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs1107364	chr3:125904263	ISPD	chr7:16127152-16460947:-	0.27	6.47	4.74E-10	Metabolite levels	
KIRP	trans	1	rs1107366	chr3:125904165	ISPD	chr7:16127152-16460947:-	0.27	6.43	6.06E-10	Metabolite levels	
KIRP	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.52	7.8	1.46E-13	Educational attainment	
KIRP	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.48	-6.98	2.42E-11	Educational attainment	
KIRP	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.53	7.88	8.52E-14	Educational attainment	
KIRP	trans	1	rs16867818	chr4:11089058	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.02	1.86E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs16877805	chr4:11088505	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.02	1.86E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs16878009	chr4:11097904	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.02	1.86E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs16878016	chr4:11098036	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.12	1.01E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs16878038	chr4:11099194	CSAG2	chrX:151922445-151928737:+;chrX	0.35	7.29	3.63E-12	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.38E-14	Educational attainment	
KIRP	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.52	7.7	2.76E-13	Educational attainment	
KIRP	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.52	7.7	2.76E-13	Educational attainment	
KIRP	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.57	-6.34	1.0E-9	Total ventricular volume (Alzheimer's disease interaction)	
KIRP	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.53	7.97	4.62E-14	Educational attainment	
KIRP	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs3810265	chr19:50223266	TSPY4	chrY:9195406-9198201:+;chrY	-0.19	-6.45	5.41E-10	Panic disorder	
KIRP	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.45E-14	Educational attainment	
KIRP	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.54	8.03	3.1E-14	Educational attainment	
KIRP	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.37E-14	Educational attainment	
KIRP	trans	1	rs4889910	chr17:77839795	POU2F1	chr1:167190143-167385342:+	0.43	6.48	4.44E-10	Electroencephalogram traits	
KIRP	trans	1	rs61872854	chr10:115055671	TSPY4	chrY:9195406-9198201:+;chrY	0.18	6.33	1.04E-9	Ischemic stroke	
KIRP	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.53	7.88	8.5E-14	Educational attainment	
KIRP	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.53	7.88	8.52E-14	Educational attainment	
KIRP	trans	1	rs66638636	chr4:11088255	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.02	1.86E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs67661899	chr4:11082630	CSAG2	chrX:151922445-151928737:+;chrX	0.31	6.54	3.1E-10	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs6822701	chr4:11085160	CSAG2	chrX:151922445-151928737:+;chrX	0.35	7.29	3.51E-12	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs6846943	chr4:11085532	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.02	1.86E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.32	6.4	7.16E-10	Migraine without aura	
KIRP	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.53	7.81	1.32E-13	Educational attainment	
KIRP	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.45E-14	Educational attainment	
KIRP	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.55	-8.32	4.61E-15	Educational attainment	
KIRP	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.52	7.64	3.89E-13	Educational attainment	
KIRP	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.45E-14	Educational attainment	
KIRP	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.52	7.64	3.89E-13	Educational attainment	
KIRP	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.53	7.97	4.62E-14	Educational attainment	
KIRP	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.52	7.64	3.89E-13	Educational attainment	
KIRP	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.53	7.88	8.49E-14	Educational attainment	
KIRP	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.53	7.88	8.49E-14	Educational attainment	
KIRP	trans	1	rs7081732	chr10:77430441	GAGE13	chrX:49188094-49323261:+	0.24	6.74	9.77E-11	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	
KIRP	trans	1	rs7081732	chr10:77430441	GAGE2B	chrX:49216634-49242997:+	0.25	6.95	2.84E-11	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	
KIRP	trans	1	rs7081732	chr10:77430441	GAGE2E	chrX:49197607-49204921:+	0.25	7	2.14E-11	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	
KIRP	trans	1	rs73223117	chr4:11093897	CSAG2	chrX:151922445-151928737:+;chrX	0.38	7.59	5.34E-13	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs73223119	chr4:11096829	CSAG2	chrX:151922445-151928737:+;chrX	0.34	7.02	1.86E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs7655566	chr4:11087495	CSAG2	chrX:151922445-151928737:+;chrX	0.33	6.91	3.61E-11	Attention function in attention deficit hyperactive disorder	
KIRP	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.53	7.93	6.13E-14	Educational attainment	
KIRP	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.53	-7.99	4.3E-14	Educational attainment	
KIRP	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.49	7.23	5.11E-12	Educational attainment	
KIRP	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.52	7.76	1.84E-13	Educational attainment	
KIRP	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.53	7.97	4.62E-14	Educational attainment	
KIRP	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.52	7.59	5.55E-13	Educational attainment	
KIRP	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.55	-8.09	2.13E-14	Educational attainment	
KIRP	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.54	8.02	3.36E-14	Educational attainment	
KIRP	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.55	8.13	1.7E-14	Educational attainment	
KIRP	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.53	7.97	4.62E-14	Educational attainment	
KIRP	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.51	-7.53	7.89E-13	Educational attainment	
KIRP	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.52	7.7	2.76E-13	Educational attainment	
KIRP	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.52	7.7	2.76E-13	Educational attainment	
KIRP	trans	1	rs9826454	chr3:135953220	EFCAB4B	chr12:3716318-3862366:-	0.48	6.3	1.26E-9	Body mass index;Height	
KIRP	trans	1	rs9873704	chr3:125901902	ISPD	chr7:16127152-16460947:-	0.26	6.27	1.49E-9	Metabolite levels	
KIRP	trans	1	rs9874508	chr3:125902417	ISPD	chr7:16127152-16460947:-	-0.26	-6.31	1.2E-9	Metabolite levels	
KIRP	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.53	7.97	4.62E-14	Educational attainment	
